Name,Protein name,Orientation,Length
Q92508,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),i5-26o27-44i62-80o119-139i194-214o218-238i248-268o309-329i415-439o440-456i462-480o511-530i575-594o597-617i628-647o680-696i802-827o830-845i857-872o926-946i987-1007o1013-1027i1037-1057o1097-1117i1157-1177o1182-1201i1217-1239o1283-1297i1683-1701o1705-1720i1729-1749o1786-1795i1960-1979o2000-2017i2031-2051o2061-2081i2170-2194o2432-2459i,2521
Q9H5I5,Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B),i5-26o27-44i59-79o120-139i218-238o241-259i266-289o336-352i495-515o518-533i539-560o583-597i678-700o704-719i732-752o787-805i933-955o958-972i982-1002o1061-1074i1114-1138o1139-1154i1169-1187o1227-1236i1291-1310o1313-1330i1348-1367o1412-1424i1924-1939o1940-1955i1964-1984o2020-2029i2189-2211o2229-2246i2260-2278o2290-2305i2406-2426o2664-2685i,2752
O00555,"Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I) (BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)",i102-118o139-159i169-179o180-189i226-244o338-358i488-506o517-537i553-570o575-584i613-632o687-711i1244-1262o1278-1302i1311-1330o1338-1347i1375-1395o1488-1508i1567-1584o1599-1619i1631-1649o1653-1662i1693-1710o1788-1809i,2506
O43497,Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1),i82-101o119-139i157-168o169-178i211-228o372-394i744-764o777-792i813-823o827-836i867-887o940-960i1277-1295o1308-1330i1346-1366o1370-1379i1412-1432o1514-1533i1613-1630o1645-1665i1680-1695o1701-1710i1746-1762o1829-1847i,2377
O95180,Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2),i101-121o135-150i151-160o176-189i233-253o396-411i794-814o824-845i859-871o872-883i917-937o992-1011i1299-1313o1326-1342i1343-1352o1369-1384i1433-1452o1534-1549i1619-1636o1651-1669i1686-1701o1711-1720i1749-1766o1838-1858i,2353
P35499,Sodium channel protein type 4 subunit alpha (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4),i132-150o164-177i195-205o206-218i253-273o424-444i579-597o612-632i644-655o656-665i703-719o780-797i1032-1043o1046-1055i1071-1086o1102-1117i1160-1179o1270-1290i1354-1372o1384-1404i1421-1437o1441-1450i1483-1501o1573-1597i,1836
Q00975,"Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III) (BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2)",i99-115o136-156i166-176o177-186i220-240o334-354i484-502o516-536i549-566o571-580i609-628o687-707i1151-1169o1185-1197i1198-1209o1221-1236i1281-1301o1394-1417i1472-1490o1506-1525i1540-1555o1561-1570i1599-1618o1685-1707i,2339
Q01118,Sodium channel protein type 7 subunit alpha (Putative voltage-gated sodium channel subunit alpha Nax) (Sodium channel protein cardiac and skeletal muscle subunit alpha) (Sodium channel protein type VII subunit alpha),i120-135o151-161i182-194o199-208i238-258o371-389i506-522o539-559i571-583o584-595i630-646o706-721i935-953o971-982i983-992o1005-1017i1059-1079o1171-1188i1252-1270o1281-1300i1316-1331o1344-1354i1380-1400o1471-1492i,1682
Q01668,"Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)",i127-147o166-181i197-215o233-242i271-290o384-404i525-545o557-577i590-605o609-618i650-669o728-748i887-905o925-945i957-973o974-983i1015-1035o1130-1150i1209-1225o1239-1259i1275-1286o1313-1323i1347-1369o1446-1463i,2161
Q13698,"Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1)",i52-72o91-106i121-140o161-170i196-215o314-332i433-452o466-486i502-514o518-527i559-578o635-659i801-818o831-851i868-884o885-895i921-945o1043-1065i1123-1138o1152-1172i1187-1200o1258-1268i1269-1286o1360-1380i,1873
Q13936,"Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2)",i126-145o162-173i174-183o194-213i268-290o382-402i525-544o558-578i593-606o610-619i654-670o727-747i901-919o932-950i958-973o994-1014i1049-1069o1164-1184i1243-1258o1271-1291i1308-1320o1336-1348i1408-1427o1504-1524i,2221
Q14524,Sodium channel protein type 5 subunit alpha (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5) (hH1),i132-149o159-177i195-206o207-218i253-273o388-408i723-736o751-761i762-771o783-798i839-858o916-934i1206-1224o1242-1253i1254-1263o1276-1291i1334-1351o1448-1465i1529-1547o1559-1577i1592-1602o1603-1612i1656-1676o1746-1771i,2016
Q15858,Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7),i127-145o155-172i190-200o201-213i248-268o377-397i745-763o778-798i810-822o823-834i866-885o945-963i1193-1204o1207-1216i1232-1247o1263-1278i1321-1338o1431-1453i1516-1534o1546-1557i1558-1567o1580-1595i1643-1663o1735-1755i,1988
Q15878,"Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II) (BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3)",i91-109o130-150i159-170o171-180i218-238o329-349i477-497o507-527i543-560o565-574i603-622o681-701i1154-1172o1185-1196i1197-1206o1221-1240i1288-1308o1401-1421i1480-1497o1512-1532i1547-1559o1569-1578i1607-1626o1701-1722i,2313
Q8IZF0,Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1),i40-56o72-88i109-127o141-151i181-201o300-320i385-405o418-438i453-466o474-483i509-525o574-594i887-905o920-938i953-971o982-991i1018-1038o1134-1152i1215-1229o1241-1261i1278-1293o1299-1312i1336-1356o1423-1443i,1738
Q99250,Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2),i130-148o162-175i193-209o210-219i251-271o402-420i760-778o790-800i801-811o825-843i881-900o961-978i1209-1227o1245-1256i1257-1266o1279-1294i1337-1354o1449-1469i1532-1551o1562-1573i1574-1583o1596-1612i1659-1679o1751-1771i,2005
Q9NY46,Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3),i129-147o161-174i192-202o203-215i250-270o401-419i761-779o791-812i826-840o841-850i882-901o961-979i1207-1225o1243-1254i1255-1264o1277-1292i1335-1352o1446-1464i1527-1545o1561-1578i1590-1600o1601-1610i1654-1674o1746-1766i,2000
Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3),i80-100o114-129i130-139o155-168i209-231o375-392i641-659o671-686i687-696o706-720i764-784o840-858i1171-1189o1202-1218i1219-1228o1245-1260i1306-1322o1410-1425i1489-1506o1521-1541i1556-1568o1581-1590i1619-1638o1708-1728i,2223
Q9UQD0,Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6),i133-151o165-178i196-206o207-219i254-274o388-406i754-772o784-805i819-836o837-846i875-894o954-972i1199-1217o1235-1246i1247-1257o1269-1284i1327-1344o1445-1460i1523-1541o1553-1567i1586-1596o1597-1606i1650-1670o1741-1765i,1980
O60840,Voltage-dependent L-type calcium channel subunit alpha-1F (Voltage-gated calcium channel subunit alpha Cav1.4),i96-113o132-147i168-180o199-208i237-256o350-370i530-549o563-583i596-613o620-633i655-675o733-754i872-890o903-930i939-958o959-968i1000-1020o1115-1135i1194-1209o1224-1244i1259-1272o1290-1299i1327-1346o1416-1440i,1977
P35498,Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1),i129-147o161-174i192-208o209-218i250-270o400-418i769-787o799-811i812-822o837-852i890-909o970-987i1219-1237o1258-1273i1347-1364o1460-1480i1542-1560o1572-1583i1584-1593o1606-1622i1669-1689o1761-1781i,2009
Q9UI33,Sodium channel protein type 11 subunit alpha (Peripheral nerve sodium channel 5) (PN5) (Sensory neuron sodium channel 2) (Sodium channel protein type XI subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.9) (hNaN),i131-147o166-179i196-206o207-216i256-276o377-394i578-596o608-620i621-631o643-661i703-718o788-806i1057-1075o1092-1104i1105-1114o1127-1143i1175-1195o1287-1303i1367-1385o1401-1417i1498-1518o1579-1599i,1791
Q9Y5Y9,Sodium channel protein type 10 subunit alpha (Peripheral nerve sodium channel 3) (PN3) (hPN3) (Sodium channel protein type X subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.8),i131-148o156-173i191-201o202-211i249-269o374-392i666-684o699-719i788-805o868-886i1153-1172o1185-1200i1201-1210o1223-1237i1281-1298o1396-1413i1477-1495o1507-1527i1544-1560o1569-1578i1604-1626o1697-1717i,1956
O96008,Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5),o101-129-160-186-215-246-270-297-322-352,361
Q15849,"Urea transporter 2 (Solute carrier family 14 member 2) (Urea transporter, kidney)",i127-147o150-170i184-195o205-220i235-250o300-311i315-334o345-361i370-386o401-413i591-609o612-632i646-657o669-683i697-712o762-773i777-796o803-823i832-848o862-875i,920
P21796,Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM),o56-81-112-136-166-190-218-243-274,283
Q969M1,Mitochondrial import receptor subunit TOM40B (Protein TOMM40-like),o62-107-133-162-193-217-244-269-299,308
O15438,ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3),o35-55i72-96o103-123i136-156o171-190i311-329o350-370i423-447o451-471i534-555o568-593i966-986o1020-1040i1086-1107o1108-1128i1197-1217o1223-1243i,1527
O95255,ATP-binding cassette sub-family C member 6 (EC 7.6.2.-) (EC 7.6.2.3) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E) (Multidrug resistance-associated protein 6),o35-55i71-92o104-124i134-153o168-186i309-329o349-366i423-448o451-471i534-553o567-592i942-962o992-1012i1063-1084o1085-1102i1172-1192o1199-1219i,1503
P33527,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),o37-57i75-94o106-126i136-157o173-191i320-340o365-385i440-460o465-485i547-567o582-607i972-992o1023-1043i1090-1111o1112-1132i1201-1221o1227-1247i,1531
Q09428,ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1),o30-50i75-95o106-122i135-155o169-189i299-319o359-373i428-455o460-479i542-561o582-597i1008-1028o1069-1085i1139-1160o1161-1181i1251-1271o1277-1297i,1581
Q4G0N8,Sodium/hydrogen exchanger 10 (Na(+)/H(+) exchanger 10) (NHE-10) (Solute carrier family 9 member 10) (Solute carrier family 9 member C1) (Sperm-specific Na(+)/H(+) exchanger) (sNHE),o15-33i39-59o78-93i104-129o139-154i167-187o208-234i242-262o266-277i294-314o327-352i361-381o400-419i613-633o644-664i675-695o707-717i,1177
Q5T3U5,ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7),o29-50i68-89o102-122i133-153o172-188i286-306o323-343i394-417o422-445i505-528o537-562i883-904o978-991i1042-1063o1064-1077i1153-1173o1181-1205i,1492
Q92887,ATP-binding cassette sub-family C member 2 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multidrug resistance protein) (Canalicular multispecific organic anion transporter 1) (Multidrug resistance-associated protein 2),o30-50i66-88o102-117i130-151o166-184i318-338o365-378i436-456o462-482i545-565o582-600i976-996o1028-1049i1102-1120o1121-1140i1211-1229o1235-1255i,1545
Q9UPQ8,Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15),i20-39o44-61i81-95o110-130i140-155o164-185i192-209o225-248i257-275o298-318i339-354o358-376i403-423o438-458i477-493o502-516i525-537o,538
Q5TAH2,Sodium/hydrogen exchanger 11 (Na(+)/H(+) exchanger 11) (NHE-11) (Solute carrier family 9 member 11) (Solute carrier family 9 member C2),o29-49i52-72o90-105i117-142o153-168i181-199o217-239i251-271o276-291i302-322o335-360i371-389o405-425i609-629o639-661i674-692o701-717i,1124
Q7Z3F1,Lysosomal cholesterol signaling protein (LYCHOS) (G-protein coupled receptor PGR22),o42-59i72-92o103-124i139-150o169-187i211-233o244-264i276-297o316-331i346-366o378-403i413-435o444-466i481-501o520-540i659-681o692-713i,870
O60706,ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2),o28-48i73-93o104-120i133-153o167-187i297-317o355-369i434-451o456-475i538-557o574-592i990-1010o1041-1063i1114-1132o1133-1153i1223-1241o1245-1265i,1549
O95427,GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N),i20o441-463i483-501o508-523i544-562o567-582i593-608o619-639i650-670o683-701i709-724o728-746i787-802o825-846i860-879o895-912i,931
Q5H8A4,GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G),i6-24o433-453i470-490o509-529i550-567o579-594i652-671o695-712i722-738o761-778i792-809o813-828i841-856o881-903i921-941o959-975i,983
Q8TAD4,Proton-coupled zinc antiporter SLC30A5 (Solute carrier family 30 member 5) (Zinc transporter 5) (ZnT-5) (ZnT-like transporter 1) (hZTL1),i33-48o62-77i104-113o121-136i152-166o207-219i240-256o271-288i307-320o346-362i419-439o445-465i486-506o525-540i592-613o620-641i,765
Q8TEQ8,GPI ethanolamine phosphate transferase 3 (EC 2.-.-.-) (Phosphatidylinositol-glycan biosynthesis class O protein) (PIG-O),i6-28o451-468i482-502o508-527i547-561o572-588i621-638o668-688i706-720o746-760i831-850o855-874i891-904o934-960i1014-1034o1048-1070i,1089
Q9BVK2,"Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)",i13-29o104-121i142-157o168-178i186-200o201-211i238-258o285-299i334-344o345-354i361-378o385-395i402-422o431-445i458-478o490-510i,526
Q9Y512,Sorting and assembly machinery component 50 homolog (Transformation-related gene 3 protein) (TRG-3),o142-171-209-256-296-366-424-460,469
Q96MT1,RING finger protein 145 (EC 2.3.2.27),i53-72o77-97i123-141o146-159i160-171o174-187i201-221o229-244i275-285o286-295i315-326o340-354i380-400o412-432i449-459o460-474i,663
Q9H330,Transmembrane protein 245 (Protein CG-2),i57-77o84-94i149-166o192-207i219-233o241-253i354-370o378-387i460-480o651-667i706-728o736-755i756-768o774-794i805-819o820-840i,879
Q13183,Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter),i14-31o39-49i56-70o87-98i123-139o142-151i227-237o267-287i330-345o373-385i421-432o457-471i474-484o498-518i539-556o,592
Q86YT5,Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5),i14-31o39-49i53-70o87-98i124-139o143-152i214-224o254-274i314-332o357-370i410-421o446-460i466-476o488-506i525-545o,568
Q8WWT9,Na(+)/dicarboxylate cotransporter 3 (NaDC-3) (hNaDC3) (Na(+)-coupled carboxylate transporter 3) (NaC3) (Sodium-dependent high-affinity dicarboxylate transporter 2) (Solute carrier family 13 member 3) (SLC13A3),i17-34o42-52i59-72o91-100i127-142o145-154i234-250o279-301i343-358o379-392i429-440o465-480i481-492o506-526i547-567o,602
Q96PB1,N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT),i24-39o314-333i364-384o402-417i434-449o460-480i490-507o516-534i551-571o605-620i639-659o674-685i703-720o735-756i775-790o,797
Q9BZW2,Solute carrier family 13 member 1 (Renal sodium/sulfate cotransporter) (Na(+)/sulfate cotransporter) (hNaSi-1),i13-30o41-50i57-69o87-96i122-138o141-150i246-256o284-308i348-363o388-399i435-447o471-486i487-497o523-532i553-573o,595
Q9UKG4,Solute carrier family 13 member 4 (Na(+)/sulfate cotransporter SUT-1) (NaS2),i13-29o40-50i55-69o86-96i122-138o141-150i268-285o313-333i377-391o416-427i466-477o502-517i518-529o554-563i581-601o,626
A0PJK1,Sodium/mannose cotransporter SLC5A10 (Sodium/glucose cotransporter 5) (Na(+)/glucose cotransporter 5) (Solute carrier family 5 member 10),o21-40i64-79o91-111i139-159o169-189i192-212o261-283i302-321o368-388i410-431o443-457i472-492o514-534i576-595o,596
A6NKB5,Pecanex-like protein 2 (Pecanex homolog protein 2),i36-53o57-77i841-861o868-880i909-925o952-972i998-1018o1032-1046i1099-1119o1127-1140i1193-1206o1220-1231i1248-1257o1271-1280i,2137
O43511,Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4),i88-108o117-130i144-153o188-208i219-239o264-285i300-317o349-367i385-395o396-405i422-442o445-463i477-493o494-514i,780
O94911,ABC-type organic anion transporter ABCA8 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 8),i30-48o223-238i267-296o300-320i329-349o398-418i862-882o1024-1033i1070-1090o1100-1123i1136-1154o1161-1171i1172-1181o1199-1217i,1621
P02730,Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233),i405-425o440-456i459-471o487-507i523-541o570-588i604-624o661-687i703-713o714-729i761-782o783-803i830-850o858-869i,911
P03905,NADH-ubiquinone oxidoreductase chain 4 (EC 7.1.1.2) (NADH dehydrogenase subunit 4),o17i27-42o65-79i94-110o115-133i148-165o196-205i232-241o261-277i285-303o312-327i351-371o391-411i436-449o,459
P04920,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2),i709-720o740-759i762-774o789-810i826-847o901-918i934-954o991-1010i1036-1047o1048-1057i1091-1110o1113-1133i1168-1180o1185-1199i,1241
P13866,Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1),o29-49i70-87o99-119i145-165o178-198i201-223o274-295i314-334o381-401i424-444o456-470i486-506o527-547i643-663o,664
P30825,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),i38-55o66-88i108-136o166-183i188-210o255-269i287-311o338-358i385-403o408-429i495-516o527-547i560-579o585-605i,629
P31639,Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2),o25-45i69-84o96-116i142-162o174-194i198-220o274-296i315-334o381-401i424-444o456-470i485-505o527-547i652-671o,672
P40879,Chloride anion exchanger (Down-regulated in adenoma) (Protein DRA) (Solute carrier family 26 member 3),i77-94o106-119i129-138o176-196i209-229o259-279i290-306o340-360i375-385o386-395i412-432o435-455i470-483o484-501i,764
P48751,Anion exchange protein 3 (AE 3) (Anion exchanger 3) (CAE3/BAE3) (Cardiac/brain band 3-like protein) (Neuronal band 3-like protein) (Solute carrier family 4 member 3),i709-720o743-759i762-773o794-811i826-840o892-910i926-946o985-1002i1025-1035o1036-1051i1083-1102o1105-1125i1155-1172o1177-1187i,1232
P52569,Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),i40-57o68-90i110-138o167-184i187-211o257-271i289-313o339-359i387-408o409-432i496-516o525-545i558-577o583-603i,658
P53794,Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3),o9-29i48-68o80-100i126-146o158-178i185-205o259-280i299-319o366-386i409-429o444-455i471-491o511-532i696-716o,718
P58743,Prestin (Solute carrier family 26 member 5),i84-101o109-126i132-149o176-196i209-229o258-278i290-309o338-358i375-395o412-433i434-453o467-478i479-490o491-501i,744
Q04671,P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog),i177-197o331-347i354-370o388-398i422-437o438-452i467-485o508-527i627-639o652-663i679-696o722-744i768-787o806-830i,838
Q13423,"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)",i476-493o501-521i527-546o558-578i596-616o622-642i646-666o672-691i702-722o740-760i778-797o801-819i833-853o857-879i,1086
Q14728,Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein),i24-35o36-45i86-97o98-107i119-136o141-161i177-198o202-222i275-295o306-326i336-356o361-381i403-422o426-442i,455
Q2M3M2,Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (hSGLT4) (Solute carrier family 5 member 9),o38-59i81-96o108-128i156-178o187-207i210-232o278-299i320-338o386-402i428-448o460-474i490-510o530-548i661-680o,681
Q2Y0W8,Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3),i479-496o519-528i564-574o575-586i599-610o694-708i728-748o780-799i825-836o837-846i882-899o902-914i952-969o976-988i,1093
Q4ZJI4,"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)",i63-85o95-118i119-139o155-172i182-206o214-230i260-270o287-304i320-334o344-354i375-384o400-420i431-448o470-490i,515
Q6U841,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),i509-529o542-566i595-610o611-620i627-645o725-739i759-779o812-830i856-870o871-880i911-931o932-950i980-1000o1006-1019i,1118
Q7LBE3,Solute carrier family 26 member 9 (Anion transporter/exchanger protein 9),i75-92o104-119i124-136o172-195i203-223o253-273i284-301o332-352i369-389o406-431i432-446o463-477i478-489o490-499i,791
Q86UD5,Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),i87-105o115-135i143-156o176-190i202-227o235-250i271-296o300-327i340-357o362-378i388-408o418-440i451-468o491-511i,537
Q8NBS3,Solute carrier family 4 member 11 (Sodium borate cotransporter 1) (NaBC1),i364-377o394-411i412-426o443-463i477-488o558-575i591-608o639-659i681-691o692-705i740-760o766-780i813-832o840-856i,875
Q8TBB6,Probable cationic amino acid transporter (Solute carrier family 7 member 14),i59-79o87-110i130-154o190-207i212-236o254-268i288-310o336-358i384-405o406-428i565-585o596-616i632-648o654-674i,771
Q96AA3,Protein RFT1 homolog,i17-36o43-62i85-105o120-140i153-174o180-202i246-270o276-296i335-355o371-391i405-425o428-450i469-489o499-519i,541
Q8WU17,E3 ubiquitin-protein ligase RNF139 (EC 2.3.2.27) (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein),i51-71o79-99i124-134o135-144i154-167o177-196i237-257o289-309i325-340o356-371i390-410o421-441i470-489o495-509i,664
Q8WWX8,Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11),o29-48i72-87o103-118i146-166o180-195i205-220o272-287i310-326o376-396i419-439o448-468i480-500o522-539i651-671o,675
Q8WWZ7,Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5),i32-52o220-240i264-290o297-317i328-348o396-416i862-882o1023-1032i1070-1091o1103-1123i1139-1157o1168-1178i1179-1189o1207-1225i,1642
Q8WY07,Cationic amino acid transporter 3 (CAT-3) (CAT3) (Cationic amino acid transporter y+) (Solute carrier family 7 member 3),i38-55o66-88i108-132o166-183i186-210o253-267i287-309o335-356i383-401o406-428i476-498o508-528i541-560o566-586i,619
Q9BY07,Electrogenic sodium bicarbonate cotransporter 4 (NBCe2) (Solute carrier family 4 member 5),i522-542o554-570i575-587o605-629i639-657o743-761i777-793o833-848i874-888o889-898i929-948o951-971i1017-1034o1040-1060i,1137
Q9NY91,Probable glucose sensor protein SLC5A4 (Solute carrier family 5 member 4),o29-49i70-87o99-119i145-169o178-198i201-223o276-296i314-334o381-401i423-444o459-470i485-506o527-547i638-658o,659
Q9UGH3,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2),i110-125o138-158i164-180o217-234i242-260o270-287i313-333o380-396i418-432o433-442i462-482o485-503i517-534o549-568i,650
Q9UHI7,Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3),i46-66o80-100i104-124o158-175i183-201o211-228i251-274o321-337i359-374o375-384i403-423o427-444i459-472o491-511i,598
Q9Y672,"Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)",i6-21o114-130i144-159o169-181i187-198o199-208i230-250o298-318i325-343o348-358i364-382o388-403i441-456o469-489i,507
Q9Y6M7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),i609-626o644-658i694-704o705-716i726-740o824-842i858-878o910-929i955-969o970-979i1010-1029o1032-1046i1082-1099o1106-1118i,1214
Q9Y6R1,Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1),i469-489o501-516i517-526o553-577i588-605o689-709i730-749o777-787i788-797o824-837i838-847o881-898i899-914o965-985i,1079
Q96RV3,Pecanex-like protein 1 (Pecanex homolog protein 1),i33-53o58-74i1003-1025o1032-1049i1073-1088o1116-1140i1163-1183o1194-1210i1266-1279o1294-1305i1361-1371o1387-1398i1413-1422o1433-1442i,2341
Q9H6A9,Pecanex-like protein 3 (Pecanex homolog protein 3),i33-53o57-77i790-812o819-831i862-876o903-923i951-972o983-997i1053-1073o1078-1093i1148-1158o1172-1181i1203-1212o1223-1232i,2034
O43246,Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4),i44-60o71-93i113-141o171-184i193-216o237-251i269-293o319-339i368-385o390-412i478-498o509-529i542-561o567-587i,635
Q63HM2,Pecanex-like protein 4 (Hepatitis C virus F protein-binding protein 2) (HCV F protein-binding protein 2) (Pecanex homolog protein 4),i45-62o71-90i140-159o171-191i217-228o247-262i291-308o316-329i356-373o389-405i448-464o471-480i495-507o521-530i,1172
Q6PIS1,Solute carrier family 23 member 3 (HPC E2-binding protein 3) (Na(+)/L-ascorbic acid transporter 3) (Sodium-dependent vitamin C transporter 3),i56-70o86-104i108-125o165-183i193-208o220-238i264-281o316-335i358-370o371-380i398-419o422-440i454-471o487-507i,610
O60337,E3 ubiquitin-protein ligase MARCHF6 (EC 2.3.2.27) (Doa10 homolog) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (Protein TEB-4) (RING finger protein 176) (RING-type E3 ubiquitin transferase MARCHF6),i97-114o139-161i291-311o332-354i371-394o421-441i480-502o527-536i633-654o675-695i721-738o770-779i813-828o849-863i,910
O15118,NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein),o270-290i350-370o621-639i652-678o686-706i731-751o759-783i833-853o1099-1117i1122-1142o1153-1173i1194-1215o1225-1251i,1278
P46977,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1) (Transmembrane protein TMC),i17-32o115-135i141-154o171-187i192-207o212-228i238-254o268-283i297-319o361-379i382-402o406-426i459-473o,705
Q1EHB4,Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12),o11-31i51-68o81-96i129-149o158-178i181-201o238-258i277-297o336-356i379-399o408-428i439-459o505-525i,618
Q5BKT4,"Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A)",i8-23o98-116i131-148o154-169i176-186o190-205i250-270o297-307i324-338o368-385i393-408o417-429i437-456o,473
Q5I7T1,"Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-B) (Asparagine-linked glycosylation protein 10 homolog B) (Potassium channel regulator 1)",i10-27o98-114i131-149o154-169i173-185o188-202i250-270o288-307i323-340o368-386i393-414o415-424i437-457o,473
Q6N075,Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2),o7-19i44-64o77-99i106-123o128-148i171-192o201-219i250-270o282-302i312-332o344-359i377-396o408-428i,450
Q6NUT2,Probable C-mannosyltransferase DPY19L2 (EC 2.4.1.-) (Dpy-19-like protein 2) (Protein dpy-19 homolog 2),i108-125o244-269i270-283o300-317i326-343o346-361i372-388o401-410i425-444o495-509i536-557o558-571i589-605o,758
Q6ZWT7,Lysophospholipid acyltransferase 2 (LPLAT 2) (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase MBOAT2) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),o26-46i52-73o74-93i101-112o130-145i173-183o184-193i237-254o274-283i367-384o387-396i416-436o448-463i,520
Q7Z7B1,Phosphatidylinositol-glycan biosynthesis class W protein (PIG-W) (EC 2.3.-.-),o22-42i57-77o78-98i129-149o163-183i206-221o236-256i262-278o306-326i339-359o371-394i449-464o473-495i,504
Q86VL8,Multidrug and toxin extrusion protein 2 (MATE-2) (hMATE-2) (Kidney-specific H(+)/organic cation antiporter) (Solute carrier family 47 member 2),i39-59o67-92i115-131o153-171i220-240o249-269i291-316o328-348i369-389o410-431i441-463o467-487i579-599o,602
Q8IVB4,Sodium/hydrogen exchanger 9 (Na(+)/H(+) exchanger 9) (NHE-9) (Solute carrier family 9 member 9),o21-41i48-70o127-147i159-185o203-223i232-252o275-299i310-328o329-340i367-387o395-415i434-450o461-481i,645
Q8N695,Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8),o15-35i55-72o85-100i133-153o162-182i185-209o242-262i280-301o337-360i383-403o412-432i440-463o522-542i,610
Q8TCJ2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),i71-86o169-189i196-208o225-241i246-263o266-283i292-308o322-340i351-371o414-433i438-458o466-480i538-552o,826
Q92581,Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Solute carrier family 9 member 6),o71-91i102-122o176-196i208-233o252-271i280-303o320-348i359-376o383-392i416-436o444-464i483-499o509-532i,701
Q92911,Sodium/iodide cotransporter (Na(+)/I(-) cotransporter) (Natrium iodide transporter) (Sodium-iodide symporter) (Na(+)/I(-) symporter) (Solute carrier family 5 member 5),o17-37i57-77o87-107i135-155o164-184i187-213o244-266i282-305o342-362i384-404o415-435i443-466o528-549i,643
Q96FL8,Multidrug and toxin extrusion protein 1 (MATE-1) (hMATE-1) (Solute carrier family 47 member 1),i43-63o71-96i120-135o158-175i186-206o217-237i259-284o296-316i338-357o374-392i409-431o435-458i547-567o,570
Q8WWZ4,ATP-binding cassette sub-family A member 10 (EC 7.6.2.-),o135-155i178-205o211-231i240-260o309-328i773-793o937-946i981-1003o1012-1034i1047-1064o1071-1080i1083-1093o1114-1133i,1543
Q96T83,Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7),o71-91i98-120o176-196i211-240o252-271i280-298o324-348i358-376o377-388i415-435o443-463i483-498o508-531i,725
Q9GZV3,High affinity choline transporter 1 (hCHT1) (Hemicholinium-3-sensitive choline transporter) (CHT) (Solute carrier family 5 member 7),o7-27i49-68o84-101i130-150o162-182i185-207o239-259i272-292o333-353i378-398o405-418i435-450o482-494i,580
Q9P2K9,Protein dispatched homolog 3 (Patched domain-containing protein 2),i73-94o463-481i486-506o521-538i564-581o592-616i730-747o1180-1201i1206-1226o1238-1256i1289-1309o1321-1341i1359-1378o,1392
Q9UHC9,NPC1-like intracellular cholesterol transporter 1 (NPC1L1) (Niemann-Pick C1-like protein 1),o286-307i352-372o633-651i664-690o698-719i743-763o771-795i844-864o1139-1158i1166-1183o1194-1214i1235-1256o1266-1291i,1359
Q9Y289,Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (hSMVT) (Solute carrier family 5 member 6),o26-47i70-87o101-114i149-164o176-196i200-222o256-276i296-316o354-374i396-416o424-442i456-476o528-548i,635
Q9Y2E8,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),o60-80i87-107o124-139i156-176o191-210i220-240o261-281i299-316o320-330i361-370o379-399i417-437o448-468i,581
Q6UWJ1,Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein),o271-291i296-311o317-337i352-373o380-396i415-435o456-477i499-515o524-533i551-567o578-602i611-627o643-664i,677
Q2PZI1,Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1),i27-36o161-181i186-198o218-231i239-254o260-274i286-300o310-325i341-361o410-423i448-468o474-487i502-514o,675
Q6ZPD9,Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3),i44-64o160-182i183-197o215-231i242-261o262-278i286-306o309-325i344-362o417-437i463-479o485-499i522-540o,716
Q7Z388,Probable C-mannosyltransferase DPY19L4 (EC 2.4.1.-) (Dpy-19-like protein 4) (Protein dpy-19 homolog 4),i52-70o167-187i190-202o221-236i247-261o268-280i294-308o315-330i349-369o421-441i465-482o489-502i523-539o,723
Q9H720,PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog),i9-30o44-60i68-84o93-111i123-139o151-166i195-214o237-252i262-278o285-298i316-332o349-366i395-410o,699
O60721,Sodium/potassium/calcium exchanger 1 (Na(+)/K(+)/Ca(2+)-exchange protein 1) (Retinal rod Na-Ca+K exchanger) (Solute carrier family 24 member 1),i25-38o455-478i496-516o528-541i562-577o580-600i716-725o909-918i936-958o972-992i1011-1024o1040-1060i1069-1089o,1099
A0AV02,Solute carrier family 12 member 8 (Cation-chloride cotransporter 9),i44-62o73-93i122-142o154-174i178-203o233-251i269-289o309-329i361-381o382-402i596-613o614-631i,714
A1A5C7,Solute carrier family 22 member 23,i98-115o231-251i258-278o282-304i315-338o344-360i431-444o465-487i494-515o536-558i572-592o598-618i,686
A6NFX1,Sphingosine-1-phosphate transporter MFSD2B (Major facilitator superfamily domain-containing protein 2B) (hMfsd2b),i45-69o80-94i116-134o143-163i186-203o232-249i286-305o318-335i349-364o370-390i417-434o455-475i,504
F5H094,SLCO1B3-SLCO1B7 readthrough transcript protein (Liver specific transporter-3 transmembrane 12) (LST-3TM12) (Organic anion transporting polypeptide 1B3-1B7) (OATP1B3-1B7) (Solute carrier organic anion transporter family member 1B3-1B7) (SLCO1B3-SLCO1B7),i29-48o66-84i96-117o172-193i207-230o259-277i337-360o375-397i407-427o536-556i570-591o624-646i,687
O00400,Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1),i75-95o109-129i144-159o177-197i215-235o258-278i310-330o345-363i380-396o408-433i449-471o511-529i,549
O15244,Solute carrier family 22 member 2 (Organic cation transporter 2) (hOCT2),i23-43o151-171i178-198o202-225i236-258o264-279i349-367o378-398i405-424o431-451i465-485o495-511i,555
O15245,Solute carrier family 22 member 1 (Organic cation transporter 1) (hOCT1),i21-41o150-170i177-197o200-224i235-256o263-278i348-366o377-397i403-423o430-450i464-485o493-512i,554
O15374,Monocarboxylate transporter 5 (MCT 5) (Monocarboxylate transporter 4) (MCT 4) (Solute carrier family 16 member 4),i18-38o61-81i88-106o113-133i149-169o176-195i300-320o338-358i367-386o391-411i426-446o457-479i,487
O15427,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),i18-38o62-82i89-107o114-135i148-170o178-189i228-248o264-284i294-314o321-338i355-375o386-408i,465
O15439,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),i93-113o139-159i208-234o235-261i321-341o351-373i711-729o773-790i840-862o863-878i950-971o979-997i,1325
O15440,ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11),i179-201o219-239i290-316o317-343i401-421o434-454i857-877o919-939i990-1009o1010-1030i1100-1120o1127-1147i,1437
O43306,Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase),i152-172o178-198i210-230o237-258i259-279o285-305i669-690o696-717i744-762o812-831i836-856o896-911i,1168
O75387,Large neutral amino acids transporter small subunit 3 (L-type amino acid transporter 3) (Prostate cancer overexpressed gene 1 protein) (Solute carrier family 43 member 1),i13-33o75-98i105-125o134-154i167-188o195-215i304-324o357-377i419-439o444-459i479-499o511-531i,559
O75751,Solute carrier family 22 member 3 (Extraneuronal monoamine transporter) (EMT) (Organic cation transporter 3) (OCT3),i21-41o156-176i183-203o207-230i241-263o269-284i352-370o381-401i408-427o434-454i469-489o498-516i,556
O76082,Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5),i20-38o144-164i171-189o195-217i229-249o258-277i345-365o374-394i401-420o426-451i463-483o489-509i,557
O94956,Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Organic anion transporting polypeptide 2B1) (OATP2B1) (Solute carrier family 21 member 9),i50-69o89-109i117-138o189-209i225-248o277-296i372-394o411-432i444-464o560-580i597-617o651-672i,709
O95342,Bile salt export pump (EC 7.6.2.-) (ATP-binding cassette sub-family B member 11),i59-82o145-165i217-237o243-263i319-343o360-380i752-774o800-820i876-896o902-922i979-1000o1018-1038i,1321
O95477,Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein),i22-42o632-652i685-706o724-736i745-765o821-841i1351-1371o1703-1723i1735-1755o1768-1788i1806-1820o1848-1868i,2261
O95528,"Solute carrier family 2, facilitated glucose transporter member 10 (Glucose transporter type 10) (GLUT-10)",i13-33o49-69i76-97o98-118i134-157o166-184i233-245o269-291i298-320o408-428i448-470o476-496i,541
O95622,Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5),i242-262o268-288i299-319o328-346i347-367o375-395i761-782o789-809i836-855o906-926i927-947o988-1003i,1261
O95907,Monocarboxylate transporter 3 (MCT 3) (Solute carrier family 16 member 8),i15-35o59-79i86-106o111-132i143-163o175-186i253-273o289-309i319-338o346-363i380-400o411-431i,504
P00395,Cytochrome c oxidase subunit 1 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide I),i17-37o56-83i100-120o145-165i183-206o234-254i272-289o303-321i338-358o373-393i412-431o452-472i,513
P08183,ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243),i49-72o120-138i190-209o216-236i292-316o332-352i709-731o757-777i833-853o856-876i937-959o974-994i,1280
P11166,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)",i12-35o66-87i94-115o120-144i154-176o186-206i272-292o307-328i335-358o363-386i402-426o431-450i,492
P11168,"Solute carrier family 2, facilitated glucose transporter member 2 (Glucose transporter type 2, liver) (GLUT-2)",i10-31o98-119i125-147o152-177i186-208o218-238i304-324o339-360i367-390o395-413i433-458o463-482i,524
P11169,"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)",i10-31o64-85i92-113o118-142i152-174o184-204i270-290o305-326i333-355o364-384i400-424o429-448i,496
P13569,Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel),i78-93o125-145i198-218o223-245i309-324o348-358i859-879o918-938i991-1012o1013-1033i1101-1121o1127-1147i,1480
P14672,"Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)",i24-45o82-103i108-132o136-161i170-192o202-222i288-308o323-347i351-374o380-402i418-442o447-466i,509
P18577,Blood group Rh(CE) polypeptide (Rh polypeptide 1) (RhPI) (Rh30A) (RhIXB) (Rhesus C/E antigens) (CD antigen CD240CE),i15-32o50-69i77-98o113-132i137-157o170-186i204-228o242-259i270-285o292-309i330-349o363-388i,417
P19634,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",i13-33o106-127i130-149o155-174i192-211o228-247i257-276o295-315i339-358o411-430i449-470o480-499i,815
P21439,Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3),i55-75o117-137i192-208o218-238i294-316o336-354i708-728o756-776i832-852o857-877i936-956o973-993i,1286
P22732,"Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) (GLUT-5)",i17-39o72-93i98-121o126-151i160-183o192-212i278-291o315-339i343-365o371-389i409-434o439-459i,501
P23975,Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2),i65-85o92-112i141-164o233-253i262-282o307-329i349-369o402-417i444-470o475-495i519-538o556-575i,617
P30531,Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1),i53-73o80-100i132-152o210-230i239-259o284-306i332-348o374-394i422-447o457-474i498-517o535-557i,599
P31641,Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6),i50-70o77-102i127-150o216-236i245-265o290-310i337-352o380-400i430-458o465-482i506-525o543-563i,620
P31645,Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4),i88-108o115-135i165-185o251-271i280-300o325-345i370-387o417-436i465-489o495-515i539-558o575-595i,630
P36021,Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter),i97-117o144-164i172-192o196-213i230-250o263-280i323-340o358-378i387-407o413-431i447-467o478-500i,539
P40145,Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase),i182-202o212-232i245-266o267-288i289-310o321-341i716-733o741-761i787-806o833-852i853-873o899-914i,1251
P41440,Reduced folate transporter (FOLT) (Cyclic dinucleotide:anion antiporter SLC19A1) (Folate:anion antiporter SLC19A1) (Intestinal folate carrier 1) (IFC-1) (Placental folate transporter) (Reduced folate carrier protein) (RFC) (hRFC) (Reduced folate transporter 1) (RFT-1) (Solute carrier family 19 member 1) (hSLC19A1),i28-48o68-87i94-113o121-136i153-177o185-203i269-288o308-324i337-356o363-385i398-418o432-452i,591
P46059,"Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)",i28-47o58-78i84-103o122-139i162-183o199-219i277-297o325-345i362-382o585-605i617-637o649-667i,708
P46721,Solute carrier organic anion transporter family member 1A2 (OATP1A2) (OATP-A) (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter) (Solute carrier family 21 member 3),i21-40o58-80i87-109o158-180i194-214o246-265i317-337o354-377i390-408o512-535i548-567o600-622i,670
P48029,Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8),i61-81o88-108i140-160o231-251i260-282o305-325i346-367o395-422i445-473o480-497i521-541o559-578i,635
P48065,Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12),i45-65o72-92i124-145o209-229i238-258o283-303i330-345o373-393i423-451o458-475i499-515o536-556i,614
P48066,Sodium- and chloride-dependent GABA transporter 3 (GAT-3) (Solute carrier family 6 member 11),i59-79o86-106i138-158o224-244i253-273o298-318i345-360o388-408i438-466o470-490i514-533o551-571i,632
P48067,Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9),i109-129o136-156i188-208o286-306i315-335o360-380i407-427o450-470i506-526o530-550i570-590o610-630i,706
P49279,Natural resistance-associated macrophage protein 1 (NRAMP 1) (Solute carrier family 11 member 1),i65-78o92-107i136-156o168-188i195-216o241-259i284-307o361-381i401-418o430-447i467-487o495-516i,550
P49281,Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2),i78-87o104-118i147-172o182-199i209-227o253-276i296-319o370-392i412-429o441-460i478-497o506-527i,568
P50443,Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2),i112-130o140-154i161-176o221-239i252-269o302-318i333-350o383-403i455-475o482-495i507-528o529-546i,739
P51811,Endoplasmic reticulum membrane adapter protein XK (Kell complex 37 kDa component) (Kx antigen) (Membrane transport protein XK) (XK-related protein 1),i5-25o35-48i49-58o68-88i141-158o170-190i208-228o236-256i274-284o285-295i317-338o350-369i,444
P51828,Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7),i34-54o64-85i95-115o126-145i146-167o176-196i597-614o621-641i669-689o718-737i741-761o797-813i,1080
P53985,Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1),i16-36o60-80i87-107o112-132i144-164o167-187i263-283o299-319i329-349o354-374i390-410o423-443i,500
P54219,Chromaffin granule amine transporter (Solute carrier family 18 member 1) (Vesicular amine transporter 1) (VAT1),i22-42o141-161i168-186o192-212i232-244o258-278i303-323o336-356i366-386o391-411i429-452o458-478i,525
P55011,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2),i288-308o323-345i368-395o409-433i434-455o487-504i521-541o602-622i653-677o681-694i713-731o732-751i,1212
P55017,Solute carrier family 12 member 3 (Na-Cl cotransporter) (NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter),i136-159o172-192i219-246o260-282i287-307o340-356i374-394o454-474i506-533o534-554i564-585o586-605i,1021
P57057,Glucose-6-phosphate exchanger SLC37A1 (Glycerol-3-phosphate permease) (G-3-P permease) (Solute carrier family 37 member 1),i22-42o101-121i128-147o157-177i195-215o223-241i330-350o365-386i394-414o421-440i466-486o493-510i,533
P78363,Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM proteinv) (RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein),i22-42o647-667i700-720o731-751i760-780o836-856i1377-1397o1728-1748i1760-1780o1793-1813i1832-1852o1874-1894i,2273
P82251,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",i35-55o63-90i107-136o149-166i175-200o221-238i253-277o302-325i351-368o374-395i411-430o435-455i,487
Q01650,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),i55-75o83-107i128-157o170-186i195-219o243-260i275-299o323-348i373-389o393-417i435-452o455-478i,507
Q01959,Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3),i69-89o96-116i143-164o236-256i265-285o310-332i355-372o400-420i447-473o478-498i522-541o558-578i,620
Q02094,Ammonium transporter Rh type A (Erythrocyte membrane glycoprotein Rh50) (Erythrocyte plasma membrane 50 kDa glycoprotein) (Rh50A) (Rhesus blood group family type A glycoprotein) (Rh family type A glycoprotein) (Rh type A glycoprotein) (Rhesus blood group-associated ammonia channel) (Rhesus blood group-associated glycoprotein) (CD antigen CD241),i4-24o52-72i77-97o114-134i141-160o169-189i209-229o240-260i270-291o296-314i333-352o363-383i,409
Q02161,Blood group Rh(D) polypeptide (RHXIII) (Rh polypeptide 2) (RhPII) (Rhesus D antigen) (CD antigen CD240D),i15-32o50-69i77-97o113-132i136-157o169-186i204-228o242-259i270-288o292-309i332-349o363-388i,417
Q05940,Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2),i21-41o131-153i160-178o182-202i223-243o249-269i294-311o332-352i358-378o384-402i421-435o450-470i,514
Q08357,Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2),o9-27i49-62o89-107i117-127o143-165i183-198o214-234i497-517o534-551i571-586o592-605i622-644o,652
Q08462,Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2),i46-67o77-98i108-128o133-153i157-177o187-206i600-621o627-649i680-700o734-756i757-778o804-820i,1091
Q08828,Adenylate cyclase type 1 (EC 4.6.1.1) (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase),i62-82o96-111i122-142o162-180i181-203o214-234i609-631o635-655i673-693o727-745i749-769o784-800i,1119
Q13621,Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (Kidney-specific Na-K-Cl symporter),i177-200o211-237i260-287o301-325i326-347o380-396i414-438o493-513i545-566o567-587i603-624o625-643i,1099
Q13635,Protein patched homolog 1 (PTC) (PTC1),i101-121o437-457i473-493o502-522i548-568o578-598i749-769o1028-1048i1056-1076o1084-1104i1122-1141o1155-1175i,1447
Q14916,Sodium-dependent phosphate transport protein 1 (Na(+)/PI cotransporter 1) (Na/Pi-4) (Renal Na(+)-dependent phosphate cotransporter 1) (Renal sodium-dependent phosphate transport protein 1) (Renal sodium-phosphate transport protein 1) (Sodium/phosphate cotransporter 1) (Solute carrier family 17 member 1),i21-42o82-99i110-130o131-151i173-193o200-220i257-277o302-322i339-358o365-385i397-417o431-451i,467
Q16348,"Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)",i58-78o88-108i114-134o140-160i184-204o218-238i296-316o344-364i381-401o612-632i644-664o675-695i,729
Q16572,Vesicular acetylcholine transporter (VAChT) (Solute carrier family 18 member 3),i34-54o124-146i153-172o175-195i214-236o243-263i290-307o329-349i357-376o381-402i418-438o449-469i,532
Q2M3G0,ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5) (EC 7.6.2.2),i46-66o108-130i182-201o208-228i284-308o326-346i691-713o737-757i813-833o839-859i917-939o955-975i,1257
Q3KNS1,Patched domain-containing protein 3 (Patched-related protein),i138-158o383-400i413-434o447-463i486-506o515-540i603-621o800-820i826-843o855-872i896-916o924-949i,954
Q496J9,Synaptic vesicle glycoprotein 2C,i152-176o192-212i219-239o243-263i279-301o321-336i436-454o581-604i610-630o634-654i671-693o698-718i,727
Q4U2R8,Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1),i21-36o136-156i163-182o187-207i221-244o251-264i338-358o369-389i396-415o425-445i459-479o484-504i,563
Q4VNC1,Probable cation-transporting ATPase 13A4 (EC 7.2.2.-) (P5-ATPase isoform 4),i32-42o43-52i202-215o224-242i401-414o435-448i904-921o931-951i971-993o1039-1057i1070-1087o1109-1129i,1196
Q5SR56,Hippocampus abundant transcript-like protein 1 (Major facilitator superfamily domain-containing 14B),i48-61o80-101i111-129o132-152i169-189o197-215i254-267o291-313i320-339o343-359i381-401o429-449i,506
Q5VTY9,Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2) (MART-2) (Skinny hedgehog protein 1),i6-26o70-88i94-109o113-128i134-149o168-185i244-265o286-306i365-375o386-402i430-447o466-483i,493
Q695T7,Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1),i41-61o68-88i120-140o193-213i222-242o268-288i305-325o415-435i460-482o488-508i532-552o581-603i,634
Q6J4K2,"Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",o98-114i142-159o171-191i201-221o227-251i360-376o388-407i420-436o459-479i488-509o525-547i555-573o,584
Q6NT16,MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT),i35-55o71-91i101-120o128-148i176-187o196-216i238-259o272-294i304-326o332-351i379-399o406-428i,456
Q6NUT3,Major facilitator superfamily domain-containing protein 12,i24-44o58-78i94-112o128-147i167-189o219-239i280-300o312-331i342-361o366-385i403-423o445-467i,480
Q6PXP3,"Solute carrier family 2, facilitated glucose transporter member 7 (Glucose transporter type 7) (GLUT-7) (hGLUT7)",i23-45o78-99i104-127o132-157i166-188o198-218i284-297o321-345i349-371o378-395i416-440o445-464i,512
Q6ZQN7,Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20),i107-130o145-165i175-195o230-250i265-286o315-333i382-404o419-443i454-474o579-600i613-634o662-689i,724
Q6ZSM3,Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12),i45-65o88-108i116-136o141-161i173-198o205-217i283-303o319-339i350-370o376-394i410-430o441-463i,516
Q6ZSS7,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog),i73-90o104-124i133-152o287-309i330-346o370-389i448-468o481-501i510-530o535-555i574-594o601-622i,791
Q7L0J3,Synaptic vesicle glycoprotein 2A,i166-188o206-226i233-253o256-277i293-315o335-349i448-468o596-619i625-645o649-669i685-708o713-731i,742
Q7L1I2,Synaptic vesicle glycoprotein 2B,i110-130o149-169i178-195o200-220i238-258o278-294i391-411o536-560i566-586o591-614i629-649o654-672i,683
Q7RTY0,Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13),i10-30o54-74i81-101o106-126i142-163o170-186i216-235o252-272i280-300o306-326i341-361o372-392i,426
Q7RTY1,Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9),i11-34o53-73i80-100o105-125i137-157o169-185i305-325o342-364i372-392o398-415i431-451o462-483i,509
Q86UG4,Solute carrier organic anion transporter family member 6A1 (Cancer/testis antigen 48) (CT48) (Gonad-specific transporter) (GST) (Organic anion-transporting polypeptide 6A1) (Organic anion-transporting polypeptide I) (OATP-I) (Solute carrier family 21 member 19),i108-128o145-165i173-193o231-251i265-285o315-333i385-406o423-444i457-474o580-600i614-634o665-689i,719
Q86UK0,Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12),i23-43o1065-1085i1111-1136o1144-1169i1174-1194o1251-1271i1747-1764o1984-2009i2035-2056o2068-2088i2099-2119o2186-2203i,2595
Q86UQ4,ATP-binding cassette sub-family A member 13 (EC 7.6.2.-),i23-43o3568-3588i3614-3636o3648-3668i3678-3698o3754-3772i4227-4246o4457-4474i4504-4525o4536-4557i4568-4588o4655-4671i,5058
Q86VW1,Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2) (Fly-like putative transporter 2) (FLIPT2) (Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6),i22-42o155-175i183-203o207-231i241-264o269-284i360-378o389-409i416-435o442-462i483-498o504-520i,577
Q86WA9,Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11),i52-70o79-94i101-114o122-142i153-170o199-218i242-262o308-325i379-399o406-419i433-448o451-465i,606
Q86WB7,Protein unc-93 homolog A (HmUnc-93A) (Unc-93A),i8-28o42-62i69-86o93-110i138-159o202-222i257-276o292-314i320-340o347-367i384-405o409-431i,457
Q8IUA7,ATP-binding cassette sub-family A member 9 (EC 7.6.2.-),i31-51o221-239i268-295o301-321i330-350o399-419i864-884o1027-1036i1071-1092o1105-1125i1138-1153o1201-1220i,1624
Q8IVM8,Organic anion transporter 7 (OAT7) (Organic anion/short-chain fatty acid exchanger) (Solute carrier family 22 member 9),i18-37o147-166i174-194o198-221i232-255o260-275i351-368o380-400i408-427o434-452i472-492o496-515i,553
Q8IVW8,Sphingosine-1-phosphate transporter SPNS2 (Protein spinster homolog 2),i102-127o140-162i169-188o193-214i229-249o261-281i316-336o364-384i398-418o423-442i460-479o505-525i,549
Q8IY34,Solute carrier family 15 member 3 (Osteoclast transporter) (Peptide transporter 3) (Peptide/histidine transporter 2) (hPHT2),i33-58o75-94i103-123o159-179i201-220o227-247i312-333o373-394i407-428o462-477i496-517o540-560i,581
Q8IZY2,Phospholipid-transporting ATPase ABCA7 (EC 7.6.2.1) (ABCA-SSN) (ATP-binding cassette sub-family A member 7) (Autoantigen SS-N) (Macrophage ABC transporter),i22-42o542-562i595-616o626-646i655-675o730-750i1243-1263o1584-1604i1616-1636o1649-1669i1687-1696o1729-1749i,2146
Q8N139,ATP-binding cassette sub-family A member 6 (EC 7.6.2.-),i31-51o222-242i265-293o298-318i327-347o396-416i854-875o1018-1027i1062-1082o1094-1116i1129-1146o1196-1214i,1617
Q8N370,Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2),i13-33o87-110i117-137o146-166i179-200o207-227i324-345o365-385i424-444o449-464i484-504o516-536i,569
Q8N4F4,Steroid transmembrane transporter SLC22A24 (Solute carrier family 22 member 24),i18-36o147-163i174-192o201-220i235-255o260-275i351-369o380-400i407-426o435-455i470-490o495-515i,552
Q8N697,Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1),i36-62o77-96i105-125o156-176i194-216o223-243i317-338o367-392i405-422o455-475i487-510o536-553i,577
Q8NA29,Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A) (HsMFSD2A) (MFSD2a),o47-67i95-116o129-149i159-176o196-217i257-277o311-331i345-365o371-390i395-414o438-458i485-505o,543
Q8NBI5,Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3),i10-30o70-92i98-118o125-145i158-179o188-208i279-299o321-339i366-385o393-413i425-447o457-477i,491
Q8NCC5,Sugar phosphate exchanger 3 (Solute carrier family 37 member 3),i21-37o83-105i113-133o143-163i177-201o207-227i292-315o333-349i357-375o383-402i428-448o456-476i,494
Q8NCK7,Monocarboxylate transporter 11 (MCT 11) (Solute carrier family 16 member 11),i35-56o78-98i106-125o131-151i163-188o195-215i243-263o280-301i311-332o341-361i376-396o406-426i,471
Q8NDX2,Vesicular glutamate transporter 3 (VGluT3) (Solute carrier family 17 member 8),i77-98o131-150i159-178o185-200i222-242o249-269i310-324o354-374i391-409o416-436i448-468o482-502i,589
Q8NFM4,Adenylate cyclase type 4 (EC 4.6.1.1) (ATP pyrophosphate-lyase 4) (Adenylate cyclase type IV) (Adenylyl cyclase 4),i29-47o61-79i91-108o119-134i140-161o174-194i586-605o611-631i664-684o722-736i742-761o790-807i,1077
Q8NHS3,Major facilitator superfamily domain-containing protein 8 (Ceroid-lipofuscinosis neuronal protein 7),i41-61o76-96i105-126o133-152i172-192o212-232i270-290o307-327i338-358o418-438i452-476o483-503i,518
Q8NHX9,Two pore channel protein 2 (Two pore calcium channel protein 2),i85-102o127-142i157-168o169-179i217-238o290-310i434-455o467-489i503-523o540-559i581-601o672-692i,752
Q8TCC7,Organic anion transporter 3 (hOAT3) (Organic anion/dicarboxylate exchanger) (Solute carrier family 22 member 8),i19-40o124-144i151-171o175-197i208-231o237-251i326-346o357-377i384-404o410-430i448-466o472-492i,542
Q8TDB8,"Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14) (GLUT-14)",i34-55o88-109i116-137o142-166i176-198o208-228i294-314o329-349i357-379o388-408i424-448o453-472i,520
Q8TE54,Anion exchange transporter (Solute carrier family 26 member 7),i51-71o78-93i100-115o147-165i178-195o228-247i258-278o309-327i381-401o404-422i436-451o455-473i,656
Q8TED4,Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2),i23-39o86-108i116-137o143-165i179-203o209-229i297-316o337-354i364-382o390-407i434-454o461-482i,501
Q92536,"Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)",i50-70o78-102i123-152o165-181i191-214o236-253i268-292o316-341i366-383o386-410i426-447o448-470i,515
Q92685,"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)",i43-59o123-142i151-160o177-191i194-208o209-226i231-251o288-307i338-353o358-374i379-399o407-422i,438
Q92959,Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2),i33-52o72-92i100-121o170-192i206-228o258-276i327-349o364-387i400-419o514-534i551-571o606-626i,643
Q96BD0,Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),i104-124o143-163i172-192o228-248i263-287o311-330i385-405o421-444i454-474o579-599i615-635o666-688i,722
Q96BI1,Solute carrier family 22 member 18 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein) (Efflux transporter-like protein) (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Organic cation transporter-like protein 2) (ORCTL-2) (Solute carrier family 22 member 1-like) (Tumor-suppressing STF cDNA 5 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein) (p45-Beckwith-Wiedemann region 1 A) (p45-BWR1A),i25-47o60-80i90-110o117-137i154-175o180-200i241-261o278-298i306-325o328-348i364-388o393-413i,424
Q96F81,Protein dispatched homolog 1,i190-210o500-520i526-546o557-577i605-624o633-658i724-736o984-1002i1006-1030o1039-1054i1083-1099o1111-1127i,1524
Q96J65,ATP-binding cassette sub-family C member 12 (Multidrug resistance-associated protein 9),i123-145o162-186i234-259o262-287i345-360o377-398i793-811o857-874i927-948o949-969i1031-1048o1057-1074i,1359
Q8TF71,Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1),i68-88o115-135i143-163o168-184i204-224o232-249i292-312o330-350i359-378o385-403i419-439o450-472i,515
Q96J66,ATP-binding cassette sub-family C member 11 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 8),i163-185o202-226i278-300o301-325i384-404o421-441i804-822o867-885i938-959o960-980i1052-1069o1075-1095i,1382
Q96N87,Inactive sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),i27-47o54-74i105-126o179-199i208-228o253-273i291-311o399-422i443-461o474-494i518-538o566-588i,628
Q96NR3,Patched domain-containing protein 1,i26-44o271-289i298-318o329-347i372-390o401-427i500-520o699-718i725-742o755-772i795-815o823-846i,888
Q96NT5,Proton-coupled folate transporter (HsPCFT) (hPCFT) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1),i27-38o85-107i115-137o142-164i179-199o209-228i268-288o306-326i332-352o357-375i389-414o423-443i,459
Q96Q91,Anion exchange protein 4 (AE 4) (Anion exchanger 4) (Sodium bicarbonate cotransporter 5) (Solute carrier family 4 member 9),i412-432o448-459i460-470o494-514i530-550o624-645i664-684o712-732i759-779o816-833i834-852o900-918i,983
Q96QE2,Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13),i81-106o122-142i149-167o173-190i208-230o240-258i326-345o364-384i393-414o507-527i547-567o573-592i,648
Q96RN1,Testis anion transporter 1 (Anion exchange transporter) (Solute carrier family 26 member 8),i96-113o126-140i148-162o197-217i228-248o278-294i312-327o358-376i430-451o452-470i485-500o504-519i,970
Q96S37,Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1) (URAT1) (Urate:anion antiporter SLC22A12),i22-34o147-167i174-193o198-218i232-252o260-275i351-369o380-400i407-426o435-455i470-490o495-515i,553
Q96SL1,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),i52-75o91-111i118-138o147-167i180-205o230-250i282-303o317-339i345-369o381-401i414-437o443-463i,478
Q99758,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],i22-44o255-275i306-329o344-364i373-393o449-469i926-944o1102-1111i1146-1166o1179-1199i1213-1231o1303-1324i,1704
Q99884,Sodium-dependent proline transporter (Solute carrier family 6 member 7),i46-66o73-93i122-145o213-233i242-262o287-307i328-348o377-397i430-452o456-476i496-516o536-556i,636
Q9BSA9,Endosomal/lysosomal proton channel TMEM175 (Transmembrane protein 175) (hTMEM175),i34-56o78-100i107-128o139-160i185-205o211-230i258-282o310-332i339-360o376-396i417-440o443-469i,504
Q9BXP2,Solute carrier family 12 member 9 (Cation-chloride cotransporter 6) (hCCC6) (Cation-chloride cotransporter-interacting protein 1) (CCC-interacting protein 1) (hCIP1) (Potassium-chloride transporter 9) (WO3.3),i40-60o73-97i120-147o165-186i187-215o264-284i298-322o344-366i395-413o414-439i453-474o475-494i,914
Q9BXS9,Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1) (Pendrin-L1),i94-112o121-136i143-157o183-201i214-231o264-283i293-312o344-363i417-437o443-457i472-487o491-506i,759
Q9BYT1,Voltage-gated purine nucleotide uniporter SLC17A9 (Solute carrier family 17 member 9) (Vesicular nucleotide transporter) (VNUT),i28-48o64-80i91-111o118-136i158-178o185-202i239-259o276-296i313-330o338-358i370-390o402-422i,436
Q9BYW1,"Solute carrier family 2, facilitated glucose transporter member 11 (Glucose transporter type 11) (GLUT-11)",i13-37o65-89i95-115o121-146i156-178o188-208i274-294o310-335i339-361o367-390i405-430o436-455i,496
Q9BZC7,ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2),i22-42o699-717i750-771o783-803i815-833o892-912i1456-1478o1792-1802i1840-1861o1872-1892i1905-1925o1987-2008i,2435
Q9BZV2,Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3),i12-32o55-74i81-99o108-128i146-165o171-191i278-296o317-334i346-366o369-392i405-426o439-460i,496
Q9H015,Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (ETTh) (Organic cation/carnitine transporter 1) (OCTN1),i20-40o144-164i171-191o195-217i228-252o259-275i339-359o372-392i399-418o425-447i459-482o487-507i,551
Q9H1C4,Protein unc-93 homolog B1 (Unc-93B1) (hUNC93B1),i64-82o113-134i135-155o159-179i223-243o285-306i343-360o377-397i403-423o433-453i470-491o495-515i,597
Q9H1V8,Sodium-dependent neutral amino acid transporter SLC6A17 (Sodium-dependent neurotransmitter transporter NTT4) (Solute carrier family 6 member 17),i69-89o96-116i148-168o223-243i252-273o297-317i338-355o457-478i495-512o526-546i569-589o616-638i,727
Q9H2B4,Sulfate anion transporter 1 (SAT-1) (Solute carrier family 26 member 1),i73-91o100-115i123-137o180-198i211-228o261-281i292-309o341-360i414-434o440-454i466-487o488-503i,701
Q9H2J7,Sodium-dependent neutral amino acid transporter B(0)AT2 (Sodium- and chloride-dependent neurotransmitter transporter NTT73) (Sodium-coupled branched-chain amino-acid transporter 1) (Solute carrier family 6 member 15) (Transporter v7-3),i70-90o97-117i149-169o224-244i253-274o302-320i335-356o458-479i496-513o527-547i571-591o617-639i,730
Q9H2V7,Protein spinster homolog 1 (HSpin1) (Spinster-like protein 1) (Spns1),i59-83o97-119i126-145o150-171i188-206o218-238i273-293o323-343i357-377o382-402i420-438o464-484i,528
Q9H2X9,Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter),i121-143o158-180i207-230o254-278i281-302o419-439i454-481o497-519i559-582o586-608i615-634o635-657i,1139
Q9H310,Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein),i15-34o62-82i87-107o125-145i152-172o180-200i220-240o252-272i281-303o307-329i344-364o395-415i,458
Q9H3U5,Major facilitator superfamily domain-containing protein 1 (Smooth muscle cell-associated protein 4) (SMAP-4),i43-66o83-103i111-132o136-156i171-194o213-233i266-286o304-324i331-350o356-374i391-411o418-441i,465
Q9H490,Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U),i5-20o82-99i138-152o161-175i179-191o194-205i230-248o288-306i313-326o332-352i355-373o386-406i,435
Q9H7F0,Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16),i29-39o40-49i211-224o233-251i411-426o449-460i938-956o966-986i1007-1028o1074-1092i1105-1123o1144-1164i,1226
Q9HCJ1,Progressive ankylosis protein homolog (ANK),i21-41o49-67i90-105o132-151i159-179o191-211i241-261o276-296i327-346o373-383i399-421o428-450i,492
Q9HD20,Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase),i71-89o99-116i242-261o262-282i442-464o481-501i987-1007o1019-1032i1052-1073o1098-1119i1133-1151o1171-1191i,1204
Q9NP59,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),i26-51o60-80i94-114o134-154i183-199o202-224i307-329o341-363i373-393o452-472i492-514o522-542i,571
Q9NP91,Sodium- and chloride-dependent transporter XTRP3 (Sodium/imino-acid transporter 1) (Solute carrier family 6 member 20) (Transporter rB21A homolog),i14-34o41-61i91-114o166-186i195-215o240-260i281-300o390-410i432-460o463-483i504-526o555-576i,592
Q9NPD5,Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (OATP1B3) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8),i29-48o64-84i96-117o172-193i207-230o259-277i337-357o376-397i410-428o534-557i569-589o624-646i,702
Q9NQ11,Polyamine-transporting ATPase 13A2 (EC 7.6.2.-),i45-55o56-65i236-249o258-276i426-446o464-475i933-952o961-978i1005-1022o1045-1065i1079-1097o1118-1138i,1180
Q9NRA2,Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular excitatory amino acid transporter) (VEAT),i42-62o110-130i137-158o159-179i201-221o228-248i279-299o329-349i366-386o392-412i424-444o458-478i,495
Q9NRM0,"Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9) (Urate transporter)",i56-78o111-132i139-159o164-189i199-221o231-251i317-337o355-375i383-404o410-433i448-473o479-497i,540
Q9NS82,Asc-type amino acid transporter 1 (Asc-1) (Solute carrier family 7 member 10),i45-65o73-100i118-147o160-176i185-210o234-251i268-290o314-339i364-383o384-408i424-443o446-469i,523
Q9NSA0,Solute carrier family 22 member 11 (Organic anion transporter 4) (OAT4) (Organic anion:dicarboxylate exchanger OAT4),i19-37o144-164i171-191o194-219i229-252o257-272i348-365o375-396i403-422o429-449i464-484o491-511i,550
Q9NSD5,Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13),i41-61o68-88i121-141o204-224i233-253o278-298i325-340o368-388i425-446o453-470i496-513o532-551i,602
Q9NY64,"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)",i26-46o69-91i97-117o120-145i155-179o183-201i257-277o292-313i320-340o370-390i407-432o438-457i,477
Q9NYB5,Solute carrier organic anion transporter family member 1C1 (Organic anion transporter 1C1) (OATP1C1) (Organic anion transporter F) (OATP-F) (Organic anion transporter polypeptide-related protein 5) (OAT-RP-5) (OATP-RP5) (Organic anion-transporting polypeptide 14) (OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter),i44-63o80-99i111-132o188-208i223-243o276-293i354-374o391-414i427-444o551-576i588-608o641-663i,712
Q9P2U7,Vesicular glutamate transporter 1 (VGluT1) (Brain-specific Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 7),i64-88o118-138i146-162o172-187i209-229o237-255i298-312o342-362i379-397o404-424i436-456o470-490i,560
Q9P2U8,Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6),i72-93o126-146i154-170o180-195i217-237o245-263i306-320o350-370i387-405o412-432i444-464o478-498i,582
Q9UBD6,Ammonium transporter Rh type C (Rh glycoprotein kidney) (Rhesus blood group family type C glycoprotein) (Rh family type C glycoprotein) (Rh type C glycoprotein) (Tumor-related protein DRC2),i11-30o61-81i86-106o124-144i151-170o179-199i219-239o251-271i280-302o306-328i343-362o396-416i,479
Q9UGQ3,"Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6) (GLUT-6)",i43-63o83-102i110-128o133-153i175-190o195-213i277-297o313-333i340-362o396-416i435-456o462-480i,507
Q9UHI5,Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8),i45-65o73-98i118-147o160-176i185-209o233-251i268-290o314-339i364-383o384-408i424-443o446-469i,535
Q9UHW9,Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3),i186-208o224-245i272-295o319-343i347-371o480-501i516-543o558-581i621-644o648-670i677-696o697-719i,1150
Q9UIG8,Solute carrier organic anion transporter family member 3A1 (OATP3A1) (Organic anion transporter polypeptide-related protein 3) (OATP-RP3) (OATPRP3) (Organic anion-transporting polypeptide D) (OATP-D) (PGE1 transporter) (Sodium-independent organic anion transporter D) (Solute carrier family 21 member 11),i41-61o79-99i108-129o178-198i213-233o265-284i350-372o387-410i418-441o535-559i573-593o624-645i,710
Q9ULQ1,Two pore channel protein 1 (Two pore calcium channel protein 1) (Voltage-dependent calcium channel protein TPC1),i107-125o138-157i173-192o195-210i233-253o297-312i442-462o477-492i507-527o531-540i570-586o666-686i,816
Q9UM01,Y+L amino acid transporter 1 (Monocyte amino acid permease 2) (MOP-2) (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1),i42-62o70-94i115-144o157-173i182-206o228-245i260-284o308-333i358-375o378-402i418-437o440-461i,511
Q9UMX9,Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Solute carrier family 45 member 2),i40-60o69-89i105-123o141-161i183-203o215-237i319-338o371-391i399-420o421-446i478-498o505-525i,530
Q9UN76,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14),i45-65o72-92i116-144o235-255i264-284o311-331i355-375o401-421i456-477o480-500i527-546o563-583i,642
Q9UP95,Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1),i119-141o156-178i205-228o252-276i280-300o415-435i451-478o494-516i556-579o583-605i613-631o632-654i,1085
Q9UPI3,Heme transporter FLVCR2 (Calcium-chelate transporter) (CCT) (Feline leukemia virus subgroup C receptor-related protein 2),i86-106o125-145i152-172o178-198i215-235o252-272i310-331o346-366i376-396o403-423i439-461o468-487i,526
Q9UPR5,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),o72-90i131-148o165-184i198-219o226-246i722-742o751-763i764-773o783-800i823-840o855-875i893-913o,921
Q9UPY5,Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT),i49-69o77-101i122-151o164-180i189-214o235-252i267-291o315-342i366-382o387-409i426-446o447-470i,501
Q9Y226,Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) (ORCTL3),i21-41o142-159i166-186o190-213i225-246o252-267i333-353o364-384i391-411o416-436i454-474o480-495i,551
Q9Y267,Solute carrier family 22 member 14 (Organic cation transporter-like 4) (ORCTL-4),i69-86o188-205i212-232o236-256i271-291o298-313i380-398o411-431i438-457o479-499i517-533o539-555i,594
Q9Y2C5,Probable small intestine urate exporter (Solute carrier family 17 member 4),i38-59o112-132i139-160o161-181i203-223o230-250i285-313o332-352i369-388o395-415i427-447o461-481i,497
Q9Y2W3,Proton-associated sugar transporter A (PAST-A) (Deleted in neuroblastoma 5 protein) (DNb-5) (Solute carrier family 45 member 1),i126-146o155-175i190-209o226-246i269-285o300-320i559-578o608-628i639-658o663-683i711-732o741-761i,782
Q9Y345,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),i200-220o227-247i274-299o392-412i421-441o466-486i513-528o557-583i611-631o635-655i675-695o715-735i,797
Q9Y5Y0,Heme transporter FLVCR1 (Feline leukemia virus subgroup C receptor-related protein 1) (Feline leukemia virus subgroup C receptor) (hFLVCR),i108-131o148-168i175-195o200-220i237-258o276-296i332-352o370-392i400-420o426-447i464-480o492-511i,555
Q9Y666,Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4),i119-141o156-178i205-228o252-270i273-302o416-436i451-478o494-516i556-580o583-605i613-631o632-654i,1083
Q9Y694,Solute carrier family 22 member 7 (Novel liver transporter) (NLT) (Organic anion transporter 2) (hOAT2),i20-40o146-166i173-193o196-217i231-254o259-273i348-364o378-398i404-423o430-452i468-486o493-512i,548
Q9Y6C5,Protein patched homolog 2 (PTC2),i58-78o393-413i429-449o458-478i502-522o531-551i687-707o964-984i992-1012o1020-1040i1058-1077o1091-1111i,1203
Q9Y6L6,Solute carrier organic anion transporter family member 1B1 (SLCO1B1) (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Organic anion transporter SLC21A6) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6),i29-48o64-84i96-117o171-193i207-230o259-277i337-357o374-397i407-427o534-558i570-590o624-644i,691
A6NK97,Solute carrier family 22 member 20 (Organic anion transporter 6) (Solute carrier family 22 member 20 pseudogene),i22-36o138-158i165-181o192-212i223-246o253-270i340-360o371-391i398-417o427-447i461-481o486-506i,555
A7MBM2,Protein dispatched homolog 2,i170-190o485-505i510-530o545-563i589-609o618-643i704-720o963-983i990-1010o1019-1034i1065-1080o1088-1107i,1401
O15375,Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5),i10-30o54-74i81-99o106-122i142-163o170-181i238-258o274-294i306-324o329-349i365-385o396-418i,505
O15403,Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6),i21-42o65-84i92-110o117-137i150-170o181-200i294-310o330-351i359-379o385-401i421-441o453-471i,523
O43934,UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET),i11-32o50-70i77-94o99-119i137-157o171-190i239-259o277-299i309-329o353-373i387-409o413-434i,449
Q4VNC0,Probable cation-transporting ATPase 13A5 (EC 7.2.2.-) (P5-ATPase isoform 5),i33-43o44-53i195-220o223-243i394-420o434-452i905-927o933-953i973-995o1039-1063i1075-1095o1115-1135i,1218
Q6ZMD2,Protein spinster homolog 3,i46-69o83-105i112-131o137-157i175-195o204-224i260-281o310-330i343-363o368-388i406-423o449-469i,512
Q6ZW05,Patched domain-containing protein 4 (p53-regulated patched protein),i42-62o237-252i263-285o294-312i336-356o371-393i463-483o659-679i683-703o714-734i756-776o784-809i,846
Q7RTM1,Proton channel OTOP1 (Otopetrin-1) (hOtop1),i61-82o92-112i135-156o167-186i201-219o269-289i311-332o347-369i393-413o424-444i546-563o577-597i,612
Q7RTS5,Proton channel OTOP3 (Otopetrin-3),i89-111o121-141i160-182o194-214i230-248o290-312i337-358o373-396i416-436o449-469i530-549o564-581i,596
Q7Z3Q1,Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 (Solute carrier family 46 member 3),i8-19o74-94i102-124o130-150i167-187o198-216i261-276o299-319i325-344o349-368i386-407o416-436i,461
Q8IZD6,Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1),i22-39o113-129i141-158o164-187i201-221o228-243i309-329o338-358i368-386o402-422i440-455o461-481i,547
Q8TCU3,Solute carrier family 7 member 13 (Sodium-independent aspartate/glutamate transporter 1) (X-amino acid transporter 2),i18-38o48-68i97-120o132-148i158-182o207-225i243-263o288-308i338-358o359-379i395-415o420-440i,470
Q8TD20,"Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)",i41-61o81-101i108-129o130-150i166-189o198-216i279-299o316-338i345-366o460-480i502-522o528-548i,617
Q96JT2,Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein),i19-39o52-72i87-106o120-140i161-181o197-217i274-292o326-342i353-372o375-395i494-514o522-542i,553
Q9BU23,Lipase maturation factor 2 (Transmembrane protein 112B) (Transmembrane protein 153),i10-30o80-95i102-115o129-143i168-188o227-247i252-267o277-286i311-332o360-385i400-420o633-656i,707
Q9BY10,Solute carrier family 46 member 2 (Thymic stromal cotransporter homolog),i24-44o77-97i107-129o135-157i173-191o205-227i284-304o321-341i348-368o372-391i407-430o439-459i,475
Q9GZN6,Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 (Solute carrier family 6 member 16),i113-133o141-163i191-211o264-284i293-315o338-358i376-403o490-517i537-554o568-588i609-631o658-678i,736
Q9H0V1,Transmembrane protein 168,i35-54o64-82i97-108o125-140i156-168o178-192i202-215o224-239i265-280o293-313i359-370o381-392i,697
Q9H2Y9,Solute carrier organic anion transporter family member 5A1 (Organic anion transporter polypeptide-related protein 4) (OATP-RP4) (OATPRP4) (Solute carrier family 21 member 15),i130-149o168-188i197-218o265-285i300-324o348-366i434-454o472-493i506-524o651-671i686-705o736-757i,848
Q9H3S5,GPI mannosyltransferase 1 (EC 2.4.1.-) (GPI mannosyltransferase I) (GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein) (PIG-M),i19-36o93-110i124-139o149-161i166-178o179-188i227-247o288-308i313-330o334-346i357-377o386-408i,423
A6NIM6,Solute carrier family 15 member 5,i42-65o79-97i110-130o154-173i192-214o221-241i309-326o346-366i383-404o433-447i470-490o510-525i,579
Q5BKX6,Solute carrier family 45 member 4,i57-77o86-106i121-140o156-177i198-216o231-251i511-527o560-578i592-612o616-631i665-685o694-714i,768
Q5GH77,XK-related protein 3 (X Kell blood group-related 3) (XTES),i35-55o67-87i99-109o110-119i166-185o197-217i235-255o265-283i301-311o312-321i345-365o377-395i,459
Q5TF39,Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B),i17o36-56i62-81o86-111i124-139o183-205i230-252o269-289i296-315o321-341i356-376o385-405i,518
Q63ZE4,Solute carrier family 22 member 10 (Organic anion transporter 5),i19-37o147-166i174-194o198-221i232-254o261-275i350-365o379-400i407-426o433-453i471-492o495-515i,541
Q6PP77,"XK-related protein 2 (Membrane protein XPLAC) (X Kell blood group-related, X-linked)",i35-55o65-77i78-87o98-118i174-190o202-222i240-260o269-286i306-316o317-327i349-370o382-402i,449
Q6T423,Solute carrier family 22 member 25 (Organic anion transporter UST6),i18-33o147-167i174-192o202-222i235-255o260-275i350-367o380-400i407-426o436-454i471-491o495-515i,547
Q6UX68,XK-related protein 5,i5-25o34-45i46-57o68-79i114-133o141-161i180-200o206-226i235-245o246-256i265-286o294-318i,686
Q6UXD7,Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7) (Myosin light polypeptide 5 regulatory protein) (MYL5),i30-51o70-90i97-120o126-146i161-181o194-215i248-268o286-306i312-334o342-362i375-395o422-442i,560
Q7RTS6,Proton channel OTOP2 (Otopetrin-2),i30-52o62-82i101-123o134-156i171-189o241-262i289-309o324-349i369-389o399-422i496-513o527-547i,562
Q7RTX9,Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14),i31-54o74-94i101-121o126-147i159-179o190-202i315-335o353-373i382-402o408-425i441-461o474-494i,510
Q8N434,Putative transporter SVOPL (SV2-related protein-like) (SVOP-like protein),i48-71o87-107i114-134o138-158i174-196o203-218i282-301o344-365i372-390o396-416i437-454o459-474i,492
Q8N468,Major facilitator superfamily domain-containing protein 4A (Major facilitator superfamily domain-containing protein 4),i19-36o55-74i82-102o107-128i144-160o223-242i312-332o347-369i377-396o401-422i437-457o466-486i,514
Q96ES6,Major facilitator superfamily domain-containing protein 3,i6-26o42-57i70-87o100-118i138-158o165-183i216-236o250-273i286-302o321-340i361-381o388-406i,412
Q96MC6,Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein),i40-60o72-93i103-121o124-144i158-178o189-207i245-259o282-305i312-331o335-350i373-393o428-448i,490
A6NKX4,Putative solute carrier family 22 member 31,i20-38o129-151i158-178o181-203i215-239o244-261i339-356o367-389i396-416o423-445i458-478o485-505i,556
Q14CX5,Transmembrane protein 180 (Major facilitator superfamily domain-containing 13A),i16-35o52-72i101-118o123-143i164-184o194-214i266-291o306-323i333-353o357-370i405-425o469-489i,517
Q5GH72,XK-related protein 7,i59-79o88-112i180-192o193-204i234-252o260-280i300-313o314-323i326-344o358-373i384-404o415-435i,579
Q8IWD5,Major facilitator superfamily domain-containing protein 6-like,i18-38o48-69i79-97o246-263i289-306o324-340i368-388o401-421i431-451o458-473i490-515o521-541i,586
Q8N4V2,Synaptic vesicle 2-related protein (SV2-related protein),i86-106o123-140i151-171o174-194i210-232o239-254i318-337o373-394i401-421o425-443i467-482o488-508i,548
Q8NBP5,Major facilitator superfamily domain-containing protein 9,i46-67o83-103i110-131o132-152i167-187o198-218i285-301o323-343i352-370o375-396i411-436o439-459i,474
O43826,Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19),i12-34o50-70i78-96o102-118i138-160o169-187i227-251o259-281i301-321o329-349i368-388o394-414i,429
O60266,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",i78-98o105-125i138-160o169-188i189-209o226-246i634-653o661-682i708-728o751-771i777-794o840-855i,1144
O60503,Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (ACIX) (Adenylyl cyclase 9) (AC9),i116-136o142-162i175-195o218-241i242-263o281-301i787-807o819-839i868-884o892-910i918-937o978-996i,1353
O60669,Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7),i16-36o60-80i87-107o112-132i144-164o176-187i247-267o283-303i313-333o340-358i374-394o407-427i,478
O60779,Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1),i30-46o73-92i98-118o121-141i159-180o188-208i295-313o334-354i361-383o387-407i421-443o456-479i,497
O00337,Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1),i84-104o112-128i150-170o179-195i206-222o274-299i340-354o367-387i411-431o537-552i572-586o,649
O76024,Wolframin,i325-346o347-362i402-422o432-447i459-474o501-516i531-540o561-571i572-581o597-613i632-652o,890
O94886,CSC1-like protein 1 (Transmembrane protein 63A),o50-71i146-166o192-211i427-443o466-483i508-523o555-573i614-629o630-639i665-685o698-713i,807
P03891,NADH-ubiquinone oxidoreductase chain 2 (EC 7.1.1.2) (NADH dehydrogenase subunit 2),i7-23o26-44i59-76o96-111i127-145o153-170i178-195o200-221i242-262o277-297i329-344o,347
P16615,"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)",i60-76o88-108i256-276o296-314i762-782o787-807i836-856o895-915i930-949o966-986i1018-1030o,1042
P48764,Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3),o57-81i82-102o108-128i144-165o181-201i211-230o251-271i295-314o368-388i406-426o437-456i,834
P98161,Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein),o3075-3095i3281-3302o3323-3344i3557-3578o3584-3602i3674-3694o3897-3917i3936-3956o3986-4003i4026-4046o4085-4105i,4303
Q13286,Battenin (Batten disease protein) (Protein CLN3),i39-54o99-119i128-144o152-172i183-202o213-231i285-298o321-337i346-365o372-390i410-430o,438
Q14542,"Equilibrative nucleoside transporter 2 (hENT2) (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Hydrophobic nucleolar protein, 36 kDa) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2)",i13-29o70-90i99-117o126-144i162-185o193-213i292-312o327-342i360-378o394-413i432-452o,456
Q14940,Sodium/hydrogen exchanger 5 (Na(+)/H(+) exchanger 5) (NHE-5) (Solute carrier family 9 member 5),o48-66i70-94o104-120i132-157o174-194i204-219o244-264i288-307o366-381i399-419o430-449i,896
Q495M3,Proton-coupled amino acid transporter 2 (Proton/amino acid transporter 2) (Solute carrier family 36 member 2) (Transmembrane domain rich protein 1) (Tramdorin-1),i59-77o85-105i149-169o202-218i226-246o265-282i298-318o338-362i379-400o406-426i441-463o,483
Q5T4D3,Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 4),i24-35o109-129i148-158o175-187i204-220o223-237i269-291o355-373i383-403o413-432i441-459o,741
Q68CP4,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),o192-215i277-290o308-325i342-357o375-394i418-437o501-518i532-552o571-588i602-617o637-654i,663
Q6AI14,Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4) (NHE-4) (Solute carrier family 9 member 4),o74-96i97-117o125-143i159-180o197-216i226-246o267-287i311-330o383-403i421-441o452-472i,798
Q6YBV0,Neutral amino acid uniporter 4 (Solute carrier family 36 member 4),i65-81o89-109i154-174o206-226i232-255o275-291i306-327o347-371i389-409o415-435i450-472o,504
Q6ZNC8,Lysophospholipid acyltransferase 1 (LPLAT 1) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase MBOAT1) (EC 2.3.1.n6) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 1) (O-acyltransferase domain-containing protein 1),o36-53i63-82o83-101i109-128o142-154i241-251o252-262i374-383o386-401i424-444o456-471i,495
Q6ZXV5,Protein O-mannosyl-transferase TMTC3 (EC 2.4.1.109) (Protein SMILE) (Transmembrane and TPR repeat-containing protein 3),i9-18o94-111i120-129o146-158i169-187o190-200i236-256o320-338i347-367o377-390i405-422o,915
Q7RTT9,Equilibrative nucleoside transporter 4 (hENT4) (Plasma membrane monoamine transporter) (PMAT) (Solute carrier family 29 member 4),i69-89o108-127i136-156o167-187i201-224o232-252i354-374o386-408i416-436o447-467i485-505o,530
Q7Z2H8,Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1),i49-69o78-98i142-162o196-211i216-240o260-276i290-310o332-354i373-393o399-419i434-456o,476
Q7Z442,Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2),o1345-1365i1553-1573o1594-1615i1821-1845o1855-1882i1947-1967o2182-2202i2220-2239o2267-2288i2312-2332o2373-2391i,2459
Q7Z443,Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3),o698-718i906-924o947-965i1153-1177o1187-1213i1285-1301o1464-1483i1502-1519o1551-1571i1591-1611o1649-1669i,1732
Q86VD9,GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3),i36-51o124-148i152-172o182-193i214-225o230-241i258-275o318-338i368-384o391-402i414-430o,579
Q8IUR5,Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 1),i28-39o116-132i142-153o170-182i203-218o221-235i314-329o354-374i383-402o412-428i440-459o,882
Q8IVJ1,Solute carrier family 41 member 1,i99-123o135-155i181-201o215-242i257-277o286-306i319-337o352-368i411-427o439-464i479-504o,513
Q8N394,Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane and TPR repeat-containing protein 2),i14o89-109i114-126o142-156i169-185o189-204i225-245o310-328i393-413o423-443i454-468o,836
Q8NBJ9,SID1 transmembrane family member 2,o297-317i449-469o500-521i547-567o580-595i606-626o633-653i689-708o717-735i746-768o797-817i,832
Q8NBW4,Neutral amino acid transporter 9 (Solute carrier family 38 member 9) (Up-regulated in lung cancer 11),i120-140o147-167i199-225o284-300i310-334o357-377i395-415o438-458i480-500o508-528i541-559o,561
Q8NFF2,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),i23-40o101-123i139-159o173-193i207-221o228-248i455-480o487-508i523-536o557-576i587-607o,622
Q8TB61,Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2),o36-57i109-129o154-174i187-201o209-230i240-255o269-288i302-319o337-357i366-381o392-411i,432
Q8TDX9,Polycystin-1-like protein 1 (Polycystin-1L1) (PC1-like 1 protein) (Polycystic kidney disease protein 1-like 1),o1751-1769i1957-1976o1993-2014i2136-2157o2170-2190i2291-2306o2521-2540i2559-2576o2613-2627i2650-2667o2712-2732i,2849
Q92521,GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B),i61-78o142-162i170-185o195-210i216-231o235-244i257-279o312-333i338-355o362-378i387-406o,554
Q969I6,Sodium-coupled neutral amino acid transporter 4 (Amino acid transporter A3) (Na(+)-coupled neutral amino acid transporter 4) (Solute carrier family 38 member 4) (System A amino acid transporter 3) (System N amino acid transporter 3),i82-99o105-125i153-173o196-216i221-242o332-350i367-390o410-434i453-471o477-499i513-538o,547
Q96GZ6,Solute carrier family 41 member 3,i67-87o101-121i147-171o187-207i223-244o252-272i286-303o314-334i377-396o406-429i445-462o,507
Q8WUG5,Solute carrier family 22 member 17 (24p3 receptor) (24p3R) (Brain-type organic cation transporter) (Lipocalin-2 receptor) (Neutrophil gelatinase-associated lipocalin receptor) (NgalR),o100-118i129-149o153-175i186-209o215-230i308-321o337-359i366-386o411-429i448-468o473-492i,538
Q8WUX1,Sodium-coupled neutral amino acid transporter 5 (Solute carrier family 38 member 5) (System N transporter 2),i51-73o78-99i126-146o168-188i194-214o258-273i296-316o335-355i376-395o400-420i440-460o,472
Q96JW4,Solute carrier family 41 member 2,i161-184o196-216i242-262o279-303i318-338o346-366i380-398o410-430i471-490o499-522i539-564o,573
Q96N66,Lysophospholipid acyltransferase 7 (LPLAT 7) (EC 2.3.1.-) (1-acylglycerophosphatidylinositol O-acyltransferase) (Bladder and breast carcinoma-overexpressed gene 1 protein) (Leukocyte receptor cluster member 4) (Lysophosphatidylinositol acyltransferase) (LPIAT) (Lyso-PI acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7) (h-mboa-7),o6-22i32-47o51-66i73-89o103-117i195-212o232-241i355-365o366-375i397-412o429-445i,472
Q96QD8,Sodium-coupled neutral amino acid symporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2),i77-95o101-121i150-177o191-211i218-238o292-312i330-350o370-394i413-431o438-459i473-495o,506
Q99624,Sodium-coupled neutral amino acid transporter 3 (N-system amino acid transporter 1) (Na(+)-coupled neutral amino acid transporter 3) (Solute carrier family 38 member 3) (System N amino acid transporter 1),i70-90o96-114i144-164o187-207i213-233o286-301i321-344o364-386i404-425o432-452i469-491o,504
Q99808,"Equilibrative nucleoside transporter 1 (hENT1) (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (es nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1)",i13-29o83-107i112-130o139-157i175-199o207-227i292-311o324-342i360-378o394-413i432-452o,456
Q9BV10,"Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (EC 2.4.1.260) (Asparagine-linked glycosylation protein 12 homolog) (hALG12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog) (Membrane protein SB87)",i12-27o97-115i124-144o151-165i169-183o187-200i209-231o267-284i288-306o312-325i343-365o,488
Q9BZD2,Equilibrative nucleoside transporter 3 (hENT3) (Solute carrier family 29 member 3),i52-72o106-126i135-153o163-182i200-222o232-252i306-326o345-369i378-396o413-433i451-471o,475
Q9H2H9,Sodium-coupled neutral amino acid symporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),i77-95o101-121i149-169o190-212i223-238o275-293i310-333o352-372i394-411o417-439i453-474o,487
Q9H598,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (hVIAAT),i122-142o147-162i205-229o242-257i266-286o306-323i340-360o380-400i431-450o458-478i490-512o,525
Q9H6U8,"Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)",i64-75o141-161i172-192o195-210i214-230o231-243i251-269o311-331i346-363o371-391i412-433o,611
Q9HAB3,"Solute carrier family 52, riboflavin transporter, member 2 (Porcine endogenous retrovirus A receptor 1) (PERV-A receptor 1) (Protein GPR172A) (Riboflavin transporter 3) (hRFT3)",i11-32o47-68i79-99o113-133i147-167o196-216i277-297o308-332i339-359o370-392i406-426o,445
Q9HAS3,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (hCNT3),i103-123o132-148i174-191o201-218i227-244o296-322i362-376o389-409i430-453o559-574i594-608o,691
Q9HC58,Sodium/potassium/calcium exchanger 3 (Na(+)/K(+)/Ca(2+)-exchange protein 3) (Solute carrier family 24 member 3),i23-43o111-133i149-169o183-203i217-232o238-255i480-502o510-531i546-559o580-599i610-630o,644
Q9NP58,ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5) (Mitochondrial ABC transporter 3) (Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter),o27-47i73-93o107-127i148-168o186-206i264-284o292-312i376-397o398-418i500-520o530-550i,842
Q9NQ40,"Solute carrier family 52, riboflavin transporter, member 3 (Riboflavin transporter 2) (hRFT2)",i7-25o43-61i73-93o107-127i138-158o222-242i300-321o336-355i361-383o397-413i429-451o,469
Q9NTG1,Polycystin family receptor for egg jelly (PKD and REJ homolog) (Polycystic kidney disease and receptor for egg jelly-related protein),o1184-1204i1390-1408o1427-1440i1574-1600o1610-1632i1711-1731o1961-1981i1997-2017o2046-2066i2089-2111o2146-2166i,2253
Q9NUD9,GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V),i14-29o120-134i148-168o171-184i189-203o204-214i237-257o328-347i379-397o412-421i467-485o,493
Q9NVC3,Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7),i54-72o83-103i130-150o178-194i202-224o241-255i278-298o321-341i371-389o394-415i433-453o,462
Q9NWF4,"Solute carrier family 52, riboflavin transporter, member 1 (Porcine endogenous retrovirus A receptor 2) (PERV-A receptor 2) (huPAR-2) (Protein GPR172B) (Riboflavin transporter 1) (hRFT1)",i10-32o47-68i79-99o113-133i147-167o196-216i280-300o315-335i342-362o373-395i409-429o,448
Q9P1W3,Calcium permeable stress-gated cation channel 1 (Transmembrane protein 63C),o38-58i133-153o184-204i410-430o450-473i491-511o550-570i600-619o620-630i652-673o692-706i,806
Q9UBY0,Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2),o85-107i108-128o136-154i170-191o208-227i237-257o275-295i319-338o391-411i429-449o460-479i,812
Q9UI40,Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2),i39-52o139-158i189-198o205-226i242-256o263-280i501-521o536-554i569-586o603-623i631-650o,661
Q9UKY4,Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2),i55-71o146-164i170-189o197-211i223-243o244-262i283-300o596-618i636-657o665-685i700-720o,750
Q9Y6A1,Protein O-mannosyl-transferase 1 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 1),i17-28o109-124i131-142o154-174i184-204o205-220i262-283o597-619i636-657o661-681i696-716o,747
A6NNN8,Putative sodium-coupled neutral amino acid transporter 8 (Solute carrier family 38 member 8),i29-49o56-79i106-127o151-166i175-197o215-234i250-274o294-314i344-365o371-392i408-431o,435
O00624,Sodium-dependent phosphate transport protein 3 (Na(+)/PI cotransporter 3) (Sodium/phosphate cotransporter 3) (Solute carrier family 17 member 2),i20-40o93-113i120-141o142-162i184-203o211-231i273-293o313-333i350-370o374-396i408-428o,439
Q495N2,Proton-coupled amino acid transporter 3 (Proton/amino acid transporter 3) (Solute carrier family 36 member 3) (Tramdorin-2),i48-64o73-93i137-157o186-206i211-235o253-271i285-307o326-350i367-388o394-414i432-452o,470
Q5T3F8,CSC1-like protein 2 (Transmembrane protein 63B),o41-62i158-178o204-221i435-455o478-495i520-535o566-586i626-642o643-654i680-698o711-726i,832
Q8IZM9,Probable sodium-coupled neutral amino acid transporter 6 (N-system amino acid transporter 1) (NAT-1) (Na(+)-coupled neutral amino acid transporter 6) (Solute carrier family 38 member 6),i51-69o75-95i124-145o165-185i188-211o249-267i284-307o327-347i370-388o394-416i429-451o,456
Q9HBR0,Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10),i11-31o36-56i83-108o124-142i153-173o194-211i229-250o272-292i323-339o345-366i377-397o,1119
Q9NX78,Protein O-mannosyl-transferase TMEM260 (EC 2.4.1.109) (Transmembrane protein 260),i28-40o100-114i121-133o148-163i175-188o192-206i219-239o295-312i321-338o356-376i391-404o,707
Q9NXL6,SID1 transmembrane family member 1,o310-331i443-464o498-516i542-562o575-590i601-621o628-648i684-703o712-730i740-763o792-812i,827
G3V0H7,Putative solute carrier organic anion transporter family member 1B7 (Liver-specific organic anion transporter 3) (LST-3) (Putative organic anion transporting polypeptide 1B7) (OATP1B7),o19-37i49-70o125-146i160-183o213-230i290-313o328-350i360-380o489-509i523-544o577-599i,640
Q8NE00,Transmembrane protein 104,i15-37o43-64i145-167o205-225i233-254o273-287i307-327o350-374i398-413o422-442i469-490o,496
O43868,Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2) (CNT 2) (hCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside co-transporter) (SPNT) (Solute carrier family 28 member 2),i80-99o107-119i149-165o174-189i201-216o267-276i336-349o362-375i412-425o533-546i568-577o,658
O00476,Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (NPT4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3),i41-61o103-112i126-146o154-174i212-232o256-276i292-311o318-338i350-369o384-404i,420
O14983,"Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) (SR Ca(2+)-ATPase 1) (EC 7.2.2.10) (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)",i60-76o88-108i256-276o296-314i760-781o788-808i832-857o896-916i931-950o967-987i,1001
O43520,Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1),i119-134o145-154i336-357o386-406i959-971o983-1003i1033-1054o1072-1090i1097-1117o1143-1166i,1251
O76062,Delta(14)-sterol reductase TM7SF2 (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (Another new gene 1 protein) (C-14 sterol reductase) (C14SR) (Putative sterol reductase SR-1) (Sterol C14-reductase) (Transmembrane 7 superfamily member 2),i17-36o62-80i101-116o133-148i188-208o221-241i255-275o287-305i352-362o363-384i,418
O94823,Phospholipid-transporting ATPase VB (EC 7.6.2.1) (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B),i93-113o116-131i313-333o367-387i1121-1130o1145-1165i1195-1215o1226-1241i1252-1272o1298-1318i,1461
O95436,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),i98-118o145-164i219-234o363-383i417-427o428-437i465-474o485-501i527-547o554-575i,690
P05023,Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1),i96-117o130-150i291-312o320-340i776-796o802-822i854-873o920-936i952-974o986-1004i,1023
P13637,Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3),i82-102o122-142i281-298o310-328i766-782o793-813i844-856o910-926i942-960o977-998i,1013
P20020,Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1),i106-126o155-175i367-386o419-439i856-876o883-903i928-948o972-991i1006-1027o1040-1060i,1220
P20648,Potassium-transporting ATPase alpha chain 1 (EC 7.2.2.19) (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump),i99-119o143-163i300-319o332-349i784-803o814-834i855-877o930-949i964-982o998-1018i,1035
P23634,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),i101-121o151-171i357-376o409-429i844-864o871-891i916-936o960-979i994-1015o1028-1048i,1241
P32418,Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1),o82-95i139-154o170-190i204-222o236-252i804-825o834-852i875-892o907-926i945-964o,973
P35523,"Chloride channel protein 1 (ClC-1) (Chloride channel protein, skeletal muscle)",i118-138o161-178i269-280o281-290i305-322o348-368i391-414o456-477i485-505o556-569i,988
P48651,Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I),i42-58o69-88i103-121o161-183i186-204o218-240i287-307o319-339i354-371o381-403i,473
P50993,Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-2),i94-115o128-148i289-310o318-338i773-793o798-820i851-870o917-933i949-971o985-1005i,1020
P51788,Chloride channel protein 2 (ClC-2),i92-114o134-152i279-295o318-342i364-384o431-452i459-471o472-481i528-542o543-553i,898
P51798,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),i127-148o177-197i226-236o237-246i327-342o375-395i414-434o488-511i515-536o578-598i,805
P51800,Chloride channel protein ClC-Ka (Chloride channel Ka) (ClC-K1),i52-62o63-72i240-250o282-302i325-340o399-419i428-438o439-448i473-491o500-511i,687
P51801,Chloride channel protein ClC-Kb (Chloride channel Kb) (ClC-K2),i51-61o62-71i240-250o282-302i325-340o398-418i428-438o439-448i473-491o498-512i,687
P54707,Potassium-transporting ATPase alpha chain 2 (HK alpha 2) (Non-gastric H(+)/K(+) ATPase subunit alpha) (EC 7.2.2.19) (Non-gastric Na(+)/K(+) ATPase subunit alpha) (EC 7.2.2.13) (Proton pump) (Sodium pump),i104-124o147-167i304-324o336-353i788-807o818-838i865-885o933-953i968-988o1003-1024i,1039
P57103,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),o78-94i138-153o169-189i203-223o231-251i758-780o789-806i829-846o861-880i899-918o,927
P61619,Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1),i34-53o77-96i118-138o145-165i173-193o241-261i289-309o355-375i421-441o446-462i,476
P78381,UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT),i35-52o69-88i112-132o139-159i167-184o201-221i235-253o269-287i295-313o322-340i,396
P78382,CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (CST) (Solute carrier family 35 member A1),i10-30o46-64i88-108o115-135i142-160o176-196i210-228o244-262i270-288o297-315i,337
P78383,Solute carrier family 35 member B1 (ATP/ADP exchanger ER) (AXER) (Endoplasmic reticulum ATP/ADP translocase) (UDP-galactose transporter-related protein 1) (UGTrel1),i12-32o51-71i85-105o113-131i138-156o174-189i204-222o239-259i278-287o294-313i,322
P98194,Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1) (SPCA1),i83-93o102-122i265-283o294-314i703-723o731-751i779-795o810-826i843-860o878-898i,919
P98196,Phospholipid-transporting ATPase IH (EC 7.6.2.1) (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A),i72-87o97-109i292-314o349-370i891-903o915-935i964-984o1002-1022i1029-1053o1066-1092i,1134
P98198,Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),i75-92o95-113i291-313o343-363i899-911o923-943i973-994o1010-1030i1037-1057o1083-1106i,1209
Q01814,Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2),i103-123o153-173i391-410o443-463i879-899o906-926i951-971o995-1014i1029-1050o1063-1083i,1243
Q03518,Antigen peptide transporter 1 (APT1) (EC 7.4.2.14) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein) (RING4),i16-36o54-76i93-113o134-154i187-207o228-248i299-319o329-349i419-439o444-464i,748
Q03519,Antigen peptide transporter 2 (APT2) (EC 7.4.2.14) (ATP-binding cassette sub-family B member 3) (Peptide supply factor 2) (Peptide transporter PSF2) (PSF-2) (Peptide transporter TAP2) (Peptide transporter involved in antigen processing 2) (Really interesting new gene 11 protein) (RING11),i8-23o55-65i66-75o99-119i150-170o192-216i268-288o294-306i378-392o414-431i,686
Q06495,Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1),i101-121o152-167i222-237o349-369i403-413o414-423i451-460o471-491i513-533o540-560i,639
Q0GE19,Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7),i11-23o40-58i74-95o112-123i140-159o169-187i202-222o234-254i271-280o299-319i,340
Q13336,"Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte)",i66-87o90-110i120-136o144-164i175-191o233-251i255-274o281-301i310-330o340-353i,389
Q13530,Serine incorporator 3 (Tumor differentially expressed protein 1),i40-57o97-117i131-151o160-180i205-225o237-256i269-289o332-350i405-424o441-466i,473
Q13733,Sodium/potassium-transporting ATPase subunit alpha-4 (Na(+)/K(+) ATPase alpha-4 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-4),i104-125o138-158i299-319o328-348i782-802o808-828i861-879o925-942i958-978o991-1010i,1029
Q14739,Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase),i212-232o258-278i297-312o329-346i385-405o418-438i452-472o484-502i549-565o566-581i,615
Q16720,Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3),i106-126o156-176i365-384o417-437i853-873o880-900i925-945o969-988i1003-1024o1037-1057i,1220
Q2M3R5,Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20),i73-85o102-117i131-151o165-176i187-201o225-241i255-273o286-303i314-332o339-357i,365
Q53GD3,Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1) (hTPPT1),i36-56o230-250i253-275o309-329i355-379o442-465i495-505o506-515i594-616o639-661i,710
Q5GH76,"XK-related protein 4 (hXKR4) [Cleaved into: XK-related protein 4, processed form]",i113-134o143-164i307-326o334-351i373-393o399-417i431-448o457-467i468-477o489-509i,650
Q6ICL7,Solute carrier family 35 member E4,i49-66o79-94i110-130o139-154i164-179o189-198i220-240o255-276i282-302o309-328i,350
Q6NXT6,Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor),i111-121o122-139i160-179o194-214i238-258o274-286i311-322o338-355i403-417o430-450i,567
Q71RS6,Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5),o69-92i113-128o142-160i176-190o197-217i336-356o368-386i403-416o438-456i467-487o,500
Q75T13,GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1),i8-29o593-610i639-650o679-694i732-745o749-758i818-838o854-868i882-899o908-918i,922
Q76EJ3,Nucleotide sugar transporter SLC35D2 (Homolog of Fringe connection protein 1) (HFRC1) (SQV7-like protein) (SQV7L) (Solute carrier family 35 member D2) (UDP-galactose transporter-related protein 8) (UGTrel8),i25-44o58-75i94-111o126-139i145-163o170-188i203-223o238-260i268-288o296-316i,337
Q7Z403,Transmembrane channel-like protein 6 (Epidermodysplasia verruciformis protein 1) (Protein LAK-4),i249-272o341-359i435-455o470-490i514-529o552-563i564-574o602-618i651-673o717-737i,805
Q7Z769,Solute carrier family 35 member E3 (Bladder cancer-overexpressed gene 1 protein),i14-31o44-62i77-97o100-120i132-146o153-173i187-207o224-246i251-271o278-297i,313
Q8IU68,Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2),i110-136o203-218i304-320o334-358i378-393o423-432i435-445o483-499i532-553o598-615i,726
Q8IWA5,Choline transporter-like protein 2 (Solute carrier family 44 member 2),i34-55o233-253i259-280o316-335i364-384o445-468i502-512o513-522i597-619o640-662i,706
Q8N130,Sodium-dependent phosphate transport protein 2C (Sodium-phosphate transport protein 2C) (Na(+)-dependent phosphate cotransporter 2C) (Sodium/inorganic phosphate cotransporter IIC) (Sodium/phosphate cotransporter 2C) (Na(+)/Pi cotransporter 2C) (NaPi-2c) (Solute carrier family 34 member 3),i73-93o119-139i192-209o322-342i377-390o391-400i424-433o444-464i486-506o514-534i,599
Q8N357,Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog),i8-25o48-68i89-109o115-135i145-164o176-196i212-232o261-279i293-310o317-336i,371
Q8NB49,Phospholipid-transporting ATPase IG (EC 7.6.2.1) (ATPase IQ) (ATPase class VI type 11C) (P4-ATPase flippase complex alpha subunit ATP11C),i70-85o95-107i291-311o347-368i885-897o909-929i959-981o996-1016i1023-1046o1061-1090i,1132
Q8NCS7,Choline transporter-like protein 5 (Solute carrier family 44 member 5),i40-60o243-263i266-287o326-346i371-393o459-479i509-519o520-529i611-631o651-673i,719
Q93084,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 7.2.2.10) (Calcium pump 3),i60-76o88-108i256-276o296-314i760-781o788-808i832-857o899-914i931-950o967-987i,999
Q969S0,Nucleotide sugar transporter SLC35B4 (Solute carrier family 35 member B4) (UDP-xylose and UDP-N-acetylglucosamine transporter) (YEA4 homolog),i3-20o34-52i66-86o93-111i118-137o158-180i195-211o240-260i267-287o294-314i,331
Q96A29,GDP-fucose transporter 1 (Solute carrier family 35 member C1),i38-58o74-95i117-135o140-160i168-186o196-216i230-248o266-286i298-311o321-340i,364
Q96G79,Probable UDP-sugar transporter protein SLC35A4 (Solute carrier family 35 member A4),i19-32o52-72i86-106o113-133i140-161o189-204i218-237o251-271i280-296o304-322i,324
Q8TF62,Probable phospholipid-transporting ATPase IM (EC 7.6.2.1) (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4),i55-72o75-93i272-294o324-344i881-893o905-925i955-975o992-1012i1019-1039o1065-1085i,1192
Q8WUD6,Cholinephosphotransferase 1 (hCPT1) (EC 2.7.8.2) (AAPT1-like protein) (Diacylglycerol cholinephosphotransferase 1),i65-83o98-113i131-151o159-179i191-209o226-247i264-282o294-309i326-341o349-369i,406
Q8WUM9,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),o25-39i64-77o106-120i133-143o158-180i197-215o228-250i535-544o562-579i650-672o,679
Q8WWI5,Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92),i29-50o213-233i239-263o289-310i333-359o384-408i440-450o451-460i535-559o570-590i,657
Q9BVG9,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),i63-82o96-112i127-147o189-211i214-232o246-268i314-334o346-369i382-397o410-433i,487
Q9BZW4,Transmembrane 6 superfamily member 2,i6-24o34-54i63-83o110-131i140-160o170-190i219-234o267-287i298-316o333-352i,377
Q9C0D9,Ethanolaminephosphotransferase 1 (hEPT1) (EC 2.7.8.1) (Selenoprotein I) (SelI),i52-71o91-106i122-144o154-172i188-205o221-243i259-279o291-305i320-338o345-366i,397
Q9H2D1,Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32),i85-95o96-105i121-131o132-142i186-196o197-206i225-235o236-248i282-293o294-303i,315
Q9H3H5,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase),o11-38i59-78o92-118i122-143o167-186i193-213o219-242i251-269o272-293i376-400o,408
Q9H6D3,"XK-related protein 8 (hXkr8) [Cleaved into: XK-related protein 8, processed form]",i13-35o43-67i135-154o162-179i201-211o212-221i229-246o259-274i285-305o318-338i,395
Q9HCE9,Anoctamin-8 (Transmembrane protein 16H),i249-269o282-302i353-381o397-417i437-458o473-492i751-761o764-774i808-824o843-863i,1232
Q9HCP6,Protein-cysteine N-palmitoyltransferase HHAT-like protein (Glycerol uptake/transporter homolog) (Hedgehog acyltransferase-like protein),i11-31o75-92i100-113o117-132i251-271o300-309i366-380o385-403i430-445o468-483i,504
Q9NP78,ABC-type oligopeptide transporter ABCB9 (EC 7.4.2.6) (ATP-binding cassette sub-family B member 9) (ATP-binding cassette transporter 9) (ABC transporter 9 protein) (hABCB9) (TAP-like protein) (TAPL),i6-26o48-68i81-99o116-137i185-206o229-249i300-320o330-350i418-428o445-465i,766
Q9NQQ7,Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein),i14-34o47-67i87-107o110-131i138-156o163-183i201-221o240-264i270-290o297-319i,365
Q9NRX5,Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2),i40-58o89-109i124-143o152-172i197-218o229-249i261-281o312-329i387-408o421-446i,453
Q9NTI2,Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2),i88-108o118-133i312-334o363-385i879-899o911-931i960-980o998-1014i1029-1049o1069-1089i,1188
Q9NTN3,Nucleotide sugar transporter SLC35D1 (Solute carrier family 35 member D1) (UDP-galactose transporter-related protein 7) (UGTrel7) (UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter) (UDP-GlcA/UDP-GalNAc transporter),i39-59o73-90i109-127o133-153i160-177o185-205i218-237o254-274i287-303o311-331i,355
Q9P241,Phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D),i98-118o122-136i322-342o370-390i1122-1134o1146-1166i1196-1216o1226-1246i1253-1276o1297-1317i,1426
Q9UBH6,Solute carrier family 53 member 1 (Phosphate exporter SLC53A1) (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor) (Xenotropic and polytropic retrovirus receptor 1),i235-257o271-291i316-337o345-360i403-414o446-464i477-497o510-530i557-579o591-602i,696
Q9UBM7,7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Delta7-sterol reductase) (Sterol Delta(7)-reductase) (Sterol reductase SR-2),i40-60o97-114i146-161o180-197i235-253o270-288i304-322o337-353i409-419o420-441i,475
Q9Y2D2,UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3),i7-24o41-59i87-104o111-131i138-156o173-194i208-226o242-262i268-288o296-314i,325
Q9Y2G3,Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B),i66-81o91-103i285-307o338-363i887-896o911-931i961-983o999-1019i1026-1051o1063-1089i,1177
Q9Y2Q0,Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1),i68-90o99-114i293-315o344-361i859-879o891-911i940-960o978-994i1009-1029o1049-1072i,1164
Q9Y6K0,Choline/ethanolaminephosphotransferase 1 (hCEPT1) (EC 2.7.8.1) (EC 2.7.8.2) (1-alkenyl-2-acylglycerol choline phosphotransferase) (EC 2.7.8.22),i87-105o118-135i153-173o181-201i211-231o248-269i286-304o317-331i346-363o371-391i,416
Q5T1Q4,Solute carrier family 35 member F1,i61-79o94-114i132-149o160-176i186-206o221-236i249-268o283-303i312-330o337-355i,408
Q8NG04,Putative solute carrier family 26 member 10P,i39-48o54-69i76-91o116-136i149-169o200-215i229-249o283-300i352-372o378-393i,563
Q8TBE7,Solute carrier family 35 member G2 (Transmembrane protein 22),i104-121o136-154i166-186o196-209i223-238o255-274i287-306o318-336i345-365o372-394i,412
Q9H1N7,Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (3'-phosphoadenosine 5'-phosphosulfate transporter) (PAPS transporter 2) (Solute carrier family 35 member B3),i78-98o113-133i146-166o170-190i200-216o229-243i260-279o298-318i325-345o351-369i,401
A6NH21,Serine incorporator 4,i62-83o118-138i152-172o180-204i223-244o255-275i288-308o336-356i427-447o464-486i,518
P0C7Q6,Solute carrier family 35 member G6 (Acyl-malonyl-condensing enzyme 1-like protein 3) (Transmembrane protein 21B),i40-57o72-87i104-124o132-148i159-178o194-209i222-241o254-270i280-300o310-326i,338
P0CK96,Solute carrier family 35 member E2B,i75-92o106-126i142-162o171-186i197-215o222-237i260-277o296-316i328-344o351-367i,405
Q08AI6,Putative sodium-coupled neutral amino acid transporter 11 (Solute carrier family 38 member 11),o6-26i55-75o93-115i124-144o164-184i200-220o241-262i279-299o308-327i340-362o,406
Q12767,Transmembrane protein 94,i65-85o94-112i280-301o317-337i1092-1113o1124-1141i1169-1189o1228-1252i1267-1287o1307-1327i,1356
Q24JQ0,Transmembrane protein 241,i7-21o40-54i69-87o97-112i123-141o151-163i182-197o217-236i248-265o273-291i,296
Q5GH70,"XK-related protein 9 (hXKR9) [Cleaved into: XK-related protein 9, processed form]",i8-28o38-58i133-154o162-180i206-216o217-226i230-248o261-276i290-307o318-338i,373
Q5GH73,XK-related protein 6,i130-150o160-181i292-311o319-336i358-369o370-382i386-402o416-431i442-462o474-494i,641
Q5M8T2,Solute carrier family 35 member D3 (Fringe connection-like protein 1),i9-27o43-59i79-96o110-123i130-148o156-174i189-207o226-248i253-273o282-303i,416
Q6UXY8,Transmembrane channel-like protein 5,i450-473o526-545i620-640o655-675i699-714o733-744i745-754o787-802i832-857o901-921i,1006
Q7Z402,Transmembrane channel-like protein 7,i163-185o264-284i363-383o404-425i444-462o496-506i507-516o552-576i601-622o666-679i,723
Q7Z404,Transmembrane channel-like protein 4,i164-186o252-270i349-369o391-411i434-449o484-494i495-504o536-556i589-611o654-667i,712
Q7Z5M5,Transmembrane channel-like protein 3,i142-165o226-246i320-340o362-382i399-415o509-519i520-529o570-584i620-640o676-697i,1100
Q7Z5S9,Transmembrane protein 144,o12-23i39-59o67-86i94-114o126-145i187-207o233-253i266-286o292-312i323-342o,345
Q8IXU6,Solute carrier family 35 member F2,i39-59o73-93i111-128o136-156i162-184o197-215i227-247o261-281i291-309o316-334i,374
Q8IY50,Solute carrier family 35 member F3 (Thiamine transporter SLC35F3),i66-87o98-118i149-169o180-198i204-224o232-252i266-288o302-323i329-345o356-378i,421
Q8WV83,Solute carrier family 35 member F5 (Hepatitis C virus NS5A-transactivated protein 3) (HCV NS5A-transactivated protein 3),i70-90o101-121i240-260o268-288i298-318o327-347i361-381o397-417i425-441o452-472i,523
Q96K37,Solute carrier family 35 member E1,i27-47o61-80i109-130o137-157i163-181o188-208i222-240o260-280i293-309o316-333i,410
Q96KT7,Solute carrier family 35 member G5 (Acyl-malonyl-condensing enzyme 1-like protein 2),i40-57o72-87i104-124o133-148i159-178o193-209i222-241o254-270i280-300o307-325i,338
Q96SA4,Serine incorporator 2 (Tumor differentially expressed protein 2-like),i40-61o96-116i131-150o158-179i205-225o237-257i268-289o318-339i389-409o422-445i,455
Q9BS91,UDP-sugar transporter protein SLC35A5 (Solute carrier family 35 member A5),i17-37o54-74i94-115o120-142i148-168o232-249i264-285o304-324i330-350o357-375i,424
Q9BZW5,Transmembrane 6 superfamily member 1,i5-23o33-53i63-82o111-131i139-157o169-186i218-239o266-287i297-315o331-351i,370
Q9H9S3,Protein transport protein Sec61 subunit alpha isoform 2 (Sec61 alpha-2),i34-53o77-96i118-138o145-165i173-193o241-261i289-309o354-375i421-441o446-462i,476
A4IF30,Solute carrier family 35 member F4,i165-185o196-216i253-268o278-296i302-322o330-350i365-386o402-422i427-443o454-474i,521
P0C7Q5,Putative solute carrier family 35 member G4 (Acyl-malonyl-condensing enzyme 1-like protein 1),i40-57o72-87i105-122o133-148i159-178o193-209i222-241o254-270i280-300o310-325i,338
Q8N808,Solute carrier family 35 member G3 (Acyl-malonyl-condensing enzyme 1) (Transmembrane protein 21A),i39-57o72-87i104-124o131-148i159-178o190-209i222-241o254-271i281-300o310-325i,338
O43861,Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B),i146-171o184-195i375-398o413-428i940-955o963-983i1013-1034o1042-1062i1067-1087o1112-1133i,1147
O60312,Phospholipid-transporting ATPase VA (EC 7.6.2.1) (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A),i86-107o108-124i310-330o362-379i1098-1108o1121-1141i1171-1191o1201-1221i1228-1248o1272-1292i,1499
O60423,Phospholipid-transporting ATPase IK (EC 7.6.2.1) (ATPase class I type 8B member 3),i160-177o180-195i376-398o427-447i1005-1017o1029-1049i1078-1100o1116-1137i1138-1167o1187-1207i,1300
O75110,Probable phospholipid-transporting ATPase IIA (EC 7.6.2.1) (ATPase class II type 9A),i69-94o106-118i298-321o332-351i851-866o874-894i924-946o953-973i978-998o1012-1033i,1047
O75185,Calcium-transporting ATPase type 2C member 2 (ATPase 2C2) (EC 7.2.2.10) (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2) (SPCA2),i110-120o133-153i295-310o328-342i732-753o761-781i809-825o840-857i874-892o909-928i,946
B7ZAQ6,Golgi pH regulator A (Protein GPR89A) (Putative MAPK-activating protein PM01) (Putative NF-kappa-B-activating protein 90),o5-26i39-63o75-95i110-128o146-166i289-309o339-360i378-398o426-444i,455
O75907,Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase),i86-109o129-146i169-186o189-208i275-296o326-353i405-423o429-446i451-473o,488
O75908,Sterol O-acyltransferase 2 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 2) (ACAT-2) (Cholesterol acyltransferase 2),i120-140o163-181i202-220o226-243i294-319o336-359i426-442o447-464i475-496o,522
O95674,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),i69-89o92-112i124-153o166-186i194-219o222-247i260-281o335-357i380-401o,445
P35575,Glucose-6-phosphatase catalytic subunit 1 (EC 3.1.3.9) (Glucose-6-phosphatase) (G-6-Pase) (G6Pase) (Glucose-6-phosphatase alpha) (G6Pase-alpha),o32-47i61-76o118-127i151-169o180-195i209-227o261-277i292-309o320-341i,357
P35610,Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1),i138-157o177-199i226-246o250-267i320-345o362-385i452-468o473-490i502-522o,550
P38435,Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase),i64-80o113-136i137-152o165-174i201-216o252-272i277-294o301-310i362-377o,758
P49768,Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)],i85-103o128-153i160-189o195-213i220-240o243-260i383-399o403-421i435-461o,467
P49810,Presenilin-2 (PS-2) (EC 3.4.23.-) (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit],i91-109o135-159i166-195o201-219i226-246o249-266i364-380o384-402i416-442o,448
Q0D2K0,Magnesium transporter NIPA4 (Ichthyin) (NIPA-like protein 4) (Non-imprinted in Prader-Willi/Angelman syndrome region protein 4),o56-76i104-124o130-145i156-174o196-216i224-247o262-282i296-313o323-342i,404
Q12887,"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)",i163-179o189-207i234-254o257-274i286-301o312-327i361-374o379-399i411-429o,443
Q12908,"Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)",o30-50i68-90o95-104i129-149o165-182i196-215o226-244i267-276o289-307i,348
Q14973,Hepatic sodium/bile acid cotransporter (Cell growth-inhibiting gene 29 protein) (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (NTCP) (Solute carrier family 10 member 1) (SLC10A1),o27-46i60-83o93-108i120-141o158-176i190-210o221-241i259-270o282-304i,349
Q3KNW5,Sodium-dependent organic anion transporter (SOAT) (Solute carrier family 10 member 6) (SLC10A6),o33-53i66-90o98-115i127-147o165-183i196-216o224-245i264-273o288-308i,377
Q6P1A2,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),o42-57i68-84o90-107i112-132o146-157i234-247o273-282i418-438o454-469i,487
Q6UX01,Protein LMBR1L (Limb region 1 protein homolog-like) (Lipocalin-1-interacting membrane receptor) (LIMR),o23-41i67-87o111-131i154-172o194-212i301-319o351-371i392-409o433-452i,489
Q6ZNB7,Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195),o40-60i76-101o115-131i169-181o185-199i335-355o363-383i390-404o419-433i,445
Q7RTP0,Magnesium transporter NIPA1 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 1) (Spastic paraplegia 6 protein),o30-48i68-88o93-113i120-138o160-180i188-209o229-248i259-280o291-311i,329
Q7Z2K6,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),i73-92o416-433i454-475o492-510i526-543o554-567i581-603o622-642i652-672o,904
Q86VE9,Serine incorporator 5,i37-57o90-110i124-144o154-174i198-218o230-248i261-281o311-331i392-412o,423
Q8IUH8,Signal peptide peptidase-like 2C (SPP-like 2C) (SPPL2c) (EC 3.4.23.-) (Intramembrane protease 5) (IMP-5),o185-205i253-273o277-297i322-340o347-367i376-396o440-457i471-494o498-518i,684
Q8IWX5,Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2),i89-109o121-141i167-179o189-209i215-235o248-264i280-293o320-342i375-392o,399
Q8TCT6,Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4),o18-33i73-91o96-118i141-159o163-181i188-211o263-283i315-335o338-358i,384
Q8TCT7,Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) (Intramembrane protease 4) (IMP-4) (Presenilin homologous protein 4) (PSH4) (Presenilin-like protein 1),o173-193i223-243o247-267i295-314o320-340i349-369o413-430i444-467o471-491i,592
Q8TCT8,Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2),o171-191i220-240o244-268i287-306o312-332i341-361o400-420i437-458o463-480i,520
Q8TCT9,Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase),o32-52i75-96o101-125i160-178o182-200i207-225o257-277i291-312o316-336i,377
Q92544,Transmembrane 9 superfamily member 4 (Tumor cannibalism associated protein 1),o281-302i347-367o377-397i413-435o450-470i502-522o535-556i572-592o604-625i,642
Q92903,Phosphatidate cytidylyltransferase 1 (EC 2.7.7.41) (CDP-DAG synthase 1) (CDP-DG synthase 1) (CDP-diacylglycerol synthase 1) (CDS 1) (CDP-diglyceride pyrophosphorylase 1) (CDP-diglyceride synthase 1) (CTP:phosphatidate cytidylyltransferase 1),i83-106o109-129i141-170o178-203i211-237o238-263i279-299o354-374i397-418o,461
Q96EP9,Sodium/bile acid cotransporter 4 (Na(+)/bile acid cotransporter 4) (Solute carrier family 10 member 4),o104-121i137-161o171-186i198-218o237-254i268-288o299-319i338-347o362-382i,437
Q96H96,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",i84-101o110-130i157-175o182-198i204-224o232-252i277-295o303-312i338-353o,371
Q96HH6,Transmembrane protein 19,i19-39o52-69i77-92o96-107i133-152o172-188i220-240o255-271i312-333o,336
Q8WVP7,Limb region 1 protein homolog (Differentiation-related gene 14 protein),o20-40i61-83o107-128i147-168o190-208i297-313o345-366i387-404o428-447i,490
Q96S06,Lipase maturation factor 1 (Transmembrane protein 112),i54-72o126-142i146-161o177-191i205-226o265-283i287-304o310-330i369-384o,567
Q9BUM1,Glucose-6-phosphatase 3 (G-6-Pase 3) (G6Pase 3) (EC 3.1.3.9) (Glucose-6-phosphatase beta) (G6Pase-beta) (Ubiquitous glucose-6-phosphatase catalytic subunit-related protein),o29-49i53-76o109-129i144-164o168-186i200-220o251-265i284-301o306-332i,346
Q9BX79,Receptor for retinol uptake STRA6 (Retinol-binding protein receptor STRA6) (Stimulated by retinoic acid gene 6 protein homolog),o51-71i101-121o145-165i170-189o206-225i296-316o367-382i429-442o474-490i,667
Q9BX95,Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1),i138-153o163-181i212-221o231-248i257-278o290-309i322-332o362-387i418-438o,441
Q9H237,Protein-serine O-palmitoleoyltransferase porcupine (EC 2.3.1.250) (Protein MG61),o25-43i51-68o73-88i97-112o126-139i193-203o204-215i398-415o447-456i,461
Q9NQR9,Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 3.1.3.9) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein),o28-41i57-72o114-123i148-167o178-193i208-228o259-275i290-310o319-339i,355
Q9NUN5,Lysosomal cobalamin transport escort protein LMBD1 (LMBD1) (HDAg-L-interacting protein NESI) (LMBR1 domain-containing protein 1) (Nuclear export signal-interacting protein),o11-33i48-71o97-119i145-161o193-213i306-326o365-385i410-429o489-511i,540
Q9NX61,Transmembrane protein 161A (Adaptive response to oxidative stress protein 29) (AROS-29),o18i104-124o135-155i168-187o225-247i265-285o316-334i376-386o446-468i,479
Q9Y5Z9,UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (EC 2.5.1.39) (Transitional epithelial response protein 1),i55-73o83-101i133-153o160-178i185-205o212-229i256-276o281-293i315-332o,338
O15321,Transmembrane 9 superfamily member 1 (MP70 protein family member) (hMP70),o237-257i310-330o339-359i382-397o413-433i467-486o499-519i536-555o569-589i,606
P0CG08,Golgi pH regulator B (Protein GPR89B),o5-26i39-63o75-95i110-128o146-166i289-309o339-360i378-398o426-444i,455
Q68DH5,G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2),o3-21i33-56o106-129i152-172o189-209i388-402o431-453i476-492o528-546i,695
Q6P499,NIPA-like protein 3,o35-51i76-96o100-120i134-154o175-193i202-222o241-261i271-291o303-321i,406
Q99805,Transmembrane 9 superfamily member 2 (p76),o302-323i367-387o398-418i434-455o470-491i521-543o556-576i593-612o631-652i,663
P09131,P3 protein (Solute carrier family 10 member 3),o191-208i224-248o258-273i283-305o323-340i354-370o385-403i419-434o449-469i,477
Q5PT55,Sodium/bile acid cotransporter 5 (Na(+)/bile acid cotransporter 5) (Solute carrier family 10 member 5),o143-159i175-195o207-224i236-256o274-291i305-329o335-355i373-384o398-418i,438
Q6NVV3,Magnesium transporter NIPA3 (NIPA-like protein 1) (Non-imprinted in Prader-Willi/Angelman syndrome region protein 3),o68-88i116-136o141-161i168-188o208-228i236-261o274-294i306-326o337-357i,410
Q6ZN68,Putative C-mannosyltransferase DPY19L2P2 (EC 2.4.1.-) (Dpy-19-like protein 2 pseudogene 2) (Protein dpy-19 homolog 2-like 2),o56-77i82-93o115-127i137-153o156-171i182-198o204-220i237-257o299-319i,376
Q8N8Q9,Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2),o10-30i57-78o84-99i114-128o150-170i178-203o216-236i250-267o279-299i,360
Q8NDZ6,Transmembrane protein 161B,o17i104-125o136-156i170-190o228-248i268-285o316-330i367-386o457-477i,487
Q9H841,NIPA-like protein 2,o48-65i88-108o115-130i144-161o180-200i209-229o247-263i281-297o309-327i,383
Q9HD45,Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein),o224-244i294-314o322-342i364-384o396-416i449-469o482-502i519-539o551-571i,589
A0PJX8,Transmembrane protein 82,o27-44i72-87o91-108i123-139o151-167i203-223o236-251i265-281o288-305i,343
A1A5B4,Anoctamin-9 (Transmembrane protein 16J) (Tumor protein p53-inducible protein 5) (p53-induced gene 5 protein),i191-213o261-282i334-354o373-393i424-443o544-564i599-619o704-724i,782
O00219,Hyaluronan synthase 3 (EC 2.4.1.212) (Hyaluronate synthase 3) (Hyaluronic acid synthase 3) (HA synthase 3),i11-31o45-65i382-402o409-422i437-448o449-459i478-499o510-536i,553
O00341,Excitatory amino acid transporter 5 (Retinal glutamate transporter) (Solute carrier family 1 member 7),i17-37o56-77i89-114o219-237i257-277o298-319i365-391o452-472i,560
O15260,Surfeit locus protein 4,i28-46o68-85i92-108o117-133i156-175o179-200i201-221o239-255i,269
O43292,Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (hGAA1),i22-42o371-394i424-444o463-479i496-516o526-535i543-564o597-617i,621
O94759,Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2) (LTrpC-2) (LTrpC2) (Transient receptor potential channel 7) (TrpC7) (Transient receptor potential melastatin 2),i753-763o764-773i797-817o832-841i867-888o897-916i934-951o1024-1046i,1503
O96005,Putative lipid scramblase CLPTM1 (Cleft lip and palate transmembrane protein 1),i52-73o355-375i390-410o417-435i476-496o507-529i543-561o565-583i,669
P00156,Cytochrome b (Complex III subunit 3) (Complex III subunit III) (Cytochrome b-c1 complex subunit 3) (Ubiquinol-cytochrome-c reductase complex cytochrome b subunit),i33-53o84-99i115-133o178-198i229-245o289-307i323-339o349-369i,380
P03886,NADH-ubiquinone oxidoreductase chain 1 (EC 7.1.1.2) (NADH dehydrogenase subunit 1),o3-23i70-88o100-118i135-155o172-187i221-241o253-273i293-307o,318
P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34),i18-37o62-80i91-111o127-140i164-184o192-212i256-275o320-339i,888
P35670,Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa],i653-673o694-714i731-750o767-780i922-942o971-984i1323-1343o1353-1368i,1465
P43003,Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1) (GLAST-1) (Solute carrier family 1 member 3),i48-68o87-108i123-145o237-260i270-297o319-340i386-412o473-494i,542
P43004,Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2),i44-64o84-105i120-142o239-257i269-296o317-339i385-411o472-493i,574
P43005,Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Neuronal and epithelial glutamate transporter) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1),i18-38o58-79i94-116o209-229i239-266o286-308i354-380o441-462i,524
P43007,Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (Solute carrier family 1 member 4),i42-62o81-102i117-139o218-237i257-277o298-320i369-390o453-473i,532
P48664,Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6),i56-76o95-116i131-153o265-285i295-322o344-365i411-437o498-518i,564
P48995,Short transient receptor potential channel 1 (TrpC1) (Transient receptor protein 1) (TRP-1),i351-361o362-371i384-404o423-439i455-475o497-517i537-558o624-644i,793
P51790,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),i129-150o208-229i353-366o387-408i428-448o499-520i527-545o606-615i,818
P51793,H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4),i71-92o150-171i295-308o330-350i370-390o441-462i469-487o546-555i,760
P51795,H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5) (ClC-5) (Chloride transporter ClC-5),i128-149o207-228i352-365o387-407i427-447o497-518i524-544o602-611i,816
P51797,H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6),i81-102o130-150i280-294o331-351i375-396o465-486i536-545o554-567i,869
Q04656,Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein),i653-673o721-733i748-767o784-797i939-959o985-1000i1357-1377o1387-1402i,1500
Q12770,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),i19-39o280-300i313-333o345-365i402-423o424-444i519-539o710-730i,1279
Q13488,V-type proton ATPase 116 kDa subunit a 3 (V-ATPase 116 kDa subunit a 3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3),i389-406o407-423i445-465o535-555i571-592o631-649i747-756o771-791i,830
Q13507,Short transient receptor potential channel 3 (TrpC3) (Transient receptor protein 3) (TRP-3) (hTrp-3) (hTrp3),i419-429o430-439i459-477o506-526i544-564o609-630i650-670o722-738i,921
Q14656,Transmembrane protein 187 (Protein ITBA1),i8-25o51-72i84-105o111-131i140-158o162-179i192-210o225-245i,261
Q15049,Membrane protein MLC1,i53-71o91-100i119-129o147-162i200-215o232-245i260-276o303-318i,377
Q15629,Translocating chain-associated membrane protein 1 (Protein TRAM1),i24-44o80-102i123-141o165-185i193-213o218-235i250-274o296-316i,374
Q15758,Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5),i52-72o95-116i131-153o226-245i265-285o306-328i374-401o461-481i,541
Q32M45,Anoctamin-4 (Transmembrane protein 16D),i353-373o421-442i506-526o548-568i593-613o716-736i769-789o887-898i,955
Q4KMQ2,Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F),i301-321o373-393i458-476o510-526i552-572o670-690i727-743o837-852i,910
Q5BJD5,Transmembrane protein 41B (Protein stasimon),i52-72o109-130i131-142o145-170i197-208o209-218i228-248o263-283i,291
Q5T9L3,Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog) (EVI) (Putative NF-kappa-B-activating protein 373),i16-36o233-253i269-289o304-324i332-352o381-401i432-452o472-492i,541
Q5XXA6,Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2),i334-354o403-423i520-540o566-586i607-627o732-752i785-805o892-912i,986
Q6IWH7,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),i349-376o417-438i502-521o544-560i588-608o711-731i764-784o852-872i,933
Q6TCH4,Membrane progestin receptor delta (mPR delta) (Membrane progesterone P4 receptor delta) (Membrane progesterone receptor delta) (Progesterone and adipoQ receptor family member 6) (Progestin and adipoQ receptor family member 6),i49-69o82-102i114-134o151-169i187-202o225-241i252-277o295-321i,344
Q75V66,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),i302-330o377-398i463-483o516-532i557-577o676-696i733-749o835-854i,913
Q7KZN9,Cytochrome c oxidase assembly protein COX15 homolog,i72-90o154-171i184-202o223-242i263-284o321-343i355-375o382-402i,410
Q86TM6,E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1),i4-24o43-66i77-95o103-120i136-159o172-194i209-223o224-235i,617
Q8N2M4,Lysoplasmalogenase TMEM86A (EC 3.3.2.2) (Transmembrane protein 86A),i15-30o37-56i68-87o92-113i120-136o144-162i177-196o204-224i,240
Q8N4M1,Choline transporter-like protein 3 (Solute carrier family 44 member 3),i33-54o213-233i240-262o283-305i334-354o385-395i534-554o566-586i,653
Q8N609,Translocating chain-associated membrane protein 1-like 1,i24-44o80-100i123-141o165-185i193-213o218-239i250-274o298-316i,369
Q8N661,Lysoplasmalogenase TMEM86B (EC 3.3.2.2) (Transmembrane protein 86B),i25-40o47-67i76-93o97-115i124-140o148-166i174-189o197-218i,226
Q8N8R3,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),i66-79o96-111i150-160o161-170i192-203o204-213i251-262o263-273i,303
Q8NFB2,Transmembrane protein 185A (Protein FAM11A),i15-30o42-60i84-101o112-132i142-158o170-191i214-232o244-259i,350
Q8TDI7,Transmembrane channel-like protein 2 (Transmembrane cochlear-expressed protein 2),i253-276o337-357i431-452o471-487i509-525o644-662i694-715o751-772i,906
Q8TDI8,Transmembrane channel-like protein 1 (Transmembrane cochlear-expressed protein 1),i189-212o273-293i366-387o408-428i446-459o585-600i637-656o692-713i,760
Q92535,Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (Phosphatidylinositol-glycan biosynthesis class C protein) (PIG-C),i53-73o83-103i122-137o148-164i173-190o199-214i227-244o249-270i,297
Q92819,Hyaluronan synthase 2 (EC 2.4.1.212) (Hyaluronate synthase 2) (Hyaluronic acid synthase 2) (HA synthase 2),i12-33o43-63i374-399o406-419i434-445o446-456i476-496o511-534i,552
Q92839,Hyaluronan synthase 1 (EC 2.4.1.212) (Hyaluronate synthase 1) (Hyaluronic acid synthase 1) (HA synthase 1) (HuHAS1),i23-42o52-72i400-424o429-449i461-471o472-481i501-522o541-563i,578
Q93050,V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),i392-409o410-425i448-465o537-554i572-592o635-653i751-760o773-793i,837
Q96GC9,Vacuole membrane protein 1 (Transmembrane protein 49),i77-95o116-136i189-199o200-209i257-267o268-277i285-310o371-384i,406
Q8TEZ7,Membrane progestin receptor beta (mPR beta) (Lysosomal membrane protein in brain 1) (Membrane progesterone P4 receptor beta) (Membrane progesterone receptor beta) (Progesterone and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member VIII),i76-96o110-129i143-163o175-193i211-229o245-262i281-301o320-341i,354
Q96K78,Adhesion G-protein coupled receptor G7 (G-protein coupled receptor 128),i11-30o436-458i469-489o528-549i567-590o625-645i670-692o699-722i,797
Q96KA5,Lipid scramblase CLPTM1L (Cisplatin resistance-related protein 9) (CRR9p) (Cleft lip and palate transmembrane protein 1-like protein) (CLPTM1-like protein),i11-26o284-305i325-340o347-362i403-423o432-452i468-488o494-508i,538
Q96S97,Myeloid-associated differentiation marker (Protein SB135),i35-55o67-87i101-120o138-158i172-192o205-225i239-260o294-312i,322
Q9BTD3,Transmembrane protein 121,i11-29o39-59i74-94o112-132i150-168o177-197i216-236o247-265i,319
Q9BYT9,Anoctamin-3 (Transmembrane protein 16C),i398-418o466-487i551-571o593-613i638-658o758-778i811-831o915-935i,981
Q9H3K2,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),i83-93o94-103i128-145o160-180i191-209o214-234i244-264o275-293i,345
Q9HBG4,V-type proton ATPase 116 kDa subunit a 4 (V-ATPase 116 kDa isoform a 4) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform),i394-411o412-428i450-467o541-558i576-596o639-657i754-763o779-796i,840
Q9HCX4,Short transient receptor potential channel 7 (TrpC7) (Transient receptor protein 7) (TRP-7) (hTRP7),i348-359o360-371i385-405o438-454i470-490o539-559i579-599o648-672i,862
Q9NP94,Zinc transporter ZIP2 (6A1) (Eti-1) (Solute carrier family 39 member 2) (Zrt- and Irt-like protein 2) (ZIP-2) (hZIP2),o9-29i44-64o106-124i165-185o195-215i225-245o255-275i289-308o,309
Q9NQ90,Anoctamin-2 (Transmembrane protein 16B),i366-386o435-455i539-559o583-603i624-644o749-769i802-822o908-928i,1003
Q9NUM3,Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9),o7-26i37-58o106-126i150-167o176-196i211-229o243-260i286-303o,307
Q9NV64,Transmembrane protein 39A,i73-94o114-138i156-175o186-202i288-307o321-338i420-440o448-463i,488
Q9NW15,Anoctamin-10 (Transmembrane protein 16K),i208-228o241-261i317-337o353-373i401-421o501-521i554-574o591-611i,660
Q9NY26,Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1) (ZIP-1) (hZIP1),o31-51i68-88o111-131i180-200o209-229i238-260o270-289i303-322o,324
Q9UBN4,Short transient receptor potential channel 4 (TrpC4) (Trp-related protein 4) (hTrp-4) (hTrp4),i330-340o341-350i363-383o404-418i433-453o476-498i512-534o600-620i,977
Q9UKV5,E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78),i16-36o82-107i122-139o145-166i186-206o215-235i262-282o285-302i,643
Q9UL62,Short transient receptor potential channel 5 (TrpC5) (Transient receptor protein 5) (TRP-5) (hTRP-5) (hTRP5),i328-338o339-350i364-384o405-419i434-454o477-497i513-535o604-624i,973
Q9UP38,Frizzled-1 (Fz-1) (hFz1) (FzE1),i51-62o321-343i354-375o404-425i446-468o489-511i537-557o600-622i,647
Q9UQ05,Potassium voltage-gated channel subfamily H member 4 (Brain-specific eag-like channel 2) (BEC2) (Ether-a-go-go-like potassium channel 1) (ELK channel 1) (ELK1) (Voltage-gated potassium channel subunit Kv12.3),i228-248o264-282i308-326o327-336i360-382o425-434i454-464o465-474i,1017
Q9Y210,Short transient receptor potential channel 6 (TrpC6) (Transient receptor protein 6) (TRP-6),i403-413o414-423i443-462o490-508i528-548o593-614i634-654o706-722i,931
Q9Y256,CAAX prenyl protease 2 (EC 3.4.-.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1),o36-56i72-89o112-132i177-188o193-213i226-249o254-272i283-303o,329
Q9Y487,V-type proton ATPase 116 kDa subunit a 2 (V-ATPase 116 kDa subunit a 2) (Lysosomal H(+)-transporting ATPase V0 subunit a 2) (TJ6) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2),i397-414o415-428i452-469o552-572i588-607o648-666i766-775o788-808i,856
A6NDP7,Myeloid-associated differentiation marker-like protein 2,i21-41o53-70i87-106o129-148i163-183o196-216i231-251o279-297i,307
Q15035,Translocating chain-associated membrane protein 2,i25-43o75-92i120-136o160-180i192-208o213-228i248-268o289-311i,370
Q4ZIN3,Membralin (Transmembrane protein 259),i67-89o302-322i329-339o344-355i356-367o375-395i404-420o429-445i,620
Q6ZVX9,Membrane progestin receptor epsilon (mPR epsilon) (Membrane progesterone P4 receptor epsilon) (Membrane progesterone receptor epsilon) (Progesterone and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member IX),i85-106o119-142i152-172o207-227i244-259o281-292i309-329o348-368i,377
Q86WK9,Membrane progestin receptor alpha (mPR alpha) (Membrane progesterone P4 receptor alpha) (Membrane progesterone receptor alpha) (Progesterone and adipoQ receptor family member 7) (Progestin and adipoQ receptor family member 7) (Progestin and adipoQ receptor family member VII),i72-92o104-124i138-158o172-188i207-222o238-255i274-294o315-334i,346
Q96IK0,Transmembrane protein 101 (Putative NF-kappa-B-activating protein 130),i18-32o55-71i77-93o109-124i144-160o179-195i200-220o237-252i,257
Q9BRY0,Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3),o9-27i43-63o86-106i170-190o200-220i230-250o260-279i293-312o,314
Q9H0C3,Transmembrane protein 117,i16-31o66-87i109-129o155-171i199-217o240-255i302-319o394-414i,514
Q9NXK6,Membrane progestin receptor gamma (mPR gamma) (Membrane progesterone P4 receptor gamma) (Membrane progesterone receptor gamma) (Progesterone and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member V),i49-70o82-104i114-134o151-169i183-202o223-238i249-273o295-317i,330
Q5W0B7,Transmembrane protein 236,i9-28o47-69i89-109o129-144i233-252o260-278i288-311o318-336i,351
Q6ZUK4,Transmembrane protein 26,i7-27o36-54i68-85o143-159i177-192o206-228i254-276o285-305i,368
Q96HV5,Transmembrane protein 41A,i4-22o67-87i90-99o102-127i153-164o165-174i185-207o219-239i,264
Q9GZU3,Transmembrane protein 39B,i78-99o121-135i158-180o191-207i289-308o318-335i421-441o446-464i,492
Q9NVA4,Transmembrane protein 184C (Transmembrane protein 34),i17-35o48-68i83-100o116-133i176-192o212-232i253-269o288-306i,438
Q9P2C4,Transmembrane protein 181,i154-173o312-332i349-370o378-399i415-434o456-477i495-513o536-556i,612
A6NJY1,Putative SLC9B1-like protein SLC9B1P1 (Solute carrier family 9 subfamily B member 1 pseudogene 1),i27-37o54-71i87-104o111-120i142-155o167-187i237-247o248-257i,282
B2RXF0,Transmembrane protein 229A,i59-74o92-104i122-140o157-174i244-264o278-291i310-328o347-367i,380
Q9BXQ6,Transmembrane protein 121B (Cat eye syndrome critical region protein 6),i198-215o226-246i318-338o350-370i392-410o426-446i468-490o498-515i,578
Q9H7F4,Transmembrane protein 185B (Protein FAM11B),i15-30o42-60i84-101o113-131i142-158o170-191i214-232o244-262i,350
A0A1B0GVZ9,Transmembrane protein 269,i11o18-36i53-68o72-87i106-118o124-138i157-168o173-188i,203
O43808,Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17),i10-20o21-30i68-83o102-123i170-185o205-221i270-280o281-292i,307
O60725,Protein-S-isoprenylcysteine O-methyltransferase (EC 2.1.1.100) (Isoprenylcysteine carboxylmethyltransferase) (Prenylated protein carboxyl methyltransferase) (PPMT) (Prenylcysteine carboxyl methyltransferase) (pcCMT),i18-33o43-58i68-85o93-107i130-149o159-176i214-227o231-241i,284
A1L3X0,Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very long chain 3-ketoacyl-CoA synthase 7) (Very long chain 3-oxoacyl-CoA synthase 7),o28-53i67-87o113-133i145-162o171-193i206-227o237-257i,281
A6NDV4,Transmembrane protein 8B (Nasopharyngeal carcinoma-associated gene 6 protein) (Protein NAG-5) (Protein NGX6),o230-254i259-277o293-313i319-336o343-363i379-400o407-425i,472
A6NI61,Protein myomaker (Myoblast fusion maker) (Transmembrane protein 226) (Transmembrane protein 8C),o4-25i32-49o65-85i94-109o117-134i151-171o178-195i,221
A8MYU2,"Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)",o25-45i104-124o139-159i164-184o189-209i227-245o292-308i,1149
O00144,Frizzled-9 (Fz-9) (hFz9) (FzE6) (CD antigen CD349),o233-254i264-287o311-337i355-376o397-421i449-468o507-529i,591
O00155,Probable G-protein coupled receptor 25,o40-65i77-97o114-135i156-176o199-223i245-267o288-310i,361
O00222,Metabotropic glutamate receptor 8 (mGluR8),o584-608i621-641o648-668i696-716o747-768i782-803o819-843i,908
O00254,Proteinase-activated receptor 3 (PAR-3) (Coagulation factor II receptor-like 2) (Thrombin receptor-like 2),o96-120i129-151o164-189i209-231o258-286i302-323o339-361i,374
O00270,"12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor (12-(S)-HETE receptor) (12-HETER) (G-protein coupled receptor 31) (GPR31/12-HETER)",o16-41i51-72o85-110i131-152o175-198i223-248o266-285i,319
O00421,C-C chemokine receptor-like 2 (Chemokine receptor CCR11) (Chemokine receptor X) (Putative MCP-1 chemokine receptor),o40-64i75-95o105-126i149-169o199-221i239-260o283-303i,344
O00574,C-X-C chemokine receptor type 6 (CXC-R6) (CXCR-6) (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD antigen CD186),o32-55i68-88o100-125i149-169o189-213i232-253o268-291i,342
O00590,Atypical chemokine receptor 2 (C-C chemokine receptor D6) (Chemokine receptor CCR-10) (Chemokine receptor CCR-9) (Chemokine-binding protein 2) (Chemokine-binding protein D6),o47-72i83-107o115-140i161-181o208-231i251-272o292-315i,384
O14514,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],o952-972i982-1002o1011-1031i1053-1071o1091-1113i1136-1156o1164-1187i,1584
O14524,Nuclear envelope integral membrane protein 1,o161-177i185-195o196-206i216-236o246-266i276-296o301-310i,444
O14804,Trace amine-associated receptor 5 (TaR-5) (Trace amine receptor 5) (hTaar5) (Putative neurotransmitter receptor),o35-59i71-93o109-130i151-171o199-220i254-274o286-308i,337
O14842,Free fatty acid receptor 1 (G-protein coupled receptor 40),o7-28i44-64o81-102i125-148o179-203i225-249o259-278i,300
O14843,Free fatty acid receptor 3 (G-protein coupled receptor 41),o16-41i52-73o90-111i133-153o180-205i226-250o259-279i,346
O15303,Metabotropic glutamate receptor 6 (mGluR6),o586-610i623-643o650-670i698-718o749-770i784-805o821-845i,877
O15354,Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1) (ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor) (PAELR),o260-285i298-320o336-357i380-400o443-463i494-514o529-551i,613
O15529,G-protein coupled receptor 42,o16-41i52-73o90-111i133-153o180-205i226-250o259-279i,346
O15552,Free fatty acid receptor 2 (G-protein coupled receptor 43),o9-33i46-67o80-105i126-147o175-200i221-246o257-276i,330
O43193,Motilin receptor (G-protein coupled receptor 38),o38-63i75-96o113-134i155-177o247-270i299-320o338-358i,412
O43194,G-protein coupled receptor 39,o31-54i71-91o110-130i152-172o223-243i284-304o324-346i,453
O43603,Galanin receptor type 2 (GAL2-R) (GALR-2),o26-51i62-85o100-121i142-161o186-208i237-257o275-295i,387
O43613,Orexin/Hypocretin receptor type 1 (Hypocretin receptor type 1) (Orexin receptor type 1) (Ox-1-R) (Ox1-R) (Ox1R),o45-69i83-108o117-142i161-182o214-236i299-324o338-361i,425
O43614,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),o52-77i91-116o125-146i169-191o218-244i305-330o344-367i,444
O75473,Leucine-rich repeat-containing G-protein coupled receptor 5 (G-protein coupled receptor 49) (G-protein coupled receptor 67) (G-protein coupled receptor HG38),o562-583i594-616o639-660i681-701o725-745i768-791o800-823i,907
O75783,Rhomboid-related protein 1 (RRP) (EC 3.4.21.105) (Rhomboid-like protein 1),i195-214o252-275i281-302o313-333i339-359o372-392i405-427o,438
O75844,CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog),o19-38i80-102o120-141i168-189o196-215i346-365o384-410i,475
O75899,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),o479-502i518-536o551-576i598-617o653-676i691-713o718-741i,941
O94910,Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2),o865-885i894-914o923-943i965-985o1004-1024i1049-1069o1076-1096i,1474
O95047,Olfactory receptor 2A4 (Olfactory receptor 2A10) (Olfactory receptor OR6-37),o24-48i58-78o97-119i144-165o196-221i240-259o272-289i,310
O95136,Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5),o35-57i71-91o109-128i148-168o190-210i235-255o270-290i,353
O95490,Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1),o852-872i881-901o910-930i952-972o991-1011i1036-1056o1063-1083i,1459
O95977,Sphingosine 1-phosphate receptor 4 (S1P receptor 4) (S1P4) (Endothelial differentiation G-protein coupled receptor 6) (Sphingosine 1-phosphate receptor Edg-6) (S1P receptor Edg-6),o52-72i84-104o122-141i162-182o204-224i253-273o291-309i,384
P00414,Cytochrome c oxidase subunit 3 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide III),i15-35o40-58i81-101o130-147i162-182o197-220i240-256o,261
P03999,Short-wave-sensitive opsin 1 (Blue cone photoreceptor pigment) (Blue-sensitive opsin) (BOP),o36-60i71-93o109-130i150-172o200-221i250-270o284-306i,348
P04000,Long-wave-sensitive opsin 1 (Red cone photoreceptor pigment) (Red-sensitive opsin) (ROP),o55-79i90-112o127-149i168-191o219-240i269-289o303-325i,364
P04001,Medium-wave-sensitive opsin 1 (Green cone photoreceptor pigment) (Green-sensitive opsin) (GOP),o55-79i90-112o127-149i168-191o220-240i269-289o305-325i,364
P04201,Proto-oncogene Mas,o37-57i68-89o106-128i150-170o186-212i226-250o263-283i,325
P07550,Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor),o34-58i70-95o108-129i150-171o198-220i275-295o307-327i,413
P08100,Rhodopsin (Opsin-2),o39-61i75-95o112-133i154-175o204-224i253-273o286-309i,348
P08172,Muscarinic acetylcholine receptor M2,o23-46i60-80o98-119i140-162o185-207i389-409o423-443i,466
P08173,Muscarinic acetylcholine receptor M4,o32-57i69-89o107-128i149-171o194-216i402-422o436-456i,479
P08588,Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor),o56-84i94-120o133-154i173-196o223-248i320-349o355-377i,477
P08908,5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A),o37-63i73-95o110-132i153-173o195-216i347-367o383-403i,422
P08912,Muscarinic acetylcholine receptor M5,o30-53i67-87o105-126i147-169o192-214i444-464o479-498i,532
P08913,Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR),o49-74i86-111o122-144i167-187o210-232i390-410o425-444i,465
P0DMS8,Adenosine receptor A3,o15-37i49-72o84-106i127-149o178-198i232-252o262-284i,318
P11229,Muscarinic acetylcholine receptor M1,o25-48i62-82o100-121i142-164o187-209i367-387o402-421i,460
P13945,Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor),o37-62i72-97o112-133i154-174o204-225i294-314o328-346i,408
P14416,D(2) dopamine receptor (Dopamine D2 receptor),o36-59i72-93o109-130i154-175o189-213i373-398o410-430i,443
P16473,Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R),o419-440i451-473o497-517i538-560o580-602i626-645o661-681i,764
P18089,Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR),o13-38i50-75o86-108i131-149o171-193i372-391o408-429i,450
P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1 (EC 1.3.1.22) (SR type 1) (Steroid 5-alpha-reductase 1) (S5AR 1),o12-29i54-72o82-102i114-132o151-166i194-212o216-231i,259
P18825,Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR),o51-77i89-114o125-147i170-190o209-231i383-407o419-440i,462
P20309,Muscarinic acetylcholine receptor M3,o68-91i105-125o143-164i185-207o230-252i493-513o528-547i,590
P21452,Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2),o33-59i70-92o108-129i150-168o199-222i252-272o288-308i,398
P21453,Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363),o49-69i83-103o121-140i160-180o202-222i258-278o295-312i,382
P21462,fMet-Leu-Phe receptor (fMLP receptor) (N-formyl peptide receptor) (FPR) (N-formylpeptide chemoattractant receptor),o27-50i62-83o101-121i141-162o206-226i243-266o285-305i,350
P21554,Cannabinoid receptor 1 (CB-R) (CB1) (CANN6),o117-142i155-175o188-212i233-255o274-299i345-365o378-399i,472
P21728,D(1A) dopamine receptor (Dopamine D1 receptor),o24-49i61-83o98-119i139-159o195-215i274-295o313-333i,446
P21730,C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor) (C5a-R) (C5aR) (CD antigen CD88),o35-64i71-94o106-132i153-174o197-224i241-267o281-304i,350
P21731,Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor),o30-52i67-87o107-128i150-172o194-219i247-270o290-311i,343
P21917,D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor),o34-59i69-93o109-135i151-171o192-214i347-367o383-403i,419
P21918,D(1B) dopamine receptor (D(5) dopamine receptor) (D1beta dopamine receptor) (Dopamine D5 receptor),o41-61i78-100o115-136i157-178o226-246i298-319o341-361i,477
P22888,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R),o364-385i396-418o441-462i483-503o526-547i571-590o606-626i,699
P23945,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),o367-387i399-421o444-465i486-508o529-550i574-593o609-629i,695
P24390,ER lumen protein-retaining receptor 1 (KDEL endoplasmic reticulum protein retention receptor 1) (KDEL receptor 1) (Putative MAPK-activating protein PM23),o3-21i34-53o58-79i95-108o115-135i150-172o178-195i,212
P24530,Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type),o99-124i138-163o172-197i218-239o268-294i324-345o363-388i,442
P25021,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),o19-43i55-77o93-114i135-156o181-203i236-256o271-291i,359
P25024,C-X-C chemokine receptor type 1 (CXC-R1) (CXCR-1) (CDw128a) (High affinity interleukin-8 receptor A) (IL-8R A) (IL-8 receptor type 1) (CD antigen CD181),o41-65i76-97o112-133i152-173o200-224i244-264o286-308i,350
P25025,C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182),o50-74i85-106o121-142i164-182o209-233i252-273o295-317i,360
P25090,N-formyl peptide receptor 2 (FMLP-related receptor I) (FMLP-R-I) (Formyl peptide receptor-like 1) (HM63) (Lipoxin A4 receptor) (LXA4 receptor) (RFP),o28-50i62-83o101-121i141-162o206-226i243-266o287-306i,351
P25100,Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a),o99-121i133-154o171-192i213-233o254-275i350-370o384-404i,572
P25101,Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR),o81-103i117-142o156-181i202-223o250-276i307-328o346-371i,427
P25103,Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1),o34-55i72-93o107-128i149-170o194-215i251-272o286-307i,407
P25105,Platelet-activating factor receptor (PAF-R) (PAFr),o17-41i52-75o88-113i134-154o182-207i231-257o274-296i,342
P25106,Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1),o46-68i81-102o120-140i163-180o210-236i253-274o296-318i,362
P25116,Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor),o103-128i137-160o173-198i217-239o266-291i312-339o352-374i,425
P25929,Neuropeptide Y receptor type 1 (NPY1-R),o45-65i77-97o117-137i155-175o212-232i261-281o300-320i,384
P27544,Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299),o60-78i103-123o148-168i177-196o201-218i242-263o279-307i,350
P28221,5-hydroxytryptamine receptor 1D (5-HT-1D) (5-HT1D) (Serotonin 1D alpha receptor) (5-HT-1D-alpha) (Serotonin receptor 1D),o39-64i75-97o113-134i155-176o197-218i302-326o338-359i,377
P28222,5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B),o50-74i87-109o124-145i166-186o207-229i315-339o349-371i,390
P28223,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),o77-101i108-133o150-171i192-212o234-256i324-348o360-382i,471
P28288,ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70),o12-26i84-104o126-143i203-220o221-244i311-322o323-333i,659
P28335,5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C),o56-80i87-111o129-151i168-189o214-236i312-336o348-370i,458
P28336,Neuromedin-B receptor (NMB-R) (Epididymis tissue protein Li 185a) (Neuromedin-B-preferring bombesin receptor),o45-69i80-101o119-139i161-181o211-233i267-287o304-327i,390
P28566,5-hydroxytryptamine receptor 1E (5-HT-1E) (5-HT1E) (S31) (Serotonin receptor 1E),o23-47i60-82o97-118i139-159o180-202i292-314o325-347i,365
P29274,Adenosine receptor A2a,o8-29i44-68o75-100i122-144o172-198i236-259o265-288i,412
P29275,Adenosine receptor A2b,o8-32i44-67o80-101i122-144o182-203i236-256o270-292i,332
P29371,Neuromedin-K receptor (NKR) (NK-3 receptor) (NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3),o87-108i125-146o160-181i202-221o248-268i302-322o337-358i,465
P30411,B2 bradykinin receptor (B2R) (BK-2 receptor),o62-82i94-115o133-153i176-197o222-245i270-292o312-335i,391
P30518,Vasopressin V2 receptor (V2R) (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor),o39-61i76-97o114-135i159-179o204-229i272-292o307-328i,371
P30542,Adenosine receptor A1,o10-34i47-68o82-103i124-146o180-201i236-256o268-290i,326
P30550,Gastrin-releasing peptide receptor (GRP-R) (GRP-preferring bombesin receptor),o41-62i78-99o115-136i157-178o209-231i266-286o302-324i,384
P30556,Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1 receptor),o28-52i65-87o103-124i143-162o193-214i241-262o276-296i,359
P30559,Oxytocin receptor (OT-R),o39-63i75-97o114-135i155-175o203-225i276-294o310-332i,389
P30872,Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R) (SST1) (SRIF-2),o58-84i95-116o132-153i173-195o220-248i272-293o304-326i,391
P30874,Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SST2) (SRIF-1),o44-69i80-101o117-138i161-181o207-233i257-277o293-315i,369
P30939,5-hydroxytryptamine receptor 1F (5-HT-1F) (5-HT1F) (Serotonin receptor 1F),o24-49i60-82o98-119i140-160o180-202i295-315o330-350i,366
P30968,Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R),o39-58i78-97o116-137i165-184o213-232i282-300o307-326i,328
P30988,Calcitonin receptor (CT-R),o147-169i183-204o218-242i261-283o295-318i341-359o368-394i,474
P30989,Neurotensin receptor type 1 (NT-R-1) (NTR1) (High-affinity levocabastine-insensitive neurotensin receptor) (NTRH),o68-87i104-123o143-163i186-206o233-257i305-325o344-364i,418
P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2 (EC 1.3.1.22) (5 alpha-SR2) (SR type 2) (Steroid 5-alpha-reductase 2) (S5AR 2) (Type II 5-alpha reductase),o10-27i51-69o80-100i110-131o146-161i189-207o211-229i,254
P31391,Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) (SST4),o48-73i84-105o121-142i162-185o209-236i260-281o292-314i,388
P32238,Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R),o42-67i78-104o116-137i158-178o211-234i314-334o350-373i,428
P32239,Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R),o55-80i91-117o129-150i171-191o220-242i334-354o370-393i,447
P32241,Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) (Pituitary adenylate cyclase-activating polypeptide type II receptor) (PACAP type II receptor) (PACAP-R-2) (PACAP-R2) (VPAC1),o142-166i175-197o217-238i254-276o292-316i339-359o370-391i,457
P32245,Melanocortin receptor 4 (MC4-R),o44-69i82-106o124-145i166-186o192-215i249-271o281-304i,332
P32246,C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD antigen CD191),o36-60i71-91o108-129i151-171o197-223i240-264o281-304i,355
P32247,Bombesin receptor subtype-3 (BRS-3),o49-69i84-109o122-143i165-185o215-238i272-293o310-330i,399
P32248,C-C chemokine receptor type 7 (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197),o57-81i93-119o128-152i174-196o220-245i264-286o303-329i,378
P32249,G-protein coupled receptor 183 (Epstein-Barr virus-induced G-protein coupled receptor 2) (EBI2) (EBV-induced G-protein coupled receptor 2) (hEBI2),o32-57i68-89o102-127i148-168o193-217i245-266o290-311i,361
P32302,C-X-C chemokine receptor type 5 (CXC-R5) (CXCR-5) (Burkitt lymphoma receptor 1) (Monocyte-derived receptor 15) (MDR-15) (CD antigen CD185),o52-76i88-109o124-145i168-186o215-239i260-281o302-324i,372
P32745,Somatostatin receptor type 3 (SS-3-R) (SS3-R) (SS3R) (SST3) (SSR-28),o45-70i81-102o118-139i159-181o205-231i258-279o294-316i,418
P33947,ER lumen protein-retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2),o3-21i34-53o58-79i95-108o115-135i150-172o178-195i,212
P34969,5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7),o82-106i118-140o156-178i199-219o239-260i329-349o367-387i,479
P34972,Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5),o35-59i72-92o105-129i150-172o190-210i247-266o280-301i,360
P34981,Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor),o26-51i63-83o101-121i145-164o190-215i267-288o300-323i,398
P34982,Olfactory receptor 1D2 (Olfactory receptor 17-4) (OR17-4) (Olfactory receptor OR17-6) (Olfactory receptor-like protein HGMP07E),o26-49i59-79o98-120i142-163o197-222i241-260o272-289i,312
P34998,Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1),o118-139i179-203o219-247i255-282o299-324i336-360o368-396i,444
P35346,Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R) (SST5),o41-66i77-98o114-135i155-177o199-222i249-270o285-307i,364
P35348,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c),o26-51i64-85o101-122i143-163o184-205i274-294o308-328i,466
P35367,Histamine H1 receptor (H1R) (HH1R),o28-49i64-86o101-123i144-165o188-211i417-437o451-471i,487
P35368,Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor),o45-70i82-103o120-141i162-182o202-224i296-316o331-351i,520
P35372,Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP),o70-96i107-128o144-165i186-208o233-255i283-304o318-341i,400
P35408,Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor),o20-43i56-79o97-115i136-160o185-211i268-295o313-332i,488
P35414,Apelin receptor (Angiotensin receptor-like 1) (G-protein coupled receptor APJ) (G-protein coupled receptor HG11),o31-52i66-87o104-125i148-169o199-220i250-273o290-311i,380
P35462,D(3) dopamine receptor (Dopamine D3 receptor),o32-54i64-88o104-126i150-170o188-209i330-351o366-386i,400
P37288,Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor),o51-75i89-109o126-147i169-189o215-240i292-312o330-351i,418
P41143,Delta-type opioid receptor (D-OR-1) (DOR-1),o49-75i86-107o123-144i164-188o212-234i262-283o298-321i,372
P41145,Kappa-type opioid receptor (K-OR-1) (KOR-1),o58-85i96-119o133-154i174-196o223-247i275-296o312-333i,380
P41146,Nociceptin receptor (Kappa-type 3 opioid receptor) (KOR-3) (Orphanin FQ receptor),o52-77i88-109o125-146i167-189o213-236i264-285o299-322i,370
P41180,Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1),o613-635i649-667o680-696i724-744o771-792i806-823o837-856i,1078
P41231,P2Y purinoceptor 2 (P2Y2) (ATP receptor) (P2U purinoceptor 1) (P2U1) (P2U receptor 1) (Purinergic receptor),o34-59i70-91o104-129i149-171o195-220i246-271o283-309i,377
P41586,Pituitary adenylate cyclase-activating polypeptide type I receptor (PACAP type I receptor) (PACAP-R-1) (PACAP-R1),o149-176i186-210o228-252i265-290o303-329i351-371o382-403i,468
P41587,Vasoactive intestinal polypeptide receptor 2 (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2),o122-150i159-182o204-228i241-266o279-303i330-347o355-378i,438
P41594,Metabotropic glutamate receptor 5 (mGluR5),o580-604i617-637o642-664i692-714o738-759i773-793o799-819i,1212
P41595,5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B),o57-79i91-113o130-151i172-192o217-239i325-345o361-382i,481
P41597,C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192),o45-68i79-99o116-136i158-178o201-226i244-265o286-308i,374
P41968,Melanocortin receptor 3 (MC3-R),o44-64i76-100o119-140i161-181o187-210i246-268o279-301i,323
P43088,Prostaglandin F2-alpha receptor (PGF receptor) (PGF2-alpha receptor) (Prostanoid FP receptor),o30-52i69-90o110-131i153-173o200-225i251-274o287-307i,359
P43115,Prostaglandin E2 receptor EP3 subtype (PGE receptor EP3 subtype) (PGE2 receptor EP3 subtype) (PGE2-R) (Prostanoid EP3 receptor),o54-77i92-112o132-153i176-197o228-253i284-307o328-349i,390
P43119,Prostacyclin receptor (Prostaglandin I2 receptor) (PGI receptor) (PGI2 receptor) (Prostanoid IP receptor),o18-38i51-73o94-115i138-159o182-204i240-260o275-295i,386
P43220,Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R),o144-168i178-199o227-249i268-290o303-325i349-374o379-405i,463
P43657,Lysophosphatidic acid receptor 6 (LPA receptor 6) (LPA-6) (Oleoyl-L-alpha-lysophosphatidic acid receptor) (P2Y purinoceptor 5) (P2Y5) (Purinergic receptor 5) (RB intron encoded G-protein coupled receptor),o19-43i52-75o87-112i132-154o180-205i230-252o272-294i,344
P46089,G-protein coupled receptor 3 (ACCA orphan receptor),o45-66i77-101o108-132i153-173o195-214i249-269o277-297i,330
P46091,Chemerin-like receptor 2 (Chemerin chemokine-like receptor 2) (Chemokine-like receptor 2) (G-protein coupled receptor 1),o40-62i74-95o112-133i154-174o205-230i248-268o286-307i,355
P46092,C-C chemokine receptor type 10 (C-C CKR-10) (CC-CKR-10) (CCR-10) (G-protein coupled receptor 2),o47-67i79-100o116-136i160-180o205-231i248-269o293-313i,362
P46093,G-protein coupled receptor 4 (G-protein coupled receptor 6C.l) (GPR6C.l),o18-43i52-74o88-113i133-154o178-202i225-246o267-289i,362
P46663,B1 bradykinin receptor (B1R) (BK-1 receptor),o39-63i74-94o108-133i154-175o200-223i251-272o289-315i,353
P47211,Galanin receptor type 1 (GAL1-R) (GALR-1),o34-57i72-93o110-131i152-172o199-221i248-268o286-306i,349
P47804,RPE-retinal G protein-coupled receptor,o18-38i53-73o90-111i129-150o176-198i215-236o248-268i,291
P47871,Glucagon receptor (GL-R),o141-165i175-196o225-247i266-288o301-323i347-372o377-403i,477
P47872,Secretin receptor (SCT-R),o142-166i175-199o217-240i254-276o292-317i340-360o368-391i,440
P47898,5-hydroxytryptamine receptor 5A (5-HT-5) (5-HT-5A) (5-HT5A) (Serotonin receptor 5A),o40-65i78-99o116-137i159-179o200-221i286-307o321-341i,357
P47900,P2Y purinoceptor 1 (P2Y1) (ADP receptor) (Purinergic receptor),o56-77i86-109o127-147i169-189o219-241i259-279o306-326i,373
P47901,Vasopressin V1b receptor (V1bR) (AVPR V1b) (AVPR V3) (Antidiuretic hormone receptor 1b) (Vasopressin V3 receptor),o34-58i71-92o109-130i152-172o198-222i282-302o319-341i,424
P48039,Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor),o30-50i64-84o103-123i144-163o188-208i241-261o275-295i,350
P48145,Neuropeptides B/W receptor type 1 (G-protein coupled receptor 7),o38-63i74-95o111-132i157-177o202-224i251-273o287-310i,328
P48146,Neuropeptides B/W receptor type 2 (G-protein coupled receptor 8),o46-71i82-103o119-140i165-185o211-233i260-282o297-319i,333
P48546,Gastric inhibitory polypeptide receptor (GIP-R) (Glucose-dependent insulinotropic polypeptide receptor),o137-158i171-191o219-239i258-280o294-315i339-361o369-395i,466
P48960,Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta],o552-572i581-601o614-632i654-674o693-713i738-758o765-785i,835
P49019,Hydroxycarboxylic acid receptor 3 (G-protein coupled receptor 109B) (G-protein coupled receptor HM74) (G-protein coupled receptor HM74B) (Niacin receptor 2) (Nicotinic acid receptor 2),o29-54i64-84o102-123i144-164o189-209i232-257o274-297i,387
P49146,Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor),o52-72i87-107o125-145i166-186o217-237i269-289o305-325i,381
P49238,CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28),o32-56i68-88o104-125i147-167o189-215i232-253o274-296i,355
P49286,Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor),o43-63i77-97o116-136i156-176o201-221i254-274o288-308i,362
P49682,C-X-C chemokine receptor type 3 (CXC-R3) (CXCR-3) (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor) (IP-10 receptor) (CD antigen CD183),o54-79i90-111o126-147i170-190o213-240i257-277o301-321i,368
P49683,Prolactin-releasing peptide receptor (PrRP receptor) (PrRPR) (G-protein coupled receptor 10) (hGR3),o61-85i97-119o136-157i176-196o224-246i279-299o315-338i,370
P49685,G-protein coupled receptor 15 (Brother of Bonzo) (BoB),o34-56i70-90o104-129i150-170o193-216i242-266o282-305i,360
P50052,Type-2 angiotensin II receptor (Angiotensin II type-2 receptor) (AT2 receptor),o46-71i81-102o120-140i161-179o209-234i257-278o298-318i,363
P50391,Neuropeptide Y receptor type 4 (NPY4-R) (Pancreatic polypeptide receptor 1) (PP1),o41-65i78-100o116-137i157-176o213-235i266-286o302-325i,375
P50406,5-hydroxytryptamine receptor 6 (5-HT-6) (5-HT6) (Serotonin receptor 6),o29-51i63-85o100-122i143-166o188-209i270-290o303-323i,440
P51582,P2Y purinoceptor 4 (P2Y4) (P2P) (Uridine nucleotide receptor) (UNR),o36-62i72-93o106-131i151-173o197-222i246-271o283-309i,365
P51677,C-C chemokine receptor type 3 (C C CKR3) (C-C CKR-3) (CC-CKR-3) (CCR-3) (CCR3) (CKR 3) (CKR3) (Eosinophil eotaxin receptor) (CD antigen CD193),o37-60i71-91o109-129i151-170o198-223i240-261o281-304i,355
P51679,C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD antigen CD194),o41-64i76-97o113-133i155-174o200-226i243-264o285-307i,360
P51681,C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD antigen CD195),o33-56i67-87o104-124i145-165o193-218i236-257o278-300i,352
P51684,C-C chemokine receptor type 6 (C-C CKR-6) (CC-CKR-6) (CCR-6) (Chemokine receptor-like 3) (CKR-L3) (DRY6) (G-protein coupled receptor 29) (GPR-CY4) (GPRCY4) (LARC receptor) (CD antigen CD196),o48-74i84-104o120-141i160-180o212-238i255-279o304-321i,374
P51685,C-C chemokine receptor type 8 (C-C CKR-8) (CC-CKR-8) (CCR-8) (CC chemokine receptor CHEMR1) (CMKBRL2) (Chemokine receptor-like 1) (CKR-L1) (GPR-CY6) (GPRCY6) (TER1) (CD antigen CDw198),o36-61i72-92o108-129i149-171o196-219i239-263o277-304i,355
P51686,C-C chemokine receptor type 9 (C-C CKR-9) (CC-CKR-9) (CCR-9) (G-protein coupled receptor 28) (GPR-9-6) (CD antigen CDw199),o50-72i85-109o117-142i164-186o212-236i255-279o297-321i,369
P51810,G-protein coupled receptor 143 (Ocular albinism type 1 protein),o28-48i73-93o117-139i156-176o195-214i246-269o290-310i,404
P55085,"Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2]",o76-102i110-133o146-171i190-212o239-264i286-313o325-347i,397
P59538,Taste receptor type 2 member 31 (T2R31) (Taste receptor type 2 member 44) (T2R44) (Taste receptor type 2 member 53) (T2R53),o8-30i47-67o83-108i129-149o177-199i227-251o260-282i,309
P59542,Taste receptor type 2 member 19 (Taste receptor type 2 member 23) (Taste receptor type 2 member 48) (T2R48),o8-30i47-68o83-108i128-148o174-199i227-252o260-282i,299
P61073,C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor) (LESTR) (Lipopolysaccharide-associated protein 3) (LAP-3) (LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor) (SDF-1 receptor) (CD antigen CD184),o39-64i75-96o111-132i155-175o196-223i241-261o284-305i,352
Q01718,Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R),o29-49i62-86o105-126i147-168o174-194i223-244o255-278i,297
Q01726,Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R),o43-63i76-100o119-140i161-181o186-211i245-267o280-300i,317
Q02643,Growth hormone-releasing hormone receptor (GHRH receptor) (Growth hormone-releasing factor receptor) (GRF receptor) (GRFR),o129-153i163-185o202-225i241-266o282-302i327-347o356-379i,423
Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor),o187-211i220-241o283-307i320-342o358-383i406-426o438-462i,593
Q12791,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo)",o87-107i179-199o215-235i240-260o265-285i301-321o368-388i,1236
Q13255,Metabotropic glutamate receptor 1 (mGluR1),o593-617i630-650o657-677i705-725o751-772i786-807o812-832i,1194
Q13258,Prostaglandin D2 receptor (PGD receptor) (PGD2 receptor) (Prostanoid DP receptor),o21-42i61-85o107-128i150-172o197-219i265-285o306-326i,359
Q13304,Uracil nucleotide/cysteinyl leukotriene receptor (UDP/CysLT receptor) (G-protein coupled receptor 17) (P2Y-like receptor) (R12),o62-85i96-117o135-155i178-198o222-244i262-288o306-328i,367
Q13324,Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2),o115-137i151-171o186-206i225-248o263-285i308-328o337-362i,411
Q13467,Frizzled-5 (Fz-5) (hFz5) (FzE5),o237-258i268-291o313-339i356-378o399-423i451-470o502-522i,585
Q13585,Melatonin-related receptor (G protein-coupled receptor 50) (H9),o31-51i65-85o103-124i145-164o189-209i240-260o274-294i,617
Q13639,5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4),o20-40i59-79o94-116i138-158o193-213i261-281o295-315i,388
Q14246,Adhesion G protein-coupled receptor E1 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor),o607-627i636-656o667-685i711-731o751-771i795-816o823-843i,886
Q14330,N-arachidonyl glycine receptor (NAGly receptor) (G-protein coupled receptor 18),o23-47i59-79o92-117i138-159o183-209i233-257o269-289i,331
Q14332,Frizzled-2 (Fz-2) (hFz2) (FzE2),o246-268i279-300o329-350i371-393o414-436i462-482o518-540i,565
Q14416,Metabotropic glutamate receptor 2 (mGluR2),o568-590i605-625o632-652i680-700o726-747i761-782o795-819i,872
Q14831,Metabotropic glutamate receptor 7 (mGluR7),o591-615i628-648o655-675i703-723o754-775i789-810o826-850i,915
Q14832,Metabotropic glutamate receptor 3 (mGluR3),o577-599i614-634o639-661i689-709o735-756i770-791o803-828i,879
Q14833,Metabotropic glutamate receptor 4 (mGluR4),o588-612i625-645o652-672i700-720o751-772i786-807o823-847i,912
Q15077,P2Y purinoceptor 6 (P2Y6),o27-52i62-84o97-122i143-165o189-214i240-265o278-304i,328
Q15546,Monocyte to macrophage differentiation factor (Progestin and adipoQ receptor family member 11) (Progestin and adipoQ receptor family member XI),i29-49o60-82i95-115o128-146i152-170o181-195i204-224o,238
Q15722,Leukotriene B4 receptor 1 (LTB4-R 1) (LTB4-R1) (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7) (P2Y7),o20-41i55-75o92-113i139-159o179-199i222-242o269-289i,352
Q15743,Ovarian cancer G-protein coupled receptor 1 (OGR-1) (G-protein coupled receptor 68) (GPR12A) (Sphingosylphosphorylcholine receptor),o23-47i56-78o92-117i137-158o182-206i229-250o267-289i,365
Q15761,Neuropeptide Y receptor type 5 (NPY5-R) (NPY-Y5 receptor) (NPYY5-R) (Y5 receptor),o42-65i78-99o116-137i156-176o209-232i370-390o405-428i,445
Q16570,Atypical chemokine receptor 1 (Duffy antigen/chemokine receptor) (Fy glycoprotein) (GpFy) (Glycoprotein D) (Plasmodium vivax receptor) (CD antigen CD234),o61-83i98-118o131-149i167-187o208-228i242-262o284-307i,336
Q16581,C3a anaphylatoxin chemotactic receptor (C3AR) (C3a-R),o25-47i59-84o98-118i138-159o341-361i378-402o418-438i,482
Q16602,Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor),o141-162i176-197o212-235i254-276o288-311i334-352o364-387i,461
Q5HYA8,Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67),o519-541i560-589o609-625i689-704o730-750i940-951o952-963i,995
Q5NUL3,Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1),o41-64i77-97o114-134i156-177o208-228i266-289o302-323i,361
Q5QJU3,Alkaline ceramidase 2 (AlkCDase 2) (Alkaline CDase 2) (haCER2) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like),o33-53i63-83o95-110i123-142o149-166i177-194o210-230i,275
Q5T601,Adhesion G-protein coupled receptor F1 (G protein-coupled receptor 110) (G protein-coupled receptor KPG_012) (G protein-coupled receptor PGR19),o591-611i625-645o661-681i700-720o745-765i792-812o821-841i,910
Q5T6X5,G-protein coupled receptor family C group 6 member A (hGPRC6A) (G-protein coupled receptor GPCR33) (hGPCR33),o594-615i632-651o663-686i705-725o749-771i783-803o812-831i,926
Q5VW38,Protein GPR107 (Lung seven transmembrane receptor 1),o262-284i294-314o338-358i369-387o402-421i497-515o526-546i,600
Q6PJF5,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),i404-426o667-681i693-711o725-736i748-768o771-791i803-825o,856
Q6PRD1,Probable G-protein coupled receptor 179 (Probable G-protein coupled receptor 158-like 1) (GPR158-like),o382-401i417-437o446-475i494-511o542-562i576-598o606-628i,2367
Q6QNK2,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25),o571-591i602-622o632-652i674-695o712-734i761-780o785-805i,874
Q6TCH7,Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG),i70-91o106-128i140-160o170-190i204-219o240-256i275-295o,311
Q6U736,Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin) (Transmembrane protein 13),o34-56i70-92o109-129i149-171o198-220i254-274o287-309i,354
Q6W5P4,Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility),o53-73i85-106o123-144i165-185o209-233i276-296o311-332i,371
Q6ZMG9,Ceramide synthase 6 (CerS6) (LAG1 longevity assurance homolog 6) (Sphingoid base N-palmitoyltransferase CERS6) (EC 2.3.1.291),o38-55i132-153o178-198i206-224o230-248i262-284o303-323i,384
Q6ZP29,Lysosomal amino acid transporter 1 homolog (PQ-loop repeat-containing protein 2) (Solute carrier family 66 member 1),o37-58i71-91o97-117i135-144o182-200i216-236o253-275i,291
Q7RTX0,Taste receptor type 1 member 3 (Sweet taste receptor T1R3),o569-591i606-624o638-660i681-702o728-751i763-783o792-812i,852
Q7RTX1,Taste receptor type 1 member 1 (G-protein coupled receptor 70),o567-590i604-623o632-660i680-700o726-747i761-782o790-809i,841
Q7Z429,Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3),i165-185o197-215i226-246o255-273i283-303o308-326i345-365o,371
Q7Z602,Probable G-protein coupled receptor 141 (G-protein coupled receptor PGR13),o20-43i53-73o87-111i132-152o180-202i227-247o267-286i,305
Q86SQ3,Putative adhesion G protein-coupled receptor E4P (EGF-like module receptor 4) (EGF-like module-containing mucin-like hormone receptor-like 4) (G-protein coupled receptor 127) (G-protein coupled receptor PGR16),o196-214i224-244o253-273i300-320o341-357i382-405o415-434i,457
Q86SQ4,Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)],o869-889i900-917o929-953i971-992o1019-1042i1067-1088o1093-1113i,1221
Q86SQ6,Adhesion G protein-coupled receptor A1 (G-protein coupled receptor 123),o20-41i55-74o85-103i135-155o176-199i256-277o285-305i,560
Q86UW1,Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha),o49-69i88-108o113-135i180-200o219-239i257-277o296-316i,340
Q86V24,Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II),i146-168o182-202i214-234o246-266i274-294o311-330i349-369o,386
Q86Y34,Adhesion G protein-coupled receptor G3 (G-protein coupled receptor 97) (G-protein coupled receptor PGR26),o274-292i308-328o338-366i378-400o432-452i476-496o503-523i,549
Q8IU89,Ceramide synthase 3 (CerS3) (Dihydroceramide synthase 3) (LAG1 longevity assurance homolog 3) (Sphingosine N-acyltransferase CERS3) (EC 2.3.1.24) (Ultra-long-chain ceramide synthase CERS3) (EC 2.3.1.298) (Very-long-chain ceramide synthase CERS3) (EC 2.3.1.297),o39-56i135-154o178-198i209-221o231-251i263-283o301-323i,383
Q8IWK6,Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125),o762-783i797-816o827-845i877-897o917-940i996-1017o1025-1045i,1321
Q8IY49,Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X),i37-57o67-87i102-122o135-153i183-200o209-226i235-255o,270
Q8IYL9,Psychosine receptor (G-protein coupled receptor 65) (T-cell death-associated gene 8 protein),o15-40i49-71o85-110i130-151o179-204i227-251o271-293i,337
Q8IZF2,Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116),o1014-1038i1052-1072o1090-1110i1129-1149o1173-1193i1220-1240o1246-1269i,1346
Q8IZF3,Adhesion G protein-coupled receptor F4 (G-protein coupled receptor 115) (G-protein coupled receptor PGR18),o407-427i441-461o476-497i516-536o560-580i606-626o633-655i,695
Q8IZF6,Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112),o2748-2768i2779-2799o2808-2832i2849-2871o2893-2914i2941-2958o2965-2985i,3080
Q8IZP9,Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6),o633-653i664-681o693-717i735-756o784-807i834-854o858-881i,1017
Q8N2U9,Solute carrier family 66 member 2 (PQ-loop repeat-containing protein 1),o13-35i49-69o76-96i143-163o169-187i204-223o228-248i,271
Q8N5B7,Ceramide synthase 5 (CerS5) (LAG1 longevity assurance homolog 5) (Sphingoid base N-palmitoyltransferase CERS5) (EC 2.3.1.291) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24),o47-64i145-163o187-203i214-234o242-257i268-292o310-332i,392
Q8N6U8,G-protein coupled receptor 161 (G-protein coupled receptor RE2),o31-52i65-85o102-123i144-166o188-211i272-292o306-326i,529
Q8NBQ7,Aquaporin-11 (AQP-11),o16-34i47-67o77-93i118-138o163-183i193-213o236-258i,271
Q8NFJ5,Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1),o29-49i66-86o99-119i134-154o177-197i211-233o245-265i,357
Q8NFJ6,Prokineticin receptor 2 (PK-R2) (G-protein coupled receptor 73-like 1) (G-protein coupled receptor I5E) (GPR73b) (GPRg2),o54-77i90-112o131-151i171-191o223-244i276-297o314-335i,384
Q8NG98,Olfactory receptor 7D4 (OR19-B) (Odorant receptor family subfamily D member 4RT) (Olfactory receptor OR19-7),o26-49i59-74o98-120i143-163o197-219i241-260o274-290i,312
Q8NHC4,Olfactory receptor 10J5 (Olfactory receptor OR1-28),o25-49i59-82o98-120i145-166o196-221i240-259o271-289i,309
Q8TDN7,Alkaline ceramidase 1 (AlkCDase 1) (Alkaline CDase 1) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 3) (N-acylsphingosine amidohydrolase 3),o28-48i58-78o90-104i118-137o143-161i172-189o205-226i,264
Q8TDS4,Hydroxycarboxylic acid receptor 2 (G-protein coupled receptor 109A) (G-protein coupled receptor HM74A) (Niacin receptor 1) (Nicotinic acid receptor),o29-54i64-84o102-123i144-164o186-209i232-256o272-297i,363
Q8TDS5,Oxoeicosanoid receptor 1 (5-oxo-ETE G-protein coupled receptor) (G-protein coupled receptor 170) (G-protein coupled receptor R527) (G-protein coupled receptor TG1019),o94-119i129-149o167-188i209-229o253-273i296-320o339-358i,423
Q8TDT2,Probable G-protein coupled receptor 152 (G-protein coupled receptor PGR5),o32-52i68-88o106-127i148-169o191-214i238-259o276-298i,470
Q8TDU6,G-protein coupled bile acid receptor 1 (G-protein coupled receptor GPCR19) (hGPCR19) (Membrane-type receptor for bile acids) (M-BAR) (hBG37) (BG37),o20-40i51-71o86-106i126-146o166-186i229-249o262-282i,330
Q8TDU9,Relaxin-3 receptor 2 (RLN3 receptor 2) (G-protein coupled receptor 100) (G-protein coupled receptor GPCR142) (Insulin-like peptide INSL5 receptor) (Relaxin family peptide receptor 4),o40-63i78-99o117-137i160-181o209-229i248-271o290-311i,374
Q8TDV0,G-protein coupled receptor 151 (G-protein coupled receptor PGR7) (GPCR-2037) (Galanin receptor 4) (Galanin-receptor-like protein) (GalRL),o38-60i75-94o116-134i154-174o201-223i251-271o287-309i,419
Q8TE23,Taste receptor type 1 member 2 (G-protein coupled receptor 71) (Sweet taste receptor T1R2),o566-588i602-622o635-656i680-700o726-748i761-780o789-809i,839
Q92633,Lysophosphatidic acid receptor 1 (LPA receptor 1) (LPA-1) (Lysophosphatidic acid receptor Edg-2),o51-74i87-107o126-144i164-184o206-226i260-280o291-311i,364
Q92847,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),o48-67i81-101o118-139i161-181o209-233i264-285o303-323i,366
Q969F8,KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor),o43-67i79-101o117-138i158-180o203-226i264-285o304-326i,398
Q969X1,Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1),i102-122o135-152i163-183o192-210i220-241o249-267i286-306o,311
Q96A54,Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I),i135-157o171-191i203-223o235-255i266-283o300-319i338-358o,375
Q96B21,Transmembrane protein 45B,o6-23i47-67o86-108i116-136o146-166i175-195o217-237i,275
Q96BI3,Gamma-secretase subunit APH-1A (APH-1a) (Aph-1alpha) (Presenilin-stabilization factor),o4-26i32-59o70-91i118-139o157-179i186-207o211-231i,265
Q96CC6,Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho),i405-428o666-680i692-710o724-735i747-767o770-790i804-825o,855
Q96CP7,TLC domain-containing protein 1 (Calfacilitin),o8-26i48-66o84-104i112-130o136-153i173-195o206-226i,247
Q96FM1,Post-GPI attachment to proteins factor 3 (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1),o99-119i136-156o170-190i194-214o225-245i258-278o283-299i,320
Q96G23,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2) (EC 2.3.1.297),o39-56i136-156o179-199i208-225o229-249i264-286o304-324i,380
Q96G91,P2Y purinoceptor 11 (P2Y11),o30-51i66-87o104-125i146-166o202-226i246-270o298-325i,374
Q8WW43,Gamma-secretase subunit APH-1B (APH-1b) (Aph-1beta) (Presenilin-stabilization factor-like),o4-26i32-60o71-91i116-136o156-178i186-206o211-231i,257
Q8WXD0,Relaxin receptor 2 (G-protein coupled receptor 106) (G-protein coupled receptor affecting testicular descent) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2),o420-439i453-473o497-518i538-558o588-613i640-660o672-693i,754
Q8WXG9,Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta],o5910-5930i5940-5959o5972-5993i6011-6032o6057-6080i6105-6126o6132-6155i,6306
Q96KK4,Olfactory receptor 10C1 (Hs6M1-17) (Olfactory receptor 10C2),o24-48i59-81o97-119i143-165o196-218i240-259o271-291i,312
Q96LB1,Mas-related G-protein coupled receptor member X2,o32-56i66-88o104-125i147-167o185-207i221-249o263-283i,330
Q96LB2,Mas-related G-protein coupled receptor member X1 (Sensory neuron-specific G-protein coupled receptor 3/4),o30-53i63-85o97-118i138-163o178-200i214-242o255-275i,322
Q96MV1,TLC domain-containing protein 4 (Transmembrane protein 56),o7-30i53-71o88-108i117-132o141-157i177-197o218-238i,263
Q96N19,Integral membrane protein GPR137 (Transmembrane 7 superfamily member 1-like 1 protein),o24-49i60-81o97-117i141-160o176-196i218-238o274-294i,417
Q96P65,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),o46-69i82-104o120-141i162-183o213-235i274-294o313-335i,431
Q96P66,Probable G-protein coupled receptor 101,o32-56i69-89o106-127i148-170o192-214i400-424o434-457i,508
Q96PE1,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5),o772-793i805-826o837-855i887-907o925-945i1019-1040o1048-1068i,1338
Q96RI0,Proteinase-activated receptor 4 (PAR-4) (Coagulation factor II receptor-like 3) (Thrombin receptor-like 3),o79-101i113-134o152-172i192-213o244-266i284-305o321-343i,385
Q96RI8,Trace amine-associated receptor 6 (TaR-6) (Trace amine receptor 6) (Trace amine receptor 4) (TaR-4),o33-58i69-91o107-128i150-170o198-218i260-280o295-315i,345
Q99500,Sphingosine 1-phosphate receptor 3 (S1P receptor 3) (S1P3) (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3) (S1P receptor Edg-3),o43-63i77-97o115-134i154-174o196-216i245-265o282-300i,378
Q99527,G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER),o60-85i96-117o128-153i174-194o216-236i260-284o308-328i,375
Q99677,Lysophosphatidic acid receptor 4 (LPA receptor 4) (LPA-4) (G-protein coupled receptor 23) (P2Y purinoceptor 9) (P2Y9) (P2Y5-like receptor) (Purinergic receptor 9),o41-66i76-97o109-134i154-175o200-226i250-275o291-314i,370
Q99705,Melanin-concentrating hormone receptor 1 (MCH receptor 1) (MCH-R1) (MCHR-1) (G-protein coupled receptor 24) (MCH-1R) (MCH1R) (MCHR) (SLC-1) (Somatostatin receptor-like protein),o110-135i149-169o187-208i229-249o275-298i326-346o364-383i,422
Q99788,Chemerin-like receptor 1 (Chemokine-like receptor 1) (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ),o41-64i76-97o114-135i155-176o225-245i261-282o299-319i,373
Q99835,Protein smoothened (Protein Gx),o232-254i265-285o313-337i359-378o399-424i447-471o519-538i,787
Q9BPV8,P2Y purinoceptor 13 (P2Y13) (G-protein coupled receptor 86) (G-protein coupled receptor 94),o47-68i79-101o118-139i161-182o208-232i257-278o298-320i,354
Q9BRV3,Sugar transporter SWEET1 (HsSWEET1) (RAG1-activating protein 1) (Solute carrier family 50 member 1) (Stromal cell protein),o10-30i42-63o68-88i97-117o129-149i160-180o186-206i,221
Q9BW60,Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3-oxoacyl-CoA synthase 1),o25-45i60-81o110-130i139-156o165-187i200-222o232-252i,279
Q9BWQ8,Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35) (Transmembrane BAX inhibitor motif-containing protein 2),i106-126o139-156i167-187o196-214i225-245o252-271i290-310o,316
Q9BXA5,Succinate receptor 1 (G-protein coupled receptor 91) (P2Y purinoceptor 1-like),o28-50i60-80o98-118i138-161o185-208i233-251o278-298i,334
Q9BXB1,Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48),o543-563i575-600o620-641i664-682o704-726i749-769o784-804i,951
Q9BXC0,Hydroxycarboxylic acid receptor 1 (G-protein coupled receptor 104) (G-protein coupled receptor 81),o17-42i52-72o90-111i132-152o176-197i221-245o259-281i,346
Q9BY15,Adhesion G protein-coupled receptor E3 (EGF-like module receptor 3) (EGF-like module-containing mucin-like hormone receptor-like 3),o361-381i391-410o419-439i466-484o508-528i550-570o578-601i,652
Q9BZJ7,G-protein coupled receptor 62 (G-protein coupled receptor GPCR8) (hGPCR8) (G-protein coupled receptor KPG_005),o18-38i49-69o90-111i130-150o174-193i245-262o274-293i,368
Q9BZJ8,G-protein coupled receptor 61 (Biogenic amine receptor-like G-protein coupled receptor),o44-67i77-99o117-138i159-179o207-229i288-308o324-344i,451
Q9GZQ4,Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1),o46-70i84-104o121-142i164-184o215-237i269-290o304-327i,415
Q9GZQ6,Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022),o43-68i80-102o119-139i158-178o215-237i271-291o310-331i,430
Q9GZR5,Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),o40-63i77-98o124-144i156-173o181-201i217-237o246-267i,314
Q9H1Y3,Opsin-3 (Encephalopsin) (Panopsin),o44-64i78-100o115-135i157-176o203-223i256-276o290-312i,402
Q9H228,Sphingosine 1-phosphate receptor 5 (S1P receptor 5) (S1P5) (Endothelial differentiation G-protein-coupled receptor 8) (Sphingosine 1-phosphate receptor Edg-8) (S1P receptor Edg-8),o40-61i73-95o109-131i152-173o192-213i253-273o288-308i,398
Q9H244,P2Y purinoceptor 12 (P2Y12) (ADP-glucose receptor) (ADPG-R) (P2T(AC)) (P2Y(AC)) (P2Y(cyc)) (P2Y12 platelet ADP receptor) (P2Y(ADP)) (SP1999),o28-49i60-82o99-120i142-163o189-210i238-259o280-301i,342
Q9H255,Olfactory receptor 51E2 (HPRAJ) (Olfactory receptor OR11-16) (Prostate-specific G-protein coupled receptor),o24-48i58-82o97-119i143-162o195-221i240-260o273-293i,320
Q9H3N8,Histamine H4 receptor (H4R) (HH4R) (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144),o16-40i52-73o88-108i132-153o173-195i305-325o342-361i,390
Q9H461,Frizzled-8 (Fz-8) (hFz8),o278-301i312-332o397-419i440-462o483-505i529-552o584-605i,694
Q9H5J4,Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Fatty acid elongase 2) (hELO2) (Fatty acyl-CoA elongase) (Long-chain fatty-acyl elongase) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6),o27-47i62-89o111-129i140-155o163-183i194-217o232-251i,265
Q9H8P0,Polyprenol reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3),o15-35i76-98o125-149i157-178o201-217i257-272o275-295i,318
Q9HA82,Ceramide synthase 4 (CerS4) (EC 2.3.1.-) (LAG1 longevity assurance homolog 4) (Sphingosine N-acyltransferase CERS4) (EC 2.3.1.24),o39-61i135-155o179-199i208-223o229-249i260-285o304-324i,394
Q9HAR2,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),o869-889i898-918o927-947i969-989o1008-1028i1053-1073o1080-1100i,1447
Q9HB03,Elongation of very long chain fatty acids protein 3 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL3) (Cold-inducible glycoprotein of 30 kDa) (ELOVL fatty acid elongase 3) (ELOVL FA elongase 3) (Very long chain 3-ketoacyl-CoA synthase 3) (Very long chain 3-oxoacyl-CoA synthase 3),o33-51i65-89o115-129i146-159o167-187i201-222o235-255i,270
Q9HB89,Neuromedin-U receptor 1 (NMU-R1) (G-protein coupled receptor 66) (G-protein coupled receptor FM-3),o60-85i97-118o136-157i178-199o230-256i298-323o337-359i,426
Q9HBW0,Lysophosphatidic acid receptor 2 (LPA receptor 2) (LPA-2) (Lysophosphatidic acid receptor Edg-4),o30-54i67-87o106-124i144-164o187-206i240-260o276-292i,348
Q9HBW9,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",o433-453i475-495o500-520i533-553o574-594i619-639o647-667i,690
Q9HBX8,Leucine-rich repeat-containing G-protein coupled receptor 6,o566-587i599-621o644-665i686-706o732-752i775-798o810-830i,967
Q9HBX9,Relaxin receptor 1 (Leucine-rich repeat-containing G-protein coupled receptor 7) (Relaxin family peptide receptor 1),o410-429i442-463o487-508i528-548o578-600i630-650o661-683i,757
Q9HC24,Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein),i38-58o71-89i98-118o123-143i152-172o180-196i211-232o,238
Q9HC97,G-protein coupled receptor 35 (Kynurenic acid receptor) (KYNA receptor),o21-46i57-77o88-112i133-154o170-192i218-239o257-279i,309
Q9HCN3,Post-GPI attachment to proteins factor 6 (EC 3.1.1.4) (GPI processing phospholipase A2) (GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A),o546-566i569-589o606-627i628-648o658-675i691-711o720-737i,771
Q9HCU4,Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2) (EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3),o2381-2401i2410-2430o2439-2459i2481-2501o2519-2539i2564-2581o2589-2612i,2923
Q9NPB9,Atypical chemokine receptor 4 (C-C chemokine receptor type 11) (C-C CKR-11) (CC-CKR-11) (CCR-11) (CC chemokine receptor-like 1) (CCRL1) (CCX CKR),o42-67i78-99o114-135i156-176o198-222i241-261o283-306i,350
Q9NPC1,Leukotriene B4 receptor 2 (LTB4-R 2) (LTB4-R2) (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2),o23-43i59-80o96-117i143-159o179-203i225-249o272-292i,358
Q9NPG1,Frizzled-3 (Fz-3) (hFz3),o204-226i238-258o288-309i329-349o373-395i421-441o477-498i,666
Q9NPR9,Protein GPR108 (Lung seven transmembrane receptor 2),o258-282i292-312o336-356i367-384o401-421i447-465o476-496i,543
Q9NQ84,G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3),o51-71i86-106o121-141i156-176o209-229i242-262o280-300i,441
Q9NQS5,G-protein coupled receptor 84 (Inflammation-related G-protein coupled receptor EX33),o22-44i57-78o95-116i137-159o180-200i320-340o350-373i,396
Q9NRD8,Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 2) (Long NOX 2) (NADH/NADPH thyroid oxidase p138-tox) (NADPH oxidase/peroxidase DUOX2) (NADPH thyroid oxidase 2) (Thyroid oxidase 2) (p138 thyroid oxidase),o598-619i1041-1063o1078-1102i1125-1149o1182-1207i1220-1238o1246-1259i,1548
Q9NRD9,Dual oxidase 1 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 1) (Long NOX 1) (NADPH thyroid oxidase 1) (Thyroid oxidase 1),o592-616i1044-1066o1081-1105i1128-1152o1185-1210i1223-1241o1249-1262i,1551
Q9NS75,Cysteinyl leukotriene receptor 2 (CysLTR2) (G-protein coupled receptor GPCR21) (hGPCR21) (G-protein coupled receptor HG57) (HPN321),o43-63i73-93o124-144i154-174o205-225i246-266o287-307i,346
Q9NUN7,Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC),o31-52i62-82o93-113i119-137o143-164i173-194o216-236i,267
Q9NVV0,Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B),o15-33i48-68o81-95i112-121o141-161i182-195o208-228i,291
Q9NX52,"Rhomboid-related protein 2 (RRP2) (EC 3.4.21.105) (Rhomboid-like protein 2) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment (NTF); Rhomboid-related protein 2, C-terminal fragment (CTF)]",i71-91o133-153i157-177o183-203i211-236o245-265i278-299o,303
Q9NXB9,Elongation of very long chain fatty acids protein 2 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL2) (ELOVL fatty acid elongase 2) (ELOVL FA elongase 2) (Very long chain 3-ketoacyl-CoA synthase 2) (Very long chain 3-oxoacyl-CoA synthase 2),o32-52i66-88o115-135i144-161o171-191i204-225o234-254i,296
Q9NYM4,G-protein coupled receptor 83 (G-protein coupled receptor 72),o72-92i108-130o146-167i186-206o238-260i293-313o326-348i,423
Q9NYP7,Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),o26-49i63-87o109-129i141-158o167-187i202-222o231-251i,299
Q9NYQ6,Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2),o2473-2493i2502-2522o2531-2551i2573-2592o2611-2632i2653-2673o2682-2704i,3014
Q9NYQ7,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),o2545-2562i2573-2593o2602-2622i2644-2663o2682-2703i2723-2743o2751-2774i,3312
Q9NYV7,Taste receptor type 2 member 16 (T2R16),o9-33i47-69o80-105i125-147o176-201i229-249o257-279i,291
Q9NYW0,Taste receptor type 2 member 10 (T2R10) (Taste receptor family B member 2) (TRB2),o8-30i46-69o80-108i128-148o176-198i228-250o257-280i,307
Q9NYW4,Taste receptor type 2 member 5 (T2R5),o7-32i46-68o77-105i125-146o168-193i223-243o253-275i,299
Q9NYW5,Taste receptor type 2 member 4 (T2R4),o4-32i47-67o83-105i132-149o178-200i231-251o264-282i,299
Q9NZD1,G-protein coupled receptor family C group 5 member D,o24-46i60-82o94-114i129-149o170-188i205-225o242-262i,345
Q9NZH0,G-protein coupled receptor family C group 5 member B (A-69G12.1) (Retinoic acid-induced gene 2 protein) (RAIG-2),o57-77i93-113o127-145i162-182o200-220i233-253o272-292i,403
Q9P296,C5a anaphylatoxin chemotactic receptor 2 (Complement component 5a receptor 2) (G-protein coupled receptor 77),o37-59i72-92o110-130i153-171o199-224i235-258o274-294i,337
Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1),o589-614i628-649o661-686i710-730o766-789i804-826o832-854i,961
Q9UBY5,Lysophosphatidic acid receptor 3 (LPA receptor 3) (LPA-3) (Lysophosphatidic acid receptor Edg-7),o31-53i68-88o107-125i145-165o187-207i241-261o277-295i,353
Q9UBY8,Protein CLN8,o27-42i71-86o104-123i133-151o155-175i192-212o230-250i,286
Q9UHM6,Melanopsin (Opsin-4),o73-93i107-129o145-166i187-209o237-259i297-321o331-353i,478
Q9UHX3,Adhesion G protein-coupled receptor E2 (EGF-like module receptor 2) (EGF-like module-containing mucin-like hormone receptor-like 2) (CD antigen CD312),o541-561i570-590o602-622i646-664o685-705i730-750o758-781i,823
Q9UKP6,Urotensin-2 receptor (UR-2-R) (G-protein coupled receptor 14) (Urotensin II receptor) (UR-II-R),o52-75i86-109o125-146i168-188o210-232i259-279o295-318i,389
Q9ULV1,Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344),o221-242i252-275o300-326i344-365o386-410i438-457o475-496i,537
Q9ULW2,Frizzled-10 (Fz-10) (hFz10) (FzE7) (CD antigen CD350),o229-250i260-283o307-333i351-372o393-417i445-464o503-523i,581
Q9UNW8,Probable G-protein coupled receptor 132 (G2 accumulation protein),o43-68i77-100o113-138i158-178o196-220i243-268o289-311i,380
Q9Y271,Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81),o25-49i60-81o94-119i140-160o186-211i234-255o277-298i,337
Q9Y2T6,G-protein coupled receptor 55,o24-46i61-82o96-117i139-159o179-202i228-248o268-291i,319
Q9Y5N1,Histamine H3 receptor (H3R) (HH3R) (G-protein coupled receptor 97),o35-60i71-92o109-130i152-174o197-222i360-380o396-415i,445
Q9Y5X5,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),o147-172i184-206o222-243i262-282o320-342i377-397o416-437i,522
Q9Y5Y4,Prostaglandin D2 receptor 2 (Chemoattractant receptor-homologous molecule expressed on Th2 cells) (G-protein coupled receptor 44) (CD antigen CD294),o34-56i68-89o107-127i147-168o211-231i248-269o289-308i,395
Q9Y653,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)],o405-427i445-462o477-495i519-539o568-593i609-628o637-657i,693
A5D6W6,Fat storage-inducing transmembrane protein 1 (Fat-inducing protein 1),o39i55-72o95-115i125-145o180-198i218-243o246-267i,292
A6ND48,Olfactory receptor 14I1 (Olfactory receptor 5BU1),o23-47i60-80o96-116i142-162o190-217i241-258o270-287i,311
A6NGC4,TLC domain-containing protein 2,o5-23i39-60o77-97i106-124o129-147i167-189o202-219i,264
A6NGY5,Olfactory receptor 51F1,o34-59i71-95o107-129i153-172o206-231i250-271o283-303i,319
A6NH00,Olfactory receptor 2T8,o24-47i57-77o96-118i142-164o195-219i239-257o271-290i,312
A6NND4,Olfactory receptor 2AT4 (Olfactory receptor OR11-265),o30-55i64-84o103-123i148-168o202-224i246-266o277-297i,320
O00398,Putative P2Y purinoceptor 10 (P2Y10) (P2Y-like receptor),o36-60i70-92o104-129i150-170o195-219i244-266o282-309i,339
O14626,G-protein coupled receptor 171 (G-protein coupled receptor H963),o20-40i51-72o89-110i133-154o178-200i222-246o266-288i,319
O14718,Visual pigment-like receptor peropsin,o27-51i62-83o100-121i142-163o187-210i241-261o275-297i,337
O15218,G-protein coupled receptor 182,o54-77i90-110o124-149i169-190o215-240i259-281o297-323i,404
O60412,Olfactory receptor 7C2 (Olfactory receptor 19-18) (OR19-18) (Olfactory receptor 7C3) (Olfactory receptor OR19-22),o25-49i59-74o98-120i144-164o197-219i244-259o272-289i,319
O75352,Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog) (SL15),o41-63i76-95o103-121i130-147o153-173i185-205o213-233i,247
O75388,Probable G-protein coupled receptor 32,o45-70i78-100o112-137i158-179o214-238i257-278o300-320i,356
O76001,Olfactory receptor 2J3 (Hs6M1-3) (Olfactory receptor OR6-16) (OR6-6) (Olfactory receptor 6-6),o28-51i62-82o101-123i148-169o200-225i244-263o276-293i,311
O76002,Olfactory receptor 2J2 (Hs6M1-6) (Olfactory receptor 6-8) (OR6-8) (Olfactory receptor OR6-19),o26-49i60-80o99-121i145-165o198-221i242-261o274-291i,312
O76099,Olfactory receptor 7C1 (Olfactory receptor 7C4) (Olfactory receptor OR19-16) (Olfactory receptor TPCR86),o26-49i59-74o98-120i143-164o197-219i245-260o272-292i,320
O95007,Olfactory receptor 6B1 (Olfactory receptor 7-3) (OR7-3) (Olfactory receptor OR7-9),o25-49i59-79o98-120i144-164o197-223i239-257o271-290i,311
O95222,Olfactory receptor 6A2 (Olfactory receptor 11-55) (OR11-55) (Olfactory receptor 6A1) (Olfactory receptor OR11-83) (hP2 olfactory receptor),o26-50i63-83o103-125i150-171o202-228i246-263o278-297i,327
O95371,Olfactory receptor 2C1 (OLFmf3) (Olfactory receptor 2C2) (Olfactory receptor OR16-1) (Olfactory receptor OR16-2),o25-48i59-79o100-120i143-166o197-222i241-256o273-292i,312
O95665,Neurotensin receptor type 2 (NT-R-2) (NTR2) (Levocabastine-sensitive neurotensin receptor),o33-56i72-92o110-131i154-174o205-228i298-318o338-358i,410
O95800,Probable G-protein coupled receptor 75,o42-65i81-106o121-141i162-181o202-224i323-342o357-377i,540
O95838,Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R),o174-198i211-235o262-285i300-321o340-362i387-405o418-438i,553
O95918,Olfactory receptor 2H2 (Hs6M1-12) (Olfactory receptor 2H3) (Olfactory receptor-like protein FAT11),o25-46i57-77o96-118i143-164o195-219i243-258o271-288i,312
P0C617,Olfactory receptor 5AL1 (Olfactory receptor OR11-184),o41-65i75-95o114-136i160-180o213-238i257-274o289-306i,329
P0C645,Olfactory receptor 4E1 (Olfactory receptor OR14-43),o29-54i63-83o102-124i146-168o198-227i244-261o274-293i,315
P0DN77,Medium-wave-sensitive opsin 2 (Green cone photoreceptor pigment) (Green-sensitive opsin) (GOP) (Opsin 1 cone pigments medium-wave-sensitive 2),o55-79i90-112o127-149i168-191o220-240i269-289o305-325i,364
P0DN78,Medium-wave-sensitive opsin 3 (Green cone photoreceptor pigment) (Green-sensitive opsin) (GOP) (opsin 1 cone pigments medium-wave-sensitive 3),o55-79i90-112o127-149i168-191o220-240i269-289o305-325i,364
P25089,N-formyl peptide receptor 3 (FMLP-related receptor II) (FMLP-R-II) (Formyl peptide receptor-like 2),o28-50i62-83o101-121i141-162o206-226i243-266o287-306i,353
P30953,Olfactory receptor 1E1 (Olfactory receptor 13-66) (OR13-66) (Olfactory receptor 17-2/17-32) (OR17-2) (OR17-32) (Olfactory receptor 1E5) (Olfactory receptor 1E6) (Olfactory receptor 5-85) (OR5-85) (Olfactory receptor OR17-18) (Olfactory receptor-like protein HGMP07I),o29-49i59-79o98-120i143-164o197-219i241-260o272-290i,314
P30954,Olfactory receptor 10J1 (Olfactory receptor OR1-26) (Olfactory receptor-like protein HGMP07J),o36-60i70-93o109-131i155-177o207-232i251-270o282-302i,320
P33032,Melanocortin receptor 5 (MC5-R) (MC-2),o38-61i74-94o117-138i159-179o185-208i242-264o274-297i,325
P34995,Prostaglandin E2 receptor EP1 subtype (PGE receptor EP1 subtype) (PGE2 receptor EP1 subtype) (Prostanoid EP1 receptor),o38-58i75-96o112-133i156-177o201-226i299-319o333-354i,402
P43116,Prostaglandin E2 receptor EP2 subtype (PGE receptor EP2 subtype) (PGE2 receptor EP2 subtype) (Prostanoid EP2 receptor),o26-47i69-91o111-132i154-176o195-219i264-286o298-318i,358
P46094,Chemokine XC receptor 1 (G-protein coupled receptor 5) (Lymphotactin receptor) (XC chemokine receptor 1),o32-54i68-88o100-125i145-166o183-206i226-248o267-291i,333
P46095,G-protein coupled receptor 6 (Sphingosine 1-phosphate receptor GPR6),o75-97i109-131o142-164i185-205o227-246i281-301o309-329i,362
P47775,G-protein coupled receptor 12,o49-69i81-103o114-136i157-177o199-218i254-274o281-301i,334
P47883,Putative olfactory receptor 3A4 (Olfactory receptor 17-24) (OR17-24) (Olfactory receptor 3A5),o28-52i62-85o101-123i146-167o200-222i245-260o276-294i,348
P47887,Olfactory receptor 1E2 (Olfactory receptor 17-93/17-135/17-136) (OR17-135) (OR17-136) (OR17-93) (Olfactory receptor 1E4),o26-49i59-79o100-120i151-173o206-228i250-269o281-301i,323
P47888,Olfactory receptor 3A3 (Olfactory receptor 17-201) (OR17-201) (Olfactory receptor 3A6) (Olfactory receptor 3A7) (Olfactory receptor 3A8) (Olfactory receptor OR17-22),o35-58i68-92o107-129i152-173o206-228i250-269o282-301i,321
P47893,Olfactory receptor 3A2 (Olfactory receptor 17-228) (OR17-228) (Olfactory receptor OR17-14),o35-58i68-92o107-129i152-173o206-228i251-269o282-299i,321
P49190,Parathyroid hormone 2 receptor (PTH2 receptor),o144-168i177-198o238-262i275-297o316-337i365-381o393-416i,550
P58173,Olfactory receptor 2B6 (Hs6M1-32) (Olfactory receptor 2B1) (Olfactory receptor 2B5) (Olfactory receptor 5-40) (OR5-40) (Olfactory receptor 6-31) (OR6-31) (Olfactory receptor OR6-4),o26-48i59-79o98-120i144-164o197-222i241-260o273-292i,313
P58182,Olfactory receptor 12D2 (Hs6M1-20) (Olfactory receptor OR6-28),o23-46i57-80o96-118i142-162o195-220i241-259o271-289i,307
P58872,Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein),i164-179o218-244i247-267o279-294i305-325o338-358i371-391o,404
P59533,Taste receptor type 2 member 38 (T2R38) (PTC bitter taste receptor) (Taste receptor type 2 member 61) (T2R61),o18-42i56-76o94-119i140-163o195-218i249-272o277-300i,333
P59534,Taste receptor type 2 member 39 (T2R39) (Taste receptor type 2 member 57) (T2R57),o36-61i75-96o109-137i160-180o207-232i263-283o291-314i,338
P59535,Taste receptor type 2 member 40 (T2R40) (G-protein coupled receptor 60) (Taste receptor type 2 member 58) (T2R58),o22-42i59-80o93-121i144-164o192-218i248-268o277-299i,323
P59537,Taste receptor type 2 member 43 (T2R43) (Taste receptor type 2 member 52) (T2R52),o8-33i47-67o83-108i129-149o177-199i231-251o260-282i,309
P59540,Taste receptor type 2 member 46 (T2R46) (Taste receptor type 2 member 54) (T2R54),o8-30i47-68o83-108i129-149o177-199i231-251o260-282i,309
P59541,Taste receptor type 2 member 30 (T2R30) (Taste receptor type 2 member 47) (T2R47),o8-30i47-68o83-108i129-149o177-199i231-251o260-282i,319
P59543,Taste receptor type 2 member 20 (Taste receptor type 2 member 49) (T2R49) (Taste receptor type 2 member 56) (T2R56),o7-33i46-66o80-105i128-146o177-200i231-251o259-281i,309
P59544,Taste receptor type 2 member 50 (T2R50) (Taste receptor type 2 member 51) (T2R51),o8-33i47-68o83-108i129-149o174-199i231-251o260-281i,299
P60893,Probable G-protein coupled receptor 85 (Super conserved receptor expressed in brain 2),o25-45i57-78o96-117i138-158o184-203i286-306o321-341i,370
Q13606,Olfactory receptor 5I1 (Olfactory receptor OR11-159) (Olfactory receptor-like protein OLF1),o27-51i61-81o100-122i146-168o199-221i247-261o275-292i,314
Q13607,Olfactory receptor 2F1 (Olfactory receptor 2F3) (Olfactory receptor 2F4) (Olfactory receptor 2F5) (Olfactory receptor-like protein OLF3),o25-49i59-82o98-120i144-164o197-222i241-260o273-290i,317
Q14439,G-protein coupled receptor 176 (HB-954),o43-65i79-100o119-140i162-182o204-226i268-287o303-323i,515
Q15391,P2Y purinoceptor 14 (P2Y14) (G-protein coupled receptor 105) (UDP-glucose receptor),o24-46i58-79o96-117i139-160o186-207i235-256o277-298i,338
Q15612,Olfactory receptor 1Q1 (OST226) (Olfactory receptor 1Q2) (Olfactory receptor 1Q3) (Olfactory receptor 9-A) (OR9-A) (Olfactory receptor OR9-25) (Olfactory receptor TPCR106),o25-49i59-79o98-120i144-164o197-222i242-259o273-290i,314
Q15617,Olfactory receptor 8G1 (Olfactory receptor OR11-281) (Olfactory receptor TPCR25),o25-49i59-79o98-120i144-164o197-223i245-258o273-290i,311
Q15620,Olfactory receptor 8B8 (Olfactory receptor TPCR85) (Olfactory-like receptor JCG8),o25-49i59-79o98-120i142-166o197-222i245-256o273-290i,311
Q15760,Probable G-protein coupled receptor 19 (GPR-NGA),o68-88i102-122o140-161i180-201o224-244i277-297o310-330i,415
Q16538,Probable G-protein coupled receptor 162 (Gene-rich cluster gene A protein),o18-38i50-72o92-113i135-156o179-200i272-292o305-325i,588
Q2T9K0,Transmembrane protein 44,o28-50i62-82o87-108i134-155o180-196i261-281o293-313i,475
Q49SQ1,Probable G-protein coupled receptor 33,o31-53i65-86o104-124i144-165o203-230i246-269o282-302i,333
Q5FWE3,Proline-rich transmembrane protein 3,o473-493i502-523o539-559i572-587o599-619i640-660o680-700i,981
Q5T848,Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158),o418-439i451-474o482-511i526-546o578-598i612-634o642-664i,1215
Q66K66,Transmembrane protein 198,o36-56i62-81o93-113i116-136o146-165i171-192o218-236i,360
Q6DWJ6,Probable G-protein coupled receptor 139 (G(q)-coupled orphan receptor GPRg1) (G-protein-coupled receptor PGR3),o31-52i65-86o103-124i148-165o182-205i229-249o265-285i,353
Q6IFH4,Olfactory receptor 6B2 (Olfactory receptor OR2-1),o26-49i59-79o98-120i144-164o197-219i241-259o273-290i,312
Q6Q0C1,Solute carrier family 25 member 47 (Hepatocellular carcinoma down-regulated mitochondrial carrier protein),o3-17i58-73o98-112i183-203o217-238i273-284o285-300i,308
Q71RH2,Ceramide synthase (EC 2.3.1.-) (Protein FAM57B) (TLC domain-containing protein 3B),o18i39-59o76-95i130-150o155-175i191-213o236-252i,274
Q7RTR8,Taste receptor type 2 member 42 (T2R42) (Taste receptor type 2 member 55) (T2R55),o8-30i47-68o84-109i130-152o180-205i236-260o265-287i,314
Q7Z3T1,Olfactory receptor 2W3 (Olfactory receptor 2W8) (Olfactory receptor OR1-49),o26-48i59-79o98-120i143-163o197-222i241-260o273-290i,314
Q7Z5H4,Vomeronasal type-1 receptor 5 (G-protein coupled receptor GPCR26) (hGPCR26) (V1r-like receptor 5),o47-69i83-103o120-141i164-184o270-280i281-290o306-321i,357
Q7Z5H5,Vomeronasal type-1 receptor 4 (G-protein coupled receptor GPCR27) (hGPCR27) (V1r-like receptor 4),o6-30i44-66o82-104i127-147o179-200i235-259o272-286i,301
Q7Z601,Probable G-protein coupled receptor 142 (G-protein coupled receptor PGR2),o160-182i195-216o234-254i278-297o312-337i358-378o394-414i,462
Q7Z7M1,Adhesion G-protein coupled receptor D2 (G-protein coupled receptor 144) (G-protein coupled receptor PGR24),o663-682i697-710o721-741i763-783o804-825i856-876o884-904i,963
Q86SP6,Probable G-protein coupled receptor 149 (G-protein coupled receptor PGR10),o36-56i69-89o110-132i156-176o190-210i311-331o343-363i,731
Q86VZ1,P2Y purinoceptor 8 (P2Y8),o24-49i60-81o94-119i139-160o191-215i236-262o277-296i,359
Q86W33,Transmembrane protein adipocyte-associated 1 (Integral membrane protein GPR175) (Transmembrane protein 227),o45-63i79-102o116-137i151-169o192-211i228-248o265-280i,373
Q8IZ08,G-protein coupled receptor 135,o103-128i140-162o186-207i227-247o275-298i333-353o367-389i,494
Q8IZF4,Adhesion G-protein coupled receptor G5 (G-protein coupled receptor 114) (G-protein coupled receptor PGR27),o250-271i283-304o313-337i354-376o410-435i457-477o485-505i,528
Q8IZF5,Adhesion G-protein coupled receptor F3 (G-protein coupled receptor 113) (G-protein coupled receptor PGR23),o776-796i810-830o843-864i885-906o927-947i974-994o1000-1023i,1079
Q8IZF7,Putative adhesion G protein-coupled receptor F2P (Adhesion G-protein coupled receptor F2) (G-protein coupled receptor 111) (G-protein coupled receptor PGR20),o448-467i486-508o520-545i561-581o604-627i652-668o679-688i,708
Q8N628,Olfactory receptor 2C3 (Olfactory receptor 2C4) (Olfactory receptor 2C5) (Olfactory receptor OR1-30),o27-49i60-80o99-121i143-167o198-220i242-261o274-293i,320
Q8NBN3,Transmembrane protein 87A (Elkin1),o226-249i260-277o306-322i333-349o360-383i407-423o443-460i,555
Q8NDV2,G-protein coupled receptor 26,o6-31i43-65o81-102i124-147o171-193i243-266o275-297i,337
Q8NFN8,Probable G-protein coupled receptor 156 (G-protein coupled receptor PGR28) (GABAB-related G-protein coupled receptor),o48-70i86-105o124-143i165-185o223-243i258-278o287-309i,814
Q8NGA0,Olfactory receptor 7G1 (Olfactory receptor 19-15) (OR19-15) (Olfactory receptor OR19-8),o26-50i62-74o98-120i143-164o197-219i241-260o272-292i,311
Q8NGC8,Olfactory receptor 11H7 (Olfactory receptor OR14-32),o25-49i59-83o98-120i143-164o194-222i241-261o272-290i,314
Q8NGD0,Olfactory receptor 4M1 (Olfactory receptor OR14-7),o25-47i59-83o98-120i143-164o197-222i243-260o272-289i,313
Q8NGE3,Olfactory receptor 10P1 (Olfactory receptor 10P2) (Olfactory receptor 10P3) (Olfactory receptor OR12-7),o26-48i59-79o99-121i144-167o198-220i244-261o274-293i,313
Q8NGG2,Olfactory receptor 5T2 (Olfactory receptor OR11-177),o64-89i98-118o137-159i183-205o236-261i280-299o312-329i,359
Q8NGH7,Olfactory receptor 52L1 (Olfactory receptor OR11-50),o45-67i77-97o116-138i162-182o215-237i258-278o292-312i,329
Q8NGI2,Olfactory receptor 52N4 (Olfactory receptor OR11-64),o27-51i61-81o100-122i146-165o196-221i242-262o277-297i,321
Q8NGI8,Olfactory receptor 5AN1 (Olfactory receptor OR11-244),o27-50i60-80o99-119i143-165o195-224i243-261o274-291i,311
Q8NGJ2,Olfactory receptor 52H1 (Olfactory receptor OR11-45),o33-57i67-94o106-128i152-172o202-227i249-269o282-302i,320
Q8NGK2,Olfactory receptor 52B4 (Olfactory receptor OR11-3),o29-51i63-86o100-122i146-165o196-221i243-263o276-296i,314
Q8NGM9,Olfactory receptor 8D4 (Olfactory receptor OR11-275),o25-49i59-79o98-120i143-166o197-222i245-260o275-290i,314
Q8NGN3,Olfactory receptor 10G4 (Olfactory receptor OR11-278),o23-47i57-77o97-117i142-163o195-218i240-259o270-287i,311
Q8NGQ1,Olfactory receptor 9G4 (Olfactory receptor OR11-216),o41-64i74-94o113-135i159-181o212-238i256-274o288-305i,327
Q8NGR2,Olfactory receptor 1L6 (Olfactory receptor 1L7) (Olfactory receptor OR9-30),o63-86i96-116o135-157i179-201o234-256i278-297o310-327i,347
Q8NGR6,Olfactory receptor 1B1 (Olfactory receptor 9-B) (OR9-B) (Olfactory receptor OR9-26),o28-51i63-84o100-122i146-166o203-225i247-266o278-298i,318
Q8NGS2,Olfactory receptor 1J2 (HSA5) (HTPCRX15) (OST044) (Olfactory receptor 1J3) (Olfactory receptor 1J5) (Olfactory receptor OR9-19),o26-49i59-79o98-120i143-163o197-219i241-256o272-292i,313
Q8NGS8,Olfactory receptor 13C5 (Olfactory receptor OR9-11),o25-48i59-79o98-120i144-164o197-220i241-260o279-296i,318
Q8NGT0,Olfactory receptor 13C9 (Olfactory receptor OR9-13),o25-48i59-79o98-120i144-164o197-222i241-259o279-296i,318
Q8NGV6,Olfactory receptor 5H6 (Olfactory receptor OR3-11),o41-65i75-95o114-136i158-182o210-238i257-272o288-306i,325
Q8NGW1,Olfactory receptor 6B3 (Olfactory receptor OR2-2),o26-49i59-79o98-120i144-164o197-219i241-260o273-290i,331
Q8NGW6,Olfactory receptor 6K6 (Olfactory receptor OR1-21),o53-77i87-107o126-148i174-194o221-246i268-287o297-317i,343
Q8NGX3,Olfactory receptor 10T2 (Olfactory receptor OR1-3),o26-50i60-84o99-121i141-165o198-223i241-260o272-292i,314
Q8NGY0,Olfactory receptor 10X1 (Olfactory receptor OR1-14),o42-64i75-95o114-136i160-182o213-238i257-275o285-305i,326
Q8NGY3,Olfactory receptor 6K3 (Olfactory receptor OR1-18),o41-65i75-95o114-136i160-182o210-234i256-275o285-305i,331
Q8NH10,Olfactory receptor 8U1,o25-49i59-79o98-120i144-166o197-222i245-260o274-290i,309
Q8NH19,Olfactory receptor 10AG1 (Olfactory receptor OR11-160),o17-40i50-70o89-111i133-157o188-210i232-251o264-283i,301
Q8NH43,Olfactory receptor 4L1 (Olfactory receptor 4L2) (Olfactory receptor OR14-28),o25-49i62-82o98-120i143-164o195-223i240-260o270-287i,312
Q8NH48,Olfactory receptor 5B3 (Olfactory receptor 5B13) (Olfactory receptor OR11-239),o23-47i57-77o96-118i142-164o195-221i240-258o271-288i,314
Q8NH59,Olfactory receptor 51Q1,o27-50i63-89o100-122i147-165o199-221i243-263o276-296i,317
Q8NH69,Olfactory receptor 5W2 (Olfactory receptor 5W3) (Olfactory receptor OR11-155),o25-48i59-73o98-120i144-164o196-223i245-260o273-290i,310
Q8NH85,Olfactory receptor 8U3 (Olfactory receptor 5R1) (Olfactory receptor OR11-185),o27-49i59-77o99-120i144-164o197-223i245-260o274-292i,324
Q8NH87,Olfactory receptor 9G1 (Olfactory receptor 9G5) (Olfactory receptor OR11-114),o24-48i58-78o97-119i141-161o196-221i244-258o272-289i,305
Q8NH92,Olfactory receptor 1S1 (Olfactory receptor OR11-232),o39-62i72-92o111-133i155-177o210-235i254-273o286-303i,325
Q8NH94,Olfactory receptor 1L1 (Olfactory receptor 1L2) (Olfactory receptor 9-C) (OR9-C) (Olfactory receptor OR9-27),o76-99i109-133o148-170i192-213o247-269i291-309o322-339i,360
Q8NHC8,Olfactory receptor 2T6 (OST703) (Olfactory receptor 2T9),o25-49i59-83o98-120i143-164o197-219i241-256o273-290i,308
Q8TCB6,Olfactory receptor 51E1 (D-GPCR) (G-protein coupled receptor 164) (Olfactory receptor 52A3) (Prostate-overexpressed G protein-coupled receptor) (Prostate-specific G protein-coupled receptor 2),o27-50i63-88o100-122i146-165o196-221i242-262o275-295i,317
Q8TCW9,Prokineticin receptor 1 (PK-R1) (G-protein coupled receptor 73) (G-protein coupled receptor ZAQ) (GPR73a),o63-86i99-119o139-160i179-199o233-253i285-305o323-343i,393
Q8TDV2,Probable G-protein coupled receptor 148 (Brain and testis restricted GPCR) (G-protein coupled receptor PGR6),o51-75i87-109o123-144i166-189o215-240i265-285o299-322i,347
Q8TDV5,Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119),o7-30i43-63o80-101i122-143o166-186i229-249o260-280i,335
Q8WZ84,Olfactory receptor 8D1 (OST004) (Olfactory receptor 8D3) (Olfactory receptor OR11-301) (Olfactory receptor-like protein JCG9),o25-50i59-79o98-120i143-164o197-222i245-260o275-290i,308
Q8WZ94,Olfactory receptor 5P3 (Olfactory receptor OR11-94) (Olfactory receptor-like protein JCG1),o25-49i61-82o98-120i142-164o197-223i245-258o273-290i,311
Q969N4,Trace amine-associated receptor 8 (TaR-8) (Trace amine receptor 8) (G-protein coupled receptor 102) (Trace amine receptor 5) (TaR-5),o32-57i68-90o106-127i148-168o196-217i259-279o294-314i,342
Q969V1,Melanin-concentrating hormone receptor 2 (MCH receptor 2) (MCH-R2) (MCHR-2) (G-protein coupled receptor 145) (GPRv17) (MCH-2R) (MCH2) (MCH2R),o35-60i70-90o108-129i150-171o196-218i252-273o286-309i,340
Q96AM1,Mas-related G-protein coupled receptor member F (Mas-related gene F protein) (G-protein coupled receptor 140) (G-protein coupled receptor 168),o49-69i80-101o118-139i159-181o197-222i239-265o271-295i,343
Q96K49,Transmembrane protein 87B,o216-239i250-267o296-312i323-339o351-374i398-414o434-451i,555
Q96LA9,Mas-related G-protein coupled receptor member X4 (Sensory neuron-specific G-protein coupled receptor 5/6),o30-52i63-81o97-118i138-158o178-200i214-241o253-275i,322
Q96P68,2-oxoglutarate receptor 1 (Alpha-ketoglutarate receptor 1) (G-protein coupled receptor 80) (G-protein coupled receptor 99) (P2Y purinoceptor 15) (P2Y15) (P2Y-like GPCR) (P2Y-like nucleotide receptor),o35-60i70-90o104-129i150-170o195-219i242-263o283-305i,337
Q96P69,G-protein coupled receptor 78,o7-28i43-63o81-102i123-143o172-193i243-263o275-297i,363
Q96R48,Olfactory receptor 2A5 (Olfactory receptor 2A26) (Olfactory receptor 2A8) (Olfactory receptor 7-138/7-141) (OR7-138) (OR7-141),o24-48i58-78o98-120i143-166o197-221i241-260o273-290i,311
Q96RA2,Olfactory receptor 7D2 (HTPCRH03) (Olfactory receptor 19-4) (OR19-4) (Olfactory receptor OR19-10),o26-49i59-78o98-120i143-164o197-219i241-258o276-290i,312
Q96RI9,Trace amine-associated receptor 9 (TaR-9) (Trace amine receptor 9) (Trace amine receptor 3) (TaR-3),o34-58i69-90o107-128i150-170o198-218i260-280o295-315i,348
Q96RJ0,Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1),o24-48i60-82o98-119i140-161o189-211i253-273o288-308i,339
Q99678,G-protein coupled receptor 20,o55-79i90-111o124-146i167-188o197-217i242-266o277-300i,358
Q9BXC1,Probable G-protein coupled receptor 174,o19-45i55-77o89-114i133-155o182-206i231-255o269-295i,333
Q9BY21,G-protein coupled receptor 87 (G-protein coupled receptor 95),o45-66i77-99o117-137i160-180o206-227i254-275o295-317i,358
Q9BZJ6,Probable G-protein coupled receptor 63 (PSP24-2) (PSP24-beta),o84-104i118-138o156-177i195-215o243-263i316-336o352-373i,419
Q9GZK4,Olfactory receptor 2H1 (Hs6M1-16) (OLFR42A-9004.14/9026.2) (Olfactory receptor 2H6) (Olfactory receptor 2H8) (Olfactory receptor 6-2) (OR6-2) (Olfactory receptor OR6-32),o25-46i57-77o96-118i142-162o195-218i243-258o271-288i,316
Q9GZK6,Olfactory receptor 2J1 (Hs6M1-4) (Olfactory receptor 6-5) (OR6-5),o26-49i60-80o100-121i145-165o198-223i243-261o274-293i,312
Q9GZM6,Olfactory receptor 8D2 (Olfactory receptor OR11-303) (Olfactory receptor-like protein JCG2),o25-51i62-83o98-120i143-166o197-222i245-260o275-290i,311
Q9GZN0,Probable G-protein coupled receptor 88 (Striatum-specific G-protein coupled receptor),o34-56i68-90o114-136i159-180o192-213i286-306o319-338i,384
Q9GZP7,Vomeronasal type-1 receptor 1 (G-protein coupled receptor GPCR24) (hGPCR24) (V1r-like receptor 1) (V3r-related gene protein) (Vomeronasal olfactory receptor chromosome 19 subtype I member 1),o49-69i85-104o123-145i168-188o222-244i276-296o312-327i,353
Q9H1C0,Lysophosphatidic acid receptor 5 (LPA receptor 5) (LPA-5) (G-protein coupled receptor 92) (G-protein coupled receptor 93),o26-48i57-77o97-117i137-159o188-212i233-259o278-300i,372
Q9H205,Olfactory receptor 2AG1 (HT3) (Olfactory receptor 2AG3) (Olfactory receptor OR11-79),o26-49i59-79o98-120i143-164o197-219i245-260o273-290i,316
Q9H207,Olfactory receptor 10A5 (HP3) (Olfactory receptor 10A1) (Olfactory receptor 11-403) (OR11-403) (Olfactory receptor-like protein JCG6),o27-49i60-83o99-121i146-167o198-220i242-261o274-291i,317
Q9H208,Olfactory receptor 10A2 (HP4) (Olfactory receptor OR11-86),o13-35i49-69o85-107i132-153o184-209i228-246o260-277i,303
Q9H209,Olfactory receptor 10A4 (HP2) (Olfactory receptor-like protein JCG5),o26-49i63-83o99-121i146-167o198-220i242-261o274-291i,315
Q9H210,Olfactory receptor 2D2 (HB2) (Olfactory receptor 11-610) (OR11-610) (Olfactory receptor 2D1) (Olfactory receptor OR11-88),o26-48i59-79o98-120i144-164o197-223i241-257o272-288i,308
Q9H339,Olfactory receptor 51B5 (Odorant receptor HOR5'beta5) (Olfactory receptor OR11-37),o25-47i57-82o98-118i142-162o195-220i239-259o269-292i,312
Q9H340,Olfactory receptor 51B6 (Odorant receptor HOR5'beta6),o24-47i60-81o98-118i142-159o195-217i239-259o272-292i,312
Q9H341,Olfactory receptor 51M1 (Odorant receptor HOR5'beta7) (Olfactory receptor OR11-40),o38-60i74-96o110-132i156-175o209-231i253-273o286-306i,326
Q9H6F2,Trimeric intracellular cation channel type A (TRIC-A) (TRICA) (Transmembrane protein 38A),o20-37i52-73o86-103i108-126o145-162i184-201o210-230i,299
Q9NQN1,Olfactory receptor 2S2 (Olfactory receptor OR9-3),o27-49i60-80o99-121i145-165o197-223i243-260o279-299i,319
Q9NS66,Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3),o24-47i59-80o98-119i140-160o185-205i287-307o323-343i,373
Q9NS93,Transmembrane 7 superfamily member 3 (Seven span transmembrane protein),o292-312i320-337o348-369i372-393o407-425i432-451o485-503i,570
Q9NSD7,Relaxin-3 receptor 1 (RLN3 receptor 1) (G protein-coupled receptor SALPR) (G-protein coupled receptor GPCR135) (Relaxin family peptide receptor 3) (Somatostatin- and angiotensin-like peptide receptor),o82-105i119-140o153-178i215-235o265-288i327-351o368-392i,469
Q9NWC5,Transmembrane protein 45A (DNA polymerase-transactivated protein 4) (Dermal papilla-derived protein 7),o6-26i51-71o91-111i122-139o150-169i181-201o220-245i,275
Q9NYV8,Taste receptor type 2 member 14 (T2R14) (Taste receptor family B member 1) (TRB1),o8-33i47-68o81-109i129-152o178-203i233-253o261-283i,317
Q9NYV9,Taste receptor type 2 member 13 (T2R13) (Taste receptor family B member 3) (TRB3),o8-33i47-68o84-109i129-152o177-203i233-254o261-284i,303
Q9NYW2,Taste receptor type 2 member 8 (T2R8) (Taste receptor family B member 5) (TRB5),o8-33i47-71o83-109i132-152o183-205i237-260o266-288i,309
Q9NYW3,Taste receptor type 2 member 7 (T2R7) (Taste receptor family B member 4) (TRB4),o9-33i46-67o84-109i129-149o184-206i237-259o268-288i,318
Q9NYW6,Taste receptor type 2 member 3 (T2R3),o8-30i46-69o80-109i130-150o180-205i235-259o265-287i,316
Q9NYW7,Taste receptor type 2 member 1 (T2R1) (Taste receptor family B member 7) (TRB7),o7-33i46-66o84-102i125-145o176-198i230-250o257-280i,299
Q9P055,JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4),o55-76i92-108o151-171i192-212o215-235i251-268o278-293i,311
Q9P1P5,Trace amine-associated receptor 2 (TaR-2) (Trace amine receptor 2) (G-protein coupled receptor 58),o44-68i80-102o118-139i160-181o208-230i264-284o299-319i,351
Q9UJ42,Probable G-protein coupled receptor 160 (G-protein coupled receptor GPCR1) (hGPCR1),o27-45i57-77o97-118i137-161o185-205i244-264o273-294i,338
Q9UKL2,Olfactory receptor 52A1 (HPFH1OR) (Odorant receptor HOR3'beta4) (Olfactory receptor OR11-319),o27-51i61-89o100-122i146-165o200-222i243-263o275-297i,312
Q9Y2T5,G-protein coupled receptor 52,o45-65i88-108o117-137i160-180o204-224i266-286o297-317i,361
Q9Y585,Olfactory receptor 1A2 (Olfactory receptor 17-6) (OR17-6) (Olfactory receptor OR17-10),o26-49i59-79o98-120i142-164o196-218i240-259o270-288i,309
Q9Y5P1,Olfactory receptor 51B2 (Odorant receptor HOR5'beta3) (Olfactory receptor 51B1),o24-47i57-85o97-118i139-159o195-217i239-260o269-292i,312
Q9Y5Y3,Probable G-protein coupled receptor 45 (PSP24-1) (PSP24-alpha),o35-58i71-93o110-130i150-170o194-216i269-289o306-326i,372
A3KFT3,Olfactory receptor 2M5,o26-49i59-79o98-120i143-166o197-223i241-260o273-292i,312
A4D2G3,Olfactory receptor 2A25 (Olfactory receptor 2A27),o24-48i59-81o97-119i141-165o193-218i239-259o272-289i,310
A6NCV1,Olfactory receptor 6C74,o23-46i57-81o96-118i141-162o192-220i239-258o270-290i,312
A6NDH6,Olfactory receptor 5H15,o25-49i59-79o98-120i144-164o194-223i241-260o273-290i,313
A6NDL8,Olfactory receptor 6C68,o23-46i57-81o96-118i142-162o195-220i239-258o268-288i,312
A6NET4,Olfactory receptor 5K3,o26-49i59-79o98-120i144-164o194-219i239-257o270-288i,321
A6NF89,Olfactory receptor 6C6,o23-46i57-81o96-118i142-162o195-220i239-258o271-288i,314
A6NHA9,Olfactory receptor 4C46,o24-47i57-77o96-118i141-162o195-220i239-256o268-287i,309
A6NHG9,Olfactory receptor 5H14,o25-49i59-83o98-120i144-164o194-222i241-259o272-290i,310
A6NIJ9,Olfactory receptor 6C70,o23-47i57-81o96-118i142-162o192-220i239-258o268-288i,312
A6NJZ3,Olfactory receptor 6C65,o23-46i57-81o96-118i141-162o192-220i239-258o268-288i,312
A6NKK0,Olfactory receptor 5H1 (HTPCRX14),o25-49i59-79o98-120i144-164o194-223i241-260o273-290i,313
A6NL08,Olfactory receptor 6C75,o23-46i57-81o96-118i141-164o195-220i239-258o268-288i,312
A6NL26,Olfactory receptor 5B21,o23-47i57-77o96-118i142-162o195-220i242-255o270-287i,309
A6NM03,Olfactory receptor 2AG2,o26-49i59-79o98-120i143-164o197-222i241-261o273-290i,316
A6NM76,Olfactory receptor 6C76,o23-46i57-80o95-117i141-161o194-219i238-257o267-287i,312
A6NMS3,Olfactory receptor 5K4,o25-49i59-79o98-120i146-164o197-223i241-259o271-287i,321
A6NMZ5,Olfactory receptor 4C45,o21-46i54-74o93-115i137-161o189-217i235-254o265-282i,306
B2RN74,Olfactory receptor 11H12,o40-63i74-98o113-135i159-179o212-237i256-275o288-305i,326
C9JH25,Proline-rich transmembrane protein 4,o365-388i398-418o439-456i466-484o500-520i557-580o599-620i,899
O14581,Olfactory receptor 7A17,o26-48i59-79o98-120i143-164o197-219i241-260o274-290i,309
O43869,Olfactory receptor 2T1 (Olfactory receptor 1-25) (OR1-25) (Olfactory receptor OR1-61),o75-99i109-129o149-170i192-214o247-269i295-306o323-340i,369
O60403,Olfactory receptor 10H2 (Olfactory receptor OR19-23),o25-49i59-82o98-120i144-164o196-223i242-261o273-293i,315
O60404,Olfactory receptor 10H3 (Olfactory receptor OR19-24),o25-50i60-80o99-121i145-167o198-224i243-262o274-292i,316
O60431,Olfactory receptor 1I1 (Olfactory receptor 19-20) (OR19-20),o26-50i59-79o98-120i142-166o197-219i241-259o273-292i,355
O76000,Putative olfactory receptor 2B3 (Hs6M1-1) (Olfactory receptor OR6-14) (OR6-4) (Olfactory receptor 6-4),o26-48i59-79o98-120i144-164o197-222i241-260o273-290i,313
O76100,Olfactory receptor 7A10 (OST027) (Olfactory receptor OR19-18),o26-48i59-74o98-120i143-164o197-219i241-260o272-292i,309
O95006,Olfactory receptor 2F2 (Olfactory receptor 7-1) (OR7-1) (Olfactory receptor OR7-6),o25-49i59-82o98-118i144-164o197-219i241-260o273-290i,317
O95013,Olfactory receptor 4F21,o25-47i59-79o98-120i144-164o197-223i240-257o270-287i,312
O95221,Olfactory receptor 5F1 (Olfactory receptor 11-10) (OR11-10) (Olfactory receptor OR11-167),o25-49i59-79o98-120i144-164o197-222i241-256o273-290i,314
P0C604,Olfactory receptor 4A8 (Olfactory receptor OR11-110),o24-48i57-80o96-118i140-162o192-220i238-257o268-287i,315
P0C623,Olfactory receptor 4Q2 (olfactory receptor OR14-21),o25-49i60-80o99-121i144-165o196-221i240-257o270-287i,314
P0C626,Olfactory receptor 5G3 (Olfactory receptor 5G6) (Olfactory receptor OR11-213),o25-49i62-78o98-120i144-166o194-222i241-260o273-290i,314
P0C628,Olfactory receptor 5AC1 (Olfactory receptor OR3-2),o26-49i59-79o98-120i144-164o196-219i241-259o273-290i,307
P0C629,Olfactory receptor 10J4,o26-50i60-80o99-121i145-167o198-223i242-260o273-290i,311
P0C646,Olfactory receptor 52Z1P,o13-35i47-72o84-106i129-149o179-202i223-243o258-278i,298
P0C7N1,Olfactory receptor 8U8,o25-49i59-79o98-120i144-166o197-223i244-259o274-290i,319
P0C7N5,Olfactory receptor 8U9,o25-49i59-79o98-120i144-164o197-222i245-260o274-290i,309
P0C7T2,Olfactory receptor 2T7 (OST723) (olfactory receptor OR1-44),o16-40i50-70o90-111i133-157o188-210i232-251o265-283i,308
P0C7T3,Olfactory receptor 56A5,o30-50i62-87o101-121i147-166o200-225i244-264o277-297i,313
P0DMU2,Putative olfactory receptor 8G3 pseudogene (Olfactory receptor OR11-297),o25-50i62-77o98-120i144-164o197-223i245-258o273-290i,310
P0DN80,Olfactory receptor 5H8 (Olfactory receptor 5H8 pseudogene) (Olfactory receptor OR3-7),o25-49i61-83o98-120i142-164o194-223i240-259o272-289i,308
P0DN81,Olfactory receptor 13C7,o27-49i60-80o99-121i145-165o197-223i244-260o280-297i,318
P0DN82,Olfactory receptor 12D1,o23-47i57-80o96-118i142-162o195-217i241-259o272-289i,320
P0DQD5,Neuropeptide Y receptor type 4-2,o41-65i78-100o116-137i157-176o213-235i266-286o302-325i,375
P35410,Mas-related G-protein coupled receptor MRG (MAS-R) (MAS1-like),o77-100i110-131o148-169i192-213o222-248i265-286o297-317i,378
P47881,Olfactory receptor 3A1 (Olfactory receptor 17-40) (OR17-40) (Olfactory receptor OR17-15),o29-52i62-85o101-123i146-169o200-222i244-263o276-295i,315
P47884,Olfactory receptor 1D4 (Olfactory receptor 17-30) (OR17-30),o26-49i59-79o98-120i142-164o197-219i241-260o272-289i,311
P47890,Olfactory receptor 1G1 (Olfactory receptor 17-209) (OR17-209) (Olfactory receptor 1G2) (Olfactory receptor OR17-8),o27-49i59-74o98-120i143-163o197-222i245-256o272-290i,313
P58170,Olfactory receptor 1D5 (Olfactory receptor 17-31) (OR17-31),o26-49i59-79o98-120i142-166o197-219i241-260o272-289i,312
P58180,Olfactory receptor 4D2 (B-lymphocyte membrane protein BC2009) (Olfactory receptor OR17-24),o26-49i60-83o98-120i141-166o194-219i240-258o270-287i,307
P58181,Olfactory receptor 10A3 (HTPCRX12) (Olfactory receptor OR11-97),o25-49i59-79o98-120i144-164o197-219i241-257o273-292i,314
P59536,Taste receptor type 2 member 41 (T2R41) (Taste receptor type 2 member 59) (T2R59),o8-32i46-67o84-109i133-150o182-204i236-256o266-286i,307
P59539,Taste receptor type 2 member 45 (T2R45) (G-protein coupled receptor 59),o8-30i47-67o83-108i129-149o177-199i227-250o260-282i,299
P59551,Taste receptor type 2 member 60 (T2R60) (Taste receptor type 2 member 56) (T2R56),o19-44i58-78o95-120i143-163o192-217i248-268o278-298i,318
P59922,Putative olfactory receptor 2B8 (Hs6M1-29P),o25-48i59-79o98-120i143-166o197-222i241-260o273-292i,312
Q15615,Olfactory receptor 4D1 (Olfactory receptor 4D3) (Olfactory receptor TPCR16),o26-49i59-79o98-120i142-166o197-223i240-258o270-287i,310
Q15619,Olfactory receptor 1C1 (Olfactory receptor OR1-42) (Olfactory receptor TPCR27),o26-49i59-79o98-120i144-164o197-222i241-260o272-292i,314
Q15622,Olfactory receptor 7A5 (Olfactory receptor OR19-17) (Olfactory receptor TPCR92),o26-48i59-74o98-120i143-164o197-219i241-260o274-290i,319
Q5JQS5,Olfactory receptor 2B11,o30-52i63-83o103-124i148-168o201-225i245-264o277-296i,317
Q5TZ20,Olfactory receptor 2G6,o26-48i59-74o98-120i144-164o197-221i245-260o273-292i,316
Q5U3C3,Transmembrane protein 164,o39-57i93-113o116-136i142-163o176-192i208-229o254-274i,297
Q5UAW9,G-protein coupled receptor 157,o16-38i49-69o80-102i120-142o167-190i227-247o259-282i,335
Q6IEU7,Olfactory receptor 5M10 (Olfactory receptor OR11-207),o26-49i59-79o98-120i144-164o197-223i242-257o273-290i,315
Q6IEV9,Olfactory receptor 4C11 (Olfactory receptor OR11-136),o24-47i60-80o96-118i140-162o192-217i238-255o268-287i,310
Q6IEY1,Olfactory receptor 4F3/4F16/4F29 (Olfactory receptor OR1-1),o25-47i59-79o98-120i144-164o197-223i240-258o270-287i,312
Q6IEZ7,Olfactory receptor 2T5 (Olfactory receptor OR1-62),o30-53i63-83o102-124i146-168o201-226i245-265o276-296i,315
Q6IF00,Olfactory receptor 2T2 (Olfactory receptor OR1-43),o26-50i60-80o99-121i143-165o198-222i242-257o274-291i,324
Q6IF36,Putative olfactory receptor 8G2 (Olfactory receptor 8G4) (Olfactory receptor OR11-292) (Olfactory receptor TPCR120),o38-63i72-92o111-133i156-177o210-236i258-273o288-303i,304
Q6IF42,Olfactory receptor 2A2 (Olfactory receptor 2A17) (Olfactory receptor OR7-11),o24-48i58-78o97-119i142-163o196-218i240-259o272-289i,318
Q6IF63,Olfactory receptor 52W1 (Olfactory receptor OR11-71),o32-54i64-92o103-125i147-168o202-224i246-266o280-300i,320
Q6IF82,Olfactory receptor 4A47 (Olfactory receptor OR11-113),o24-47i57-77o96-118i140-164o192-220i241-253o269-285i,309
Q6IF99,Olfactory receptor 10K2 (Olfactory receptor OR1-4),o26-49i59-79o98-120i142-166o197-219i241-258o272-290i,312
Q6IFG1,Olfactory receptor 52E8 (Olfactory receptor OR11-54),o31-55i65-92o104-126i150-170o200-224i246-266o279-299i,317
Q6IFN5,Olfactory receptor 7E24 (Olfactory receptor OR19-14),o44-66i77-97o119-138i161-182o214-234i263-278o290-308i,339
Q6NV75,Probable G-protein coupled receptor 153 (G-protein coupled receptor PGR1),o11-31i44-64o85-106i127-147o173-193i248-266o280-298i,609
Q6ZMB5,Transmembrane protein 184A,o53-74i90-110o123-143i187-203o221-241i263-278o300-320i,413
Q6ZRR5,TLC domain-containing protein 5 (Transmembrane protein 136),o3-23i36-56o75-94i99-119o126-142i159-184o195-212i,245
Q86SM5,Mas-related G-protein coupled receptor member G (G-protein coupled receptor 169),o14-36i48-70o80-101i123-143o164-184i199-220o233-253i,289
Q86SM8,Mas-related G-protein coupled receptor member E (G-protein coupled receptor 167),o26-49i60-82o99-119i141-161o179-201i218-238o252-272i,312
Q8IXE1,Olfactory receptor 4N5 (Olfactory receptor OR14-33),o25-49i59-83o98-120i143-164o194-222i241-258o270-287i,308
Q8N0Y3,Olfactory receptor 4N4 (Olfactory receptor OR15-1) (Olfactory receptor OR15-5),o25-49i59-83o98-120i143-164o194-222i240-259o270-287i,316
Q8N0Y5,Olfactory receptor 8I2 (Olfactory receptor OR11-170),o25-49i59-77o98-120i144-164o196-221i240-256o272-289i,310
Q8N127,Olfactory receptor 5AS1 (Olfactory receptor OR11-168),o25-49i59-79o98-120i144-164o197-223i242-259o273-290i,324
Q8N146,Olfactory receptor 8H3 (Olfactory receptor OR11-172),o26-50i60-74o98-120i143-163o197-222i241-257o275-290i,312
Q8N148,Olfactory receptor 6V1 (Olfactory receptor OR7-3),o23-47i57-77o96-118i142-162o192-220i239-258o271-288i,313
Q8N162,Olfactory receptor 8H2 (Olfactory receptor OR11-171),o26-50i60-74o98-120i143-163o197-223i241-257o274-290i,312
Q8N349,Olfactory receptor 2L13 (Olfactory receptor 2L14),o24-48i58-78o97-119i143-163o196-218i240-255o272-289i,312
Q8N3F9,Integral membrane protein GPR137C (Transmembrane 7 superfamily member 1-like 2 protein),o47-69i84-104o130-150i164-186o203-223i246-266o300-322i,429
Q8N3S3,Protein PHTF2,i136-158o166-182i501-517o547-571i634-655o668-688i753-774o,785
Q8NFZ6,Vomeronasal type-1 receptor 2 (G-protein coupled receptor GPCR25) (hGPCR25) (V1r-like receptor 2),o92-114i126-145o164-189i211-231o261-282i317-340o347-369i,395
Q8NG75,Olfactory receptor 5T1 (Olfactory receptor OR11-179),o37-63i71-91o110-132i156-176o209-234i254-272o285-302i,326
Q8NG76,Olfactory receptor 2T33 (Olfactory receptor OR1-56),o24-47i57-77o96-118i142-164o195-219i239-257o271-290i,320
Q8NG77,Olfactory receptor 2T12 (Olfactory receptor OR1-57),o24-47i57-77o96-118i142-164o195-221i239-257o271-290i,320
Q8NG78,Olfactory receptor 8G5 (Olfactory receptor 8G6) (Olfactory receptor OR11-298),o60-85i94-114o133-155i179-201o232-258i280-293o308-325i,346
Q8NG80,Olfactory receptor 2L5 (Olfactory receptor 2L11) (Olfactory receptor OR1-53),o24-48i58-77o97-119i141-163o196-218i240-255o272-289i,312
Q8NG81,Olfactory receptor 2M7 (Olfactory receptor OR1-58),o26-49i59-79o98-120i142-166o197-222i241-260o273-292i,312
Q8NG83,Olfactory receptor 2M3 (Olfactory receptor 2M6) (Olfactory receptor OR1-54),o26-49i59-79o98-120i142-166o197-223i241-260o273-290i,312
Q8NG84,Olfactory receptor 2AK2 (Olfactory receptor 2AK1) (Olfactory receptor OR1-47),o41-64i74-94o114-135i158-179o212-238i256-274o288-307i,335
Q8NG85,Olfactory receptor 2L3,o24-48i58-78o97-119i141-163o196-218i240-255o272-289i,312
Q8NG92,Olfactory receptor 13H1 (Olfactory receptor ORX-1),o27-49i59-79o98-120i145-165o196-222i240-255o272-289i,308
Q8NG94,Olfactory receptor 11H1 (Olfactory receptor OR22-1),o40-63i74-97o113-135i159-179o212-237i256-275o288-305i,326
Q8NG95,Olfactory receptor 7G3 (OST085) (Olfactory receptor OR19-9),o26-49i59-74o98-120i144-164o197-219i240-260o272-290i,312
Q8NG97,Olfactory receptor 2Z1 (Olfactory receptor 2Z2) (Olfactory receptor OR19-4),o26-49i59-79o98-120i142-166o197-219i241-260o273-290i,314
Q8NG99,Olfactory receptor 7G2 (OST260) (Olfactory receptor 19-13) (OR19-13) (Olfactory receptor OR19-6),o26-49i59-74o98-120i143-164o197-219i241-260o272-292i,324
Q8NGA1,Olfactory receptor 1M1 (Olfactory receptor 19-6) (OR19-6) (Olfactory receptor OR19-5),o26-49i59-74o98-120i143-164o197-219i241-260o275-290i,313
Q8NGA2,Putative olfactory receptor 7A2 (Putative olfactory receptor 7A7),o27-51i60-80o99-121i144-165o198-220i242-261o273-291i,310
Q8NGA5,Olfactory receptor 10H4 (Olfactory receptor OR19-28),o26-50i60-80o99-121i145-165o198-224i243-260o274-292i,316
Q8NGA6,Olfactory receptor 10H5 (Olfactory receptor OR19-25) (Olfactory receptor OR19-26),o25-49i59-82o98-120i144-164o195-223i242-261o273-291i,315
Q8NGA8,Olfactory receptor 4F17 (Olfactory receptor 4F11) (Olfactory receptor 4F18) (Olfactory receptor 4F19),o19-42i52-72o91-113i135-157o190-216i233-253o263-280i,305
Q8NGB2,Olfactory receptor 4C5 (Olfactory receptor OR11-99),o47-70i80-100o119-141i163-187o218-240i257-272o283-300i,326
Q8NGB4,Olfactory receptor 4S1 (Olfactory receptor OR11-100),o25-47i60-77o96-118i140-164o192-220i238-257o268-287i,309
Q8NGB6,Olfactory receptor 4M2 (Olfactory receptor OR15-3),o25-47i59-83o98-120i143-164o197-223i243-261o272-289i,313
Q8NGB8,Olfactory receptor 4F15 (Olfactory receptor OR15-14),o25-49i59-79o98-120i144-164o197-223i240-258o270-287i,312
Q8NGB9,Olfactory receptor 4F6 (Olfactory receptor 4F12) (Olfactory receptor OR15-15),o25-49i59-79o98-120i142-164o195-223i240-260o270-287i,312
Q8NGC0,Olfactory receptor 5AU1 (Olfactory receptor OR14-38),o77-100i110-130o149-171i195-215o248-273i293-310o324-341i,362
Q8NGC1,Olfactory receptor 11G2 (Olfactory receptor OR14-34),o63-87i97-121o136-158i182-202o233-260i279-298o311-328i,345
Q8NGC2,Olfactory receptor 4E2 (Olfactory receptor OR14-42),o25-50i59-79o98-120i144-164o194-222i240-257o270-287i,313
Q8NGC3,Olfactory receptor 10G2,o30-53i64-87o103-125i148-171o199-224i246-264o275-295i,310
Q8NGC4,Olfactory receptor 10G3 (Olfactory receptor OR14-40),o26-48i60-83o99-121i143-167o195-223i242-260o272-289i,313
Q8NGC5,Olfactory receptor 6J1 (Olfactory receptor 6J2),o24-48i58-78o97-119i141-163o193-221i240-259o269-289i,347
Q8NGC6,Olfactory receptor 4K17 (Olfactory receptor OR14-29),o28-52i62-85o101-123i145-167o197-226i247-262o273-290i,315
Q8NGC7,Olfactory receptor 11H6 (Olfactory receptor OR14-35),o44-67i77-97o116-138i160-182o215-240i259-278o288-308i,330
Q8NGC9,Olfactory receptor 11H4 (Olfactory receptor OR14-36),o35-59i69-93o108-130i154-174o207-232i251-271o280-300i,324
Q8NGD1,Olfactory receptor 4N2 (Olfactory receptor OR14-13) (Olfactory receptor OR14-8),o25-49i59-79o98-120i143-164o194-222i240-257o270-287i,307
Q8NGD2,Olfactory receptor 4K2 (Olfactory receptor OR14-15),o25-49i59-79o98-120i142-164o194-223i240-260o270-287i,314
Q8NGD3,Olfactory receptor 4K5 (Olfactory receptor OR14-16),o25-49i62-82o98-120i143-164o194-223i240-259o270-287i,323
Q8NGD4,Olfactory receptor 4K1 (Olfactory receptor OR14-19),o25-49i59-79o98-120i142-164o195-223i240-260o270-287i,311
Q8NGD5,Olfactory receptor 4K14 (Olfactory receptor OR14-22),o26-50i60-83o99-121i145-165o196-224i242-260o271-288i,310
Q8NGE0,Olfactory receptor 10AD1 (Olfactory receptor OR12-1),o25-48i60-80o99-121i145-165o197-220i242-258o274-291i,317
Q8NGE1,Olfactory receptor 6C4 (Olfactory receptor OR12-10),o23-46i57-80o96-118i142-162o192-220i239-258o268-288i,309
Q8NGE2,Olfactory receptor 2AP1 (Olfactory receptor OR12-9),o23-46i60-80o96-118i140-162o192-220i239-258o268-288i,309
Q8NGE5,Olfactory receptor 10A7 (Olfactory receptor OR12-6),o25-48i59-79o100-120i142-166o197-219i241-257o272-292i,316
Q8NGE7,Olfactory receptor 9K2 (Olfactory receptor OR12-2),o50-74i84-104o123-145i169-191o222-247i270-285o296-313i,335
Q8NGE8,Olfactory receptor 4D9 (Olfactory receptor OR11-253),o26-49i59-79o98-120i143-166o194-222i244-259o270-287i,314
Q8NGE9,Olfactory receptor 9Q2,o25-49i59-79o98-120i143-166o197-223i245-260o273-290i,314
Q8NGF0,Olfactory receptor 52B6 (Olfactory receptor OR11-47),o45-69i79-99o118-139i163-183o213-238i260-280o294-314i,335
Q8NGF1,Olfactory receptor 52R1 (Olfactory receptor OR11-22),o28-48i64-87o101-123i147-166o200-225i244-264o274-297i,315
Q8NGF3,Olfactory receptor 51D1 (Olfactory receptor OR11-14),o38-62i72-99o111-133i157-176o207-232i254-274o286-306i,324
Q8NGF4,Olfactory receptor 5AP2,o31-55i65-85o104-126i148-172o202-229i247-265o279-296i,316
Q8NGF6,Olfactory receptor 10W1 (Olfactory receptor OR11-236),o16-40i50-74o89-111i135-157o188-213i236-251o264-283i,305
Q8NGF7,Olfactory receptor 5B17 (Olfactory receptor 5B20) (Olfactory receptor OR11-237),o23-49i57-77o96-118i142-164o195-221i239-257o271-288i,314
Q8NGF8,Olfactory receptor 4B1 (OST208) (Olfactory receptor OR11-106),o24-47i59-80o96-118i141-162o192-220i239-255o268-287i,309
Q8NGF9,Olfactory receptor 4X2 (Olfactory receptor OR11-105),o18-41i51-71o90-112i135-156o186-214i232-248o262-281i,303
Q8NGG0,Olfactory receptor 8J3 (Olfactory receptor OR11-173),o25-48i62-82o98-120i143-166o197-219i242-259o274-290i,315
Q8NGG1,Olfactory receptor 8J2,o25-48i59-79o98-120i143-166o198-223i242-260o274-290i,315
Q8NGG3,Olfactory receptor 5T3 (Olfactory receptor OR11-178),o55-80i89-109o128-150i174-194o227-253i272-287o303-320i,340
Q8NGG4,Olfactory receptor 8H1 (Olfactory receptor OR11-180),o25-49i59-77o97-119i143-163o196-221i240-258o273-289i,311
Q8NGG5,Olfactory receptor 8K1 (Olfactory receptor OR11-182),o31-54i68-89o104-126i147-167o203-228i251-266o279-296i,319
Q8NGG6,Olfactory receptor 8B12 (Olfactory receptor OR11-317),o25-48i58-78o97-119i142-162o196-221i244-255o272-289i,310
Q8NGG7,Olfactory receptor 8A1 (OST025) (Olfactory receptor OR11-318),o42-66i76-96o115-137i160-181o213-238i261-276o289-306i,326
Q8NGG8,Olfactory receptor 8B3 (Olfactory receptor OR11-311),o27-49i59-79o98-120i144-164o197-222i245-260o272-289i,313
Q8NGH3,Olfactory receptor 2D3 (Olfactory receptor OR11-89),o41-65i78-98o114-136i159-182o213-235i257-273o289-306i,330
Q8NGH5,Olfactory receptor 56A1 (Olfactory receptor OR11-75),o33-54i66-94o105-127i151-173o204-226i248-268o279-301i,318
Q8NGH6,Putative olfactory receptor 52L2 (Olfactory receptor OR11-74),o45-67i77-97o116-138i162-181o215-237i258-278o290-310i,319
Q8NGH8,Olfactory receptor 56A4 (Olfactory receptor OR11-49),o29-50i62-87o101-123i147-167o200-225i244-264o277-297i,313
Q8NGH9,Olfactory receptor 52E4 (Olfactory receptor OR11-55),o27-51i61-86o100-120i145-166o196-220i242-262o275-295i,312
Q8NGI0,Olfactory receptor 52N2 (Olfactory receptor OR11-57),o27-51i61-84o100-122i147-165o196-221i243-263o277-297i,321
Q8NGI1,Putative olfactory receptor 56B2,o35-58i68-95o107-129i153-173o206-228i250-270o280-302i,322
Q8NGI3,Olfactory receptor 56B1 (Olfactory receptor OR11-65),o35-58i68-92o107-129i153-173o205-231i250-270o280-302i,324
Q8NGI4,Olfactory receptor 4D11,o25-47i59-79o98-120i143-166o194-222i244-259o270-287i,311
Q8NGI6,Olfactory receptor 4D10 (Olfactory receptor OR11-251),o25-49i62-82o98-120i142-166o194-222i243-258o270-289i,311
Q8NGI7,Olfactory receptor 10V1 (Olfactory receptor OR11-256),o25-49i59-83o99-121i145-165o198-223i246-261o274-291i,309
Q8NGI9,Olfactory receptor 5A2 (Olfactory receptor OR11-248),o26-50i60-75o99-121i145-165o198-223i243-258o274-291i,324
Q8NGJ0,Olfactory receptor 5A1 (OST181) (Olfactory receptor OR11-249),o28-52i62-82o101-123i147-167o200-225i244-263o276-293i,315
Q8NGJ1,Olfactory receptor 4D6 (Olfactory receptor OR11-250),o25-49i59-83o98-120i140-164o194-220i243-258o270-287i,314
Q8NGJ3,Olfactory receptor 52E1,o24-47i58-78o97-117i142-163o193-217i239-259o272-292i,308
Q8NGJ4,Olfactory receptor 52E2,o27-51i61-89o100-120i146-166o198-220i242-262o273-293i,325
Q8NGJ5,Olfactory receptor 51L1 (Olfactory receptor OR11-31),o28-50i61-89o101-122i146-165o199-221i243-263o276-296i,315
Q8NGJ6,Olfactory receptor 51A4,o27-51i61-89o100-122i146-165o196-221i242-262o275-295i,313
Q8NGJ7,Olfactory receptor 51A2,o27-51i61-89o100-122i146-165o196-220i242-262o275-295i,313
Q8NGJ8,Olfactory receptor 51S1 (Olfactory receptor OR11-24),o35-57i69-95o106-128i152-172o201-226i248-268o281-301i,323
Q8NGJ9,Olfactory receptor 51T1 (Olfactory receptor OR11-26),o27-51i64-89o100-122i145-165o199-224i243-263o276-296i,327
Q8NGK0,Olfactory receptor 51G2 (Olfactory receptor OR11-28),o30-54i64-91o103-125i149-168o202-224i246-266o277-299i,314
Q8NGK1,Olfactory receptor 51G1 (Olfactory receptor 51G3) (Olfactory receptor OR11-29),o27-47i64-88o100-122i146-165o199-224i243-263o274-296i,321
Q8NGK3,Olfactory receptor 52K2 (Olfactory receptor OR11-7),o27-51i61-88o100-122i146-165o199-224i243-263o276-296i,314
Q8NGK4,Olfactory receptor 52K1 (Olfactory receptor OR11-8),o27-51i61-88o100-122i146-165o199-224i243-263o276-296i,314
Q8NGK5,Olfactory receptor 52M1 (Olfactory receptor OR11-11),o27-51i63-85o100-122i146-165o200-222i244-264o277-297i,317
Q8NGK6,Olfactory receptor 52I1 (Olfactory receptor OR11-13),o29-53i63-83o102-124i146-167o201-226i245-265o279-299i,324
Q8NGK9,Olfactory receptor 5D16 (Olfactory receptor OR11-154),o27-51i64-85o100-122i146-166o199-225i247-260o275-292i,328
Q8NGL0,Olfactory receptor 5L2 (HTPCRX16) (Olfactory receptor OR11-153),o25-49i59-79o98-120i144-164o197-222i245-258o273-290i,311
Q8NGL1,Olfactory receptor 5D18 (Olfactory receptor OR11-143) (Olfactory receptor OR11-152),o26-50i60-80o99-121i143-165o198-224i246-258o275-291i,313
Q8NGL2,Olfactory receptor 5L1 (OST262) (Olfactory receptor OR11-151),o25-49i59-79o98-120i144-164o197-222i245-258o273-290i,311
Q8NGL3,Olfactory receptor 5D14 (Olfactory receptor OR11-141) (Olfactory receptor OR11-150),o27-51i61-81o100-122i145-166o199-225i244-259o276-292i,314
Q8NGL4,Olfactory receptor 5D13 (Olfactory receptor OR11-142) (Olfactory receptor OR11-148),o27-51i61-75o100-122i145-168o200-224i247-259o272-292i,314
Q8NGL6,Olfactory receptor 4A15 (Olfactory receptor OR11-118),o54-77i87-111o126-148i170-192o225-250i268-285o298-317i,344
Q8NGL7,Olfactory receptor 4P4 (Olfactory receptor 4P3),o23-47i60-80o96-118i142-164o192-220i238-257o268-285i,312
Q8NGL9,Olfactory receptor 4C16 (Olfactory receptor OR11-135),o24-47i60-81o96-118i141-162o193-218i239-256o268-285i,310
Q8NGM1,Olfactory receptor 4C15 (Olfactory receptor OR11-127) (Olfactory receptor OR11-134),o24-48i58-82o97-119i141-163o193-221i239-256o269-286i,316
Q8NGM8,Olfactory receptor 6M1 (Olfactory receptor OR11-271),o23-47i57-77o96-118i141-162o194-219i238-257o270-287i,313
Q8NGN0,Olfactory receptor 4D5 (Olfactory receptor OR11-276),o25-49i59-79o98-120i142-164o195-223i241-258o270-287i,318
Q8NGN1,Olfactory receptor 6T1 (Olfactory receptor OR11-277),o25-48i59-86o98-120i144-166o194-222i241-260o273-290i,323
Q8NGN2,Olfactory receptor 10S1 (Olfactory receptor OR11-279),o39-62i75-95o112-134i157-180o211-239i255-274o284-304i,331
Q8NGN4,Olfactory receptor 10G9 (Olfactory receptor 10G10),o24-47i57-77o97-117i142-163o196-218i241-258o270-287i,311
Q8NGN5,Olfactory receptor 10G8 (Olfactory receptor OR11-282),o24-47i60-80o97-119i142-163o193-218i241-258o269-287i,311
Q8NGN6,Olfactory receptor 10G7 (Olfactory receptor OR11-283),o24-47i57-77o97-117i142-163o196-218i240-259o269-287i,311
Q8NGN7,Putative olfactory receptor 10D4,o24-48i57-77o96-118i140-160o192-219i239-257o266-286i,298
Q8NGN8,Putative olfactory receptor 4A4 (Olfactory receptor OR11-107),o24-47i57-77o96-118i140-164o193-220i242-255o269-285i,299
Q8NGP0,Olfactory receptor 4C13 (Olfactory receptor OR11-260),o24-47i57-77o96-118i141-162o195-220i238-256o268-287i,309
Q8NGP2,Olfactory receptor 8J1 (Olfactory receptor OR11-183),o25-48i59-79o98-120i143-166o197-219i242-258o275-291i,316
Q8NGP3,Olfactory receptor 5M9 (Olfactory receptor OR11-190),o23-47i57-71o96-118i142-162o195-220i240-255o271-288i,310
Q8NGP4,Olfactory receptor 5M3 (Olfactory receptor OR11-191),o23-47i57-71o96-118i142-162o195-221i243-255o271-288i,307
Q8NGP6,Olfactory receptor 5M8 (Olfactory receptor OR11-194),o24-48i58-72o97-119i142-162o196-221i244-259o272-289i,311
Q8NGP8,Olfactory receptor 5M1 (OST050) (Olfactory receptor OR11-208),o26-49i59-79o98-120i142-164o197-223i242-257o273-290i,315
Q8NGP9,Olfactory receptor 5AR1 (Olfactory receptor OR11-209),o25-49i61-82o98-120i143-166o197-223i245-258o273-290i,310
Q8NGQ2,Olfactory receptor 6Q1 (Olfactory receptor OR11-226),o27-52i61-81o102-124i148-170o201-223i245-264o277-294i,317
Q8NGQ3,Olfactory receptor 1S2 (Olfactory receptor OR11-231),o39-62i72-92o111-133i156-177o210-235i254-273o286-303i,325
Q8NGQ4,Olfactory receptor 10Q1 (Olfactory receptor OR11-233),o29-53i63-83o102-124i149-170o202-226i246-265o277-295i,319
Q8NGQ5,Olfactory receptor 9Q1,o25-49i59-79o98-120i144-166o197-225i244-255o272-289i,310
Q8NGQ6,Olfactory receptor 9I1 (Olfactory receptor OR11-228),o25-49i59-79o98-120i144-164o197-222i245-260o273-290i,314
Q8NGR1,Olfactory receptor 13A1 (Olfactory receptor OR10-3),o43-67i77-97o116-138i161-184o212-240i259-274o290-310i,328
Q8NGR3,Olfactory receptor 1K1,o27-50i60-80o99-121i144-167o198-223i242-261o273-293i,316
Q8NGR4,Olfactory receptor 5C1 (Olfactory receptor 5C2) (Olfactory receptor 9-F) (OR9-F),o29-53i63-87o102-124i146-166o201-227i249-264o278-296i,320
Q8NGR5,Olfactory receptor 1L4 (OST046) (Olfactory receptor 1L5) (Olfactory receptor 9-E) (OR9-E) (Olfactory receptor OR9-29),o27-50i60-80o99-121i144-165o198-224i242-260o274-291i,311
Q8NGR8,Olfactory receptor 1L8 (Olfactory receptor OR9-24),o28-50i60-80o99-121i143-164o198-220i242-261o273-290i,309
Q8NGR9,Olfactory receptor 1N2 (Olfactory receptor OR9-23),o43-66i76-96o115-137i160-180o214-236i258-278o291-309i,330
Q8NGS0,Olfactory receptor 1N1 (Olfactory receptor 1-26) (OR1-26) (Olfactory receptor 1N3) (Olfactory receptor OR9-22),o25-47i57-77o96-118i141-162o195-217i243-258o270-288i,311
Q8NGS1,Olfactory receptor 1J4 (HTPCRX01) (Olfactory receptor OR9-21),o26-49i59-79o98-120i143-164o197-219i241-260o272-290i,313
Q8NGS3,Olfactory receptor 1J1 (Olfactory receptor OR9-18),o26-49i59-79o98-120i142-166o197-219i241-260o272-292i,322
Q8NGS4,Olfactory receptor 13F1 (Olfactory receptor OR9-6),o25-48i59-79o98-120i142-166o197-222i241-256o273-290i,319
Q8NGS5,Olfactory receptor 13C4 (Olfactory receptor OR9-7),o25-48i59-79o98-120i143-163o194-219i241-259o279-296i,318
Q8NGS6,Olfactory receptor 13C3 (Olfactory receptor OR9-8),o55-78i89-109o128-150i172-194o226-251i271-289o308-328i,347
Q8NGS7,Olfactory receptor 13C8,o26-49i59-79o98-120i142-166o196-222i241-259o276-296i,320
Q8NGS9,Olfactory receptor 13C2 (Olfactory receptor OR9-12),o25-48i59-79o98-120i144-164o197-223i241-259o279-295i,318
Q8NGT1,Olfactory receptor 2K2 (HTPCRH06) (Olfactory receptor OR9-17),o25-48i59-79o98-120i144-164o196-221i240-259o272-289i,316
Q8NGT2,Olfactory receptor 13J1 (Olfactory receptor OR9-2),o26-48i59-83o98-120i142-162o197-221i241-260o272-292i,312
Q8NGT5,Olfactory receptor 9A2 (Olfactory receptor OR7-2),o25-47i58-83o95-116i138-160o193-218i237-256o268-285i,310
Q8NGT7,Olfactory receptor 2A12 (Olfactory receptor OR7-10),o24-48i58-78o97-119i142-163o196-218i240-259o272-289i,310
Q8NGT9,Olfactory receptor 2A1/2A42 (Olfactory receptor OR7-16) (Olfactory receptor OR7-19),o24-48i58-78o97-119i144-165o196-218i240-258o272-289i,310
Q8NGU1,Olfactory receptor 9A1 (HSHTPRX06),o25-48i58-81o98-120i141-164o197-222i241-260o272-290i,314
Q8NGU2,Olfactory receptor 9A4 (Olfactory receptor OR7-1),o25-47i58-85o98-120i143-164o197-222i241-260o272-290i,314
Q8NGU4,Putative olfactory receptor 2I1 (Putative olfactory receptor 2I2) (Putative olfactory receptor 2I3) (Putative olfactory receptor 2I4),o26-49i62-82o99-120i145-166o200-223i242-257o274-293i,316
Q8NGU9,Probable G-protein coupled receptor 150,o47-65i85-106o125-145i163-183o231-253i296-316o335-355i,434
Q8NGV0,Olfactory receptor 2Y1 (Olfactory receptor OR5-2),o26-48i59-79o98-120i145-166o196-218i240-255o272-291i,311
Q8NGV5,Olfactory receptor 13D1 (Olfactory receptor OR9-15),o57-80i91-111o130-150i177-198o226-254i273-291o305-322i,346
Q8NGV7,Olfactory receptor 5H2 (Olfactory receptor OR3-10),o31-54i64-88o103-125i149-169o199-228i246-265o277-295i,314
Q8NGX0,Olfactory receptor 11L1,o25-49i61-83o98-120i144-164o197-222i241-260o273-290i,322
Q8NGX1,Olfactory receptor 2T34 (Olfactory receptor OR1-63),o30-54i64-84o103-125i148-171o202-225i246-266o277-295i,318
Q8NGX2,Olfactory receptor 2T35 (Olfactory receptor OR1-66),o26-50i60-80o99-120i142-164o197-221i245-260o273-290i,323
Q8NGX5,Olfactory receptor 10K1 (Olfactory receptor OR1-6),o26-49i59-79o98-120i144-164o197-219i241-257o272-290i,313
Q8NGX6,Olfactory receptor 10R2 (Olfactory receptor OR1-8),o45-69i79-99o118-140i164-184o217-239i261-280o293-310i,335
Q8NGX8,Olfactory receptor 6Y1 (Olfactory receptor 6Y2) (Olfactory receptor OR1-11),o30-54i64-84o103-125i149-171o202-227i246-262o278-297i,325
Q8NGX9,Olfactory receptor 6P1 (Olfactory receptor OR1-12),o25-49i62-82o100-120i144-166o197-222i241-257o273-290i,317
Q8NGY1,Olfactory receptor 10Z1 (Olfactory receptor OR1-15),o25-49i59-79o98-120i144-164o197-222i241-260o272-292i,313
Q8NGY2,Olfactory receptor 6K2 (Olfactory receptor OR1-17),o25-49i59-79o97-119i143-163o194-222i241-261o273-291i,324
Q8NGY5,Olfactory receptor 6N1,o25-49i59-79o98-120i144-164o194-219i241-260o272-292i,312
Q8NGY6,Olfactory receptor 6N2 (Olfactory receptor OR1-23),o25-49i59-79o98-120i144-164o196-223i241-260o273-290i,317
Q8NGY9,Olfactory receptor 2L8 (Olfactory receptor OR1-46),o24-48i58-77o97-119i141-163o196-218i240-255o272-289i,312
Q8NGZ0,Olfactory receptor 2AJ1,o25-49i59-79o98-120i142-166o197-219i241-260o273-290i,328
Q8NGZ2,Olfactory receptor 14K1 (Olfactory receptor 5AY1) (Olfactory receptor OR1-39),o24-46i60-77o96-118i140-162o192-217i239-258o267-287i,314
Q8NGZ3,Olfactory receptor 13G1 (Olfactory receptor OR1-37),o22-47i56-76o95-117i139-163o194-218i238-257o270-287i,307
Q8NGZ4,Olfactory receptor 2G3 (Olfactory receptor OR1-33),o25-48i59-79o98-120i144-164o197-221i245-260o273-290i,309
Q8NGZ5,Olfactory receptor 2G2 (Olfactory receptor OR1-32),o29-51i62-82o101-121i146-167o200-223i245-263o276-295i,317
Q8NGZ6,Olfactory receptor 6F1 (Olfactory receptor OR1-38),o25-49i59-79o98-120i144-166o197-222i241-258o270-290i,308
Q8NGZ9,Olfactory receptor 2T10 (Olfactory receptor OR1-64),o27-47i59-79o100-120i144-164o197-222i241-256o273-290i,312
Q8NH00,Olfactory receptor 2T4 (Olfactory receptor OR1-60),o57-81i91-111o130-152i174-198o229-254i277-292o304-324i,348
Q8NH01,Olfactory receptor 2T11 (Olfactory receptor OR1-65),o21-46i56-76o95-117i139-161o194-218i238-253o271-287i,316
Q8NH02,Olfactory receptor 2T29,o30-53i63-83o102-124i146-168o201-226i245-265o276-296i,315
Q8NH03,Olfactory receptor 2T3,o30-54i64-84o103-125i148-171o202-226i250-265o277-295i,318
Q8NH04,Olfactory receptor 2T27 (Olfactory receptor OR1-67),o26-49i59-79o99-120i142-164o197-219i241-260o274-292i,317
Q8NH05,Olfactory receptor 4Q3 (Olfactory receptor 4Q4) (Olfactory receptor OR14-3),o25-49i63-83o99-121i144-165o195-224i242-259o271-288i,313
Q8NH06,Olfactory receptor 1P1 (Olfactory receptor 17-208) (OR17-208) (Olfactory receptor OR17-9),o40-63i73-93o112-134i156-178o210-232i254-274o287-307i,330
Q8NH07,Olfactory receptor 11H2 (Olfactory receptor OR14-1),o40-63i74-97o113-135i159-179o212-237i256-275o288-305i,326
Q8NH08,Olfactory receptor 10AC1 (Olfactory receptor OR7-5),o27-50i60-82o102-124i148-170o201-226i245-264o277-294i,325
Q8NH09,Olfactory receptor 8S1,o26-49i59-79o98-118i144-164o196-219i241-257o268-288i,359
Q8NH16,Olfactory receptor 2L2 (HTPCRH07) (Olfactory receptor 2L12) (Olfactory receptor 2L4),o23-48i58-78o97-119i141-163o196-218i240-255o272-291i,312
Q8NH18,Olfactory receptor 5J2 (Olfactory receptor OR11-266),o25-49i59-79o98-120i142-163o197-222i241-257o273-290i,312
Q8NH37,Olfactory receptor 4C3 (Olfactory receptor OR11-98),o24-47i57-77o96-118i141-162o193-220i239-257o269-287i,302
Q8NH40,Olfactory receptor 6S1 (Olfactory receptor OR14-37),o27-50i61-84o100-122i146-168o200-225i244-263o275-295i,331
Q8NH41,Olfactory receptor 4K15 (Olfactory receptor OR14-20),o26-49i62-82o98-120i142-164o195-223i244-259o270-287i,324
Q8NH42,Olfactory receptor 4K13 (Olfactory receptor OR14-27),o25-49i62-82o98-120i143-164o194-223i240-260o270-287i,304
Q8NH49,Olfactory receptor 4X1 (Olfactory receptor OR11-104),o24-47i57-77o96-118i141-162o192-220i242-257o268-285i,305
Q8NH50,Olfactory receptor 8K5 (Olfactory receptor OR11-174),o25-48i59-73o98-120i143-164o197-222i245-260o274-290i,307
Q8NH51,Olfactory receptor 8K3 (Olfactory receptor OR11-181),o25-48i59-79o98-120i144-164o197-225i240-258o273-289i,312
Q8NH53,Olfactory receptor 52N1 (Olfactory receptor OR11-61),o27-51i61-89o100-122i146-165o196-224i242-262o277-297i,320
Q8NH54,Olfactory receptor 56A3 (Olfactory receptor 56A6),o31-51i63-88o102-124i148-168o201-226i245-264o278-298i,315
Q8NH55,Olfactory receptor 52E5,o27-51i61-88o100-122i145-166o196-218i240-260o271-291i,327
Q8NH56,Olfactory receptor 52N5 (Olfactory receptor OR11-62),o33-57i71-91o107-129i153-172o203-228i250-270o284-304i,324
Q8NH57,Olfactory receptor 52P1,o27-51i61-88o100-122i146-165o199-224i242-262o276-296i,321
Q8NH60,Olfactory receptor 52J3 (Olfactory receptor OR11-32),o27-51i61-88o100-122i143-165o198-220i242-262o275-295i,311
Q8NH61,Olfactory receptor 51F2 (Olfactory receptor OR11-23),o41-63i73-98o112-134i158-177o208-233i255-275o288-308i,342
Q8NH63,Olfactory receptor 51H1 (Olfactory receptor OR11-25),o29-51i64-89o100-122i146-165o199-222i243-263o277-297i,302
Q8NH64,Olfactory receptor 51A7 (Olfactory receptor OR11-27),o25-49i59-82o98-120i144-163o196-218i240-260o273-293i,312
Q8NH67,Olfactory receptor 52I2 (Olfactory receptor OR11-12),o55-79i89-109o128-150i172-193o227-252i271-291o305-325i,350
Q8NH70,Olfactory receptor 4A16 (Olfactory receptor OR11-117),o25-45i57-77o96-118i140-162o192-220i238-257o268-287i,328
Q8NH72,Olfactory receptor 4C6 (Olfactory receptor OR11-138),o24-48i59-81o96-118i141-164o192-220i242-257o268-287i,309
Q8NH73,Olfactory receptor 4S2 (Olfactory receptor OR11-137),o24-47i57-81o96-118i142-162o192-221i238-255o268-287i,311
Q8NH74,Olfactory receptor 10A6 (Olfactory receptor OR11-96),o25-49i59-79o98-120i144-164o197-219i241-257o273-290i,314
Q8NH76,Olfactory receptor 56B4 (Olfactory receptor OR11-67),o33-53i68-89o104-126i150-170o200-225i247-263o276-298i,319
Q8NH79,Olfactory receptor 6X1 (Olfactory receptor OR11-270),o24-47i57-81o96-118i142-164o192-220i239-258o268-288i,312
Q8NH80,Olfactory receptor 10D3 (HTPCRX09) (Olfactory receptor OR11-293),o25-49i59-79o98-120i142-166o194-219i241-256o268-288i,312
Q8NH81,Olfactory receptor 10G6 (Olfactory receptor OR11-280),o47-71i80-100o119-140i167-185o218-243i263-281o292-309i,332
Q8NH83,Olfactory receptor 4A5 (Olfactory receptor OR11-111),o24-48i57-77o96-118i140-161o191-219i237-256o267-286i,315
Q8NH89,Putative olfactory receptor 5AK3,o26-49i62-77o98-120i144-166o196-223i245-256o273-290i,298
Q8NH90,Olfactory receptor 5AK2,o25-49i59-79o98-120i144-164o194-222i245-256o273-290i,309
Q8NH93,Olfactory receptor 1L3 (Olfactory receptor 9-D) (OR9-D) (Olfactory receptor OR9-28),o26-49i59-83o98-120i143-163o197-223i241-259o271-291i,324
Q8NHA4,Olfactory receptor 2AE1 (Olfactory receptor 2AE2),o25-49i59-79o98-120i142-164o197-220i240-256o272-289i,323
Q8NHA6,Putative olfactory receptor 2W6 (Olfactory receptor OR6-3) (Putative olfactory receptor 2W7),o31-54i65-85o104-126i150-170o203-226i248-266o279-298i,318
Q8NHA8,Putative olfactory receptor 1F12P (Hs6M1-35P),o25-49i59-79o98-120i144-164o197-222i241-260o272-290i,337
Q8NHB1,Olfactory receptor 2V1,o26-50i61-79o99-121i145-167o198-220i246-261o275-293i,315
Q8NHB7,Olfactory receptor 5K1 (HTPCRX10) (Olfactory receptor OR3-8),o25-49i59-79o98-120i146-166o197-222i241-260o272-290i,308
Q8NHB8,Olfactory receptor 5K2 (Olfactory receptor OR3-9),o25-49i59-79o98-120i146-166o197-222i241-260o272-290i,316
Q8NHC5,Olfactory receptor 14A16 (Olfactory receptor 5AT1) (Olfactory receptor OR1-45),o23-46i57-77o96-118i143-164o194-217i240-257o269-289i,309
Q8NHC6,Olfactory receptor 14L1 (Olfactory receptor 5AV1),o26-49i63-80o99-121i147-167o198-223i242-261o273-291i,308
Q8NHC7,Olfactory receptor 14C36 (Olfactory receptor 5BF1) (Olfactory receptor OR1-59),o23-46i57-77o96-118i143-164o195-217i239-258o270-288i,312
Q8TBR7,TLC domain-containing protein 3A (Protein CT120) (Protein FAM57A),o3-23i38-58o76-93i118-135o145-163i181-201o224-239i,257
Q8TDS7,Mas-related G-protein coupled receptor member D (Beta-alanine receptor) (G-protein coupled receptor TGR7),o29-52i63-84o100-121i143-163o180-203i220-247o260-280i,321
Q8WZ92,Olfactory receptor 5P2 (Olfactory receptor-like protein JCG3),o25-45i55-69o94-116i140-161o190-219i241-256o269-286i,322
Q8WZA6,Olfactory receptor 1E3 (Olfactory receptor 17-210) (OR17-210) (Olfactory receptor OR17-7),o26-49i59-79o98-120i143-166o197-219i241-260o272-292i,343
Q96CH1,Probable G-protein coupled receptor 146 (G-protein coupled receptor PGR8),o28-51i64-85o103-125i147-167o186-208i234-254o276-296i,333
Q96LB0,Mas-related G-protein coupled receptor member X3 (Sensory neuron-specific G-protein coupled receptor 1/2),o30-52i63-85o97-118i140-160o178-200i214-240o255-275i,322
Q96P67,Probable G-protein coupled receptor 82,o17-39i52-73o90-115i155-175o201-222i251-274o292-312i,336
Q96R08,Olfactory receptor 5B12 (Olfactory receptor 5B16) (Olfactory receptor OR11-241),o23-47i57-77o96-118i142-162o195-221i243-258o272-288i,314
Q96R09,Olfactory receptor 5B2 (OST073) (Olfactory receptor OR11-240),o23-47i57-77o96-118i142-162o195-221i239-258o271-288i,309
Q96R27,Olfactory receptor 2M4 (HTPCRX18) (OST710) (Olfactory receptor OR1-55) (Olfactory receptor TPCR100),o26-49i59-79o98-120i142-164o197-219i241-260o273-290i,311
Q96R28,Olfactory receptor 2M2 (OST423),o26-49i59-79o98-120i143-164o197-223i241-260o273-290i,347
Q96R30,Olfactory receptor 2V2 (Olfactory receptor 2V3) (Olfactory receptor OR5-3),o26-50i60-80o99-121i147-167o198-220i242-261o275-293i,315
Q96R45,Olfactory receptor 2A7 (Olfactory receptor OR7-18),o24-48i58-78o97-119i144-165o196-221i240-259o272-289i,310
Q96R47,Olfactory receptor 2A14 (OST182) (Olfactory receptor 2A6) (Olfactory receptor OR7-12),o24-48i58-78o97-119i142-165o196-218i240-259o271-291i,310
Q96R54,Olfactory receptor 14A2 (Olfactory receptor 5AX1) (Olfactory receptor OR1-31),o23-47i60-80o96-116i140-164o192-220i239-258o268-288i,314
Q96R67,Olfactory receptor 4C12 (Olfactory receptor OR11-259),o24-47i57-77o96-118i140-162o195-217i239-256o268-287i,309
Q96R69,Olfactory receptor 4F4 (HS14a-1-A) (Olfactory receptor OR19-3),o19-42i52-72o91-113i135-157o190-215i233-253o263-280i,305
Q96R72,Olfactory receptor 4K3 (Olfactory receptor OR14-14),o25-49i62-82o98-120i142-164o194-223i240-260o270-287i,315
Q96R84,Putative olfactory receptor 1F2 (OLFmf2),o26-49i59-73o97-119i142-165o196-218i240-259o271-289i,312
Q96RB7,Olfactory receptor 5M11,o25-49i59-79o99-119i141-163o197-222i244-256o272-289i,305
Q96RC9,Olfactory receptor 8B4 (Olfactory receptor OR11-315),o25-51i59-79o97-119i141-163o196-221i240-256o272-289i,309
Q96RD0,Olfactory receptor 8B2 (Olfactory receptor OR11-309),o27-49i59-79o98-120i144-164o197-222i245-260o272-289i,313
Q96RD1,Olfactory receptor 6C1 (OST267),o23-46i57-81o96-118i141-162o192-220i239-258o268-288i,312
Q96RD2,Olfactory receptor 52B2 (Olfactory receptor OR11-70),o27-52i61-86o100-122i146-165o198-223i242-262o276-296i,323
Q96RD3,Olfactory receptor 52E6 (Olfactory receptor OR11-58),o27-51i64-86o100-122i145-166o196-220i242-262o273-295i,313
Q99679,Probable G-protein coupled receptor 21,o29-53i76-90o104-125i148-168o192-212i253-273o284-304i,349
Q99680,G-protein coupled receptor 22,o42-65i79-105o117-138i157-179o209-232i314-334o350-370i,433
Q9BXE9,Vomeronasal type-1 receptor 3 (V1r-like receptor 3),o8-28i45-70o83-108i130-149o180-202i237-258o266-286i,311
Q9GZK3,Olfactory receptor 2B2 (Hs6M1-10) (Olfactory receptor 2B9) (Olfactory receptor 6-1) (OR6-1),o26-48i59-79o98-120i144-164o197-222i241-260o273-292i,357
Q9GZK7,Olfactory receptor 11A1 (Hs6M1-18) (Olfactory receptor 11A2) (Olfactory receptor OR6-30),o27-51i61-84o99-121i143-167o198-224i242-262o271-291i,315
Q9H2C5,Olfactory receptor 52A5 (Odorant receptor HOR3'beta5) (Olfactory receptor OR11-33),o29-51i61-85o100-122i146-165o200-222i244-264o277-297i,316
Q9H2C8,Olfactory receptor 51V1 (Odorant receptor HOR3'beta1) (Olfactory receptor 51A12) (Olfactory receptor OR11-36),o36-58i68-95o107-129i153-172o206-228i250-270o283-303i,321
Q9H343,Olfactory receptor 51I1 (Odorant receptor HOR5'beta11) (Olfactory receptor OR11-39),o29-51i64-84o100-122i145-165o199-221i243-263o276-296i,314
Q9H344,Olfactory receptor 51I2 (Odorant receptor HOR5'beta12) (Olfactory receptor OR11-38),o26-49i62-82o98-120i143-163o197-219i241-261o274-294i,312
Q9H346,Olfactory receptor 52D1 (Odorant receptor HOR5'beta14) (Olfactory receptor OR11-43),o30-52i62-89o101-123i147-166o197-222i243-263o278-298i,318
Q9NS67,Probable G-protein coupled receptor 27 (Super conserved receptor expressed in brain 1),o23-43i55-77o97-118i140-160o180-202i285-305o321-341i,375
Q9NYW1,Taste receptor type 2 member 9 (T2R9) (Taste receptor family B member 6) (TRB6),o8-30i46-71o81-109i130-150o181-203i234-257o262-285i,312
Q9NZP0,Olfactory receptor 6C3 (HSA8),o22-45i56-79o95-117i140-161o191-219i238-256o267-287i,311
Q9NZP2,Olfactory receptor 6C2 (HSA3),o23-46i57-81o96-118i141-162o192-220i239-258o268-288i,312
Q9NZP5,Olfactory receptor 5AC2 (HSA1),o27-51i61-81o100-122i145-166o198-221i243-262o275-292i,309
Q9P1P4,Putative trace amine-associated receptor 3 (TaR-3) (Trace amine receptor 3) (hTaar3) (G-protein coupled receptor 57),o42-56i68-90o106-127i148-169o196-218i258-278o289-312i,343
Q9P1Q5,Olfactory receptor 1A1 (Olfactory receptor 17-7) (OR17-7) (Olfactory receptor OR17-11),o26-49i59-79o98-120i142-164o196-218i240-259o270-290i,309
Q9UGF5,Olfactory receptor 14J1 (Hs6M1-28) (Olfactory receptor 5U1) (Olfactory receptor OR6-25),o23-47i60-80o96-116i142-164o195-217i239-258o270-290i,321
Q9UGF6,Olfactory receptor 5V1 (Hs6M1-21) (Olfactory receptor OR6-26),o25-48i59-79o98-120i144-164o197-222i241-256o272-292i,321
Q9UGF7,Olfactory receptor 12D3 (Hs6M1-27) (Olfactory receptor OR6-27),o24-47i57-77o96-118i140-162o195-221i241-259o272-289i,316
Q9UMS5,Protein PHTF1,i99-120o128-141i478-497o526-548i611-632o642-662i729-753o,762
Q9UPC5,Probable G-protein coupled receptor 34,o56-80i91-112o125-150i171-192o217-239i267-291o311-330i,381
Q9Y3N9,Olfactory receptor 2W1 (Hs6M1-15) (Olfactory receptor OR6-13),o25-48i59-79o98-120i144-164o197-221i241-260o273-290i,320
Q9Y4A9,Olfactory receptor 10H1 (Olfactory receptor OR19-27),o25-49i59-82o98-120i144-164o195-223i242-261o274-291i,318
Q9Y519,Transmembrane protein 184B (Putative MAPK-activating protein FM08),o45-65i81-101o111-131i178-194o213-233i255-269o290-310i,407
Q9Y5P0,Olfactory receptor 51B4 (Odorant receptor HOR5'beta1),o25-47i60-80o96-117i141-161o194-219i238-258o271-291i,310
A0A096LPK9,Olfactory receptor 4N4C,o25-49i59-83o98-120i143-164o194-222i240-259o270-287i,316
A0A0X1KG70,Olfactory receptor 4M2,o25-47i59-86o98-120i143-164o197-223i243-261o272-289i,313
A6NFY4,Nuclear envelope integral membrane protein 2,o149-159i160-169o177-198i207-227o239-257i269-289o292-316i,417
P0C7N8,Olfactory receptor 9G9,o24-48i58-78o97-117i141-161o196-221i244-258o272-289i,305
P0DSN6,Putative taste receptor type 2 member 33 (T2R33) (hGR33),o8-33i47-67o83-108i129-149o177-199i231-251o260-282i,309
P0DTE0,Putative taste receptor type 2 member 36 (T2R36) (hGR36),o8-33i47-67o80-108i128-148o177-199i231-251o260-282i,309
Q86V85,Integral membrane protein GPR180 (Intimal thickness-related receptor),o172-193i205-227o246-266i285-304o321-342i357-381o390-410i,440
Q8N4S7,Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV),i49-70o80-102i115-135o145-165i176-190o206-222i241-259o,273
Q8N755,Solute carrier family 66 member 3 (PQ-loop repeat-containing protein 3),o8-22i39-56o64-84i93-107o112-133i147-166o171-192i,202
Q8NBT3,Transmembrane protein 145,o175-194i207-227o242-262i277-297o317-336i349-369o381-401i,493
Q8NH21,Olfactory receptor 4F5,o19-42i52-72o91-113i135-157o190-216i233-253o263-280i,305
P0DTL5,Transmembrane protein 276,o9-27i35-55o60-80i90-105o115-133i138-155o166-181i,192
O43731,ER lumen protein-retaining receptor 3 (KDEL endoplasmic reticulum protein retention receptor 3) (KDEL receptor 3),o3-21i34-53o58-79i95-108o115-135i150-167o178-195i,214
O43749,Olfactory receptor 1F1 (Olfactory receptor 16-35) (OR16-35) (Olfactory receptor 1F10) (Olfactory receptor 1F4) (Olfactory receptor 1F5) (Olfactory receptor 1F6) (Olfactory receptor 1F7) (Olfactory receptor 1F8) (Olfactory receptor 1F9) (Olfactory receptor OR16-4),o26-49i59-79o98-120i143-166o197-219i241-260o272-292i,312
O60241,Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2),o937-957i967-985o998-1019i1038-1056o1076-1098i1150-1173o1181-1201i,1585
O60242,Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3),o882-902i912-931o940-960i983-1001o1023-1043i1099-1119o1126-1146i,1522
O60353,Frizzled-6 (Fz-6) (hFz6),o200-222i234-254o284-305i325-348o369-391i417-437o473-494i,706
O60478,Integral membrane protein GPR137B (Transmembrane 7 superfamily member 1 protein),o43-68i80-100o120-140i158-178o193-213i236-257o289-313i,399
O60755,Galanin receptor type 3 (GAL3-R) (GALR-3),o20-41i59-82o97-118i141-161o183-205i236-256o274-294i,368
O60883,G-protein coupled receptor 37-like 1 (Endothelin B receptor-like protein 2) (ETBR-LP-2),o130-154i168-189o205-226i249-269o311-331i361-381o396-419i,481
O60931,Cystinosin,o122-142i162-182o206-226i238-258o262-282i298-318o336-356i,367
O75084,Frizzled-7 (Fz-7) (hFz7) (FzE3),o255-277i288-309o338-359i380-402o423-445i471-491o527-549i,574
A0PK00,Transmembrane protein 120B,i132-152o159-179i187-207o219-236i270-290o302-322i,339
B0YJ81,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 1) (HACD1) (Cementum-attachment protein) (CAP) (Protein-tyrosine phosphatase-like member A),i74-95o111-131i138-158o168-188i203-223o248-268i,288
O14494,Phospholipid phosphatase 1 (EC 3.1.3.-) (EC 3.1.3.106) (EC 3.1.3.4) (EC 3.6.1.75) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a),i9-29o56-77i101-121o174-185i197-215o228-246i,284
O14495,Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP),i34-54o86-106i130-149o198-213i226-243o256-274i,311
O14520,Aquaporin-7 (AQP-7) (Aquaglyceroporin-7) (Aquaporin adipose) (AQPap) (Aquaporin-7-like),i41-59o68-88i113-133o168-190i200-220o253-276i,342
O14569,Transmembrane reductase CYB561D2 (EC 7.2.1.3) (Cytochrome b561 domain-containing protein 2) (Putative tumor suppressor protein 101F6),i18-38o47-67i85-105o123-143i157-178o190-210i,222
O14678,Lysosomal cobalamin transporter ABCD4 (EC 7.6.2.8) (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69),i40-61o82-96i161-181o184-210i280-293o315-324i,606
O14681,Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein),i71-89o121-141i174-194o202-217i240-255o259-268i,340
O14735,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase),i6-28o34-54i65-85o90-110i139-158o171-195i,213
O14863,Probable proton-coupled zinc antiporter SLC30A4 (Solute carrier family 30 member 4) (Zinc transporter 4) (ZnT-4),i115-135o138-163i181-200o216-236i275-295o303-325i,429
O15503,Insulin-induced gene 1 protein (INSIG-1),i85-107o127-144i160-181o186-204i210-230o246-263i,277
O15554,Intermediate conductance calcium-activated potassium channel protein 4 (SK4) (SKCa 4) (SKCa4) (IKCa1) (IK1) (KCa3.1) (KCa4) (Putative Gardos channel),i25-45o56-79i105-120o150-167i207-226o265-282i,427
O43315,Aquaporin-9 (AQP-9) (Aquaglyceroporin-9) (Small solute channel 1),i30-49o58-78i103-124o158-180i190-210o243-266i,295
O43462,Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease) (SREBPs intramembrane protease),o4-24i75-99o160-174i225-246o444-461i493-514o,519
O43525,Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3),i123-143o156-176i198-214o222-231i261-281o331-349i,872
O43526,Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2),i93-113o128-148i168-185o191-200i232-252o293-311i,872
O75762,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor),i720-740o765-785i804-824o830-850i874-894o935-956i,1119
O94778,Aquaporin-8 (AQP-8),i38-57o69-86i114-131o155-177i184-204o229-249i,261
O95259,Potassium voltage-gated channel subfamily H member 1 (Ether-a-go-go potassium channel 1) (EAG channel 1) (h-eag) (hEAG1) (Voltage-gated potassium channel subunit Kv10.1),i222-239o249-269i295-312o346-356i377-397o478-502i,989
O95864,Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2),i131-154o158-178i266-276o277-288i293-315o316-326i,444
P04839,Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome),i9-29o52-72i99-121o170-192i204-224o270-289i,570
P16389,Potassium voltage-gated channel subfamily A member 2 (NGK1) (Voltage-gated K(+) channel HuKIV) (Voltage-gated potassium channel HBK5) (Voltage-gated potassium channel subunit Kv1.2),i164-182o222-242i254-275o290-305i328-349o389-410i,499
P17658,Potassium voltage-gated channel subfamily A member 6 (Voltage-gated potassium channel HBK2) (Voltage-gated potassium channel subunit Kv1.6),i175-194o265-282i295-309o349-358i373-397o434-455i,529
P21817,Ryanodine receptor 1 (RYR-1) (RyR1) (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor),i4563-4583o4642-4662i4790-4804o4805-4815i4838-4858o4915-4938i,5038
P22001,Potassium voltage-gated channel subfamily A member 3 (HGK5) (HLK3) (HPCN3) (Voltage-gated K(+) channel HuKIII) (Voltage-gated potassium channel subunit Kv1.3),i235-254o297-315i327-341o370-380i395-419o456-477i,575
P22459,Potassium voltage-gated channel subfamily A member 4 (HPCN2) (Voltage-gated K(+) channel HuKII) (Voltage-gated potassium channel HBK4) (Voltage-gated potassium channel HK1) (Voltage-gated potassium channel subunit Kv1.4),i308-327o373-388i403-417o450-460i475-499o536-557i,653
P22460,Potassium voltage-gated channel subfamily A member 5 (HPCN1) (Voltage-gated potassium channel HK2) (Voltage-gated potassium channel subunit Kv1.5),i251-269o323-344i356-377o393-411i434-455o495-515i,613
P29972,Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule),i13-33o50-68i95-115o136-156i166-186o211-231i,269
P30301,Lens fiber major intrinsic protein (Aquaporin-0) (MIP26) (MP26),i12-32o42-60i87-107o131-149i158-178o203-223i,263
P39210,Protein Mpv17,i18-38o52-70i89-99o100-111i130-149o156-169i,176
P41181,Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct),i12-32o42-60i87-107o127-147i158-176o203-224i,271
P45844,ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog),i427-445o457-477i507-525o534-555i568-586o650-669i,678
P48547,Potassium voltage-gated channel subfamily C member 1 (NGK2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),i191-209o247-266i278-291o315-325i345-366o413-433i,511
P49447,Transmembrane ascorbate-dependent reductase CYB561 (EC 7.2.1.-) (Cytochrome b-561) (Cytochrome b561),i17-36o53-71i85-106o123-143i159-179o198-220i,251
P51787,Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1),i123-143o155-173i200-215o221-230i262-282o328-343i,676
P55061,Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6),i32-47o53-73i85-103o114-134i140-164o169-187i,237
P55064,Aquaporin-5 (AQP-5),i13-33o43-63i88-108o132-148i158-179o205-225i,265
P55087,Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4),i37-57o70-89i116-136o156-176i185-205o232-252i,323
P56696,Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4),i99-119o132-152i174-191o197-206i238-258o298-317i,695
P57088,Transmembrane protein 33 (Protein DB83) (SHINC-3),i26-46o51-71i83-103o111-131i156-166o167-176i,247
Q03721,Potassium voltage-gated channel subfamily C member 4 (KSHIIIC) (Voltage-gated potassium channel subunit Kv3.4),i227-245o280-301i313-334o342-355i381-401o451-471i,635
Q07326,Phosphatidylinositol-glycan biosynthesis class F protein (PIG-F) (GPI11 homolog),i14-31o43-61i83-99o113-129i155-175o183-205i,219
Q09470,Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1),i168-187o223-241i253-267o298-308i323-347o384-405i,495
Q12809,Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1),i409-429o454-471i489-501o502-512i548-570o639-656i,1159
Q12893,Transmembrane protein 115 (Placental protein 6) (Protein PL6),i21-41o58-85i98-119o135-149i166-186o190-208i,351
Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B (EC 3.1.4.17) (CGIPDE1) (CGIP1) (Cyclic GMP-inhibited phosphodiesterase B) (CGI-PDE B)",i78-96o117-137i152-172o192-211i219-237o243-267i,1112
Q13433,Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6),o326-346i357-377o424-444i657-678o685-705i725-745o,755
Q13520,Aquaporin-6 (AQP-6) (Aquaporin-2-like) (Kidney-specific aquaporin) (hKID),i26-46o56-74i101-121o141-161i172-188o215-235i,282
Q13563,Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2),i220-241o469-489i506-526o553-573i598-619o655-675i,968
Q13571,Lysosomal-associated transmembrane protein 5 (Lysosomal-associated multitransmembrane protein 5) (Retinoic acid-inducible E3 protein),i20-40o63-83i92-102o103-112i141-152o188-206i,262
Q14003,Potassium voltage-gated channel subfamily C member 3 (KSHIIID) (Voltage-gated potassium channel subunit Kv3.3),i291-309o347-365i383-401o409-422i448-468o518-538i,757
Q14028,Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP),i654-676o691-709i740-750o751-761i795-812o858-876i,1251
Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",i61-81o130-151i159-178o185-206i210-227o239-255i,1141
Q14571,"Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)",i2228-2248o2261-2281i2308-2328o2350-2372i2395-2415o2521-2541i,2701
Q14573,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",i2203-2223o2237-2256i2284-2301o2325-2346i2369-2389o2497-2517i,2671
Q14643,"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)",i2283-2303o2315-2335i2362-2382o2406-2426i2449-2469o2578-2598i,2758
Q14721,Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1),i190-209o232-249i261-279o295-305i331-351o392-412i,858
Q15043,Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),o155-175i186-207o224-244i399-419o427-446i462-484o,492
Q15070,Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein) (OXA1-like protein),i141-152o153-162i217-234o261-277i291-311o314-332i,435
Q15413,Ryanodine receptor 3 (RYR-3) (RyR3) (Brain ryanodine receptor-calcium release channel) (Brain-type ryanodine receptor) (Type 3 ryanodine receptor),i4413-4433o4477-4498i4622-4637o4638-4647i4670-4690o4747-4770i,4870
Q16322,Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8),i217-236o273-291i303-317o348-357i372-396o433-454i,511
Q2QL34,Mpv17-like protein (M-LP homolog) (M-LPH),i16-35o52-67i82-94o95-108i122-143o148-166i,196
Q504Y0,Zinc transporter ZIP12 (LIV-1 subfamily of ZIP zinc transporter 8) (LZT-Hs8) (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12),o369-389i403-427o448-468i603-623o629-651i662-682o,691
Q53TN4,Plasma membrane ascorbate-dependent reductase CYBRD1 (EC 7.2.1.3) (Cytochrome b reductase 1) (Duodenal cytochrome b) (Ferric-chelate reductase 3),i8-32o48-69i79-105o119-144i152-179o198-222i,286
Q5JUK3,Potassium channel subfamily T member 1 (KCa4.1),i98-118o156-176i188-208o214-226i252-272o305-325i,1230
Q5M7Z0,E3 ubiquitin-protein ligase RNFT1 (EC 2.3.2.27) (Protein PTD016) (RING finger and transmembrane domain-containing protein 1),i150-167o170-186i205-223o247-272i288-306o321-341i,435
Q5SNT2,Transmembrane protein 201 (Spindle-associated membrane protein 1),o17-32i219-236o298-316i325-341o354-374i644-662o,666
Q5T197,E3 ubiquitin-protein ligase DCST1 (EC 2.3.2.27) (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase),i45-65o80-96i116-133o376-389i464-480o551-571i,706
Q5VWC8,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 4) (HACD4) (Protein-tyrosine phosphatase-like A domain-containing protein 2),i20-40o57-77i88-103o112-127i143-168o191-211i,232
Q5VZY2,Phospholipid phosphatase 4 (EC 3.1.3.4) (EC 3.6.1.75) (Phosphatidic acid phosphatase type 2 domain-containing protein 1A),i4-24o53-72i83-105o149-159i179-194o204-221i,271
Q658P3,Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6) (hTSAP6) (pHyde) (hpHyde),i214-232o259-279i305-325o357-377i394-414o431-451i,488
Q687X5,"Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)",i202-220o246-267i293-313o347-365i386-403o418-438i,459
Q6NTF9,Rhomboid domain-containing protein 2,i20-37o67-87i100-120o134-148i161-182o183-200i,364
Q6NXT4,Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6),i34-52o58-83i101-119o137-155i201-219o227-248i,461
Q6P5W5,Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4),o328-348i367-387o403-423i559-579o587-607i618-638o,647
Q6PIU1,Potassium voltage-gated channel subfamily V member 1 (Neuronal potassium channel alpha subunit HNKA) (Voltage-gated potassium channel subunit Kv8.1),i211-230o241-259i277-292o310-323i346-366o407-427i,500
Q6PML9,"Proton-coupled zinc antiporter SLC30A9, mitochondrial (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9)",i239-259o265-287i311-331o342-364i398-413o421-443i,568
Q6UVM3,Potassium channel subfamily T member 2 (Sequence like an intermediate conductance potassium channel subunit) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1),i64-83o105-123i135-155o161-173i199-219o252-272i,1135
Q6UX65,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),i10-28o55-73i91-110o120-141i155-179o206-226i,266
Q6XR72,Calcium/manganese antiporter SLC30A10 (Solute carrier family 30 member 10) (Zinc transporter 10) (ZnT-10),i12-32o35-55i79-101o115-135i241-264o283-296i,485
Q6Y1H2,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B),i41-61o77-97i104-123o132-152i169-189o214-234i,254
Q6ZMH5,Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5) (ZIP-5),o213-234i244-264o288-308i445-466o476-497i508-529o,540
Q7RTX7,Cation channel sperm-associated protein 4 (CatSper4),i93-111o125-145i158-178o181-191i214-231o281-303i,472
Q7Z2D5,Phospholipid phosphatase-related protein type 4 (Brain-specific phosphatidic acid phosphatase-like protein 1) (Inactive 2-lysophosphatidate phosphatase PLPPR4) (Lipid phosphate phosphatase-related protein type 4) (Plasticity-related gene 1 protein) (PRG-1),i70-90o122-144i175-198o253-263i280-298o308-327i,763
Q7Z2W7,Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6) (LTrpC-6) (LTrpC6) (Transient receptor potential p8) (Trp-p8),i735-755o767-783i797-815o830-847i863-883o954-974i,1104
Q7Z4N2,Transient receptor potential cation channel subfamily M member 1 (Long transient receptor potential channel 1) (LTrpC1) (Melastatin-1),i831-851o861-881i898-916o929-943i962-982o1050-1070i,1603
Q86TG1,Transmembrane protein 150A (Transmembrane protein 150),i5-25o78-96i112-129o139-161i172-197o206-229i,271
Q86VZ5,Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Medulla oblongata-derived protein) (Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23),i132-156o182-204i215-235o280-296i304-325o333-346i,413
Q86XQ3,Cation channel sperm-associated protein 3 (CatSper3) (Ca(v)-like protein) (One-repeat calcium channel-like protein),i51-71o83-100i116-131o141-154i178-196o246-264i,398
Q8IUH4,Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Huntingtin-interacting protein 14-related protein) (HIP14-related protein) (Huntingtin-interacting protein HIP3RP) (Putative MAPK-activating protein PM03) (Putative NF-kappa-B-activating protein 209) (Zinc finger DHHC domain-containing protein 13) (DHHC-13),i292-310o317-334i347-368o376-392i471-491o519-539i,622
Q8IUH5,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17),i305-325o328-345i357-379o385-403i481-501o530-550i,632
Q8IUX1,"Complex I assembly factor TMEM126B, mitochondrial (Transmembrane protein 126B)",i72-83o84-93i107-127o146-161i194-204o205-214i,230
Q8IV77,Cyclic nucleotide-gated cation channel alpha-4 (Cyclic nucleotide-gated channel alpha-4) (CNG channel alpha-4) (CNG-4) (CNG4),i36-56o66-86i116-130o138-147i169-189o245-263i,575
Q8IWU4,Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8),i80-100o104-124i141-161o176-196i218-238o246-266i,369
Q8IXM6,Nurim (Nuclear envelope membrane protein) (Nuclear rim protein),i6-26o59-79i95-113o136-159i201-210o218-230i,262
Q8IYP9,Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23),i92-106o110-130i138-158o171-186i303-323o349-371i,409
Q8IZK6,Mucolipin-2 (Transient receptor potential channel mucolipin 2) (TRPML2),i66-86o291-313i343-363o375-397i420-440o481-502i,566
Q8N5G2,Macoilin (Macoilin-1) (Transmembrane protein 57),i29-51o52-62i74-96o97-114i120-140o154-174i,664
Q8N682,DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator),i10-30o56-72i91-111o121-143i158-181o199-220i,238
Q8N6M3,Acyl-coenzyme A diphosphatase FITM2 (EC 3.6.1.-) (Fat storage-inducing transmembrane protein 2) (Fat-inducing protein 2),i23-38o58-81i94-114o149-167i187-213o216-237i,262
Q8N8Q8,"Cytochrome c oxidase assembly protein COX18, mitochondrial (COX18Hs) (Cytochrome c oxidase assembly protein 18)",i82-94o95-105i168-188o223-239i254-274o278-296i,333
Q8NBI2,Lysosomal membrane ascorbate-dependent ferrireductase CYB561A3 (EC 7.2.1.3) (Cytochrome b ascorbate-dependent protein 3) (Cytochrome b561 family member A3) (Lysosomal cytochrome b) (LCytb),i6-28o45-66i81-102o116-141i151-176o198-219i,242
Q8NBM4,Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1),i19-34o57-78i92-113o128-143i159-177o178-193i,344
Q8NEB5,Phospholipid phosphatase 5 (EC 3.1.3.4) (EC 3.6.1.75) (Phosphatidic acid phosphatase type 2 domain-containing protein 1B),i10-30o59-78i89-111o156-165i185-200o210-227i,264
Q8NEC5,Cation channel sperm-associated protein 1 (CatSper1) (hCatSper),i447-468o480-500i514-529o541-551i583-601o647-667i,780
Q8NER1,Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1),i434-454o472-497i511-531o537-556i577-599o659-687i,839
Q8NET8,Transient receptor potential cation channel subfamily V member 3 (TrpV3) (Vanilloid receptor-like 3) (VRL-3),i440-460o481-507i521-541o547-566i587-609o653-681i,790
Q8NEW0,Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) (Znt-like transporter 2),i38-58o64-84i105-123o142-159i237-258o265-285i,376
Q8NFT2,Metalloreductase STEAP2 (EC 1.16.1.-) (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer) (PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1),i216-232o259-279i305-325o357-377i394-414o431-451i,490
Q8NHU3,Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) (Sphingomyelin synthase 2),i76-100o126-149i159-179o223-240i248-269o275-291i,365
Q8TAE7,Potassium voltage-gated channel subfamily G member 3 (Voltage-gated potassium channel subunit Kv10.1) (Voltage-gated potassium channel subunit Kv6.3),i172-190o222-242i256-274o285-300i323-344o388-405i,436
Q8TBJ4,Phospholipid phosphatase-related protein type 1 (Inactive 2-lysophosphatidate phosphatase PLPPR1) (Lipid phosphate phosphatase-related protein type 1) (Plasticity-related gene 3 protein) (PRG-3),i17-35o71-91i124-148o202-215i226-244o256-276i,325
Q8TD22,Sideroflexin-5,i163-173o174-184i250-260o261-270i290-300o301-310i,340
Q8TD43,Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4),i780-803o813-833i864-884o893-910i930-947o1018-1038i,1214
Q8TDD5,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),i63-83o286-308i338-358o370-392i415-435o473-497i,553
Q8TDN1,Potassium voltage-gated channel subfamily G member 4 (Voltage-gated potassium channel subunit Kv6.4),i222-241o262-282i294-308o332-348i371-392o430-450i,519
Q8TDN2,Potassium voltage-gated channel subfamily V member 2 (Voltage-gated potassium channel subunit Kv8.2),i261-279o301-322i334-348o384-393i411-432o469-489i,545
Q8TEB9,Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4),i22-43o79-93i103-126o140-153i168-188o192-206i,315
Q92482,Aquaporin-3 (AQP-3) (Aquaglyceroporin-3),i29-48o57-77i102-122o158-179i189-209o242-265i,292
Q92504,"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)",o136-156i169-189o219-237i381-401o418-435i448-466o,469
Q92736,Ryanodine receptor 2 (RYR-2) (RyR2) (hRYR-2) (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor),i4502-4522o4571-4593i4719-4734o4735-4744i4767-4787o4844-4867i,4967
Q92952,Small conductance calcium-activated potassium channel protein 1 (SK1) (SKCa 1) (SKCa1) (KCa2.1),i110-130o137-160i186-201o226-246i277-301o345-365i,543
Q92953,Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2),i194-212o236-253i265-282o302-317i335-356o393-413i,911
Q96GM1,Phospholipid phosphatase-related protein type 2 (Inactive phospholipid phosphatase PLPPR2) (Lipid phosphate phosphatase-related protein type 2) (Plasticity-related gene 4 protein) (PRG-4),i18-36o72-92i126-150o210-228i235-256o266-285i,343
Q96GQ5,RUS family member 1,i99-115o132-152i164-184o187-207i235-253o259-276i,468
Q96H72,Zinc transporter ZIP13 (LIV-1 subfamily of ZIP zinc transporter 9) (LZT-Hs9) (Solute carrier family 39 member 13) (Zrt- and Irt-like protein 13) (ZIP-13),o68-89i108-125o152-169i280-300o316-336i350-370o,371
Q96IV6,Fatty acid hydroxylase domain-containing protein 2,i28-46o76-97i134-154o168-188i223-240o247-260i,333
Q96IZ2,Androgen-dependent TFPI-regulating protein (Fatty acid esters of hydroxy fatty acids hydrolase ADTRP) (FAHFA hydrolase ADTRP) (EC 3.1.-.-),i5-24o45-63i86-106o124-144i155-175o191-211i,230
Q8WTR4,Glycerophosphodiester phosphodiesterase domain-containing protein 5 (Glycerophosphocholine phosphodiesterase GDPD5) (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 2) (Phosphoinositide phospholipase C GDPD5) (EC 3.1.4.11),i43-63o86-113i123-143o160-180i193-213o498-517i,605
Q96KK3,Potassium voltage-gated channel subfamily S member 1 (Delayed-rectifier K(+) channel alpha subunit 1) (Voltage-gated potassium channel subunit Kv9.1),i221-239o274-292i307-321o340-355i376-396o436-453i,526
Q96L42,Potassium voltage-gated channel subfamily H member 8 (ELK1) (hElk1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Voltage-gated potassium channel subunit Kv12.1),i226-246o258-276i302-319o323-333i354-374o449-467i,1107
Q96LT4,Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8),i149-173o199-221i232-252o296-312i320-341o347-356i,415
Q96NB2,Sideroflexin-2,i147-157o158-167i225-236o237-246i266-276o277-286i,322
Q96P56,Cation channel sperm-associated protein 2 (CatSper2),i109-129o144-163i177-197o205-215i243-263o318-338i,530
Q96PH1,NADPH oxidase 5 (EC 1.6.3.-),i237-257o269-296i313-338o366-386i395-415o419-440i,765
Q96PR1,Potassium voltage-gated channel subfamily C member 2 (Shaw-like potassium channel) (Voltage-gated potassium channel Kv3.2),i230-248o281-299i314-335o343-356i382-402o452-472i,638
Q96PS8,Aquaporin-10 (AQP-10) (Aquaglyceroporin-10) (Small intestine aquaporin),i25-46o56-76i101-121o156-178i187-207o242-264i,301
Q96Q80,Derlin-3 (Degradation in endoplasmic reticulum protein 3) (DERtrin-3) (Der1-like protein 3),i15-35o57-79i94-116o117-132i145-165o169-185i,235
Q96QT4,Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7),i856-876o886-906i923-943o957-977i1000-1016o1071-1091i,1865
Q99726,Probable proton-coupled zinc antiporter SLC30A3 (Solute carrier family 30 member 3) (Zinc transporter 3) (ZnT-3),i82-97o106-126i143-163o178-198i236-256o264-284i,388
Q9BQ31,Potassium voltage-gated channel subfamily S member 3 (Delayed-rectifier K(+) channel alpha subunit 3) (Voltage-gated potassium channel subunit Kv9.3),i186-205o224-242i254-268o288-304i321-345o382-402i,491
Q9BRI3,Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2),i80-100o104-124i141-161o176-196i221-241o249-269i,372
Q9BTX1,Nucleoporin NDC1 (hNDC1) (Transmembrane protein 48),i25-47o68-89i115-136o167-187i218-235o264-282i,674
Q9BUN8,Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1),i16-31o70-89i95-115o123-137i155-166o171-189i,251
Q9BVK8,BOS complex subunit TMEM147 (Protein NIFIE 14) (Transmembrane protein 147),i36-53o68-84i101-121o139-155i167-187o197-217i,224
Q9BX84,Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6),i842-862o872-892i909-929o940-957i977-993o1044-1064i,2022
Q9BXJ8,Ion channel TACAN (Transmembrane protein 120A) (Transmembrane protein induced by tumor necrosis factor alpha),i136-156o163-183i191-211o223-240i274-294o306-326i,343
Q9C0K1,Metal cation symporter ZIP8 (BCG-induced integral membrane protein in monocyte clone 103 protein) (LIV-1 subfamily of ZIP zinc transporter 6) (LZT-Hs6) (Solute carrier family 39 member 8) (Zrt- and Irt-like protein 8) (ZIP-8),o130-150i161-182o199-219i366-386o394-413i430-453o,460
Q9GZP9,Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa),i19-36o57-79i94-116o117-132i145-165o169-185i,239
Q9GZU1,Mucolipin-1 (ML1) (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1) (TRPML1),i66-86o299-321i351-371o383-405i428-448o492-513i,580
Q9H172,ATP-binding cassette sub-family G member 4 (EC 7.6.2.-),i396-414o426-446i476-494o503-524i537-555o618-637i,646
Q9H1D0,Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2),i368-388o426-448i464-483o490-509i530-552o597-617i,765
Q9H221,ATP-binding cassette sub-family G member 8 (EC 7.6.2.-) (Sterolin-2),i414-435o450-472i492-519o528-552i557-575o641-663i,673
Q9H222,ATP-binding cassette sub-family G member 5 (EC 7.6.2.-) (Sterolin-1),i384-404o422-442i468-489o501-521i529-549o624-644i,651
Q9H252,Potassium voltage-gated channel subfamily H member 6 (Ether-a-go-go-related gene potassium channel 2) (ERG-2) (Eag-related protein 2) (Ether-a-go-go-related protein 2) (hERG-2) (hERG2) (Voltage-gated potassium channel subunit Kv11.2),i261-281o302-319i345-360o369-378i399-419o491-511i,994
Q9H295,Dendritic cell-specific transmembrane protein (DC-STAMP) (hDC-STAMP) (Dendrocyte-expressed seven transmembrane protein) (IL-four-induced protein) (FIND) (Transmembrane 7 superfamily member 4),i33-55o58-73i97-115o214-223i297-317o380-389i,470
Q9H2S1,Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2),i137-155o165-188i214-229o254-270i305-329o373-393i,579
Q9H300,"Presenilin-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]",i99-109o110-119i219-239o245-263i309-326o332-347i,379
Q9H3M0,Potassium voltage-gated channel subfamily F member 1 (Voltage-gated potassium channel subunit Kv5.1) (kH1),i183-201o222-242i257-272o288-298i324-344o385-402i,494
Q9HBA0,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Osm-9-like TRP channel 4) (OTRPC4) (Transient receptor potential protein 12) (TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2) (VRL-2) (Vanilloid receptor-related osmotically-activated channel) (VR-OAC),i470-490o508-534i548-568o573-593i609-636o694-722i,871
Q9HBY0,NADPH oxidase 3 (EC 1.6.3.-) (Mitogenic oxidase 2) (MOX-2) (gp91phox homolog 3) (GP91-3),i11-31o53-73i101-122o168-192i202-222o267-287i,568
Q9HC07,Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL),o98-120i129-150o161-175i236-261o268-288i299-319o,324
Q9HCC8,Glycerophosphoinositol inositolphosphodiesterase GDPD2 (EC 3.1.4.43) (Glycerophosphodiester phosphodiesterase 3) (Glycerophosphodiester phosphodiesterase domain-containing protein 2) (Osteoblast differentiation promoting factor),i39-60o83-107i118-140o156-176i189-209o491-511i,539
Q9HCF6,Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2),i898-918o928-948i965-985o996-1010i1029-1049o1112-1132i,1732
Q9NPH5,NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase),i17-34o59-83i106-125o159-179i189-213o283-303i,578
Q9NQA5,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),i328-348o386-408i424-443o450-469i490-512o557-577i,729
Q9NQW8,Cyclic nucleotide-gated cation channel beta-3 (Cone photoreceptor cGMP-gated channel subunit beta) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-3) (CNG channel beta-3),i217-237o253-271i299-309o310-319i353-373o418-438i,809
Q9NR82,Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5),i127-147o159-180i202-219o225-234i266-286o327-345i,932
Q9NRK6,"ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)",i168-189o217-238i289-308o314-333i393-414o434-453i,738
Q9NS40,Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Voltage-gated potassium channel subunit Kv11.3),i412-432o453-470i495-512o520-529i550-570o642-662i,1196
Q9NSA2,Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1),i184-205o230-251i263-281o290-303i326-347o387-408i,647
Q9NUT2,"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial ATP-binding cassette 1) (M-ABC1) (Mitochondrial sulfonylurea-receptor) (MITOSUR)",i145-167o198-216i269-289o294-316i374-394o415-435i,735
Q9NVV5,Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-),i7-24o41-60i89-109o128-145i158-176o197-214i,238
Q9NWW5,Ceroid-lipofuscinosis neuronal protein 6 (Protein CLN6),o84-93i117-130o176-194i206-225o230-247i260-281o,311
Q9NZ01,"Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)",i87-107o129-148i158-178o196-211i248-260o265-274i,308
Q9NZM6,Polycystin-2-like protein 2 (Polycystin-2L2) (Polycystic kidney disease 2-like 2 protein) (Polycystin-L2),i29-49o278-298i315-335o366-383i408-429o465-485i,624
Q9NZQ8,Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein),i732-752o768-783i807-827o836-853i873-893o953-973i,1165
Q9NZV8,Potassium voltage-gated channel subfamily D member 2 (Voltage-gated potassium channel subunit Kv4.2),i185-205o227-246i261-279o294-303i321-345o381-403i,630
Q9P035,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),i150-170o187-207i215-233o243-263i279-301o324-344i,362
Q9P0L9,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog) (Polycystin-L) (Polycystin-L1),i101-121o348-368i385-406o438-454i478-499o535-555i,805
Q9P1Z3,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,i98-118o127-145i172-190o209-222i251-261o325-344i,774
Q9UGI6,Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3),i283-302o315-339i363-378o405-423i454-478o522-542i,731
Q9UHJ9,Post-GPI attachment to proteins factor 2 (FGF receptor-activating protein 1),i21-43o76-96i111-133o144-164i182-202o215-236i,254
Q9UIX4,Potassium voltage-gated channel subfamily G member 1 (Voltage-gated potassium channel subunit Kv6.1) (kH2),i228-246o268-288i303-318o338-354i377-398o437-457i,513
Q9UJ96,Potassium voltage-gated channel subfamily G member 2 (Cardiac potassium channel subunit) (Voltage-gated potassium channel subunit Kv6.2),i178-196o220-238i251-268o284-299i322-342o381-401i,466
Q9UJA2,Cardiolipin synthase (CMP-forming) (CLS) (EC 2.7.8.41) (Protein GCD10 homolog),i109-129o135-155i164-187o194-214i240-262o269-289i,301
Q9UK17,Potassium voltage-gated channel subfamily D member 3 (Voltage-gated potassium channel subunit Kv4.3),i183-203o228-246i258-276o291-300i318-342o378-400i,655
Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2),i212-233o245-263i290-308o325-335i367-377o441-460i,889
Q9UL54,Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2),i950-960o964-979i988-1006o1016-1032i1038-1053o1056-1067i,1235
Q9ULD8,Potassium voltage-gated channel subfamily H member 3 (Brain-specific eag-like channel 1) (BEC1) (Ether-a-go-go-like potassium channel 2) (ELK channel 2) (ELK2) (Voltage-gated potassium channel subunit Kv12.2),i226-246o263-278i306-319o327-337i358-381o480-500i,1083
Q9ULF5,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),o408-428i439-459o498-518i732-752o759-780i801-821o,831
Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338),i395-415o428-448i478-497o506-527i536-556o628-646i,655
Q9Y3Q4,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,i263-287o296-314i341-359o376-386i418-428o492-511i,1203
Q9Y5Q0,Fatty acid desaturase 3 (FADS3) (EC 1.14.19.-) (Delta(13) fatty acid desaturase) (Delta(13) desaturase),i133-156o160-180i265-279o280-290i294-314o317-330i,445
Q9Y5S1,Transient receptor potential cation channel subfamily V member 2 (TrpV2) (Osm-9-like TRP channel 2) (OTRPC2) (Vanilloid receptor-like protein 1) (VRL-1),i391-410o431-452i470-490o495-514i535-556o621-641i,764
Q9Y5S8,NADPH oxidase 1 (NOX-1) (EC 1.-.-.-) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1),i10-31o52-72i99-121o173-193i203-223o270-289i,564
Q9Y5U4,Insulin-induced gene 2 protein (INSIG-2),i29-51o71-88i104-125o130-148i154-175o190-207i,225
Q9Y6M5,Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1) (Zinc transporter 1),i11-29o35-57i79-101o114-134i249-269o313-333i,507
A6NC51,Modulator of macroautophagy TMEM150B (Protein DRAM-3) (Transmembrane protein 150B) (Transmembrane protein 224),i7-24o54-72i85-105o115-136i150-172o180-203i,233
Q32ZL2,Phospholipid phosphatase-related protein type 5 (Lipid phosphate phosphatase-related protein type 5) (Phosphatidic acid phosphatase type 2d) (Plasticity-related gene 5 protein) (PRG-5),i12-30o66-87i122-143o196-210i221-241o251-271i,321
Q567V2,Mpv17-like protein 2,i25-43o62-79i102-113o114-124i144-162o169-182i,206
Q5HYJ1,"Trans-2,3-enoyl-CoA reductase-like (EC 1.3.1.-) (Steroid 5-alpha-reductase 2-like 2 protein)",i143-163o182-204i217-235o250-267i293-316o320-337i,363
Q6T4P5,Phospholipid phosphatase-related protein type 3 (Inactive phospholipid phosphatase PLPPR3) (Lipid phosphate phosphatase-related protein type 3) (PAP-2-like protein 2) (Plasticity-related gene 2 protein) (PRG-2),i21-39o73-95i133-153o208-218i235-251o263-278i,718
Q6W3E5,Glycerophosphodiester phosphodiesterase domain-containing protein 4 (EC 3.1.-.-) (Glycerophosphodiester phosphodiesterase 6) (UgpQ),i11o32-54i70-87o108-128i163-178o469-489i,623
Q6YI46,Transmembrane protein 64,i123-140o160-173i176-185o191-213i274-294o311-329i,380
Q86UB9,Transmembrane protein 135 (Peroxisomal membrane protein 52) (PMP52),i152-162o163-172i254-265o266-275i328-343o348-361i,458
Q8N8Q1,Probable transmembrane reductase CYB561D1 (EC 7.2.1.3) (Cytochrome b561 domain-containing protein 1),i28-44o54-74i92-112o129-149i165-185o197-217i,229
Q8NGA4,Putative G-protein coupled receptor GPR32P1 (G-protein coupled 32 pseudogene) (G-protein coupled 32 pseudogene 1) (G-protein coupled receptor GPCR39) (hGPCR39),o45-67i79-101o117-137i158-178o214-239i261-271o,272
Q96EX2,E3 ubiquitin-protein ligase RNFT2 (RING finger and transmembrane domain-containing protein 2) (Transmembrane protein 118),i159-179o183-198i214-235o259-284i297-317o329-349i,444
Q9BZJ4,Probable mitochondrial glutathione transporter SLC25A39 (Solute carrier family 25 member 39),i127-144o162-182i227-240o257-277i323-333o334-344i,359
Q9H920,E3 ubiquitin ligase RNF121 (EC 2.3.2.27) (RING finger protein 121),o52-72i82-97o104-123i139-164o178-193i305-324o,327
Q9UHE8,Metalloreductase STEAP1 (EC 1.16.1.-) (Six-transmembrane epithelial antigen of prostate 1),i75-91o117-139i164-182o218-238i253-273o290-310i,339
Q9ULS6,Potassium voltage-gated channel subfamily S member 2 (Delayed-rectifier K(+) channel alpha subunit 2) (Voltage-gated potassium channel subunit Kv9.2),i188-206o230-248i259-277o302-311i329-350o386-406i,477
A6NL99,Putative aquaporin-7-like protein 3,i41-59o68-88i113-133o168-190i200-220o253-276i,342
A6NM10,Aquaporin-12B (AQP-12B),i8-24o59-75i100-121o147-168i175-194o216-237i,295
A6NMU1,Olfactory receptor 52A4,o29-53i63-91o102-124i147-167o199-224i245-265o,304
A8MWK0,"Putative fatty acid desaturase 2-like protein FADS2B (Fatty acid desaturase 2 pseudogene 1) (Fatty acid desaturase 2B, pseudogene)",i167-191o195-215i301-313o314-323i331-352o353-370i,482
B9EJG8,Transmembrane protein 150C,i9-29o67-85i98-118o128-150i163-184o193-213i,249
Q5JRS4,Olfactory receptor 10J3,o26-50i60-80o99-121i146-167o198-223i242-261o,329
Q5T1A1,DC-STAMP domain-containing protein 2,i26-46o52-72i94-113o326-337i412-432o501-516i,773
Q6ZNA5,Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2),o372-392i413-434o446-466i481-501o513-533i569-589o,592
Q8IXF9,Aquaporin-12A (AQP-12),i8-24o59-75i100-121o147-168i175-194o216-237i,295
Q8N1S5,Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11),o9-31i44-64o79-99i267-287o290-307i322-340o,342
Q8N413,Solute carrier family 25 member 45,o6-20i61-76o102-117i175-184o202-222i269-284o,288
Q8N4F7,RING finger protein 175,o53-73i83-98o105-124i142-163o179-194i304-325o,328
Q8NGY7,Putative olfactory receptor 10J6,o25-49i59-82o100-120i144-166o196-221i240-260o,276
Q8TBP6,Probable mitochondrial glutathione transporter SLC25A40 (Mitochondrial carrier family protein) (Solute carrier family 25 member 40),i111-123o146-159i207-220o235-256i299-309o310-324i,338
Q8TC26,Transmembrane protein 163,i91-112o117-137i152-174o190-210i223-243o249-273i,289
Q96RP8,Potassium voltage-gated channel subfamily A member 7 (Voltage-gated potassium channel subunit Kv1.7),i144-162o209-229i241-262o274-289i312-333o373-394i,456
Q99463,Putative neuropeptide Y receptor type 6 (NPY6-R) (NPY Y1-like receptor) (Putative pancreatic polypeptide receptor 2) (PP2),o40-60i73-95o111-132i151-171o210-230i262-278o,290
Q9BR26,Osteoclast stimulatory transmembrane protein (OC-STAMP),i48-71o82-102i121-142o228-239i303-319o403-413i,566
Q9Y3P4,Rhomboid domain-containing protein 3,i16-31o57-77i89-110o124-133i143-160o165-183i,386
A0A075B734,Aquaporin-7B,i45-63o72-92i120-138o174-194i205-225o259-281i,347
Q0VDI3,Transmembrane protein 267,i20-37o51-71i80-92o114-131i142-157o178-198i,215
Q5T9Z0,Transmembrane epididymal protein 1 (Human epididymis-specific protein 9) (He9),i28-48o69-87i97-117o129-149i158-178o202-219i,273
O43688,Phospholipid phosphatase 2 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 2) (PAP2-gamma) (PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c) (PAP-2c) (PAP2c),i8-28o55-77i98-120o171-183i194-212o225-243i,288
O43772,Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20),i79-92o114-128i180-193o212-228i270-280o281-290i,301
O60427,Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1),i130-153o157-177i265-276o277-286i293-315o316-326i,444
O60741,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1) (BCNG-1),i143-164o176-194i221-239o256-266i298-308o372-391i,890
O75027,"Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7) (ABC transporter 7 protein)",i140-160o185-206i259-287o291-311i380-397o415-430i,752
O43490,Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133),o107-130i158-179o435-457i481-509o793-813i,865
O75845,Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase),o31-52i77-97o117-137i171-186o192-206i,299
O95070,Protein YIF1A (54TMp) (YIP1-interacting factor homolog A),i139-159o174-192i204-225o229-249i270-288o,293
O95992,Cholesterol 25-hydroxylase (EC 1.14.99.38) (Cholesterol 25-monooxygenase) (h25OH),o38-61i92-108o122-142i179-193o198-210i,272
P00846,ATP synthase subunit a (F-ATPase protein 6),o19-31i70-88o98-117i191-203o204-214i,226
P03923,NADH-ubiquinone oxidoreductase chain 6 (EC 7.1.1.2) (NADH dehydrogenase subunit 6),o5-20i26-46o51-69i85-105o148-168i,174
P30536,Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR),o6-26i47-67o79-99i106-126o135-155i,169
Q08722,Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47),o142-162i176-198o208-228i237-261o269-289i,323
Q15125,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein)",o28-50i64-86o117-141i148-168o183-208i,230
Q15800,Methylsterol monooxygenase 1 (EC 1.14.18.9) (C-4 methylsterol oxidase) (Sterol-C4-methyl oxidase),o49-72i100-119o136-156i190-206o211-222i,293
Q1HG43,Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein),o22-43i50-72o175-199i204-227o249-270i,343
Q1HG44,Dual oxidase maturation factor 2 (Dual oxidase activator 2),o22-42i51-72o175-199i204-225o248-268i,320
Q53HI1,Protein unc-50 homolog (Periodontal ligament-specific protein 22) (PDLs22) (Protein GMH1 homolog) (hGMH1) (Uncoordinated-like protein),i83-103o114-136i159-179o189-210i224-244o,259
Q5BJH7,Protein YIF1B (YIP1-interacting factor homolog B),i157-175o193-211i222-243o246-264i292-309o,314
Q5TGU0,Translocator protein 2 (Peripheral-type benzodiazepine receptor-like protein 1),o5-23i45-65o77-97i104-124o130-150i,170
Q6ZT21,Transmembrane protein with metallophosphoesterase domain (EC 3.1.-.-),i15-27o48-64i87-107o122-142i167-182o,453
Q6ZT89,Solute carrier family 25 member 48,i61-81o103-124i181-201o217-237i277-297o,311
Q86TL2,Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110),o36-54i70-92o107-129i156-176o192-213i,294
Q8IY26,Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 (EC 3.1.3.-) (EC 3.6.1.-) (EC 3.6.1.68) (Lipid phosphatase-related protein-B) (LPRP-B) (PA-PSP) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (PPAP2 domain-containing protein 2) (Phospholipid phosphatase 6) (Presqualene diphosphate phosphatase) (Type 1 polyisoprenoid diphosphate phosphatase),i136-155o165-187i218-227o233-253i260-280o,295
Q8N271,Prominin-2 (PROM-2) (Prominin-like protein 2) (hPROML2),o104-127i152-174o426-449i473-498o780-800i,834
Q969M3,Protein YIPF5 (Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5) (Smooth muscle cell-associated protein 5) (SMAP-5) (YIP1 family member 5) (YPT-interacting protein 1 A),i127-144o149-169i180-200o208-224i238-256o,257
Q96EC8,Protein YIPF6 (YIP1 family member 6),i91-105o120-138i151-171o183-203i213-233o,236
Q99437,V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (Vacuolar proton pump 21 kDa proteolipid subunit c'') (hATPL),i4-24o52-72i91-111o138-159i172-196o,205
Q9BSA4,Protein tweety homolog 2 (hTTY2),o45-65i88-108o214-234i241-261o389-409i,534
Q9BSE2,Transmembrane protein 79 (Mattrin),i201-221o242-259i284-304o312-330i340-361o,394
Q9BSR8,Protein YIPF4 (YIP1 family member 4),i115-132o136-154i167-187o193-211i225-241o,244
Q9BWQ6,Protein YIPF2 (YIP1 family member 2),i125-145o164-184i200-220o227-247i257-277o,316
Q9BY08,Emopamil-binding protein-like (Emopamil-binding-related protein),o12-30i44-64o98-118i129-148o165-185i,206
Q9C0H2,Protein tweety homolog 3 (hTTY3),o43-63i87-105o211-231i238-258o388-407i,523
Q9GZM5,"Protein YIPF3 (Killer lineage protein 1) (Natural killer cell-specific antigen KLIP1) (YIP1 family member 3) [Cleaved into: Protein YIPF3, 36 kDa form III]",i153-168o187-207i218-237o243-265i275-295o,350
Q9H2C2,Protein ARV1 (hARV1),i103-117o144-164i179-199o210-223i235-255o,271
Q9H313,Protein tweety homolog 1 (hTTY1),o44-64i92-109o215-235i242-263o392-411i,450
Q9H8M5,Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2),o260-280i314-334o342-363i370-380o381-390i,875
Q9NPG8,Palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) (Zinc finger protein 374),o3-25i67-87o101-117i194-217o256-276i,344
Q9UBM1,Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (PEMT2) (Phospholipid methyltransferase) (PLMT),o14-31i51-66o96-106i143-155o161-175i,199
Q9Y548,Protein YIPF1 (YIP1 family member 1),i120-140o165-183i201-221o228-246i257-281o,306
P16260,Solute carrier family 25 member 16 (Graves disease autoantigen) (GDA) (Graves disease carrier protein) (GDC) (Graves' didease protein) (hGP) (Mitochondrial solute carrier protein homolog),i103-112o134-145i196-213o241-261i312-325o,332
Q86YN1,Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1),o32-53i59-80o104-120i137-154o164-183i,238
Q8N8F6,Protein YIPF7 (Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 9) (YIP1 family member 7),i150-167o172-192i203-223o229-247i261-279o,280
Q8NBV4,Inactive phospholipid phosphatase 7 (Phosphatidic acid phosphatase type 2 domain-containing protein 3),i115-134o145-166i197-206o212-232i239-259o,271
Q96P88,Putative gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor),o28-48i74-86o118-137i178-202o217-236i,292
Q9H342,Olfactory receptor 51J1 (Odorant receptor HOR5'beta8) (Olfactory receptor 51J2),o29-49i64-88o199-222i244-266o277-294i,316
Q9NR77,Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane protein),i34-55o73-93i111-131o148-169i174-194o,195
Q9NRU3,Metal transporter CNNM1 (Ancient conserved domain-containing protein 1) (Cyclin-M1),o226-249i282-302o326-346i364-374o375-384i,951
P0CK97,Solute carrier family 35 member E2A,i75-92o106-126i143-153o154-163i181-190o,266
Q3KQZ1,Solute carrier family 25 member 35,i66-77o78-87i205-215o216-226i277-288o,300
Q6NZ63,STEAP family member 1B,i56-72o98-120i145-165o197-217i233-244o,245
Q8TDU5,Putative vomeronasal receptor-like protein 4 (G-protein coupled receptor GPCR23) (hGPCR23),o15-36i49-69o88-110i133-153o185-205i,208
Q0P6H9,Transmembrane protein 62,o430-451i481-501o527-549i574-594o602-623i,643
Q5SWH9,Transmembrane protein 69,i98-117o125-143i159-178o182-202i216-232o,247
Q6QAJ8,Transmembrane protein 220,i9-25o32-49i62-82o98-111i123-143o,160
Q6UWH6,Protein TEX261,o9-30i44-62o67-84i95-115o125-144i,196
Q8N816,Uncharacterized protein KRT10-AS1 (Transmembrane protein 99),i68-78o79-88i95-112o193-214i221-239o,258
A0PK11,Clarin-2,i11-30o99-121i136-157o187-209i,232
A5PLL7,Plasmanylethanolamine desaturase 1 (EC 1.14.19.77) (Transmembrane protein 189),i47-67o73-97i141-154o165-185i,270
A5X5Y0,5-hydroxytryptamine receptor 3E (5-HT3-E) (5-HT3E) (Serotonin receptor 3E),o247-272i279-297o308-329i434-454o,456
O00180,Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1),i23-44o133-153i185-205o247-264i,336
O00237,E3 ubiquitin-protein ligase RNF103 (EC 2.3.2.27) (KF-1) (hKF-1) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103 homolog) (Zfp-103),i5-19o324-344i353-375o411-431i,685
O00322,Uroplakin-1a (UP1a) (Tetraspanin-21) (Tspan-21) (Uroplakin Ia) (UPIa) (UPKa),i15-42o64-84i92-115o231-251i,258
O00501,Claudin-5 (Transmembrane protein deleted in VCFS) (TMDVCF),i8-28o82-102i117-137o161-181i,218
O00591,Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi),o243-266i271-292o305-327i417-438o,440
O00767,Stearoyl-CoA desaturase (hSCD1) (EC 1.14.19.1) (Acyl-CoA desaturase) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase),i73-93o98-118i218-237o242-263i,359
O14493,Claudin-4 (Clostridium perfringens enterotoxin receptor) (CPE-R) (CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein),i10-30o82-102i117-137o161-181i,209
O14649,Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1),i9-29o108-128i159-179o223-243i,394
O14684,Prostaglandin E synthase (EC 5.3.99.3) (Glutathione peroxidase PTGES) (EC 1.11.1.-) (Glutathione transferase PTGES) (EC 2.5.1.18) (Microsomal glutathione S-transferase 1-like 1) (MGST1-L1) (Microsomal prostaglandin E synthase 1) (MPGES-1) (p53-induced gene 12 protein),o13-33i76-92o97-118i128-149o,152
O14764,Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta),o249-271i275-297o309-331i430-449o,452
O14817,Tetraspanin-4 (Tspan-4) (Novel antigen 2) (NAG-2) (Transmembrane 4 superfamily member 7),i12-35o54-74i82-106o202-224i,238
O14828,Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3),i170-190o199-217i234-254o275-295i,347
O14880,"Glutathione S-transferase 3, mitochondrial (GST-3) (EC 2.5.1.-) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20)",o9-29i56-80o85-105i115-134o,152
O14894,Transmembrane 4 L6 family member 5 (Tetraspan transmembrane protein L6H),i10-30o47-68i91-111o158-178i,197
O15121,Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Cell migration-inducing gene 15 protein) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1) (Membrane lipid desaturase) (Retinol isomerase) (EC 5.2.1.-),i43-61o68-88i184-205o206-226i,323
O15126,Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1),i155-175o184-202i219-239o261-281i,338
O15127,Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2),i155-175o184-202i219-239o261-281i,329
O15243,Leptin receptor gene-related protein (Endospanin-1) (Leptin receptor overlapping transcript protein) (OB-R gene-related protein) (OB-RGRP),i7-27o34-52i69-89o100-120i,131
O15258,Protein RER1,i41-62o63-83i121-141o146-166i,196
O15551,Claudin-3 (Clostridium perfringens enterotoxin receptor 2) (CPE-R 2) (CPE-receptor 2) (Rat ventral prostate.1 protein homolog) (hRVP1),i9-29o81-101i116-136o160-180i,220
O75508,Claudin-11 (Oligodendrocyte-specific protein),i8-27o83-103i122-143o156-177i,207
O75712,Gap junction beta-3 protein (Connexin-31) (Cx31),i21-41o71-93i132-152o186-206i,270
O75841,Uroplakin-1b (UP1b) (Tetraspanin-20) (Tspan-20) (Uroplakin Ib) (UPIb),i13-37o57-81i89-110o230-253i,260
O75915,PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27),i40-61o64-84i99-116o119-139i,188
O76090,Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2),i32-53o72-91i232-252o271-288i,585
O95069,Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1),i62-80o172-192i224-245o288-308i,426
O95197,Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII),i856-877o878-893i954-975o976-994i,1032
O95214,Leptin receptor overlapping transcript-like 1 (Endospanin-2),i7-27o34-52i69-89o98-118i,131
O95264,5-hydroxytryptamine receptor 3B (5-HT3-B) (5-HT3B) (Serotonin receptor 3B),o239-264i271-288o300-318i419-438o,441
O95279,Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2),i6-26o113-133i164-184o226-242i,499
O95377,Gap junction beta-5 protein (Connexin-31.1) (Cx31.1),i20-40o71-93i132-149o185-206i,273
O95452,Gap junction beta-6 protein (Connexin-30) (Cx30),i23-43o74-93i132-156o190-210i,261
O95471,Claudin-7 (CLDN-7),i8-27o82-102i118-138o162-182i,211
O95484,Claudin-9,i10-30o82-102i117-137o161-181i,217
O95500,Claudin-14,i8-27o82-102i117-137o161-181i,239
O95562,Vesicle transport protein SFT2B (SFT2 domain-containing protein 2),i37-57o65-85i99-119o123-147i,160
O95563,Mitochondrial pyruvate carrier 2 (Brain protein 44),i39-49o50-60i70-90o94-115i,127
O95772,STARD3 N-terminal-like protein (MLN64 N-terminal domain homolog),i54-74o97-117i126-142o154-171i,234
O95807,Transmembrane protein 50A (Small membrane protein 1),i23-43o58-73i95-117o126-147i,157
O95832,Claudin-1 (Senescence-associated epithelial membrane protein),i8-28o82-102i118-138o162-182i,211
O95858,Tetraspanin-15 (Tspan-15) (Tetraspan NET-7) (Transmembrane 4 superfamily member 15),i24-47o63-83i94-115o232-254i,294
O95859,Tetraspanin-12 (Tspan-12) (Tetraspan NET-2) (Transmembrane 4 superfamily member 12),i13-35o63-81i90-115o222-245i,305
P02708,Acetylcholine receptor subunit alpha,o231-256i263-281o298-318i429-451o,457
P03915,NADH-ubiquinone oxidoreductase chain 5 (EC 7.1.1.2) (NADH dehydrogenase subunit 5),i121-132o140-150i180-189o213-222i,603
P07510,Acetylcholine receptor subunit gamma,o242-266i274-292o308-329i475-495o,517
P08034,Gap junction beta-1 protein (Connexin-32) (Cx32) (GAP junction 28 kDa liver protein),i21-41o71-91i136-156o189-210i,283
P08247,Synaptophysin (Major synaptic vesicle protein p38),i27-47o106-127i140-160o205-216i,313
P08962,CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Lysosome integral membrane protein 1) (Limp1) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63),i13-33o52-74i84-106o203-225i,238
P10620,Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I),o13-33i75-95o102-122i131-149o,155
P11049,Leukocyte antigen CD37 (Tetraspanin-26) (Tspan-26) (CD antigen CD37),i14-38o56-78i86-109o242-265i,281
P11230,Acetylcholine receptor subunit beta,o245-270i277-295o305-332i470-490o,501
P11836,B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1) (Bp35) (Leukocyte surface antigen Leu-16) (Membrane-spanning 4-domains subfamily A member 1) (CD antigen CD20),i57-78o85-105i121-141o189-209i,297
P13498,Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox),i12-27o36-52i88-107o108-126i,195
P14867,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1),o252-274i280-300o312-334i422-443o,456
P17302,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),i24-42o72-92i156-176o208-228i,382
P17787,Neuronal acetylcholine receptor subunit beta-2,o234-259i266-284o300-321i461-483o,502
P18505,Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1),o245-267i273-293o305-327i452-473o,474
P18507,Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2),o274-296i300-322o334-356i444-465o,467
P19075,Tetraspanin-8 (Tspan-8) (Transmembrane 4 superfamily member 3) (Tumor-associated antigen CO-029),i8-35o58-73i84-107o206-230i,237
P19397,Leukocyte surface antigen CD53 (Cell surface glycoprotein CD53) (Tetraspanin-25) (Tspan-25) (CD antigen CD53),i9-36o55-70i81-104o184-204i,219
P20292,Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein),o12-28i58-75o83-100i111-128o,161
P21145,Myelin and lymphocyte protein (T-lymphocyte maturation-associated protein),i22-42o54-75i89-109o127-147i,153
P21926,CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9),i10-37o59-77i88-111o195-217i,228
P23415,Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit),o251-272i276-298o310-332i426-446o,457
P23416,Glycine receptor subunit alpha-2,o257-278i285-304o316-338i421-441o,452
P23942,Peripherin-2 (Retinal degeneration slow protein) (Tetraspanin-22) (Tspan-22),i19-41o63-83i102-122o261-283i,346
P24046,Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor),o282-305i309-331o343-365i458-477o,479
P27449,V-type proton ATPase 16 kDa proteolipid subunit c (V-ATPase 16 kDa proteolipid subunit c) (Vacuolar proton pump 16 kDa proteolipid subunit c),o13-33i56-76o93-114i127-152o,155
P27701,CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82),i12-35o54-76i84-108o228-250i,267
P28472,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3),o245-267i273-293o305-327i451-472o,473
P28476,Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor),o262-285i289-311o323-345i444-463o,465
P29033,Gap junction beta-2 protein (Connexin-26) (Cx26),i21-41o71-91i138-158o190-210i,226
P29973,"cGMP-gated cation channel alpha-1 (Cyclic nucleotide-gated cation channel 1) (Cyclic nucleotide-gated channel alpha-1) (CNG channel alpha-1) (CNG-1) (CNG1) (Cyclic nucleotide-gated channel, photoreceptor) (Rod photoreceptor cGMP-gated channel subunit alpha)",i163-181o195-213i299-317o371-389i,686
P30532,Neuronal acetylcholine receptor subunit alpha-5,o251-275i282-299o316-337i430-451o,468
P30926,Neuronal acetylcholine receptor subunit beta-4,o233-257i264-282o298-319i461-481o,498
P31644,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5),o259-281i286-307o319-341i428-449o,462
P32297,Neuronal acetylcholine receptor subunit alpha-3,o241-266i273-291o307-328i478-498o,505
P33897,ATP-binding cassette sub-family D member 1 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy protein) (ALDP),i92-112o131-151i208-233o238-258i,745
P34903,Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3),o277-299i304-325o337-359i458-479o,492
P35212,Gap junction alpha-4 protein (Connexin-37) (Cx37),i22-42o72-92i156-176o208-229i,333
P36382,Gap junction alpha-5 protein (Connexin-40) (Cx40),i22-42o72-92i154-175o206-224i,358
P36383,Gap junction gamma-1 protein (Connexin-45) (Cx45) (Gap junction alpha-7 protein),i21-41o71-92i181-201o230-250i,396
P36544,Neuronal acetylcholine receptor subunit alpha-7,o231-255i262-280o296-317i470-490o,502
P41732,Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231),i18-40o60-80i90-112o213-235i,249
P43681,Neuronal acetylcholine receptor subunit alpha-4,o243-268i275-297o309-330i601-621o,627
P46098,5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor),o242-267i274-292o303-321i456-475o,478
P47869,Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2),o252-274i279-300o312-334i420-441o,451
P47870,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2),o244-266i272-292o304-326i490-511o,512
P48165,Gap junction alpha-8 protein (Connexin-50) (Cx50) (Lens fiber protein MP70),i22-42o72-92i155-175o204-224i,433
P48167,Glycine receptor subunit beta (Glycine receptor 58 kDa subunit),o270-290i296-316o328-350i476-496o,497
P48169,Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4),o258-280i285-306o318-340i521-542o,554
P48230,Transmembrane 4 L6 family member 4 (Intestine and liver tetraspan membrane protein) (IL-TMP),i10-30o46-66i90-112o159-179i,202
P48509,CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151),i18-43o59-78i89-113o222-242i,253
P51674,Neuronal membrane glycoprotein M6-a (M6a),i30-47o80-101i129-153o213-232i,278
P54849,Epithelial membrane protein 1 (EMP-1) (CL-20) (Protein B4B) (Tumor-associated membrane protein),i4-24o66-86i95-115o132-154i,157
P54851,Epithelial membrane protein 2 (EMP-2) (Protein XMP),i5-25o66-87i95-116o141-163i,167
P54852,Epithelial membrane protein 3 (EMP-3) (Hematopoietic neural membrane protein 1) (HNMP-1) (Protein YMP),i4-24o65-88i96-120o137-157i,163
P55344,Lens fiber membrane intrinsic protein (MP18) (MP19) (MP20),i6-25o66-86i99-119o140-160i,173
P55851,Dicarboxylate carrier SLC25A8 (Mitochondrial uncoupling protein 2) (UCP 2) (Solute carrier family 25 member 8) (UCPH),i187-197o215-235i269-279o280-290i,309
P56180,Putative tyrosine-protein phosphatase TPTE (EC 3.1.3.48) (Cancer/testis antigen 44) (CT44) (Transmembrane phosphatase with tensin homology) (Tumor antigen BJ-HCC-5),i94-115o127-147i158-178o196-206i,551
P56557,Transmembrane protein 50B (HCV p7-trans-regulated protein 3),i24-42o60-75i97-119o128-148i,158
P56746,Claudin-15,i4-24o74-100i116-138o161-183i,228
P56747,Claudin-6 (Skullin),i8-30o82-102i117-137o161-181i,220
P56748,Claudin-8,i6-26o82-102i118-139o164-186i,225
P56750,Claudin-17,i8-28o82-102i118-138o162-185i,224
P56856,Claudin-18,i8-27o81-101i119-139o172-194i,261
P57739,Claudin-2 (SP82),i8-27o82-102i117-137o161-181i,230
P57789,Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit),i71-90o182-202i234-255o299-319i,538
P58418,Clarin-1 (Usher syndrome type-3 protein),i8-29o99-121i135-155o189-209i,232
P60033,CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81),i10-37o61-79i90-113o202-227i,236
P60201,Myelin proteolipid protein (PLP) (Lipophilin),i19-36o68-88i154-176o239-258i,277
P62079,Tetraspanin-5 (Tspan-5) (Tetraspan NET-4) (Transmembrane 4 superfamily member 9),i18-40o62-82i93-115o233-254i,268
P62955,Voltage-dependent calcium channel gamma-7 subunit (Neuronal voltage-gated calcium channel gamma-7 subunit) (Transmembrane AMPAR regulatory protein gamma-7) (TARP gamma-7),i9-30o101-121i129-153o177-197i,275
P78334,Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon),o280-301i308-327o339-361i483-504o,506
P78369,Claudin-10 (Oligodendrocyte-specific protein-like) (OSP-like),i8-27o81-101i116-137o159-179i,228
P81408,Protein ENTREP3 (Endosomal transmembrane epsin interactor 3) (Protein COTE1),i33-59o67-87i93-115o173-194i,668
Q00765,Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2),i37-52o57-70i90-110o118-127i,189
Q01362,High affinity immunoglobulin epsilon receptor subunit beta (FcERI) (Fc epsilon receptor I beta-chain) (IgE Fc receptor subunit beta) (Membrane-spanning 4-domains subfamily A member 2),i60-80o102-113i131-150o182-197i,244
Q01453,Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3),i5-25o67-87i96-116o134-156i,160
Q03395,Rod outer segment membrane protein 1 (ROSP1) (Tetraspanin-23) (Tspan-23),i20-44o61-83i103-125o264-286i,351
Q04844,Acetylcholine receptor subunit epsilon,o240-265i273-291o301-328i457-479o,493
Q04941,Proteolipid protein 2 (Differentiation-dependent protein A4) (Intestinal membrane A4 protein),i25-45o51-71i85-104o112-133i,152
Q05901,Neuronal acetylcholine receptor subunit beta-3,o234-258i265-282o300-320i429-450o,458
Q06432,"Voltage-dependent calcium channel gamma-1 subunit (Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma)",i11-29o109-129i135-155o180-204i,222
Q07001,Acetylcholine receptor subunit delta,o246-271i278-296o306-333i472-494o,517
Q13021,MAL-like protein (Protein BENE),i28-48o58-79i90-111o127-150i,153
Q13454,Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33),o197-217i223-242o284-302i313-334o,348
Q13491,Neuronal membrane glycoprotein M6-b (M6b),i35-55o87-107i135-159o224-241i,265
Q14714,Sarcospan (K-ras oncogene-associated protein) (Kirsten-ras-associated protein),i54-77o86-107i123-144o193-214i,243
Q14849,StAR-related lipid transfer protein 3 (Metastatic lymph node gene 64 protein) (MLN 64) (Protein CAB1) (START domain-containing protein 3) (StARD3),i55-72o95-115i123-136o149-169i,445
Q15012,Lysosomal-associated transmembrane protein 4A (Golgi 4-transmembrane-spanning transporter MTP),i29-49o80-100i117-132o161-181i,233
Q15041,ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Apoptotic regulator in the membrane of the endoplasmic reticulum),i42-62o67-87i136-153o162-171i,203
Q15822,Neuronal acetylcholine receptor subunit alpha-2,o265-290i297-315o331-352i503-523o,529
Q15825,Neuronal acetylcholine receptor subunit alpha-6,o240-265i272-290o306-327i466-488o,494
Q16280,Cyclic nucleotide-gated olfactory channel (Cyclic nucleotide-gated cation channel 2) (Cyclic nucleotide-gated channel alpha-2) (CNG channel alpha-2) (CNG-2) (CNG2),i142-162o174-192i278-296o351-368i,664
Q16281,Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3),i171-188o200-220i303-324o379-396i,694
Q16445,Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6),o242-264i269-290o302-324i420-441o,453
Q16563,Synaptophysin-like protein 1 (Pantophysin),i34-54o117-137i151-172o209-232i,259
Q16617,Protein NKG7 (G-CSF-induced gene 1 protein) (GIG-1 protein) (Granule membrane protein of 17 kDa) (GMP-17) (Natural killer cell protein 7) (p15-TIA-1),i7-25o60-78i92-111o131-153i,165
Q16625,Occludin,i67-87o140-160i173-194o244-265i,522
Q16799,Reticulon-1 (Neuroendocrine-specific protein),i598-619o620-638i699-720o721-740i,776
Q16873,Leukotriene C4 synthase (LTC4 synthase) (EC 4.4.1.20) (Glutathione S-transferase LTC4) (EC 2.5.1.-) (Leukotriene-C(4) synthase) (Leukotriene-C4 synthase),o7-27i49-74o78-96i111-131o,150
Q2KHT4,Germ cell-specific gene 1 protein,i16-35o154-176i189-209o233-253i,349
Q2M2E3,Outer dense fiber protein 4 (Outer dense fiber of sperm tails protein 4) (Testis-specific protein oppo 1) (hOPPO1),i82-101o130-139i148-168o181-202i,257
Q2M3C6,Transmembrane protein 266 (hTMEM266) (HV1-related protein 1) (HsHVRP1),i103-123o137-160i172-190o200-209i,531
Q3T906,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],i18-38o716-725i1210-1220o1221-1230i,1256
Q3YBM2,Transmembrane protein 176B (Protein LR8),i65-85o98-111i126-147o208-223i,270
Q401N2,Zinc-activated ligand-gated ion channel (Ligand-gated ion channel zinc-activated 1) (Ligand-gated ion-channel receptor L2),o234-254i262-280o291-309i369-391o,412
Q53FP2,Novel acetylcholine receptor chaperone,i9-26o63-83i89-108o112-132i,167
Q53FV1,ORM1-like protein 2 (Adoplin-2),i21-41o47-64i101-116o122-139i,153
Q53R12,Transmembrane 4 L6 family member 20,i14-35o50-71i89-109o191-211i,229
Q5BJF2,Sigma intracellular receptor 2 (Sigma-2 receptor) (Sigma2 receptor) (Meningioma-associated protein 30) (Transmembrane protein 97),i10-30o68-89i98-120o141-162i,176
Q5BJH2,Transmembrane protein 128,i50-70o81-103i118-138o144-164i,165
Q5J8X5,Membrane-spanning 4-domains subfamily A member 13 (Testis-expressed transmembrane protein 4),i17o38-55i67-87o108-128i,152
Q5T442,Gap junction gamma-2 protein (Connexin-46.6) (Cx46.6) (Connexin-47) (Cx47) (Gap junction alpha-12 protein),i26-46o74-95i217-237o266-286i,439
Q5T4F4,Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27),i70-88o89-109i179-200o201-223i,411
Q5W0Z9,Palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Acyltransferase ZDHHC20) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 20) (DHHC20) (Zinc finger DHHC domain-containing protein 20),i13-35o50-74i170-191o208-229i,365
Q674R7,Autophagy-related protein 9B (APG9-like 2) (Nitric oxide synthase 3-overlapping antisense gene protein) (Protein sONE),i211-233o279-301i525-548o558-575i,924
Q69YG0,Transmembrane protein 42,i37-57o69-89i100-120o127-144i,159
Q6DN12,Multiple C2 and transmembrane domain-containing protein 2,i691-705o706-716i795-811o814-823i,878
Q6DN14,Multiple C2 and transmembrane domain-containing protein 1,i808-820o821-841i913-933o934-943i,999
Q6IC98,GRAM domain-containing protein 4 (Death-inducing protein),i229-247o248-257i338-352o356-372i,578
Q6NSJ5,Volume-regulated anion channel subunit LRRC8E (Leucine-rich repeat-containing protein 8E),i24-48o117-135i259-277o308-333i,796
Q6NUK1,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Short calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),i347-357o358-368i385-394o397-407i,477
Q6P1K1,Heme transporter HRG1 (Heme-responsive gene 1 protein homolog) (HRG-1) (hHRG-1) (Solute carrier family 48 member 1),i12-32o39-58i73-97o108-128i,146
Q6P9F7,Volume-regulated anion channel subunit LRRC8B (Leucine-rich repeat-containing protein 8B) (T-cell activation leucine repeat-rich protein) (TA-LRRP),i24-48o120-138i262-280o311-336i,803
Q6QHC5,Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 (EC 1.14.18.5) (EC 1.14.19.17) (Degenerative spermatocyte homolog 2) (Sphingolipid 4-desaturase) (Sphingolipid C4-monooxygenase),i43-61o66-88i185-205o206-226i,323
Q6RW13,Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein),i10-28o29-46i54-74o87-107i,159
Q6UW68,Transmembrane protein 205,o13-37i53-73o86-106i163-183o,189
Q6UWP7,Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1),i48-59o60-69i344-364o369-383i,414
Q6UX40,Transmembrane protein 107,i7-27o53-71i81-102o111-131i,140
Q6UX98,Probable palmitoyltransferase ZDHHC24 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 24),i19-39o52-73i138-161o194-216i,284
Q6XPS3,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)",i75-97o110-130i140-160o175-188i,522
Q6ZP80,Transmembrane protein 182,i7-27o115-138i148-170o199-222i,229
Q6ZUX7,LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein),i10-29o102-122i132-154o183-203i,228
Q6ZVE7,Vesicle transport protein GOT1A (Golgi transport 1 homolog A) (hGOT1b),i10-30o35-50i65-80o84-98i,132
Q70Z44,5-hydroxytryptamine receptor 3D (5-HT3-D) (5-HT3D) (Serotonin receptor 3D),o233-254i262-279o308-328i432-452o,454
Q7L1W4,Volume-regulated anion channel subunit LRRC8D (Leucine-rich repeat-containing protein 5) (Leucine-rich repeat-containing protein 8D) (HsLRRC8D),i24-48o164-182i309-330o361-386i,858
Q7L5A8,Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase) (Fatty acid hydroxylase domain-containing protein 1),i167-188o213-233i271-291o296-314i,372
Q7Z3C6,Autophagy-related protein 9A (APG9-like 1) (mATG9),i62-84o129-154i372-397o407-424i,839
Q7Z418,Potassium channel subfamily K member 18 (TWIK-related individual potassium channel) (TWIK-related spinal cord potassium channel),i24-44o131-148i283-304o336-355i,384
Q7Z7N9,Transmembrane protein 179B,i9-29o65-85i98-121o165-185i,219
Q86SK9,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (HSCD5) (Stearoyl-CoA 9-desaturase) (Stearoyl-CoA desaturase 2),i47-67o72-92i192-211o216-237i,330
Q86UF1,Tetraspanin-33 (Tspan-33) (Penumbra) (hPen) (Proerythroblast new membrane),i25-49o64-84i93-118o236-256i,283
Q86VI4,Lysosomal-associated transmembrane protein 4B (Lysosome-associated transmembrane protein 4-beta),i116-136o163-183i200-215o245-265i,317
Q86VR2,Reticulophagy regulator 3,i69-83o89-99i169-184o195-207i,466
Q86WV6,Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173),i21-31o47-60i96-105o117-134i,379
Q8IU99,Calcium homeostasis modulator protein 1 (Protein FAM26C),i17-32o51-71i107-120o182-202i,346
Q8IVQ6,Palmitoyltransferase ZDHHC21 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 21) (DHHC-21) (Zinc finger DHHC domain-containing protein 21),i13-36o45-69i134-155o177-199i,265
Q8IWT6,Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (HsLRRC8A) (Swelling protein 1),i24-48o124-142i268-286o317-342i,810
Q8IY95,Transmembrane protein 192,i48-68o94-114i139-157o171-192i,271
Q8IZ96,CKLF-like MARVEL transmembrane domain-containing protein 1 (Chemokine-like factor superfamily member 1),i21-40o47-68i79-100o110-130i,169
Q8IZN3,Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14),i62-82o93-110i210-230o251-271i,488
Q8IZR5,CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4),i59-75o86-107i123-143o151-172i,234
Q8N0U8,Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4),i17-36o82-102i108-130o138-155i,176
Q8N138,ORM1-like protein 3,i21-40o47-64i101-116o122-139i,153
Q8N144,Gap junction delta-3 protein (Connexin-31.9) (Cx31.9) (Gap junction alpha-11 protein) (Gap junction chi-1 protein),i24-45o77-94i137-160o189-210i,294
Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1),o272-294i298-320o332-354i442-463o,465
Q8N1M1,Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3),i31-54o72-90i229-249o269-288i,668
Q8N2H4,Protein SYS1 homolog,i15-37o65-85i94-109o117-137i,156
Q8N4S9,MARVEL domain-containing protein 2 (Tricellulin),i195-215o255-275i291-312o341-361i,558
Q8N5M9,Protein jagunal homolog 1,i40-60o72-92i97-117o138-158i,183
Q8N6F1,Claudin-19,i8-27o82-102i118-139o162-182i,224
Q8N6L1,Keratinocyte-associated protein 2 (KCP-2) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2) (Oligosaccharyl transferase subunit KCP2),i9-23o40-55i71-89o92-108i,136
Q8N966,Palmitoyltransferase ZDHHC22 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 22) (DHHC-22) (zDHHC22),i9-31o47-69i126-148o183-202i,263
Q8N9I5,Fatty acid desaturase 6 (EC 1.14.19.-),i54-74o80-89i196-206o207-216i,356
Q8NBD8,Transmembrane protein 229B,i15-30o47-64i74-95o115-136i,167
Q8NC44,Reticulophagy regulator 2,i80-96o103-112i193-202o209-224i,543
Q8NCG7,Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta),i18-41o58-79i97-119o132-153i,672
Q8NCM2,Potassium voltage-gated channel subfamily H member 5 (Ether-a-go-go potassium channel 2) (hEAG2) (Voltage-gated potassium channel subunit Kv10.2),i217-236o246-266i345-367o447-464i,988
Q8NFU1,Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1),i32-53o72-91i232-252o273-288i,509
Q8NG11,Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14),i17-41o61-81i90-115o233-254i,270
Q8NHS1,Claudin domain-containing protein 2,i10-28o59-81i95-116o130-150i,167
Q8TAA9,Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1),i113-133o152-172i184-206o219-241i,524
Q8TAC9,Secretory carrier-associated membrane protein 5 (Secretory carrier membrane protein 5) (hSCAMP5),i40-63o71-90i107-126o148-169i,235
Q8TAF8,LHFPL tetraspan subfamily member 5 protein (Lipoma HMGIC fusion partner-like 5 protein) (Tetraspan membrane protein of hair cell stereocilia),i25-45o99-119i129-149o179-199i,219
Q8TAZ6,CKLF-like MARVEL transmembrane domain-containing protein 2 (Chemokine-like factor superfamily member 2),i85-105o116-136i147-168o179-198i,248
Q8TBG9,Synaptoporin,i4-20o81-103i115-136o176-196i,265
Q8TBM7,Transmembrane protein 254,i15-33o61-81i93-103o104-113i,123
Q8TDW0,Volume-regulated anion channel subunit LRRC8C (Factor for adipocyte differentiation 158) (Leucine-rich repeat-containing protein 8C),i26-48o126-146i266-284o319-339i,803
Q969E2,Secretory carrier-associated membrane protein 4 (Secretory carrier membrane protein 4),i43-63o71-90i105-124o152-167i,229
Q969K7,Transmembrane protein 54 (Beta-casein-like protein) (Protein CAC-1),i18-38o62-77i94-114o159-175i,222
Q969L2,Protein MAL2,i38-57o68-88i103-123o148-171i,176
Q969S6,Transmembrane protein 203,i17-35o47-67i84-102o112-130i,136
Q969W1,Palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Abl-philin 2) (Zinc finger DHHC domain-containing protein 16) (DHHC-16),i78-98o115-134i200-219o267-287i,377
Q96A59,MARVEL domain-containing protein 3,i200-220o272-293i301-325o361-382i,401
Q96B96,Lipid droplet assembly factor 1 (Promethin) (Transmembrane protein 159),i50-65o66-86i100-110o111-124i,161
Q96CE8,Transmembrane 4 L6 family member 18,i10-30o52-68i91-113o160-178i,201
Q96D31,Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A),i92-105o120-140i175-196o234-255i,301
Q96D96,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein),i101-121o139-161i170-190o198-218i,273
Q96DZ7,Transmembrane 4 L6 family member 19 (Osteoclast maturation-associated gene 4 protein) (Tetraspan membrane protein OCTM4),i22-38o59-79i98-118o176-196i,209
Q96DZ9,CKLF-like MARVEL transmembrane domain-containing protein 5 (Chemokine-like factor superfamily member 5),i36-56o59-79i162-178o186-206i,223
Q96FX8,p53 apoptosis effector related to PMP-22 (Keratinocyte-associated protein 1) (KCP-1) (P53-induced protein PIGPC1) (Transmembrane protein THW),i13-32o79-99i107-128o153-173i,193
Q96FZ5,CKLF-like MARVEL transmembrane domain-containing protein 7 (Chemokine-like factor superfamily member 7),i45-65o77-97i113-132o140-160i,175
Q96GR4,Palmitoyltransferase ZDHHC12 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 12) (DHHC-12) (Zinc finger DHHC domain-containing protein 12) (Zinc finger protein 400),i11-30o44-67i141-161o178-200i,267
Q96HA9,Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma),i91-111o128-139i185-205o212-227i,241
Q96HE8,Transmembrane protein 80,i94-116o127-148i160-181o190-211i,216
Q96HJ5,Membrane-spanning 4-domains subfamily A member 3 (CD20 antigen-like protein) (Hematopoietic-specific transmembrane protein 4) (HTm4),i50-70o90-110i122-145o169-195i,214
Q96HR9,Receptor expression-enhancing protein 6 (Polyposis locus protein 1-like 1),i36-51o56-71i86-106o111-131i,211
Q96IW7,Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2),i190-208o227-247i253-271o276-295i,307
Q8WTX9,Palmitoyltransferase ZDHHC1 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 1) (Zinc finger DHHC domain-containing protein 1) (DHHC-1) (Zinc finger protein 377),i51-71o78-103i178-202o242-262i,485
Q8WV19,Vesicle transport protein SFT2A (SFT2 domain-containing protein 1) (pRGR1),i36-56o63-83i98-118o122-143i,159
Q8WVZ1,Palmitoyltransferase ZDHHC19 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 19) (DHHC-19),i29-49o59-79i156-177o192-214i,309
Q8WXA8,5-hydroxytryptamine receptor 3C (5-HT3-C) (5-HT3C) (Serotonin receptor 3C),o249-271i280-297o310-329i425-445o,447
Q8WXS5,Voltage-dependent calcium channel gamma-8 subunit (Neuronal voltage-gated calcium channel gamma-8 subunit) (Transmembrane AMPAR regulatory protein gamma-8) (TARP gamma-8),i21-41o129-149i158-181o204-224i,425
Q8WY98,Transmembrane protein 234,o8-17i57-77o82-102i108-128o,164
Q96JQ5,Membrane-spanning 4-domains subfamily A member 4A (CD20 antigen-like 1) (Four-span transmembrane protein 1),i65-85o102-117i134-155o186-200i,239
Q96MV8,Palmitoyltransferase ZDHHC15 (EC 2.3.1.225) (Acyltransferase ZDHHC15) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 15) (DHHC-15),i19-41o55-77i173-193o211-232i,337
Q96MX0,CKLF-like MARVEL transmembrane domain-containing protein 3 (Chemokine-like factor superfamily member 3),i44-61o67-87i100-121o131-151i,182
Q96Q45,Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein),i227-249o268-288i303-322o358-376i,408
Q96RD7,Pannexin-1,i41-61o107-127i218-238o267-287i,426
Q96T54,Potassium channel subfamily K member 17 (2P domain potassium channel Talk-2) (Acid-sensitive potassium channel protein TASK-4) (TWIK-related acid-sensitive K(+) channel 4) (TWIK-related alkaline pH-activated K(+) channel 2) (TALK-2),i23-43o131-151i179-200o244-264i,332
Q96T55,Potassium channel subfamily K member 16 (2P domain potassium channel Talk-1) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1),i14-35o123-140i171-191o234-254i,309
Q99735,Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Glutathione peroxidase MGST2) (EC 1.11.1.-) (Leukotriene C4 synthase MGST2) (EC 4.4.1.20) (Microsomal glutathione S-transferase II) (Microsomal GST-II),o10-25i49-74o77-97i110-131o,147
Q99928,Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3),o255-277i281-303o315-337i444-465o,467
Q9BQB6,"Vitamin K epoxide reductase complex subunit 1 (EC 1.17.4.4) (Vitamin K1 2,3-epoxide reductase subunit 1)",i9-29o75-95i101-123o130-148i,163
Q9BQJ4,Transmembrane protein 47 (Brain cell membrane protein 1) (Transmembrane 4 superfamily member 10),i21-40o79-103i114-135o151-172i,181
Q9BRB3,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein) (PIG-Q),i282-293o391-402i446-458o461-470i,760
Q9BRL7,Vesicle-trafficking protein SEC22c (SEC22 vesicle-trafficking protein homolog C) (SEC22 vesicle-trafficking protein-like 3),i184-204o221-241i249-266o272-286i,303
Q9BT67,NEDD4 family-interacting protein 1 (Breast cancer-associated protein SGA-1M) (NEDD4 WW domain-binding protein 5) (Putative MAPK-activating protein PM13) (Putative NF-kappa-B-activating protein 164) (Putative NFKB and MAPK-activating protein),i117-129o130-139i149-164o179-197i,221
Q9BTV4,Transmembrane protein 43 (Protein LUMA),i34-51o314-334i350-370o374-389i,400
Q9BTX3,Transmembrane protein 208,i25-45o51-71i98-119o122-142i,173
Q9C0B5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),i14-35o47-67i149-169o184-206i,715
Q9GZW8,Membrane-spanning 4-domains subfamily A member 7 (CD20 antigen-like 4) (CD20/FC-epsilon-RI-beta family member 4) (Four-span transmembrane protein 2),i47-67o86-99i116-136o184-201i,240
Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10),o238-261i268-286o301-322i429-449o,450
Q9H0U3,Magnesium transporter protein 1 (MagT1) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1) (Oligosaccharyl transferase subunit MAGT1) (Implantation-associated protein) (IAP),o185-205i211-230o272-291i301-322o,335
Q9H2L4,Transmembrane protein 60,i9-25o36-58i78-98o108-128i,133
Q9H2W1,Membrane-spanning 4-domains subfamily A member 6A (CD20 antigen-like 3) (Four-span transmembrane protein 3),i47-67o87-99i116-137o186-202i,248
Q9H427,Potassium channel subfamily K member 15 (Acid-sensitive potassium channel protein TASK-5) (TWIK-related acid-sensitive K(+) channel 5) (Two pore potassium channel KT3.3) (Two pore K(+) channel KT3.3),i9-29o108-128i159-179o223-243i,330
Q9H6L5,Reticulophagy regulator 1 (Reticulophagy receptor 1),i93-109o119-133i196-214o224-233i,497
Q9H6R6,Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Transmembrane protein H4) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) (Zinc finger protein 376),i22-43o57-77i144-164o203-225i,413
Q9H8X9,Palmitoyltransferase ZDHHC11 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 11) (DHHC-11) (Zinc finger protein 399),i41-61o70-90i169-193o231-252i,412
Q9NPC2,Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2) (Two pore K(+) channel KT3.2),i9-29o108-128i159-179o223-243i,374
Q9NPI0,Transmembrane protein 138,i9-24o40-60i80-100o115-133i,162
Q9NQC3,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),i1014-1034o1039-1054i1115-1136o1137-1155i,1192
Q9NRC1,Suppressor of tumorigenicity 7 protein (Protein FAM4A1) (Protein HELG),i23-35o62-82i512-523o524-533i,585
Q9NRZ5,1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta),i15-29o30-39i308-330o336-356i,378
Q9NRZ7,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma),i11-25o26-39i308-331o335-352i,376
Q9NTQ9,Gap junction beta-4 protein (Connexin-30.3) (Cx30.3),i20-40o71-91i132-149o185-206i,266
Q9NUE0,Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 18) (DHHC-18) (Zinc finger DHHC domain-containing protein 18),i91-111o122-140i236-256o278-298i,388
Q9NUH8,Transmembrane protein 14B,i13-31o39-57i63-83o88-107i,114
Q9NV12,Transmembrane protein 140,i12-32o85-103i115-135o151-171i,185
Q9NV92,NEDD4 family-interacting protein 2 (NEDD4 WW domain-binding protein 5A) (Putative MAPK-activating protein PM04/PM05/PM06/PM07) (Putative NF-kappa-B-activating protein 413),i232-244o245-254i264-279o294-312i,336
Q9NWH2,Transmembrane protein 242,i31-41o42-51i82-92o93-102i,141
Q9NX47,E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (Mitochondrial ubiquitin ligase) (MITOL) (RING finger protein 153) (RING-type E3 ubiquitin transferase MARCHF5),i99-114o141-156i209-224o239-252i,278
Q9NX76,CKLF-like MARVEL transmembrane domain-containing protein 6 (Chemokine-like factor superfamily member 6),i40-59o70-91i107-127o135-155i,183
Q9NXF8,Palmitoyltransferase ZDHHC7 (EC 2.3.1.225) (Acyltransferase ZDHHC7) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 7) (DHHC-7),i45-69o80-98i175-195o215-238i,308
Q9NYG2,Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3),i44-66o74-94i172-192o214-235i,299
Q9NYG8,Potassium channel subfamily K member 4 (TWIK-related arachidonic acid-stimulated potassium channel protein) (TRAAK) (Two pore potassium channel KT4.1) (Two pore K(+) channel KT4.1),i6-24o118-138i172-191o234-254i,393
Q9NYZ1,Golgi apparatus membrane protein TVP23 homolog B,i37-57o61-71i126-146o154-172i,205
Q9NZS9,Bifunctional apoptosis regulator (RING finger protein 47),i279-288o361-378i397-412o417-439i,450
Q9P003,Protein cornichon homolog 4 (CNIH-4) (Cornichon family AMPA receptor auxiliary protein 4),o5-25i47-64o68-83i115-134o,139
Q9P0N5,Transmembrane protein 216,i20-44o56-76i87-109o116-137i,145
Q9P0S3,ORM1-like protein 1 (Adoplin-1),i21-43o47-67i101-116o124-139i,153
Q9P0S9,Transmembrane protein 14C,i12-30o36-56i61-81o86-106i,112
Q9UBJ2,ATP-binding cassette sub-family D member 2 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR),i105-127o144-164i224-248o251-271i,740
Q9UBN1,Voltage-dependent calcium channel gamma-4 subunit (Neuronal voltage-gated calcium channel gamma-4 subunit) (Transmembrane AMPAR regulatory protein gamma-4) (TARP gamma-4),i10-30o108-128i137-160o183-203i,327
Q9UBR5,Chemokine-like factor (C32),i19-39o46-65i78-98o108-129i,152
Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9),o239-262i269-287o302-323i458-476o,479
Q9UI14,Prenylated Rab acceptor protein 1 (PRA1 family protein 1),i79-91o95-112i132-146o152-169i,185
Q9UIJ5,Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Acyltransferase ZDHHC2) (EC 2.3.1.-) (Reduced expression associated with metastasis protein) (Ream) (Reduced expression in cancer protein) (Rec) (Zinc finger DHHC domain-containing protein 2) (DHHC-2) (Zinc finger protein 372),i17-39o52-75i171-191o209-230i,367
Q9UKR5,Ergosterol biosynthetic protein 28 homolog,i11-28o48-68i79-99o105-125i,140
Q9ULC8,Palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8) (Zinc finger protein 378),i15-35o47-67i149-169o184-206i,765
Q9ULH0,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),i500-518o525-545i660-680o691-706i,1771
Q9ULK5,Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2),i107-129o148-168i180-202o215-237i,521
Q9UN88,Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta),o269-289i295-315o327-349i610-631o,632
Q9Y257,Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence),i5-25o121-142i173-193o236-253i,313
Q9Y320,Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14),i24-40o63-78i89-106o112-126i,296
Q9Y342,Plasmolipin (Plasma membrane proteolipid),i37-56o68-88i102-122o142-162i,182
Q9Y397,Palmitoyltransferase ZDHHC9 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 9) (DHHC-9) (DHHC9) (Zinc finger protein 379) (Zinc finger protein 380),i36-56o67-84i184-204o225-245i,364
Q9Y3E0,Vesicle transport protein GOT1B (Germ cell tumor 2) (Golgi transport 1 homolog B) (Putative NF-kappa-B-activating protein 470) (hGOT1a),i10-30o34-52i65-80o85-105i,138
Q9Y4D2,Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.116) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha),i18-43o61-81i97-120o134-154i,1042
Q9Y5I7,Claudin-16 (Paracellin-1) (PCLN-1),i7-26o80-100i116-140o164-184i,235
Q9Y698,Voltage-dependent calcium channel gamma-2 subunit (Neuronal voltage-gated calcium channel gamma-2 subunit) (Transmembrane AMPAR regulatory protein gamma-2) (TARP gamma-2),i10-30o106-124i134-157o178-198i,323
Q9Y6G1,Transmembrane protein 14A,o4-19i29-44o53-69i78-98o,99
Q9Y6H8,Gap junction alpha-3 protein (Connexin-46) (Cx46),i22-42o72-92i150-173o202-222i,435
A0PK05,Transmembrane protein 72 (Kidney-specific secretory protein of 37 kDa),i10-28o43-62i93-105o113-130i,275
A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor),o268-291i295-317o329-351i446-465o,467
O43657,Tetraspanin-6 (Tspan-6) (A15 homolog) (Putative NF-kappa-B-activating protein 321) (T245 protein) (Tetraspanin TM4-D) (Transmembrane 4 superfamily member 6),i20-42o60-80i88-113o211-231i,245
P0C7U3,Probable palmitoyltransferase ZDHHC11B (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 11B) (DHHC-11B),i43-64o70-90i168-193o231-257i,371
P30408,Transmembrane 4 L6 family member 1 (Membrane component chromosome 3 surface marker 1) (Tumor-associated antigen L6),i10-30o48-68i90-113o162-182i,202
P56880,Claudin-20,i8-28o82-102i117-137o161-181i,219
P57773,Gap junction alpha-9 protein (Connexin-58) (Cx58) (Connexin-59) (Cx59) (Gap junction alpha-10 protein),i22-42o72-92i158-180o210-230i,515
Q12999,Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence),i14-34o46-66i73-97o171-194i,210
Q5VXT5,Synaptophysin-like protein 2,i36-56o117-137i151-172o210-233i,272
Q5VXU1,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 2) (Protein FAM77B) (T-cell lymphoma breakpoint-associated target protein 1),i9-27o34-54i61-82o148-165i,208
Q6PEY0,Gap junction beta-7 protein (Connexin-25) (Cx25),i21-41o71-93i125-143o178-198i,223
Q6UXU4,Germ cell-specific gene 1-like protein (GSG1-like protein),i9-29o133-153i174-194o218-238i,331
Q7Z7J7,LHFPL tetraspan subfamily member 4 protein (GABAA receptor regulatory Lhfpl4) (Lipoma HMGIC fusion partner-like 4 protein),i22-42o97-117i127-147o177-197i,247
Q86WI0,LHFPL tetraspan subfamily member 1 protein (Lipoma HMGIC fusion partner-like 1 protein),i7-28o86-106i119-139o169-189i,220
Q86X19,Transmembrane protein 17,i47-65o78-101i110-130o142-162i,198
Q8IZV2,CKLF-like MARVEL transmembrane domain-containing protein 8 (Chemokine-like factor superfamily member 8),i43-62o73-93i106-127o142-164i,173
Q8N7P3,Claudin-22,i11-30o82-102i118-138o164-183i,220
Q8NFK1,Gap junction gamma-3 protein (Connexin-30.2) (Cx30.2) (Connexin-31.3) (Cx31.3) (Gap junction epsilon-1 protein),i23-43o76-96i133-153o195-215i,279
Q8NFU0,Bestrophin-4 (Vitelliform macular dystrophy 2-like protein 2),i31-54o73-91i232-253o284-303i,473
Q969M2,Gap junction alpha-10 protein (Connexin-62) (Cx62),i24-44o72-92i161-181o210-230i,543
Q96FV3,Tetraspanin-17 (Tspan-17) (F-box only protein 23) (Tetraspan protein SB134) (Transmembrane 4 superfamily member 17),i20-42o64-84i95-117o235-256i,270
Q96HP8,Transmembrane protein 176A (Hepatocellular carcinoma-associated antigen 112),i53-75o90-105i113-133o193-207i,235
Q96JA4,Membrane-spanning 4-domains subfamily A member 14 (Testis development protein NYD-SP21),i44-63o76-92i109-130o154-163i,679
Q96QS1,Tetraspanin-32 (Tspan-32) (Protein Phemx),i15-35o60-84i89-113o197-219i,320
Q96RD6,Pannexin-2,i56-74o123-142i232-250o289-307i,677
Q96SN7,Protein orai-2 (CAP-binding protein complex-interacting protein 2) (Transmembrane protein 142B),i66-79o94-114i149-171o196-216i,254
Q9BRQ5,Protein orai-3 (Transmembrane protein 142C),i65-80o96-115i152-172o244-264i,295
Q9BSN7,Transmembrane protein 204 (Claudin-like protein 24),i6-26o101-121i137-153o168-188i,226
Q9BXT2,Voltage-dependent calcium channel gamma-6 subunit (Neuronal voltage-gated calcium channel gamma-6 subunit),i39-59o139-162i169-189o221-241i,260
Q9H1Z9,Tetraspanin-10 (Tspan-10) (Oculospanin),i79-102o121-141i152-174o293-313i,355
Q9NY35,Claudin domain-containing protein 1 (Membrane protein GENX-3745),i8-29o139-161i171-193o214-235i,253
Q9UBU6,Protein FAM8A1 (Autosomal highly conserved protein),i254-272o304-324i369-380o381-390i,413
Q9UF02,Voltage-dependent calcium channel gamma-5 subunit (Neuronal voltage-gated calcium channel gamma-5 subunit) (Transmembrane AMPAR regulatory protein gamma-5) (TARP gamma-5),i9-29o101-121i129-153o177-197i,275
Q9UGQ2,Calcium channel flower homolog (Calcium channel flower domain-containing protein 1),i29-49o58-78i102-118o119-133i,172
Q9UKL4,Gap junction delta-2 protein (Connexin-36) (Cx36) (Gap junction alpha-9 protein),i23-43o73-94i200-223o252-272i,321
Q9UNL2,Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma),i31-48o59-77i143-157o164-180i,185
Q9Y2U2,Potassium channel subfamily K member 7,i11-31o120-140i172-192o233-253i,307
A6NFC5,Transmembrane protein 235,i7-28o95-116i125-149o176-199i,223
A6NFC9,Putative olfactory receptor 2W5 pseudogene,o26-50i59-79o98-118i145-164o,320
A6NH52,Golgi apparatus membrane protein TVP23 homolog A,i36-55o60-69i124-144o151-169i,213
A6NM45,Putative claudin-24 (Claudin-21),i12-30o82-102i118-138o164-184i,220
A6NN92,Putative gap junction epsilon-1 protein (Connexin-23) (Cx23),i25-43o75-95i114-138o171-196i,205
B3SHH9,Transmembrane protein 114,i8-29o105-128i134-159o187-210i,223
C9JDP6,Putative claudin-25,i11-30o82-102i118-140o165-185i,229
O60320,Protein ENTREP2 (Endosomal transmembrane epsin interactor 2) (Transmembrane protein 228),i31-57o65-85i92-113o176-196i,539
O60637,Tetraspanin-3 (Tspan-3) (Tetraspanin TM4-A) (Transmembrane 4 superfamily member 8),i12-36o55-71i82-105o212-232i,253
O75954,Tetraspanin-9 (Tspan-9) (Tetraspan NET-5),i11-36o54-74i82-106o204-224i,239
O95857,Tetraspanin-13 (Tspan-13) (Tetraspan NET-6) (Transmembrane 4 superfamily member 13),i18-35o45-68i73-97o165-186i,204
P0DKB6,Mitochondrial pyruvate carrier 1-like protein,i23-33o34-43i62-73o80-97i,136
P56749,Claudin-12,i10-30o88-108i132-152o174-194i,244
Q494W8,CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10),o141-165i172-190o206-227i380-400o,412
Q4KMZ8,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1) (Protein FAM77C),i9-27o34-54i61-82o147-164i,207
Q53RY4,Keratinocyte-associated protein 3 (KCP-3),i21-39o63-78i93-117o164-180i,240
Q53S58,Transmembrane protein 177,i15-25o26-37i167-187o198-218i,311
Q5JRV8,Transmembrane protein 255A (Protein FAM70A),i30-51o59-79i89-115o221-242i,349
Q5JW98,Calcium homeostasis modulator protein 4 (Protein FAM26D),i15-30o49-69i104-124o187-202i,314
Q5R3K3,Calcium homeostasis modulator protein 6 (Protein FAM26F),i17-30o49-69i102-119o176-193i,315
Q86XJ0,Calcium homeostasis modulator protein 3 (Protein A),i11-31o50-70i102-119o178-198i,344
Q8IVV8,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 4) (Protein FAM77A),i9-27o34-54i61-82o147-164i,208
Q8N5U1,Membrane-spanning 4-domains subfamily A member 15,i73-93o109-123i140-159o173-193i,240
Q8NBL3,Transmembrane protein 178A,i6-28o179-199i209-230o256-278i,297
Q8NCR9,Clarin-3 (Transmembrane protein 12) (Usher syndrome type-3A-like protein 1),i8-28o94-113i128-147o180-200i,226
Q8NHV5,Modulator of smoothened protein (Attenuator of hedgehog),i4-24o69-89i101-121o142-161i,167
Q8WV15,Transmembrane protein 255B (Protein FAM70B),i26-46o58-75i88-109o195-217i,326
Q8WVE6,Transmembrane protein 171,i23-44o57-77i113-133o160-180i,324
Q8WXS4,Voltage-dependent calcium channel gamma-like subunit (Neuronal voltage-gated calcium channel gamma-like subunit) (Transmembrane protein 37),i28-46o90-111i125-147o160-180i,190
Q96B33,Claudin-23,i9-26o82-102i115-132o160-181i,292
Q96ET8,Golgi apparatus membrane protein TVP23 homolog C,i38-57o61-70i127-147o160-169i,276
Q96KN9,Gap junction delta-4 protein (Connexin-40.1) (Cx40.1),i24-44o77-97i147-167o196-217i,370
Q96PG2,Membrane-spanning 4-domains subfamily A member 10 (CD20 antigen-like 7),i59-79o94-110i122-142o172-190i,267
Q96QZ0,Pannexin-3,i40-59o109-128i215-232o268-288i,392
Q96SJ8,Tetraspanin-18 (Tspan-18),i12-36o50-72i83-108o219-241i,248
Q9BSK0,MARVEL domain-containing protein 1,i33-50o60-81i96-116o139-159i,173
Q9BY19,Membrane-spanning 4-domains subfamily A member 8 (Four-span transmembrane protein 4) (Membrane-spanning 4-domains subfamily A member 8B),i75-95o101-121i139-160o182-202i,250
Q9H3V2,Membrane-spanning 4-domains subfamily A member 5 (CD20 antigen-like 2) (Testis-expressed transmembrane protein 4),i52-72o81-105i119-141o162-186i,200
Q9HA72,Calcium homeostasis modulator protein 2 (Protein FAM26B),i20-35o55-75i102-122o186-202i,323
Q9HB14,Potassium channel subfamily K member 13 (Tandem pore domain halothane-inhibited potassium channel 1) (THIK-1),i20-41o125-145i197-217o259-279i,408
Q9HB15,Potassium channel subfamily K member 12 (Tandem pore domain halothane-inhibited potassium channel 2) (THIK-2),i39-60o144-164i216-236o278-298i,430
Q9NXJ0,Membrane-spanning 4-domains subfamily A member 12,i93-113o128-148i162-183o201-221i,267
Q9UKR8,Tetraspanin-16 (Tspan-16) (Tetraspanin TM4-B) (Transmembrane 4 superfamily member 16),i14-36o57-77i86-110o218-228i,245
Q9Y693,LHFPL tetraspan subfamily member 6 protein (Lipoma HMGIC fusion partner),i8-28o86-106i120-140o170-190i,200
A0A1B0GTI8,Transmembrane protein 272,i21-41o52-72i107-127o151-171i,187
A0A286YF58,Transmembrane protein 271,i9-29o52-68i121-141o218-239i,385
A0A494BZU4,Putative transmembrane protein 217B,i6-26o58-78i87-107o121-141i,170
A1L157,Tetraspanin-11 (Tspan-11),i16-43o61-82i89-113o220-241i,253
A6NGA9,Transmembrane protein 202,i59-77o120-141i153-175o191-212i,273
A6NGB7,Transmembrane protein 221,i9-32o70-93i121-145o151-169i,291
A8MUP6,Germ cell-specific gene 1-like protein 2 (GSG1-like protein 2),i9-28o121-143i161-181o205-225i,293
A8MWL6,Putative synaptogyrin-2 like protein,i26-45o70-90i105-125o146-164i,223
A8MWL7,Transmembrane protein 14DP,i13-31o39-57i63-83o88-107i,114
H3BS89,Transmembrane protein 178B,i6-28o170-192i199-224o250-272i,294
H7C241,Claudin-34,i12-32o91-111i126-146o177-199i,214
O14683,Tumor protein p53-inducible protein 11 (p53-induced gene 11 protein),i64-84o105-121i131-151o159-179i,189
O95473,Synaptogyrin-4,i25-45o68-88i104-125o143-163i,234
P0C672,Tetraspanin-19 (Tspan-19),i12-36o58-78i84-108o212-234i,248
P0C7T8,Transmembrane protein 253,i32-53o65-80i96-116o140-152i,217
P0DP42,Transmembrane protein 225B,i16-34o77-97i109-130o149-170i,221
Q3C1V0,Membrane-spanning 4-domains subfamily A member 18,i156-176o190-204i221-239o257-272i,400
Q587I9,Vesicle transport protein SFT2C (SFT2 domain-containing protein 3),i77-97o108-126i143-163o167-188i,215
Q5HYL7,Transmembrane protein 196,i11-31o49-67i73-96o111-130i,178
Q5VVB8,Putative transmembrane protein 244,i17-39o65-81i92-108o117-127i,128
Q69YW2,Protein stum homolog,i55-66o67-76i97-110o111-120i,141
Q6GV28,Transmembrane protein 225,i11-30o68-86i98-119o139-160i,225
Q6ICI0,LHFPL tetraspan subfamily member 7 protein (Transmembrane protein 211),i5-22o68-93i104-124o152-172i,200
Q6ZVK1,Transmembrane protein 179 (Transmembrane protein 179A),i8-28o73-90i108-128o175-193i,233
Q86UP9,LHFPL tetraspan subfamily member 3 protein (Lipoma HMGIC fusion partner-like 3 protein),i36-56o110-130i140-160o190-210i,236
Q8N2U0,Transmembrane protein 256,i11-27o49-59i66-86o93-112i,113
Q8N4W6,DnaJ homolog subfamily C member 22,i10-20o31-46i85-99o109-120i,341
Q8N5C1,Calcium homeostasis modulator protein 5 (Protein FAM26E),i16-30o49-69i100-120o181-199i,309
Q8N7C4,Transmembrane protein 217,i14-32o65-84i93-113o129-147i,229
Q8N8D7,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 3) (Protein FAM77D),i9-29o34-54i62-82o147-164i,197
Q8NCL8,Transmembrane protein 116,i24-44o86-108i141-161o171-194i,245
Q8NCS4,Transmembrane protein 35B (ZMYM6 neighbor protein),i7-24o63-78i86-103o109-127i,154
Q96AQ2,Transmembrane protein 125,i35-57o68-87i114-135o146-166i,219
Q96HH4,Transmembrane protein 169,i161-175o176-185i208-222o223-232i,297
A6NML5,Transmembrane protein 212,i11-31o44-64i78-101o147-167i,194
O43759,Synaptogyrin-1,i27-44o70-90i105-126o149-169i,233
O43760,Synaptogyrin-2 (Cellugyrin),i26-45o73-88i106-126o147-167i,224
O43761,Synaptogyrin-3,i27-44o70-90i106-126o148-168i,229
O60359,Voltage-dependent calcium channel gamma-3 subunit (Neuronal voltage-gated calcium channel gamma-3 subunit) (Transmembrane AMPAR regulatory protein gamma-3) (TARP gamma-3),i10-30o106-127i134-158o177-197i,315
O60635,Tetraspanin-1 (Tspan-1) (Tetraspan NET-1) (Tetraspanin TM4-C),i10-34o56-77i87-109o212-236i,241
O60636,Tetraspanin-2 (Tspan-2) (Tetraspan NET-3),i11-38o58-76i87-110o186-211i,221
O60831,PRA1 family protein 2,i41-62o65-85i100-121o122-142i,178
O75204,Transmembrane protein 127,i34-49o95-116i129-146o175-196i,238
O75298,Reticulon-2 (Neuroendocrine-specific protein-like 1) (NSP-like protein 1) (Neuroendocrine-specific protein-like I) (NSP-like protein I) (NSPLI),i358-373o376-394i459-474o480-489i,545
O75311,Glycine receptor subunit alpha-3,o256-277i284-303o315-337i431-451o,464
A0AVI4,E3 ubiquitin-protein ligase TM129 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TM129),o6-21i57-77o93-113i,362
A2RU14,Transmembrane protein 218,o9-29i38-58o82-100i,115
A6NNB3,Interferon-induced transmembrane protein 5 (Bone-restricted interferon-induced transmembrane protein-like protein) (BRIL) (Dispanin subfamily A member 1) (DSPA1),i37-48o49-58i85-105o,132
O00258,Guided entry of tail-anchored proteins factor 1 (Congenital heart disease 5 protein) (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein),o9-29i100-120o149-169i,174
O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit)",i64-85o91-111i123-143o,159
O15399,"Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D)",o584-604i657-674o845-869i,1336
O15431,High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],o70-89i133-157o158-177i,190
O15432,Protein SLC31A2 (Copper transporter 2) (hCTR2) (Solute carrier family 31 member 2),o24-43i94-118o119-139i,143
O43424,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)",o567-587i638-658o831-851i,1007
O94876,Transmembrane and coiled-coil domains protein 1,i589-599o600-609i622-638o,653
O95406,Protein cornichon homolog 1 (CNIH-1) (Cornichon family AMPA receptor auxiliary protein 1) (Protein cornichon homolog) (T-cell growth-associated molecule 77) (TGAM77),i11-29o57-77i123-142o,144
P03897,NADH-ubiquinone oxidoreductase chain 3 (EC 7.1.1.2) (NADH dehydrogenase subunit 3),o3-23i56-73o86-106i,115
P04844,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II) (RPN-II) (Ribophorin-2),o540-560i574-595o599-621i,631
P05141,"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]",i210-221o222-231i278-291o,298
P05496,"ATP synthase F(0) complex subunit C1, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 1) (ATP synthase proteolipid P1) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C1) (ATPase protein 9) (ATPase subunit c)",i73-83o84-95i108-134o,136
P12235,"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)",i210-221o222-231i278-291o,298
P12236,"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]",i210-221o222-231i278-291o,298
P17152,"Transmembrane protein 11, mitochondrial (Protein PM1) (Protein PMI)",i81-99o107-124i173-190o,192
P37059,17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 2) (EC 1.1.1.62) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239),o9-24i34-52o55-72i,387
P39086,"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)",o578-597i654-674o835-855i,918
P42261,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)",o539-557i618-638o806-826i,906
P42262,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)",o546-564i625-645o813-833i,883
P42263,"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)",o555-573i636-656o824-844i,894
P48058,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)",o547-565i626-646o814-834i,902
P48201,"ATP synthase F(0) complex subunit C3, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 3) (ATP synthase proteolipid P3) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C3) (ATPase protein 9) (ATPase subunit c)",i79-89o90-101i114-140o,142
P49069,Guided entry of tail-anchored proteins factor CAMLG (Calcium signal-modulating cyclophilin ligand),i190-207o210-228i270-288o,296
P51572,B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28),o5-27i47-67o103-116i,246
P60602,Reactive oxygen species modulator 1 (ROS modulator 1) (Epididymis tissue protein Li 175) (Glyrichin) (Mitochondrial targeting GxxxG motif protein) (MTGM) (Protein MGR2 homolog),i19-30o31-40i64-77o,79
P61803,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (Defender against cell death 1) (DAD-1),i26-48o53-73i93-111o,113
Q05586,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",o560-581i628-648o811-834i,938
Q06055,"ATP synthase F(0) complex subunit C2, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 2) (ATP synthase proteolipid P2) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C2) (ATPase protein 9) (ATPase subunit c)",i78-88o89-100i113-139o,141
Q12879,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)",o555-576i626-646o817-841i,1464
Q13002,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)",o563-582i639-659o820-840i,908
Q13003,"Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)",o565-584i641-661o821-841i,919
Q13224,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)",o556-577i627-647o818-842i,1484
Q14957,"Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)",o554-574i627-644o815-835i,1233
Q16099,"Glutamate receptor ionotropic, kainate 4 (GluK4) (Excitatory amino acid receptor 1) (EAA1) (Glutamate receptor KA-1) (KA1)",o546-566i624-644o805-825i,956
Q16478,"Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2)",o545-565i623-643o804-824i,980
Q16653,Myelin-oligodendrocyte glycoprotein,o156-176i209-219o220-229i,247
Q16739,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),o11-32i283-307o315-334i,394
Q53EU6,Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3) (hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta) (MAG-1),o10-30i144-160o161-174i,434
Q5J8M3,ER membrane protein complex subunit 4 (Cell proliferation-inducing gene 17 protein) (Transmembrane protein 85),i70-90o96-116i134-149o,183
Q6P4Q7,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),o186-209i241-261o269-289i,775
Q6PI25,Protein cornichon homolog 2 (CNIH-2) (Cornichon family AMPA receptor auxiliary protein 2) (Cornichon-like protein),i11-31o73-93i139-158o,160
Q6PI78,Transmembrane protein 65,i122-143o156-177i207-227o,240
Q71RG4,Transmembrane and ubiquitin-like domain-containing protein 2,o36-54i270-290o298-318i,321
Q7Z5B4,Protein RIC-3 (Resistant to inhibitor of cholinesterase 3),o9-24i96-106o107-116i,369
Q7Z6L0,Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3),i269-279o280-289i315-336o,340
Q86UL3,Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) (TSARG7),o14-36i162-179o180-197i,456
Q8IVP5,FUN14 domain-containing protein 1,i54-68o74-89i139-154o,155
Q8IXB3,Trafficking regulator of GLUT4 1 (Dispanin subfamily B member 1) (DSPB1) (Interferon-induced transmembrane domain-containing protein D3) (Protein located at seventeen-p-thirteen point three 1) (Tumor suppressor candidate 5),i105-115o116-125i151-170o,177
Q8N6C5,Immunoglobulin superfamily member 1 (IgSF1) (Immunoglobulin-like domain-containing protein 1) (Inhibin-binding protein) (InhBP) (Pituitary gland-specific factor 2) (p120),o519-539i562-571o1262-1281i,1336
Q8N6I4,Lysosomal enzyme trafficking factor (GNPTAB cleavage and activity factor) (GCAF) (Transmembrane protein 251),i40-60o98-118i128-143o,163
Q8NE01,Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3),o138-158i193-213o223-243i,707
Q8NE79,Blood vessel epicardial substance (hBVES) (Popeye domain-containing protein 1) (Popeye protein 1),o40-60i66-86o93-113i,360
Q8TBE1,Protein cornichon homolog 3 (CNIH-3) (Cornichon family AMPA receptor auxiliary protein 3),i11-31o73-93i139-159o,160
Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L)",o675-695i744-760o932-952i,1115
Q92604,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (2-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.62) (Acyl-CoA:monoacylglycerol acyltransferase LPGAT1) (EC 2.3.1.22) (Lysophospholipid acyltransferase 7) (LPLAT7) (EC 2.3.1.-) (Stearoyl-CoA:1-lyso-2-acyl-PE acyltransferase),i22-32o33-43i342-362o,370
Q92982,Ninjurin-1 (Nerve injury-induced protein 1) [Cleaved into: Secreted ninjurin-1 (Soluble ninjurin-1)],i47-64o78-102i118-139o,152
Q96B42,Transmembrane protein 18,o26-44i53-73o93-113i,140
Q96ER9,Mitochondrial potassium channel (MITOK) (Coiled-coil domain-containing protein 51),i202-212o213-222i387-408o,411
Q8WVE7,Transmembrane protein 170A,o50-70i84-104o122-142i,144
Q96K19,E3 ubiquitin-protein ligase RNF170 (EC 2.3.2.27) (Putative LAG1-interacting protein) (RING finger protein 170) (RING-type E3 ubiquitin transferase RNF170),o25-45i194-214o219-244i,258
Q96S66,Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1),o184-204i216-232o336-353i,551
Q96T53,Ghrelin O-acyltransferase (EC 2.3.1.-) (Membrane-bound O-acyltransferase domain-containing protein 4) (O-acyltransferase domain-containing protein 4),o14-29i42-56o60-74i,435
Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL)",i63-92o113-137i145-166o,169
Q99943,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15),o7-27i38-48o49-58i,283
Q9BRK0,Receptor expression-enhancing protein 2,o9-21i39-62o68-77i,252
Q9BRR3,Post-GPI attachment to proteins factor 4 (Post-GPI attachment to proteins GalNAc transferase 4) (Transmembrane protein 246),i27-47o262-281i291-308o,403
Q9BU79,Transmembrane protein 243 (MDR1- and mitochondrial taxol resistance-associated protein) (MM-TRAG),i30-52o60-80i94-113o,118
Q9BUV8,GEL complex subunit OPTI (Obligate partner of TMCO1 insertase) (Rab5-interacting protein) (RIP5) (Respirasome Complex Assembly Factor 1),i44-65o68-86i108-124o,137
Q9BV81,ER membrane protein complex subunit 6 (Transmembrane protein 93),i29-44o49-65i87-107o,110
Q9BVC6,Transmembrane protein 109 (Mitsugumin-23) (Mg23),o131-156i159-176o186-199i,243
Q9BVT8,Transmembrane and ubiquitin-like domain-containing protein 1 (Dendritic cell-derived ubiquitin-like protein) (DULP) (Hepatocyte odd protein shuttling protein) (Ubiquitin-like protein SB144) [Cleaved into: iHOPS],o11-29i195-215o223-243i,246
Q9BWH2,FUN14 domain-containing protein 2 (Cervical cancer proto-oncogene 3 protein) (HCC-3) (Hepatitis C virus core-binding protein 6),i86-101o107-119i173-188o,189
Q9BXI2,Mitochondrial ornithine transporter 2 (Solute carrier family 25 member 2),i210-220o221-230i277-286o,301
Q9H0C2,"ADP/ATP translocase 4 (ADP,ATP carrier protein 4) (Adenine nucleotide translocator 4) (ANT 4) (Solute carrier family 25 member 31) (Sperm flagellar energy carrier protein)",i222-233o234-243i292-301o,315
Q9H6H4,Receptor expression-enhancing protein 4,o23i38-59o64-77i,257
Q9H7V2,Synapse differentiation-inducing gene protein 1 (SynDIG1) (Dispanin subfamily C member 2) (DSPC2) (Transmembrane protein 90B),i182-192o193-202i227-247o,258
Q9H902,Receptor expression-enhancing protein 1 (Spastic paraplegia 31 protein),o9-22i39-62o68-77i,201
Q9NPE6,Sperm-associated antigen 4 protein (Outer dense fiber-associated protein SPAG4) (SUN domain-containing protein 4),i138-148o149-158i166-189o,437
Q9NRP0,Oligosaccharyltransferase complex subunit OSTC (Hydrophobic protein HSF-28),i32-46o87-105i121-140o,149
Q9NZ42,Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2),i18-28o29-38i57-77o,101
Q9NZG7,Ninjurin-2 (Nerve injury-induced protein 2),i33-53o65-88i106-126o,142
Q9P0I2,ER membrane protein complex subunit 3 (Transmembrane protein 111),o13-32i115-132o166-183i,261
Q9UBS9,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),o613-633i714-723o1012-1030i,1254
Q9UGP8,Translocation protein SEC63 homolog,o15-35i77-91o190-208i,760
Q9ULK0,"Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit)",o562-583i638-658o831-851i,1009
Q9UM00,Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3),o60-76i142-156o193-203i,239
Q9Y284,PAT complex subunit Asterix (Protein associated with the ER translocon of 10kDa) (PAT-10) (PAT10) (WD repeat domain 83 opposite strand) (WDR83 opposite strand),i36-51o55-70i80-97o,106
Q9Y2P5,"Long-chain fatty acid transport protein 5 (FATP-5) (Fatty acid transport protein 5) (Bile acid-CoA ligase) (BA-CoA ligase) (BAL) (Bile acyl-CoA synthetase) (BACS) (EC 6.2.1.7) (Cholate--CoA ligase) (Fatty-acid-coenzyme A ligase, very long-chain 3) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 5) (Very long-chain acyl-CoA synthetase homolog 2) (VLCS-H2) (VLCSH2) (EC 6.2.1.-) (Very long-chain acyl-CoA synthetase-related protein) (VLACS-related) (VLACSR)",o24-37i43-52o59-72i,690
Q9Y5U8,Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein),i28-44o55-67i78-99o,109
E9PQX1,Cation channel sperm-associated auxiliary subunit TMEM262 (Cation channel sperm-associated auxiliary subunit eta) (Transmembrane protein 262),o34i55-71o83-99i,116
P03901,NADH-ubiquinone oxidoreductase chain 4L (EC 7.1.1.2) (NADH dehydrogenase subunit 4L),o3-21i29-49o57-79i,98
Q3SY17,Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A52 (Mitochondrial NAD(+) transporter SLC25A52) (Mitochondrial carrier triple repeat protein 2) (Solute carrier family 25 member 52),i211-222o223-232i280-293o,297
Q5T4T1,Transmembrane protein 170B,o38-58i69-89o109-125i,132
Q6NUK4,Receptor expression-enhancing protein 3,o9-21i38-62o70-80i,255
Q8N6S5,ADP-ribosylation factor-like protein 6-interacting protein 6 (ARL-6-interacting protein 6) (Aip-6) (Phosphonoformate immuno-associated protein 1),i108-132o153-173i205-225o,226
Q8WY22,BRI3-binding protein (I3-binding protein) (Cervical cancer 1 proto-oncogene-binding protein KG19) (HCCRBP-1),o125-145i157-174o184-198i,251
Q9H1U9,Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51),i211-222o223-232i280-293o,297
Q9HBU9,Popeye domain-containing protein 2 (Popeye protein 2),o23-43i48-70o77-97i,364
Q9HBV1,Popeye domain-containing protein 3 (Popeye protein 3),o25-43i50-70o77-97i,291
Q9UDX5,Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein) (MTP18),i39-60o85-100i124-138o,166
Q9UHQ4,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),o5-25i51-68o104-117i,241
Q9ULS5,Transmembrane and coiled-coil domain protein 3,i414-424o425-436i446-460o,477
A6NDD5,Synapse differentiation-inducing gene protein 1-like (Capucin) (Dispanin subfamily C member 1) (DSPC1) (Transmembrane protein 90A),i162-172o173-182i207-227o,238
O15482,Testis-specific protein TEX28,i331-341o342-351i363-377o,410
Q6ZNR0,Transmembrane protein 91 (Dispanin subfamily C member 3) (DSPC3),i96-106o107-116i145-165o,172
Q8NH95,"Putative olfactory receptor 13C6 (Olfactory receptor, family 13, subfamily C, member 6 pseudogene) (Olfactory receptor, family 13, subfamily C, member 7 pseudogene) (Putative olfactory receptor 13C7)",o27-49i60-80o99-121i,151
Q9GIP4,Putative L-type amino acid transporter 1-like protein IMAA (hLAT1 3-transmembrane protein IMAA) (hLAT1 3TM IMAA) (hLAT1 3-transmembrane protein MMAA) (hLAT1 3TM MMAA),i55-64o84-103i133-153o,190
A0A1W2PS18,Transmembrane protein PMIS2,i71-81o84-93i130-148o,150
A6NMD0,Interferon-induced transmembrane protein 10 (Dispanin subfamily A member 3) (DSPA3),i154-165o166-175i201-221o,228
B4DJY2,Transmembrane protein 233 (Dispanin subfamily B member 2) (DSPB2) (Interferon-induced transmembrane domain-containing protein D2),i38-49o50-59i82-99o,109
O14609,"Testis-specific XK-related protein, Y-linked",o11-28i44-65o76-86i,159
Q5VZR4,Major facilitator superfamily domain-containing 14C pseudogene (Hippocampus abundant transcript-like protein 2),i48-63o80-101i111-129o,150
Q8MH63,Putative L-type amino acid transporter 1-like protein MLAS (hLAT1 3-transmembrane protein MLAS) (hLAT1 3TM MLAS),i55-75o83-107i128-157o,180
Q96PG1,Putative membrane-spanning 4-domains subfamily A member 4E,i49-69o78-96i114-123o,132
Q9NX00,Transmembrane protein 160,i70-90o97-122i135-157o,188
O60391,"Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B)",o575-595i644-661o834-855i,1043
O75069,Transmembrane and coiled-coil domains protein 2 (Cerebral protein 11),i646-656o657-668i678-692o,709
A0FGR8,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),i112-133o134-149i,921
A0FGR9,Extended synaptotagmin-3 (E-Syt3) (Chr3Syt),i35-56o57-72i,886
B7U540,"Inward rectifier potassium channel 18 (Inward rectifier K(+) channel Kir2.6) (Potassium channel, inwardly rectifying subfamily J member 18)",i81-105o158-178i,433
O00124,UBX domain-containing protein 8 (Reproduction 8 protein) (Rep-8 protein) (UBX domain-containing protein 6),i5-22o34-54i,270
O14511,"Pro-neuregulin-2, membrane-bound isoform (Pro-NRG2) [Cleaved into: Neuregulin-2 (NRG-2) (Divergent of neuregulin-1) (DON-1) (Neural- and thymus-derived activator for ERBB kinases) (NTAK)]",i98-107o406-426i,850
O14525,Astrotactin-1,o154-174i386-397o,1302
O14925,Mitochondrial import inner membrane translocase subunit Tim23,i125-135o136-145i,209
O15120,1-acyl-sn-glycerol-3-phosphate acyltransferase beta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 2) (1-AGP acyltransferase 2) (1-AGPAT 2) (Lysophosphatidic acid acyltransferase beta) (LPAAT-beta),i3-18o30-50i,278
O15342,V-type proton ATPase subunit e 1 (V-ATPase subunit e 1) (V-ATPase 9.2 kDa membrane accessory protein) (V-ATPase M9.2 subunit) (Vacuolar proton pump subunit e 1),o8-28i36-56o,81
O15547,P2X purinoceptor 6 (P2X6) (ATP receptor) (P2XM) (Purinergic receptor) (Purinergic receptor P2X-like 1),i38-59o345-362i,441
O75425,Motile sperm domain-containing protein 3,i181-197o219-233i,235
O75882,Attractin (DPPT-L) (Mahogany homolog),i66-78o1279-1301i,1429
O94777,Dolichol phosphate-mannose biosynthesis regulatory protein (Dolichol-phosphate mannose synthase subunit 2) (DPM synthase subunit 2),i8-31o49-69i,84
O95167,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (Complex I-B9) (CI-B9) (NADH-ubiquinone oxidoreductase B9 subunit),i17-27o28-37i,84
O95202,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),i206-216o217-226i,739
O95298,NADH dehydrogenase [ubiquinone] 1 subunit C2 (Complex I-B14.5b) (CI-B14.5b) (Human lung cancer oncogene 1 protein) (HLC-1) (NADH-ubiquinone oxidoreductase subunit B14.5b),i30-47o61-75i,119
O95831,"Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)",i66-76o77-86i,613
O95870,Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (hBAT5) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) (Protein G5),i60-83o99-113i,558
P00403,Cytochrome c oxidase subunit 2 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide II),o26-46i61-79o,227
P08574,"Cytochrome c1, heme protein, mitochondrial (EC 7.1.1.8) (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)",i59-77o292-306i,325
P08842,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),o183-206i213-232o,583
P16671,Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36),i8-30o440-466i,472
P24539,"ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b) (ATPase subunit b)",i75-89o100-113i,256
P27105,Stomatin (Erythrocyte band 7 integral membrane protein) (Erythrocyte membrane protein band 7.2) (Protein 7.2b),i31-42o43-54i,288
P36956,Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)],i488-507o540-566i,1147
P37088,Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (ENaCA) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA),i86-106o555-574i,669
P48048,"ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium channel, inwardly rectifying subfamily J member 1)",i81-105o157-175i,391
P48050,"Inward rectifier potassium channel 4 (HIRK2) (HRK1) (Hippocampal inward rectifier) (HIR) (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)",i57-80o149-169i,445
P48051,"G protein-activated inward rectifier potassium channel 2 (GIRK-2) (BIR1) (Inward rectifier K(+) channel Kir3.2) (KATP-2) (Potassium channel, inwardly rectifying subfamily J member 6)",i90-114o167-188i,423
P48544,"G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (IRK-4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)",i87-111o164-185i,419
P48549,"G protein-activated inward rectifier potassium channel 1 (GIRK-1) (Inward rectifier K(+) channel Kir3.1) (Potassium channel, inwardly rectifying subfamily J member 3)",i81-105o158-179i,501
P49961,Ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase 1) (EC 3.6.1.5) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (CD antigen CD39),i17-37o478-499i,510
P50416,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)",i50-77o104-122i,773
P51168,Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (ENaCB) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB),i51-71o524-545i,640
P51170,Amiloride-sensitive sodium channel subunit gamma (Epithelial Na(+) channel subunit gamma) (ENaCG) (Gamma-ENaC) (Gamma-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma) (SCNEG),i54-75o531-555i,649
P51172,Amiloride-sensitive sodium channel subunit delta (Delta-NaCH) (Epithelial Na(+) channel subunit delta) (Delta-ENaC) (ENaCD) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED),i251-271o692-715i,802
P51575,P2X purinoceptor 1 (P2X1) (ATP receptor) (Purinergic receptor),i29-50o339-358i,399
P51690,Arylsulfatase L (EC 3.1.6.1) (Arylsulfatase E) (ASE),o196-216i225-245o,589
P54829,Tyrosine-protein phosphatase non-receptor type 5 (EC 3.1.3.48) (Neural-specific protein-tyrosine phosphatase) (Striatum-enriched protein-tyrosine phosphatase) (STEP),i88-103o145-163i,565
P56373,P2X purinoceptor 3 (P2X3) (ATP receptor) (Purinergic receptor),i23-44o329-344i,397
P56975,"Pro-neuregulin-3, membrane-bound isoform (Pro-NRG3) [Cleaved into: Neuregulin-3 (NRG-3)]",i69-86o361-381i,720
P57054,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P (Down syndrome critical region protein 5) (Down syndrome critical region protein C) (Phosphatidylinositol-glycan biosynthesis class P protein) (PIG-P),i38-58o79-100i,158
P61165,Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258),o21-38i54-74o,79
P63252,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",i82-106o156-176i,427
P67812,Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18),i22-42o162-176i,179
P78329,Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78),i18-28o29-38i,520
P78348,"Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2)",i44-62o438-454i,528
P78508,"ATP-sensitive inward rectifier potassium channel 10 (ATP-dependent inwardly rectifying potassium channel Kir4.1) (Inward rectifier K(+) channel Kir1.2) (Potassium channel, inwardly rectifying subfamily J member 10)",i68-92o144-165i,379
P80365,11-beta-hydroxysteroid dehydrogenase type 2 (11-DH2) (11-beta-HSD2) (EC 1.1.1.-) (11-beta-hydroxysteroid dehydrogenase type II) (11-HSD type II) (11-beta-HSD type II) (Corticosteroid 11-beta-dehydrogenase isozyme 2) (NAD-dependent 11-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 3),i34-48o56-69i,405
Q00325,"Solute carrier family 25 member 3 (Phosphate carrier protein, mitochondrial) (Phosphate transport protein) (PTP)",i263-272o275-284i,362
Q02978,Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (alpha-oxoglutarate carrier) (Solute carrier family 25 member 11) (SLC25A11),i219-230o231-240i,314
Q12772,Sterol regulatory element-binding protein 2 (SREBP-2) (Class D basic helix-loop-helix protein 2) (bHLHd2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2)],i482-497o531-554i,1141
Q12797,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),i54-74o359-368i,758
Q13061,Triadin,i48-58o59-68i,729
Q14108,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),i5-27o434-459i,478
Q14154,"DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)]",i80-90o91-100i,515
Q14442,Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (Phosphatidylinositol-glycan biosynthesis class H protein) (PIG-H),i41-56o63-80i,188
Q14500,"ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12)",i81-105o158-178i,433
Q14654,"ATP-sensitive inward rectifier potassium channel 11 (IKATP) (Inward rectifier K(+) channel Kir6.2) (Potassium channel, inwardly rectifying subfamily J member 11)",i72-96o146-165i,390
Q15005,Signal peptidase complex subunit 2 (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit),i85-104o112-132i,226
Q15011,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (Methyl methanesulfonate (MMF)-inducible fragment protein 1),i264-284o290-302i,391
Q15526,Surfeit locus protein 1,i61-81o272-294i,300
Q15842,"ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1)",i73-97o156-177i,424
Q15884,Endosomal transmembrane epsin interactor 1 (Endosomal transmembrane binding with epsin),i7-27o86-107i,450
Q16515,"Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG)",i43-59o435-455i,512
Q16558,"Calcium-activated potassium channel subunit beta-1 (BK channel subunit beta-1) (BKbeta) (BKbeta1) (Hbeta1) (Calcium-activated potassium channel, subfamily M subunit beta-1) (Calcium-activated potassium channel subunit beta) (Charybdotoxin receptor subunit beta-1) (K(VCA)beta-1) (Maxi K channel subunit beta-1) (Slo-beta-1) (Slo-beta)",i16-36o158-178i,191
Q16821,Protein phosphatase 1 regulatory subunit 3A (Protein phosphatase 1 glycogen-associated regulatory subunit) (Protein phosphatase type-1 glycogen targeting subunit) (RG1),i1078-1090o1094-1103i,1122
Q2TAA5,"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (EC 2.4.1.131) (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)",i20-30o31-42i,492
Q3MIR4,Cell cycle control protein 50B (P4-ATPase flippase complex beta subunit TMEM30B) (Transmembrane protein 30B),i34-55o316-340i,351
Q3SXM5,Inactive hydroxysteroid dehydrogenase-like protein 1 (Short chain dehydrogenase/reductase family 12C member 3),i24-35o36-45i,330
Q3SYC2,2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (hMGAT2) (Diacylglycerol O-acyltransferase candidate 5) (hDC5) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 2),i18-45o46-59i,334
Q3ZAQ7,Vacuolar ATPase assembly integral membrane protein VMA21 (Myopathy with excessive autophagy protein),i27-48o66-86i,101
Q4ZHG4,Fibronectin type III domain-containing protein 1 (Activation-associated cDNA protein) (Expressed in synovial lining protein),o721-730i1443-1452o,1894
Q53EP0,Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37),i1181-1191o1192-1201i,1204
Q53F39,Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5),i26-41o356-374i,396
Q58HT5,Acyl-CoA wax alcohol acyltransferase 1 (EC 2.3.1.75) (Diacylglycerol O-acyltransferase 2-like protein 3) (Diacylglycerol acyltransferase 2) (Long-chain-alcohol O-fatty-acyltransferase 1),i18-38o41-54i,328
Q5MY95,Ectonucleoside triphosphate diphosphohydrolase 8 (E-NTPDase 8) (NTPDase 8) (NTPDase8) (EC 3.6.1.5),i9-30o469-491i,495
Q5RI15,"Cytochrome c oxidase assembly protein COX20, mitochondrial",i34-55o61-75i,118
Q5T0T0,E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Cellular modulator of immune recognition) (c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCHF8),i159-177o197-217i,291
Q5TGZ0,MICOS complex subunit MIC10 (Mitochondrial inner membrane organizing system protein 1),i14-34o40-55i,78
Q643R3,Lysophospholipid acyltransferase LPCAT4 (1-acylglycerol-3-phosphate O-acyltransferase 7) (1-AGP acyltransferase 7) (1-AGPAT 7) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (1-alkenylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.121) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 3) (Lysophosphatidylcholine acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase 2) (EC 2.3.1.n7) (Plasmalogen synthase),i44-54o55-64i,524
Q69384,Endogenous retrovirus group K member 6 Env polyprotein (EnvK2 protein) (Envelope polyprotein) (HERV-K(C7) envelope protein) (HERV-K(HML-2.HOM) envelope protein) (HERV-K108 envelope protein) (HERV-K_7p22.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],i79-88o638-651i,699
Q6DD88,Atlastin-3 (EC 3.6.5.-),i444-464o472-490i,541
Q6E213,Acyl-CoA wax alcohol acyltransferase 2 (EC 2.3.1.75) (11-cis-specific retinyl-ester synthase) (11-cis-RE-synthase) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diacylglycerol O-acyltransferase 2-like protein 4) (Diacylglycerol O-acyltransferase candidate 4) (hDC4) (Long-chain-alcohol O-fatty-acyltransferase 2) (Multifunctional O-acyltransferase) (Wax synthase) (hWS),i15-42o45-58i,333
Q6NT55,Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22),i23-33o34-43i,531
Q6P1M0,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-),i18o22-35i,643
Q6P1Q0,LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2),i138-148o149-158i,360
Q6P5S7,Ribonuclease kappa (RNase K) (RNase kappa) (EC 3.1.-.-) (V-type proton ATPase subunit f) (V-ATPase subunit f),i52-72o104-124i,137
Q6PCB7,Long-chain fatty acid transport protein 1 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 1) (FATP-1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 1) (Very long-chain acyl-CoA synthetase) (EC 6.2.1.-),i5-20o24-37i,646
Q6PEY1,Transmembrane protein 88,i38-58o87-107i,159
Q6UXV4,MICOS complex subunit MIC27 (Apolipoprotein O-like) (Protein FAM121A),i111-129o138-151i,268
Q6ZMZ0,E3 ubiquitin-protein ligase RNF19B (EC 2.3.2.31) (IBR domain-containing protein 3) (Natural killer lytic-associated molecule) (RING finger protein 19B),i361-371o372-381i,732
Q6ZPD8,Diacylglycerol O-acyltransferase 2-like protein 6 (EC 2.3.1.-) (Diacylglycerol O-acyltransferase candidate 3) (hDC3),i16-42o45-58i,337
Q70CQ3,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),i33-43o44-53i,517
Q7L5N7,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha),i59-69o70-86i,544
Q7Z412,Peroxisome assembly protein 26 (Peroxin-26),i250-260o261-270i,305
Q7Z5N4,Protein sidekick-1,i82-91o2009-2030i,2213
Q86T03,"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)",i213-231o247-264i,277
Q86UD3,E3 ubiquitin-protein ligase MARCHF3 (EC 2.3.2.27) (Membrane-associated RING finger protein 3) (Membrane-associated RING-CH protein III) (MARCH-III) (RING finger protein 173) (RING-type E3 ubiquitin transferase MARCHF3),i146-167o184-204i,253
Q86VF5,2-acylglycerol O-acyltransferase 3 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 3) (MGAT3) (Diacylglycerol O-acyltransferase candidate 7) (hDC7) (Diacylglycerol acyltransferase 2-like protein 7) (Monoacylglycerol O-acyltransferase 3),i29-49o52-65i,341
Q86W47,"Calcium-activated potassium channel subunit beta-4 (BK channel subunit beta-4) (BKbeta4) (Hbeta4) (Calcium-activated potassium channel, subfamily M subunit beta-4) (Charybdotoxin receptor subunit beta-4) (K(VCA)beta-4) (Maxi K channel subunit beta-4) (Slo-beta-4)",i20-40o168-188i,210
Q86X29,Lipolysis-stimulated lipoprotein receptor (Angulin-1),i70-79o260-281i,649
Q86XS8,E3 ubiquitin-protein ligase RNF130 (EC 2.3.2.27) (Goliath homolog) (H-Goliath) (RING finger protein 130) (RING-type E3 ubiquitin transferase RNF130),o195-215i386-405o,419
Q86YJ5,E3 ubiquitin-protein ligase MARCHF9 (EC 2.3.2.27) (Membrane-associated RING finger protein 9) (Membrane-associated RING-CH protein IX) (MARCH-IX) (RING finger protein 179) (RING-type E3 ubiquitin transferase MARCHF9),i185-204o219-239i,346
Q8IV31,Transmembrane protein 139,i14-31o38-59i,216
Q8N4L2,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)",i196-211o225-243i,257
Q8N4V1,ER membrane protein complex subunit 5 (Membrane magnesium transporter 1) (Transmembrane protein 32),i8-25o43-63i,131
Q8N511,Transmembrane protein 199,i146-167o179-198i,208
Q8N6D2,E3 ubiquitin-protein ligase RNF182 (EC 2.3.2.27) (RING finger protein 182) (RING-type E3 ubiquitin transferase RNF182),i184-205o211-231i,247
Q8N9A8,Nuclear envelope phosphatase-regulatory subunit 1 (NEP1-R1) (Transmembrane protein 188),i33-51o69-85i,125
Q8N9F0,N-acetylaspartate synthetase (NAA synthetase) (EC 2.3.1.17) (Camello-like protein 3) (N-acetyltransferase 8-like protein),i117-133o134-148i,302
Q8NC56,LEM domain-containing protein 2 (hLEM2),i213-231o377-397i,503
Q8NE86,"Calcium uniporter protein, mitochondrial (HsMCU) (Coiled-coil domain-containing protein 109A)",i234-256o266-283i,351
Q8NF37,Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3),i51-61o62-71i,534
Q8NHE4,V-type proton ATPase subunit e 2 (V-ATPase subunit e 2) (Lysosomal 9 kDa H(+)-transporting ATPase V0 subunit e2) (Vacuolar proton pump subunit e 2),o8-28i36-56o,81
Q8NHH9,Atlastin-2 (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) (ARL-6-interacting protein 2) (Aip-2),i476-492o500-521i,583
Q8TCG5,"Carnitine O-palmitoyltransferase 1, brain isoform (CPT1-B) (EC 2.3.1.21) (CPT IC) (Carnitine O-palmitoyltransferase I, brain isoform) (CPTI-B) (Carnitine palmitoyltransferase 1C)",i50-77o101-126i,803
Q8TCQ1,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),i159-177o197-217i,289
Q8TDB4,Protein MGARP (Corneal endothelium-specific protein 1) (CESP-1) (Hypoxia up-regulated mitochondrial movement regulator protein) (Mitochondria-localized glutamic acid-rich protein) (Ovary-specific acidic protein),i43-53o54-63i,240
Q92523,"Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1-M) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, muscle isoform) (CPT I) (CPTI-M) (Carnitine palmitoyltransferase 1B) (Carnitine palmitoyltransferase I-like protein)",i60-75o105-124i,772
Q92543,Sorting nexin-19,i29-47o48-66i,992
Q92968,Peroxisomal membrane protein PEX13 (Peroxin-13),i233-243o244-253i,403
Q93086,P2X purinoceptor 5 (P2X5) (ATP receptor) (Purinergic receptor),i29-50o329-338i,422
Q969X5,Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32),i25-45o252-270i,290
Q96A57,Transmembrane protein 230,i46-66o79-95i,120
Q96AN5,Transmembrane protein 143,i279-301o306-321i,459
Q96D05,Protein FAM241B,i89-101o105-114i,121
Q96DW6,Mitochondrial glycine transporter (Appoptosin) (Mitochondrial glycine transporter GlyC) (Solute carrier family 25 member 38),i214-224o225-234i,304
Q96E52,"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Metalloprotease-related protein 1) (MPRP-1) (Overlapping with the m-AAA protease 1 homolog)",i192-202o203-212i,524
Q96FT7,"Acid-sensing ion channel 4 (ASIC4) (Amiloride-sensitive cation channel 4) (Amiloride-sensitive cation channel 4, pituitary)",i69-89o446-466i,539
Q96G97,Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein),i27-53o231-252i,398
Q96HD1,Protein disulfide isomerase CRELD1 (EC 5.3.4.1) (Cysteine-rich with EGF-like domain protein 1),o363-383i387-405o,420
Q96IX5,"ATP synthase membrane subunit K, mitochondrial (ATP synthase membrane subunit DAPIT, mitochondrial) (Diabetes-associated protein in insulin-sensitive tissues) (HCV F-transactivated protein 2) (Up-regulated during skeletal muscle growth protein 5)",i27-37o38-47i,58
Q8WTV0,"Scavenger receptor class B member 1 (SRB1) (CD36 and LIMPII analogous 1) (CLA-1) (CD36 antigen-like 1) (Collagen type I receptor, thrombospondin receptor-like 1) (SR-BI) (CD antigen CD36)",i9-29o440-464i,552
Q8WUU8,Transmembrane protein 174,i38-60o73-90i,243
Q8WW34,Transmembrane protein 239,i111-120o157-170i,195
Q8WWF5,E3 ubiquitin-protein ligase ZNRF4 (EC 2.3.2.27) (Nixin) (RING finger protein 204) (RING-type E3 ubiquitin transferase ZNRF4) (Zinc/RING finger protein 4),i85-94o255-275i,429
Q8WXF7,Atlastin-1 (EC 3.6.5.-) (Brain-specific GTP-binding protein) (GTP-binding protein 3) (GBP-3) (hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A),i449-462o479-494i,558
Q8WZ55,Barttin,i9-27o34-54i,320
Q96KR6,"Protein FAM210B, mitochondrial",i99-119o150-170i,192
Q96PD6,2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Diacylglycerol O-acyltransferase candidate 2) (hDC2) (Diacylglycerol acyltransferase 2-like protein 1) (Monoacylglycerol O-acyltransferase 1),i19-44o48-60i,335
Q96PD7,Diacylglycerol O-acyltransferase 2 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase 2),i76-96o100-111i,388
Q96RQ1,Endoplasmic reticulum-Golgi intermediate compartment protein 2,i33-52o314-340i,377
Q96S52,GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein),i19-36o519-538i,555
Q96TA2,ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1),i293-303o304-313i,773
Q99571,P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor),i28-49o343-361i,388
Q99572,P2X purinoceptor 7 (P2X7) (ATP receptor) (P2Z receptor) (Purinergic receptor),i28-48o330-355i,595
Q99712,"ATP-sensitive inward rectifier potassium channel 15 (Inward rectifier K(+) channel Kir1.3) (Inward rectifier K(+) channel Kir4.2) (Potassium channel, inwardly rectifying subfamily J member 15)",i67-91o143-161i,375
Q9BQA9,Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros),i23-40o49-60i,187
Q9BSE4,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein,i279-296o302-314i,406
Q9BSJ8,Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein),i54-75o76-91i,1104
Q9BUB7,"Transmembrane protein 70, mitochondrial",i107-127o140-162i,260
Q9BUR5,MICOS complex subunit MIC26 (Apolipoprotein O) (MICOS complex subunit MIC23) (Protein FAM121B),i108-118o119-128i,198
Q9BV35,Mitochondrial adenyl nucleotide antiporter SLC25A23 (Mitochondrial ATP-Mg/Pi carrier protein 2) (Short calcium-binding mitochondrial carrier protein 3) (SCaMC-3) (Solute carrier family 25 member 23),i376-385o388-400i,468
Q9BVV7,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",i109-119o120-129i,248
Q9BWM7,Sideroflexin-3,i225-236o237-246i,321
Q9BX74,TM2 domain-containing protein 1 (Amyloid-beta-binding protein) (hBBP),o123-132i146-168o,207
Q9BY50,Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21),i34-54o174-188i,192
Q9C0E8,Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark),i46-66o74-94i,428
Q9H3Z4,DnaJ homolog subfamily C member 5 (Ceroid-lipofuscinosis neuronal protein 4) (Cysteine string protein) (CSP),i104-114o115-125i,198
Q9H6L2,Transmembrane protein 231,i23-43o268-292i,316
Q9H813,Proton-activated chloride channel (PAC) (hPAC) (Acid-sensitive outwardly-rectifying anion channel) (ASOR) (Proton-activated outwardly rectifying anion channel) (PAORAC) (Transmembrane protein 206) (hTMEM206),i65-85o302-318i,350
Q9H9B4,Sideroflexin-1,i226-237o238-247i,322
Q9HBM0,Vezatin,i144-166o169-185i,779
Q9HC21,Mitochondrial thiamine pyrophosphate carrier (Mitochondrial thiamine pyrophosphate transporter) (MTPPT) (Mitochondrial uncoupling protein 1) (Solute carrier family 25 member 19),i289-300o301-310i,320
Q9HD23,"Magnesium transporter MRS2 homolog, mitochondrial (MRS2-like protein)",i342-361o373-393i,443
Q9NP85,Podocin,i103-113o114-123i,383
Q9NPA1,"Calcium-activated potassium channel subunit beta-3 (BK channel subunit beta-3) (BKbeta3) (Hbeta3) (Calcium-activated potassium channel, subfamily M subunit beta-3) (Charybdotoxin receptor subunit beta-3) (K(VCA)beta-3) (Maxi K channel subunit beta-3) (Slo-beta-3)",i59-80o210-230i,279
Q9NPI9,"Inward rectifier potassium channel 16 (Inward rectifier K(+) channel Kir5.1) (Potassium channel, inwardly rectifying subfamily J member 16)",i72-95o146-166i,418
Q9NQZ7,Ectonucleoside triphosphate diphosphohydrolase 7 (NTPDase 7) (EC 3.6.1.15) (Lysosomal apyrase-like protein 1),i29-49o552-570i,604
Q9NRX6,Protein kish-B (Transmembrane protein 167B),o9-24i48-69o,74
Q9NTJ5,Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein),i521-542o549-569i,587
Q9NV29,Transmembrane protein 100,i57-78o87-107i,134
Q9NV58,E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38),i373-383o384-393i,838
Q9NV96,Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A),i50-70o325-346i,361
Q9NVH1,DnaJ homolog subfamily C member 11,i383-393o394-403i,559
Q9NVI7,ATPase family AAA domain-containing protein 3A,i296-306o307-316i,634
Q9NW97,Transmembrane protein 51,i13-33o65-83i,253
Q9NWD8,Transmembrane protein 248,i20-41o266-290i,314
Q9NWR8,"Calcium uniporter regulatory subunit MCUb, mitochondrial (MCUb) (Coiled-coil domain-containing protein 109B)",i219-242o251-268i,336
Q9NX40,OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen),i43-63o73-92i,245
Q9NX62,"Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase (Golgi-resident PAP phosphatase) (gPAPP) (EC 3.1.3.7) (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Myo-inositol monophosphatase A3) (Phosphoadenosine phosphate 3'-nucleotidase)",i8-18o19-28i,359
Q9NXE4,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),i818-832o841-857i,866
Q9NXI6,E3 ubiquitin-protein ligase RNF186 (EC 2.3.2.27) (RING finger protein 186),i155-173o181-199i,227
Q9NY59,Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II),i57-75o76-85i,655
Q9P0J0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein) (GRIM-19) (Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit),i30-40o41-51i,144
Q9P0N8,E3 ubiquitin-protein ligase MARCHF2 (EC 2.3.2.27) (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II) (MARCH-II) (RING finger protein 172) (RING-type E3 ubiquitin transferase MARCHF2),i142-160o173-197i,246
Q9P246,Stromal interaction molecule 2,i215-225o226-235i,746
Q9P2E8,E3 ubiquitin-protein ligase MARCHF4 (EC 2.3.2.27) (Membrane-associated RING finger protein 4) (Membrane-associated RING-CH protein IV) (MARCH-IV) (RING finger protein 174) (RING-type E3 ubiquitin transferase MARCHF4),i238-257o272-292i,410
Q9P2X0,Dolichol-phosphate mannosyltransferase subunit 3 (Dolichol-phosphate mannose synthase subunit 3) (DPM synthase subunit 3) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 3) (Mannose-P-dolichol synthase subunit 3) (MPD synthase subunit 3) (Prostin-1),i4-26o38-58i,92
Q9UBI4,Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP),i58-68o69-79i,398
Q9UBL9,P2X purinoceptor 2 (P2X2) (ATP receptor) (Purinergic receptor),i41-62o342-367i,471
Q9UBX3,Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10),i200-210o211-220i,287
Q9UHC3,Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1),i43-60o438-457i,531
Q9UHE5,N-acetyltransferase 8 (EC 2.3.1.-) (Acetyltransferase 2) (ATase2) (Camello-like protein 1) (Cysteinyl-conjugate N-acetyltransferase) (CCNAT) (EC 2.3.1.80),i42-57o60-78i,227
Q9UHF3,Putative N-acetyltransferase 8B (EC 2.3.1.-) (Acetyltransferase 1) (ATase1) (Camello-like protein 2),i42-57o60-78i,227
Q9UL01,Dermatan-sulfate epimerase (DS epimerase) (EC 5.1.3.19) (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2) (SART-2),o903-923i934-950o,958
Q9UQ90,Paraplegin (EC 3.4.24.-) (Cell matrix adhesion regulator) (Spastic paraplegia 7 protein),i142-162o254-272i,795
Q9Y227,Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42),i34-54o565-583i,616
Q9Y241,"HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a)",o29-49i65-84o,93
Q9Y282,Endoplasmic reticulum-Golgi intermediate compartment protein 3 (Serologically defined breast cancer antigen NY-BR-84),i26-46o344-362i,383
Q9Y2U8,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),i473-493o628-649i,911
Q9Y4W6,AFG3-like protein 2 (EC 3.4.24.-) (Paraplegin-like protein),i146-163o253-271i,797
Q9Y5T4,DnaJ homolog subfamily C member 15 (Cell growth-inhibiting gene 22 protein) (Methylation-controlled J protein) (MCJ),i36-46o47-56i,150
Q9Y5U9,Immediate early response 3-interacting protein 1,o8-22i61-81o,82
Q9Y5W7,Sorting nexin-14,i30-46o49-69i,946
Q9Y5W8,Sorting nexin-13 (RGS domain- and PHOX domain-containing protein) (RGS-PX1),i10-31o32-50i,968
Q9Y619,Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15),i210-220o221-230i,301
Q9Y679,Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1),i25-37o38-47i,410
Q9Y691,"Calcium-activated potassium channel subunit beta-2 (BK channel subunit beta-2) (BKbeta2) (Hbeta2) (Calcium-activated potassium channel, subfamily M subunit beta-2) (Charybdotoxin receptor subunit beta-2) (Hbeta3) (K(VCA)beta-2) (Maxi K channel subunit beta-2) (Slo-beta-2)",i47-70o200-220i,235
Q9Y6A9,Signal peptidase complex subunit 1 (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit),i89-109o114-131i,169
Q9Y6N1,"Cytochrome c oxidase assembly protein COX11, mitochondrial",i96-106o107-116i,276
A0PJW6,Transmembrane protein 223,i45-67o96-116i,202
A6NNE9,E3 ubiquitin-protein ligase MARCHF11 (EC 2.3.2.27) (Membrane-associated RING finger protein 11) (Membrane-associated RING-CH protein XI) (MARCH-XI) (RING-type E3 ubiquitin transferase MARCHF11),i243-264o278-299i,402
A8MV81,HIG1 domain family member 1C,i27-47o64-83i,97
O71037,Endogenous retrovirus group K member 19 Env polyprotein (EnvK3 protein) (Envelope polyprotein) (HERV-K(C19) envelope protein) (HERV-K_19q11 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],i79-88o638-654i,699
P51689,Arylsulfatase D (ASD) (EC 3.1.6.-),o200-217i229-244o,593
P54793,Arylsulfatase F (ASF) (EC 3.1.6.1),o188-208i216-232o,590
P56378,"ATP synthase subunit ATP5MJ, mitochondrial (6.8 kDa mitochondrial proteolipid protein) (MLQ) (ATP synthase membrane subunit 6.8PL)",i20-30o31-40i,58
P56385,"ATP synthase subunit e, mitochondrial (ATPase subunit e) (ATP synthase membrane subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed]",i10-20o21-30i,69
P61565,Endogenous retrovirus group K member 21 Env polyprotein (EnvK1 protein) (Envelope polyprotein) (HERV-K_12q14.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],i75-90o637-646i,698
P63135,Endogenous retrovirus group K member 7 Pol protein (HERV-K(III) Pol protein) (HERV-K102 Pol protein) (HERV-K_1q22 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],i867-876o1397-1406i,1459
Q2VYF4,"LETM1 domain-containing protein LETM2, mitochondrial (LETM1 and EF-hand domain-containing protein 2) (Leucine zipper-EF-hand-containing transmembrane protein 1-like)",i175-185o186-195i,491
Q6P1S2,Protein C3orf33 (Protein AC3-33),i33-43o44-53i,294
Q86XT9,Insulin-like growth factor-binding protein 3 receptor (IGFBP-3R) (Transmembrane protein 219),i23-43o205-225i,240
Q8IWB9,Testis-expressed protein 2 (Transmembrane protein 96),i471-491o494-514i,1127
Q8IZ57,Neurensin-1 (Neuro-p24) (Vesicular membrane protein of 24 kDa) (Vesicular membrane protein p24),i64-84o117-136i,195
Q8IZU8,Dermatan-sulfate epimerase-like protein (EC 5.1.-.-),o774-789i800-820o,1212
Q8N0U2,Transmembrane protein 61,i18-38o69-87i,210
Q8TAV4,Stomatin-like protein 3 (SLP-3),i30-41o42-51i,291
Q8TBQ9,Protein kish-A (Transmembrane protein 167) (Transmembrane protein 167A),o10-24i56-71o,72
Q8TDW4,Suppressor of tumorigenicity 7 protein-like (ST7-related protein),i36-56o81-101i,575
Q8WVI0,Ubiquinol-cytochrome-c reductase complex assembly factor 5 (Small integral membrane protein 4),i22-33o34-43i,70
Q902F8,Endogenous retrovirus group K member 8 Env polyprotein (EnvK6 protein) (Envelope polyprotein) (HERV-K115 envelope protein) (HERV-K_8p23.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],i79-88o638-651i,699
Q902F9,Endogenous retrovirus group K member 113 Env polyprotein (EnvK5 protein) (Envelope polyprotein) (HERV-K113 envelope protein) (HERV-K_19p13.11 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],i79-88o638-654i,699
Q92806,"G protein-activated inward rectifier potassium channel 3 (GIRK-3) (Inward rectifier K(+) channel Kir3.3) (Potassium channel, inwardly rectifying subfamily J member 9)",i59-82o135-156i,393
Q96B77,Transmembrane protein 186,i76-93o103-124i,213
Q96GE9,Distal membrane-arm assembly complex protein 1 (Transmembrane protein 261),i52-69o84-104i,116
Q96H78,Solute carrier family 25 member 44,i222-232o233-242i,314
Q96I36,Cytochrome c oxidase assembly protein COX14,i10-25o26-35i,57
Q96ND0,Protein FAM210A,i136-156o187-209i,272
Q96NL1,Transmembrane protein 74,i178-198o232-252i,305
Q99442,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),i196-216o227-253i,399
Q9BSJ5,Uncharacterized protein C17orf80 (Cell migration-inducing gene 3 protein) (Human lung cancer oncogene 8 protein) (HLC-8),i552-562o563-572i,609
Q9BW72,"HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b)",i47-67o83-103i,106
Q9GZY4,Cytochrome c oxidase assembly factor 1 homolog (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa),i16-26o27-37i,146
Q9H061,Transmembrane protein 126A,i159-170o171-180i,195
Q9H6K4,Optic atrophy 3 protein,i80-90o91-100i,179
Q9H6X4,Transmembrane protein 134,i123-144o155-176i,195
Q9NY37,Acid-sensing ion channel 5 (ASIC5) (Amiloride-sensitive cation channel 5) (Human intestine Na(+) channel) (HINaC),i63-82o448-468i,505
Q9UJG1,Motile sperm domain-containing protein 1,i160-176o197-211i,213
Q9UKH3,Endogenous retrovirus group K member 9 Env polyprotein (EnvK4 protein) (Envelope polyprotein) (HERV-K(C6) envelope protein) (HERV-K109 envelope protein) (HERV-K_6q14.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],i79-88o637-650i,698
Q9UNX9,"ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K(+) channel Kir2.4) (IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14)",i88-111o162-182i,436
A4D0V7,Cadherin-like and PC-esterase domain-containing protein 1,o30i499-508o,1026
A6NJY4,Transmembrane protein 238-like (FOXA1-regulated conserved small protein) (FORCP),i17-37o46-64i,79
A6PVL3,Kinocilin,i15-33o40-60i,124
E9PQ53,"NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2 (NDUFC2-KCTD14 readthrough transcript protein)",i30-47o61-75i,114
P0C7V7,Putative signal peptidase complex catalytic subunit SEC11B (EC 3.4.21.89) (SEC11 homolog B) (SEC11-like protein 2),i10-30o151-163i,166
P0C851,Phosphoinositide-interacting protein,i56-77o91-110i,137
P61570,Endogenous retrovirus group K member 25 Env polyprotein (Envelope polyprotein) (HERV-K_11q22.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],i79-88o638-651i,661
Q2WGJ8,Cation channel sperm-associated auxiliary subunit TMEM249 (Transmembrane protein 249),i61-78o89-104i,235
Q4VC39,Putative HIG1 domain family member 2B (HIG1 domain family member 2B pseudogene),i47-67o83-102i,106
Q56VL3,OCIA domain-containing protein 2 (Ovarian carcinoma immunoreactive antigen-like protein),i51-71o81-100i,154
Q5FYA8,Arylsulfatase H (ASH) (EC 3.1.6.-),o163-183i196-211o,562
Q5H9E4,Solute carrier family 25 member 53 (Mitochondrial carrier triple repeat protein 6),i211-221o222-235i,307
Q5SV17,Transmembrane protein 240,i7-27o88-111i,173
Q6P5X7,Transmembrane protein 71,i233-253o257-273i,295
Q7L211,Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13),i30-40o41-57i,337
Q86VY9,Transmembrane protein 200A,i63-84o127-143i,491
Q8IW70,Transmembrane protein 151B (Transmembrane protein 193),i65-85o112-132i,566
Q8IYS2,Uncharacterized protein KIAA2013,i18-36o592-614i,634
Q8N7S2,DnaJ homolog subfamily C member 5G (Cysteine string protein-gamma) (CSP-gamma),i122-132o133-142i,189
Q8WUT9,Solute carrier family 25 member 43,i202-212o213-222i,341
Q8WUY8,Probable N-acetyltransferase 14 (EC 2.3.1.-) (K562 cell-derived leucine-zipper-like protein 1),i44-59o62-77i,206
Q8WWA1,Transmembrane protein 40,i160-177o184-204i,233
Q96DS6,Membrane-spanning 4-domains subfamily A member 6E,i54-73o121-137i,147
Q96SK2,Transmembrane protein 209,i28-47o63-83i,561
Q9BRN9,TM2 domain-containing protein 3 (Beta-amyloid-binding protein-like protein 2) (BBP-like protein 2),o187-196i213-233o,247
Q9BX73,TM2 domain-containing protein 2 (Beta-amyloid-binding protein-like protein 1) (BBP-like protein 1),o150-165i174-199o,214
Q9GZP1,Neurensin-2,i64-86o117-139i,204
Q9HBL7,Plasminogen receptor (KT) (Plg-R(KT)),i53-73o80-97i,147
Q9NNZ3,DnaJ homolog subfamily C member 4 (DnaJ-like protein HSPF2) (Multiple endocrine neoplasia type 1 candidate protein number 18),i156-166o167-176i,241
Q9UF47,DnaJ homolog subfamily C member 5B (Cysteine-string protein isoform beta) (CSP-beta),i108-119o120-129i,199
A6NKF7,Transmembrane protein 88B,i63-77o105-125i,163
A6NKL6,Transmembrane protein 200C (Transmembrane protein TTMA) (Two transmembrane domain-containing family member A),i53-73o165-183i,621
A8MTT3,Protein CEBPZOS (CEBPZ antisense RNA 1) (CEBPZ opposite strand),i12-22o23-32i,80
A8MXV6,CMT1A duplicated region transcript 15 protein-like protein,i206-216o217-227i,281
C9JI98,Transmembrane protein 238,i38-58o69-89i,176
H3BR10,Small leucine-rich protein 1,i22-38o53-73i,107
O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial (Cytochrome c oxidase subunit VIIa 3)",i53-75o86-96i,106
O95873,Uncharacterized protein C6orf47 (Protein G4),i222-239o246-260i,294
Q17RQ9,NTPase KAP family P-loop domain-containing protein 1,i118-138o157-171i,610
Q3MIP1,"Inositol 1,4,5-trisphosphate receptor-interacting protein-like 2",i11-27o53-63i,535
Q5T2N8,ATPase family AAA domain-containing protein 3C,i71-81o82-91i,411
Q5VZI3,Transmembrane protein 268,i104-124o132-152i,342
Q629K1,Triple QxxK/R motif-containing protein (Triple repetitive-sequence of QXXK/R protein homolog),i51-61o62-71i,86
Q68D42,Transmembrane protein 215,i12-32o40-60i,235
Q69YZ2,Transmembrane protein 200B (Transmembrane protein TTMA) (Two transmembrane domain-containing family member B),i54-74o114-132i,307
Q6PIV7,Solute carrier family 25 member 34,i206-215o218-227i,304
Q7L0L9,Transmembrane protein LOC653160,o57-82i94-114o,218
Q8N0W7,FMR1 neighbor protein (Cancer/testis antigen 37) (CT37) (Sarcoma antigen NY-SAR-35),i69-90o184-204i,255
Q8N4L1,Transmembrane protein 151A,i45-65o97-115i,468
Q8N6L7,Transmembrane protein 252,i7-28o40-60i,170
Q8N8J7,Uncharacterized protein FAM241A,i92-113o114-123i,132
Q96EX1,Small integral membrane protein 12,i15-25o26-35i,92
Q96I45,Transmembrane protein 141,i34-53o60-79i,108
Q9BQ49,Small integral membrane protein 7,o5-19i56-72o,75
Q9C002,Normal mucosa of esophagus-specific gene 1 protein (Protein FOAP-11),i12-22o23-33i,83
Q9HC47,Cutaneous T-cell lymphoma-associated antigen 1 (Protein cTAGE-1) (Cancer/testis antigen 21.1) (CT21.1),i22o47-67i,74
Q9NPB0,SAYSvFN domain-containing protein 1,i97-118o119-136i,183
Q9NUB4,Uncharacterized protein C20orf141,i47-64o71-85i,165
Q9NUR3,Transmembrane protein 74B,i123-143o177-197i,256
Q9P298,HIG1 domain family member 1B (Protein CLST 11240),i29-49o66-86i,99
A0A0U1RQS6,Transmembrane protein 275,i33-53o61-79i,177
O60906,Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase) (nSMase1),i326-346o353-373i,423
O60928,"Inward rectifier potassium channel 13 (Inward rectifier K(+) channel Kir7.1) (Potassium channel, inwardly rectifying subfamily J member 13)",i55-77o135-155i,360
O75129,Astrotactin-2,o209-229i439-448o,1339
O75355,Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3) (Ecto-apyrase 3) (HB6),i23-43o490-510i,529
A0A087X1C5,Putative cytochrome P450 2D7 (EC 1.14.14.1),o6-23i,515
A0A0B4J2F0,Protein PIGBOS1 (PIGB opposite strand protein 1),o7-29i,54
A0A0K2S4Q6,Protein CD300H (CD300 antigen-like family member H),o168-190i,201
A0A1B0GTW7,Ciliated left-right organizer metallopeptidase (EC 3.4.24.-) (Leishmanolysin-like peptidase 2),o738-753i,788
A1L0T0,2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein),o17-33i,632
A2A2Y4,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),i531-550o,597
A2VDJ0,Transmembrane protein 131-like,o870-890i,1609
A6BM72,Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11),o851-871i,1044
A6NGU5,Putative glutathione hydrolase 3 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 3) (Putative gamma-glutamyltranspeptidase 3) (GGT 3) (EC 2.3.2.2) [Cleaved into: Putative glutathione hydrolase 3 heavy chain; Putative glutathione hydrolase 3 light chain],i5-25o,568
A6NI73,Leukocyte immunoglobulin-like receptor subfamily A member 5 (CD85 antigen-like family member F) (Immunoglobulin-like transcript 11) (ILT-11) (Leukocyte immunoglobulin-like receptor 9) (LIR-9) (CD antigen CD85f),o266-284i,299
A6NL88,Protein shisa-7 (Cystine-knot AMPAR modulating protein of 59 kDa) (CKAMP59) (GABA(A) receptor auxiliary subunit Shisa7) (Protein shisa-6-like),o186-206i,538
A8K4G0,CMRF35-like molecule 7 (CLM-7) (CD300 antigen-like family member B) (CMRF35-A2) (Immune receptor expressed on myeloid cells 3) (IREM-3) (Leukocyte mono-Ig-like receptor 5) (Triggering receptor expressed on myeloid cells 5) (TREM-5) (CD antigen CD300b),o152-172i,201
A8MVW5,HEPACAM family member 2 (Mitotic kinetics regulator),o351-371i,462
B2RUZ4,Small integral membrane protein 1 (Vel blood group antigen),i50-70o,78
B6A8C7,"T-cell-interacting, activating receptor on myeloid cells protein 1 (OSCAR-like transcript-2 protein) (OLT-2)",o232-252i,271
D3W0D1,Killer cell lectin-like receptor subfamily F member 2 (Lectin-like receptor F2) (Activating coreceptor NKp65),i34-51o,207
E0CX11,Short transmembrane mitochondrial protein 1,o4-19i,47
K7EJ46,Small integral membrane protein 22 (Cancer-associated small integral membrane open reading frame 1),o32-53i,83
O00168,Phospholemman (FXYD domain-containing ion transport regulator 1) (Sodium/potassium-transporting ATPase subunit FXYD1),o38-56i,92
O00198,Activator of apoptosis harakiri (BH3-interacting domain-containing protein 3) (Neuronal death protein DP5),i71-86o,91
O00206,Toll-like receptor 4 (hToll) (CD antigen CD284),o632-652i,839
O00220,Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1) (TRAIL receptor 1) (TRAIL-R1) (CD antigen CD261),o242-260i,468
O00238,Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (CD antigen CDw293),o127-148i,502
O00241,Signal-regulatory protein beta-1 (SIRP-beta-1) (CD172 antigen-like family member B) (CD antigen CD172b),o371-391i,398
O00264,Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA),o32-43i,195
O00391,Sulfhydryl oxidase 1 (hQSOX) (EC 1.8.3.2) (Quiescin Q6),o710-731i,747
O00445,Synaptotagmin-5 (Synaptotagmin V) (SytV),o30-50i,386
O00453,Leukocyte-specific transcript 1 protein (Protein B144),o12-32i,97
O00461,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",i13-33o,696
O00478,Butyrophilin subfamily 3 member A3,o251-271i,584
O00481,Butyrophilin subfamily 3 member A1 (CD antigen CD277),o251-271i,513
O00483,Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit),i13-35o,81
O00519,Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase) (EC 3.1.1.-) (Oleamide hydrolase 1),o15-29i,579
O00526,Uroplakin-2 (UP2) (Uroplakin II) (UPII),o159-179i,184
O00533,Neural cell adhesion molecule L1-like protein (Close homolog of L1) [Cleaved into: Processed neural cell adhesion molecule L1-like protein],o1083-1103i,1208
O00548,Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1),o546-566i,723
O00592,Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1),o461-481i,558
O00631,Sarcolipin,i8-26o,31
O14522,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),o747-768i,1441
O14523,Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like) (C2CD2-like) (Transmembrane protein 24),o10-31i,706
O14638,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (NPP3) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)],i23-44o,875
O14653,Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin),i191-211o,212
O14656,Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A) (EC 3.6.4.-) (Torsin family 1 member A),o26-35i,332
O14657,Torsin-1B (Torsin ATPase-1B) (EC 3.6.4.-) (Torsin family 1 member B),o28-37i,336
O14662,Syntaxin-16 (Syn16),i302-322o,325
O14669,Transmembrane gamma-carboxyglutamic acid protein 2 (Proline-rich gamma-carboxyglutamic acid protein 2) (Proline-rich Gla protein 2),o110-130i,202
O14672,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),o678-698i,748
O14756,17-beta-hydroxysteroid dehydrogenase type 6 (17-beta-HSD 6) (17-beta-HSD6) (EC 1.1.1.105) (EC 1.1.1.209) (EC 1.1.1.239) (EC 1.1.1.53) (EC 1.1.1.62) (3-alpha->beta-hydroxysteroid epimerase) (3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 6),o15i,317
O14763,Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262),o214-232i,440
O14786,Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304),o859-879i,923
O14788,"Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]",i48-68o,317
O14798,Tumor necrosis factor receptor superfamily member 10C (Antagonist decoy receptor for TRAIL/Apo-2L) (Decoy TRAIL receptor without death domain) (Decoy receptor 1) (DcR1) (Lymphocyte inhibitor of TRAIL) (TNF-related apoptosis-inducing ligand receptor 3) (TRAIL receptor 3) (TRAIL-R3) (TRAIL receptor without an intracellular domain) (CD antigen CD263),o244-258i,259
O14836,Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267),o163-183i,293
O14917,Protocadherin-17 (Protocadherin-68),o706-721i,1159
O14931,Natural cytotoxicity triggering receptor 3 (Activating natural killer receptor p30) (Natural killer cell p30-related protein) (NK-p30) (NKp30) (CD antigen CD337),o140-160i,201
O14944,Proepiregulin [Cleaved into: Epiregulin (EPR)],o119-140i,169
O14949,Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C),i40-68o,82
O14967,Calmegin,o470-492i,610
O14975,"Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase)",o4-19i,620
O15031,Plexin-B2 (MM1),o1200-1218i,1838
O15146,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)",o496-516i,869
O15155,BET1 homolog (hBET1) (Golgi vesicular membrane-trafficking protein p18),i96-115o,118
O15165,Low-density lipoprotein receptor class A domain-containing protein 4,o68-87i,306
O15173,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),o54-68i,223
O15197,Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6),o600-618i,1021
O15239,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE) (CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit),o6-26i,70
O15269,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),o16-36i,473
O15389,Sialic acid-binding Ig-like lectin 5 (Siglec-5) (CD33 antigen-like 2) (Obesity-binding protein 2) (OB-BP2) (OB-binding protein 2) (CD antigen CD170),o439-462i,551
O15393,Transmembrane protease serine 2 (EC 3.4.21.122) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain],i84-105o,492
O15394,Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2),o705-725i,837
O15400,Syntaxin-7,i239-259o,261
O15455,Toll-like receptor 3 (CD antigen CD283),o702-723i,904
O15466,"Alpha-2,8-sialyltransferase 8E (EC 2.4.99.-) (Sialyltransferase 8E) (SIAT8-E) (Sialyltransferase St8Sia V) (ST8SiaV)",i17-37o,376
O15533,Tapasin (TPN) (TPSN) (NGS-17) (TAP-associated protein) (TAP-binding protein),o414-437i,448
O42043,"Endogenous retrovirus group K member 18 Env polyprotein (Envelope polyprotein) (HERV-K(C1a) envelope protein) (HERV-K110 envelope protein) (HERV-K18 envelope protein) (HERV-K18 superantigen) (HERV-K_1q23.3 provirus ancestral Env polyprotein) (IDDMK1,2 22 envelope protein) (IDDMK1,2 22 superantigen) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)]",o526-535i,560
O43155,Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2),o542-562i,660
O43157,Plexin-B1 (Semaphorin receptor SEP),o1491-1509i,2135
O43169,Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform),i125-140o,150
O43173,"Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase (EC 2.4.99.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII)",i9-30o,380
O43174,Cytochrome P450 26A1 (CYP26A1) (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome),o28i,497
O43184,Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha),o709-729i,909
O43278,Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1) (HAI-1),o468-488i,529
O43286,"Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5)",i14-34o,388
O43291,Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2) (HAI-2) (Placental bikunin),o200-221i,252
O43300,Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein),o423-443i,516
O43451,"Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)",i14-34o,2753
O43464,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)",i112-121o,458
O43493,Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46) (TGN38 homolog) (hTGN46) (Trans-Golgi network glycoprotein 48) (hTGN48) (Trans-Golgi network glycoprotein 51) (hTGN51) (Trans-Golgi network protein 2),o385-402i,437
O43506,Disintegrin and metalloproteinase domain-containing protein 20 (ADAM 20) (EC 3.4.24.-),o691-711i,726
O43508,"Tumor necrosis factor ligand superfamily member 12 (APO3 ligand) (TNF-related weak inducer of apoptosis) (TWEAK) [Cleaved into: Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form]",i22-42o,249
O43556,Epsilon-sarcoglycan (Epsilon-SG),o317-338i,437
O43557,"Tumor necrosis factor ligand superfamily member 14 (Herpes virus entry mediator ligand) (HVEM-L) (Herpesvirus entry mediator ligand) (CD antigen CD258) [Cleaved into: Tumor necrosis factor ligand superfamily member 14, membrane form; Tumor necrosis factor ligand superfamily member 14, soluble form]",i38-58o,240
O43561,Linker for activation of T-cells family member 1 (36 kDa phosphotyrosine adapter protein) (pp36) (p36-38),o7-27i,262
O43567,E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13),o184-204i,381
O43570,Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3),o304-326i,354
O43581,Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII),o17-37i,403
O75396,Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1),i192-210o,215
O75427,Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein),i659-678o,683
O75445,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),o5042-5063i,5202
O75452,Retinol dehydrogenase 16 (EC 1.1.1.105) (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (Human epidermal retinol dehydrogenase) (hRDH-E) (Microsomal NAD(+)-dependent retinol dehydrogenase 4) (RoDH-4) (Short chain dehydrogenase/reductase family 9C member 8) (Sterol/retinol dehydrogenase),o15i,317
O75460,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],o444-463i,977
O75462,Cytokine receptor-like factor 1 (Cytokine-like factor 1) (CLF-1) (ZcytoR5),o362-371i,422
O75477,Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1) (Protein KE04) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1) (SPFH domain-containing protein 1),o8-22i,348
O75509,Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358),o350-370i,655
O75578,Integrin alpha-10,o1125-1145i,1167
O75581,Low-density lipoprotein receptor-related protein 6 (LRP-6),o1374-1394i,1613
O75631,Uroplakin-3a (UP3a) (Uroplakin III) (UPIII),o209-232i,287
O75752,"UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (Beta-1,3-GalNAc-T1) (EC 2.4.1.79) (Beta-1,3-galactosyltransferase 3) (Beta-1,3-GalTase 3) (Beta3Gal-T3) (Beta3GalT3) (b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)",i18-34o,331
O75787,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment],o312-330i,350
O75795,UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT),o492-517i,530
O75829,Leukocyte cell-derived chemotaxin 1 (Chondromodulin) [Cleaved into: Chondrosurfactant protein (CH-SP); Chondromodulin-1 (Chondromodulin-I) (ChM-I)],i42-64o,334
O75871,Carcinoembryonic antigen-related cell adhesion molecule 4 (CEA cell adhesion molecule 4) (Carcinoembryonic antigen CGM7) (Non-specific cross-reacting antigen W236),o156-176i,244
O75880,"Protein SCO1 homolog, mitochondrial",i95-112o,301
O75881,Cytochrome P450 7B1 (24-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.26) (25/26-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.29) (3-hydroxysteroid 7-alpha hydroxylase) (Oxysterol 7-alpha-hydroxylase),o22-33i,506
O75888,Tumor necrosis factor ligand superfamily member 13 (A proliferation-inducing ligand) (APRIL) (TNF- and APOL-related leukocyte expressed ligand 2) (TALL-2) (TNF-related death ligand 1) (TRDL-1) (CD antigen CD256),i29-49o,250
O75923,Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1),i2046-2066o,2080
O75976,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),o1300-1320i,1380
O76036,Natural cytotoxicity triggering receptor 1 (Lymphocyte antigen 94 homolog) (NK cell-activating receptor) (Natural killer cell p46-related protein) (NK-p46) (NKp46) (hNKp46) (CD antigen CD335),o256-274i,304
O76095,Protein JTB (Jumping translocation breakpoint protein) (Prostate androgen-regulated protein) (PAR protein),o106-126i,146
O94766,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)",i8-25o,335
O94856,Neurofascin,o1218-1238i,1347
O94898,Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2),o808-828i,1065
O94901,SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1),i292-306o,785
O94923,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),i12-28o,617
O94933,SLIT and NTRK-like protein 3,o656-676i,977
O94985,Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)],o862-880i,981
O94991,SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11),o665-688i,958
O95139,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 (Complex I-B17) (CI-B17) (NADH-ubiquinone oxidoreductase B17 subunit),i64-86o,128
O95150,"Tumor necrosis factor ligand superfamily member 15 (TNF ligand-related molecule 1) (Vascular endothelial cell growth inhibitor) [Cleaved into: Tumor necrosis factor ligand superfamily member 15, membrane form; Tumor necrosis factor ligand superfamily member 15, secreted form]",i36-56o,251
O95159,Zinc finger protein-like 1 (Zinc finger protein MCG4),i265-283o,310
O95168,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (Complex I-B15) (CI-B15) (NADH-ubiquinone oxidoreductase B15 subunit),i87-105o,129
O95169,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)",i126-146o,186
O95183,Vesicle-associated membrane protein 5 (VAMP-5) (Myobrevin),i71-91o,116
O95185,Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C),o379-401i,931
O95196,Chondroitin sulfate proteoglycan 5 (Acidic leucine-rich EGF-like domain-containing brain protein) (Neuroglycan C),o421-444i,566
O95206,Protocadherin-8 (Arcadlin),o751-771i,1070
O95249,Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28),i231-249o,250
O95256,Interleukin-18 receptor accessory protein (IL-18 receptor accessory protein) (IL-18RAcP) (EC 3.2.2.6) (Accessory protein-like) (AcPL) (CD218 antigen-like family member B) (CDw218b) (IL-1R accessory protein-like) (IL-1RAcPL) (Interleukin-1 receptor 7) (IL-1R-7) (IL-1R7) (Interleukin-18 receptor accessory protein-like) (Interleukin-18 receptor beta) (IL-18R-beta) (IL-18Rbeta) (CD antigen CD218b),o360-380i,599
O95292,Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C),i224-241o,243
O95297,Myelin protein zero-like protein 1 (Protein zero-related),o169-190i,269
O95461,"Xylosyl- and glucuronyltransferase LARGE1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) (LARGE xylosyl- and glucuronyltransferase 1) [Includes: Alpha-1,3-xylosyltransferase LARGE1 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE1 (EC 2.4.1.-)]",i11-30o,756
O95470,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),o40-56i,568
O95479,GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (GDH) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)],o28-37i,791
O95672,Endothelin-converting enzyme-like 1 (EC 3.4.24.-) (Xce protein),i62-82o,775
O95727,Cytotoxic and regulatory T-cell molecule (Class-I MHC-restricted T-cell-associated molecule) (CD antigen CD355),o290-310i,393
O95754,Semaphorin-4F (Semaphorin-M) (Sema M) (Semaphorin-W) (Sema W),o659-680i,770
O95803,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (Glucosaminyl N-deacetylase/N-sulfotransferase 3) (NDST-3) (hNDST-3) (N-heparan sulfate sulfotransferase 3) (N-HSST 3) [Includes: Heparan sulfate N-deacetylase NDST3 (EC 3.-.-.-); [heparan sulfate]-glucosamine N-sulfotransferase NDST3 (EC 2.8.2.8)],i14-30o,873
O95866,Megakaryocyte and platelet inhibitory receptor G6b (Protein G6b),o143-163i,241
O95944,Natural cytotoxicity triggering receptor 2 (Lymphocyte antigen 95 homolog) (NK cell-activating receptor) (Natural killer cell p44-related protein) (NK-p44) (NKp44) (CD antigen CD336),o194-214i,276
O96024,"Beta-1,3-galactosyltransferase 4 (Beta-1,3-GalTase 4) (Beta3Gal-T4) (Beta3GalT4) (GalT4) (b3Gal-T4) (EC 2.4.1.62) (Gal-T2) (Ganglioside galactosyltransferase) (UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase)",i5-23o,378
P00167,Cytochrome b5 (Microsomal cytochrome b5 type A) (MCB5),i113-131o,134
P00533,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),o646-667i,1210
P01019,Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4],o130-157i,485
P01130,Low-density lipoprotein receptor (LDL receptor),o790-810i,860
P01133,Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor (Urogastrone)],o1034-1054i,1207
P01135,Protransforming growth factor alpha [Cleaved into: Transforming growth factor alpha (TGF-alpha) (EGF-like TGF) (ETGF) (TGF type 1)],o99-121i,160
P01375,"Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]",i31-51o,233
P01589,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25),o241-261i,272
P01730,T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4),o397-418i,458
P01732,T-cell surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen T8/Leu-2) (CD antigen CD8a),o183-205i,235
P01833,Polymeric immunoglobulin receptor (PIgR) (Poly-Ig receptor) (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component],o640-660i,764
P01850,T cell receptor beta constant 1,o146-170i,176
P01854,Immunoglobulin heavy constant epsilon (Ig epsilon chain C region) (Ig epsilon chain C region ND),o496-518i,546
P01857,Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE),o351-371i,399
P01859,Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE),o347-367i,395
P01860,Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region),o398-418i,446
P01861,Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region),o348-368i,396
P01871,Immunoglobulin heavy constant mu (Ig mu chain C region) (Ig mu chain C region BOT) (Ig mu chain C region GAL) (Ig mu chain C region OU),o451-471i,474
P01876,Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO),o363-383i,398
P01877,Immunoglobulin heavy constant alpha 2 (Ig alpha-2 chain C region) (Ig alpha-2 chain C region BUT) (Ig alpha-2 chain C region LAN),o356-376i,391
P01880,Immunoglobulin heavy constant delta (Ig delta chain C region) (Ig delta chain C region NIG-65) (Ig delta chain C region WAH),o403-427i,430
P01889,"HLA class I histocompatibility antigen, B alpha chain (Human leukocyte antigen B) (HLA-B)",o311-331i,362
P01893,"Putative HLA class I histocompatibility antigen, alpha chain H (HLA-12.4) (HLA-AR) (MHC class I antigen H)",o308-332i,362
P01903,"HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)",o218-239i,254
P01906,"HLA class II histocompatibility antigen, DQ alpha 2 chain (DX alpha chain) (HLA class II histocompatibility antigen, DQ(6) alpha chain) (HLA-DQA1) (MHC class II DQA2)",o219-240i,255
P01909,"HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)",o218-239i,254
P01911,"HLA class II histocompatibility antigen, DRB1 beta chain (Human leukocyte antigen DRB1) (HLA-DRB1)",o228-248i,266
P01920,"HLA class II histocompatibility antigen, DQ beta 1 chain (MHC class II antigen DQB1)",o231-251i,261
P02724,Glycophorin-A (MN sialoglycoprotein) (PAS-2) (Sialoglycoprotein alpha) (CD antigen CD235a),o94-114i,150
P02786,"Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]",i66-86o,760
P03928,ATP synthase protein 8 (A6L) (F-ATPase subunit 8),o12-23i,68
P04233,HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (CD antigen CD74) [Cleaved into: Class-II-associated invariant chain peptide (CLIP)],i48-72o,296
P04234,T-cell surface glycoprotein CD3 delta chain (T-cell receptor T3 delta chain) (CD antigen CD3d),o107-125i,171
P04439,"HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)",o308-332i,365
P04440,"HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)",o226-246i,258
P04626,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),o654-674i,1255
P04629,High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA),o418-439i,796
P04798,Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),o26i,512
P04843,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1),o435-455i,607
P04921,Glycophorin-C (Glycoconnectin) (Glycophorin-D) (GPD) (Glycoprotein beta) (PAS-2') (Sialoglycoprotein D) (CD antigen CD236),o61-81i,128
P05026,Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1),i36-56o,303
P05067,Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],o701-721i,770
P05106,Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61),o719-744i,788
P05107,"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)",o703-723i,769
P05177,Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),o28i,516
P05181,Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J),o23i,493
P05362,Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54),o481-503i,532
P05538,"HLA class II histocompatibility antigen, DQ beta 2 chain (HLA class II histocompatibility antigen, DX beta chain) (MHC class II antigen DQB2)",o230-250i,268
P05556,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),o729-754i,798
P05981,Serine protease hepsin (EC 3.4.21.106) (Transmembrane protease serine 1) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain],i18-39o,417
P06028,Glycophorin-B (PAS-3) (SS-active sialoglycoprotein) (Sialoglycoprotein delta) (CD antigen CD235b),o61-81i,91
P06126,T-cell surface glycoprotein CD1a (T-cell surface antigen T6/Leu-6) (hTa1 thymocyte antigen) (CD antigen CD1a),o300-321i,327
P06127,T-cell surface glycoprotein CD5 (Lymphocyte antigen T1/Leu-1) (CD antigen CD5),o383-398i,495
P06133,UDP-glucuronosyltransferase 2B4 (UDPGT 2B4) (UGT2B4) (EC 2.4.1.17) (HLUG25) (Hyodeoxycholic acid-specific UDPGT) (UDPGTh-1),o491-515i,528
P06213,Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta],o958-978i,1382
P06340,"HLA class II histocompatibility antigen, DO alpha chain (MHC DN-alpha) (MHC DZ alpha) (MHC class II antigen DOA)",o219-240i,250
P06396,Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin),o27i,782
P06729,T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2),o213-234i,351
P06731,Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e),o691-701i,702
P06734,Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form],i24-44o,321
P06756,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain],o996-1016i,1048
P07099,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH),o3-16i,455
P07202,Thyroid peroxidase (TPO) (EC 1.11.1.8),o850-870i,933
P07204,Thrombomodulin (TM) (Fetomodulin) (CD antigen CD141),o517-537i,575
P07306,Asialoglycoprotein receptor 1 (ASGP-R 1) (ASGPR 1) (C-type lectin domain family 4 member H1) (Hepatic lectin H1) (HL-1),i41-60o,291
P07307,Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2),i56-74o,311
P07333,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115),o518-538i,972
P07359,Platelet glycoprotein Ib alpha chain (GP-Ib alpha) (GPIb-alpha) (GPIbA) (Glycoprotein Ibalpha) (Antigen CD42b-alpha) (CD antigen CD42b) [Cleaved into: Glycocalicin],o533-553i,652
P07766,T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e),o133-151i,207
P07949,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],o637-657i,1114
P08069,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],o936-957i,1367
P08138,Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD antigen CD271),o252-272i,427
P08195,Amino acid transporter heavy chain SLC3A2 (4F2 cell-surface antigen heavy chain) (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98),i183-205o,630
P08473,Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10),i31-48o,750
P08514,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]",o997-1019i,1039
P08575,Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45),o578-598i,1306
P08581,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),o934-955i,1390
P08637,Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a),o209-229i,254
P08648,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain],o1000-1020i,1049
P08684,"Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)",o25i,503
P08887,Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)],o367-388i,468
P08910,Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Lung alpha/beta hydrolase 2) (Progesterone-sensitive lipase) (EC 3.1.1.79) (Protein PHPS1-2),o13-30i,425
P08922,Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase),o1862-1882i,2347
P08F94,Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin) (Tigmin),o3858-3878i,4074
P09326,CD48 antigen (B-lymphocyte activation marker BLAST-1) (BCM1 surface antigen) (Leukocyte antigen MEM-102) (SLAM family member 2) (SLAMF2) (Signaling lymphocytic activation molecule 2) (TCT.1) (CD antigen CD48),o225-242i,243
P09564,T-cell antigen CD7 (GP40) (T-cell leukemia antigen) (T-cell surface antigen Leu-9) (TP41) (CD antigen CD7),o181-200i,240
P09601,Heme oxygenase 1 (HO-1) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 1 soluble form],i270-287o,288
P09603,Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) (Proteoglycan macrophage colony-stimulating factor) (PG-M-CSF) [Cleaved into: Processed macrophage colony-stimulating factor 1; Macrophage colony-stimulating factor 1 43 kDa subunit],o497-517i,554
P09619,Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b),o532-554i,1106
P09669,Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide VIc),i19-39o,75
P09693,T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g),o118-136i,182
P09758,Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1),o277-297i,323
P09848,Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)],o1882-1902i,1927
P09958,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE),o716-736i,794
P0DMS9,Transmembrane domain-containing protein TMIGD3,o213-233i,266
P0DN84,Sarcoplasmic/endoplasmic reticulum calcium ATPase regulator DWORF (SERCA regulator DWORF) (Dwarf open reading frame) (DWORF) (Small transmembrane regulator of ion transport 1),i12-32o,35
P0DPD6,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),i109-129o,811
P0DPD8,EEF1AKMT4-ECE2 readthrough transcript protein (EC 3.4.24.71) [Includes: Methyltransferase-like region (EC 2.1.1.-); Endothelin-converting enzyme 2 region (EC 3.4.24.71)],i180-201o,883
P0DTE4,UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17),o491-512i,527
P0DTE5,UDP-glucuronosyltransferase 2A2 (UDPGT 2A2) (EC 2.4.1.17),o500-521i,536
P0DTU3,T cell receptor alpha chain MC.7.G5 (MC.7.G5 TRA) (TR alpha chain TRAV38-2DV8*01J31*01C*01),o249-270i,275
P0DTU4,T cell receptor beta chain MC.7.G5 (TR beta chain TRBV25-1*01J2S3*01C2*01) (MC.7.G5 TRB),o283-306i,315
P10176,"Cytochrome c oxidase subunit 8A, mitochondrial (Cytochrome c oxidase polypeptide VIII-liver/heart) (Cytochrome c oxidase subunit 8-2)",i40-60o,69
P10253,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase],i12-32o,952
P10321,"HLA class I histocompatibility antigen, C alpha chain (HLA-C) (HLA-Cw) (Human leukocyte antigen C)",o308-332i,366
P10586,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR),o1261-1283i,1907
P10632,Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase),o7-20i,490
P10635,Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase),o6-23i,497
P10721,Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117),o525-543i,976
P10747,T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28),o155-177i,220
P10912,Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)],o267-287i,638
P10966,T-cell surface glycoprotein CD8 beta chain (CD antigen CD8b),o171-191i,210
P11117,Lysosomal acid phosphatase (LAP) (EC 3.1.3.2),o382-404i,423
P11215,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b),o1108-1128i,1152
P11279,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),o384-405i,417
P11362,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331),o375-395i,822
P11509,"Cytochrome P450 2A6 (EC 1.14.14.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIA6) (Coumarin 7-hydroxylase) (Cytochrome P450 IIA3) (Cytochrome P450(I))",o21i,494
P11511,Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase),o42i,503
P11686,Pulmonary surfactant-associated protein C (SP-C) (Pulmonary surfactant-associated proteolipid SPL(Val)) (SP5),i36-56o,197
P11712,Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase),o4-17i,490
P11717,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),o2310-2326i,2491
P11912,B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a),o144-164i,226
P12074,"Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver) (Cytochrome c oxidase subunit VIA-liver) (COX VIa-L)",i37-58o,109
P12314,High affinity immunoglobulin gamma Fc receptor I (IgG Fc receptor I) (Fc-gamma RI) (FcRI) (Fc-gamma RIA) (FcgammaRIa) (CD antigen CD64),o293-313i,374
P12318,Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32),o219-239i,317
P12319,High affinity immunoglobulin epsilon receptor subunit alpha (Fc-epsilon RI-alpha) (FcERI) (IgE Fc receptor subunit alpha),o204-224i,257
P12821,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]",o1260-1277i,1306
P12830,Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3],o710-730i,882
P13073,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)",i99-124o,169
P13164,Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Interferon-induced protein 17) (Interferon-inducible protein 9-27) (Leu-13 antigen) (CD antigen CD225),i86-106o,125
P13224,Platelet glycoprotein Ib beta chain (GP-Ib beta) (GPIb-beta) (GPIbB) (Antigen CD42b-beta) (CD antigen CD42c),o150-172i,206
P13473,Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b),o379-398i,410
P13584,Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450-HP),o30i,511
P13591,Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56),o724-745i,858
P13598,Intercellular adhesion molecule 2 (ICAM-2) (CD antigen CD102),o224-247i,275
P13612,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d),o978-999i,1032
P13688,Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a),o429-449i,526
P13726,Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142),o252-274i,295
P13747,"HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain E (sHLA-E)]",o308-329i,358
P13762,"HLA class II histocompatibility antigen, DR beta 4 chain (MHC class II antigen DRB4)",o228-248i,266
P13765,"HLA class II histocompatibility antigen, DO beta chain (MHC class II antigen DOB)",o225-245i,273
P14151,L-selectin (CD62 antigen-like family member L) (Leukocyte adhesion molecule 1) (LAM-1) (Leukocyte surface antigen Leu-8) (Leukocyte-endothelial cell adhesion molecule 1) (LECAM1) (Lymph node homing receptor) (TQ1) (gp90-MEL) (CD antigen CD62L),o334-355i,372
P14209,CD99 antigen (12E7) (E2 antigen) (Protein MIC2) (T-cell surface glycoprotein E2) (CD antigen CD99),o126-146i,185
P14406,"Cytochrome c oxidase subunit 7A2, mitochondrial (Cytochrome c oxidase subunit VIIa-liver/heart) (Cytochrome c oxidase subunit VIIa-L) (Cytochrome c oxidase subunit VIIaL)",i49-75o,83
P14410,"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]",i11-31o,1827
P14415,Sodium/potassium-transporting ATPase subunit beta-2 (Adhesion molecule in glia) (AMOG) (Sodium/potassium-dependent ATPase subunit beta-2),i41-61o,290
P14616,Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain],o922-942i,1297
P14625,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),o84-93i,803
P14679,Tyrosinase (EC 1.14.18.1) (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB),o474-499i,529
P14770,Platelet glycoprotein IX (GP-IX) (GPIX) (Glycoprotein 9) (CD antigen CD42a),o149-169i,177
P14778,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]",o338-356i,569
P14784,Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122),o244-265i,551
P15144,Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13),i10-32o,967
P15151,Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155),o345-365i,417
P15260,Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119),o247-268i,489
P15291,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]",i25-43o,398
P15382,Potassium voltage-gated channel subfamily E member 1 (Delayed rectifier potassium channel subunit IsK) (IKs producing slow voltage-gated potassium channel subunit beta Mink) (Minimal potassium channel),o44-66i,129
P15391,B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19),o292-313i,556
P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GM-CSF-R-alpha) (GMCSFR-alpha) (GMR-alpha) (CDw116) (CD antigen CD116),o325-346i,400
P15514,Amphiregulin (AR) (Colorectum cell-derived growth factor) (CRDGF),o199-219i,252
P15529,Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD antigen CD46),o346-366i,392
P15812,"T-cell surface glycoprotein CD1e, membrane-associated (hCD1e) (R2G1) (CD antigen CD1e) [Cleaved into: T-cell surface glycoprotein CD1e, soluble (sCD1e)]",o306-326i,388
P15813,Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d),o302-322i,335
P15907,"Beta-galactoside alpha-2,6-sialyltransferase 1 (Alpha 2,6-ST 1) (EC 2.4.3.1) (B-cell antigen CD75) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (ST6Gal I) (ST6GalI) (Sialyltransferase 1)",i10-26o,406
P15941,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],o1163-1183i,1255
P15954,"Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc)",i35-56o,63
P16066,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),o474-494i,1061
P16070,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),o650-670i,742
P16109,P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P),o774-794i,830
P16144,Integrin beta-4 (GP150) (CD antigen CD104),o723-732i,1822
P16150,Leukosialin (GPL115) (Galactoglycoprotein) (GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD antigen CD43) [Cleaved into: CD43 cytoplasmic tail (CD43-ct) (CD43ct)],o256-276i,400
P16234,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a),o528-548i,1089
P16284,Platelet endothelial cell adhesion molecule (PECAM-1) (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31),o602-620i,738
P16410,Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4) (CTLA-4) (CD antigen CD152),o166-186i,223
P16422,Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326),o268-288i,314
P16435,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),o25-44i,677
P16442,Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase) (EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase) (EC 2.4.1.37) (Histo-blood group A transferase) (A transferase) (Histo-blood group B transferase) (B transferase) (NAGAT) [Cleaved into: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form],i20-37o,354
P16471,Prolactin receptor (PRL-R),o237-258i,622
P16581,E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E),o557-577i,610
P16662,"UDP-glucuronosyltransferase 2B7 (UDPGT 2B7) (UGT2B7) (EC 2.4.1.17) (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9) (UDPGT 2B9) (UDPGTh-2)",o491-516i,529
P16871,Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127),o241-263i,459
P17181,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1),o437-457i,557
P17301,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b),o1134-1154i,1181
P17342,Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C),o484-504i,541
P17643,"5,6-dihydroxyindole-2-carboxylic acid oxidase (DHICA oxidase) (EC 1.14.18.-) (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1) (TRP) (TRP-1) (TRP1)",o478-501i,537
P17693,"HLA class I histocompatibility antigen, alpha chain G (HLA G antigen) (MHC class I antigen G) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain G (sHLA-G)]",o308-332i,338
P17813,Endoglin (CD antigen CD105),o592-614i,658
P17927,Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35),o1973-1996i,2039
P17948,Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor),o759-780i,1338
P18084,Integrin beta-5,o723-748i,799
P18433,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48),o152-172i,802
P18564,Integrin beta-6,o710-730i,788
P18627,Lymphocyte activation gene 3 protein (LAG-3) (CD antigen CD223) [Cleaved into: Secreted lymphocyte activation gene 3 protein (sLAG-3)],o450-471i,525
P18827,Syndecan-1 (SYND1) (CD antigen CD138),o255-275i,310
P18850,Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha],i378-395o,670
P19021,Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)],o867-887i,973
P19022,Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325),o724-744i,906
P19224,UDP-glucuronosyltransferase 1-6 (UDPGT 1-6) (UGT1*6) (UGT1-06) (UGT1.6) (EC 2.4.1.17) (Phenol-metabolizing UDP-glucuronosyltransferase) (UDP-glucuronosyltransferase 1-F) (UGT-1F) (UGT1F) (UDP-glucuronosyltransferase 1A6),o488-508i,532
P19235,Erythropoietin receptor (EPO-R),o251-272i,508
P19256,Lymphocyte function-associated antigen 3 (Ag3) (Surface glycoprotein LFA-3) (CD antigen CD58),o216-232i,250
P19320,Vascular cell adhesion protein 1 (V-CAM 1) (VCAM-1) (INCAM-100) (CD antigen CD106) [Cleaved into: Soluble Vascular Cell Adhesion Molecule-1],o699-719i,739
P19438,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)]",o213-233i,455
P19440,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],i5-25o,569
P19526,"Galactoside alpha-(1,2)-fucosyltransferase 1 (Alpha(1,2)FT 1) (Blood group H alpha 2-fucosyltransferase) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1) (Type 1 galactoside alpha-(1,2)-fucosyltransferase FUT1) (EC 2.4.1.69) (Type 2 galactoside alpha-(1,2)-fucosyltransferase FUT1) (EC 2.4.1.344)",i9-27o,365
P20023,Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21),o976-998i,1033
P20036,"HLA class II histocompatibility antigen, DP alpha 1 chain (DP(W3)) (DP(W4)) (HLA-SB alpha chain) (MHC class II DP3-alpha) (MHC class II DPA1)",o224-245i,260
P20138,Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33),o260-282i,364
P20273,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),o688-708i,847
P20333,"Tumor necrosis factor receptor superfamily member 1B (Tumor necrosis factor receptor 2) (TNF-R2) (Tumor necrosis factor receptor type II) (TNF-RII) (TNFR-II) (p75) (p80 TNF-alpha receptor) (CD antigen CD120b) (Etanercept) [Cleaved into: Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2 (TBP-2) (TBPII)]",o264-284i,461
P20594,Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B),o456-478i,1047
P20645,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),o191-210i,277
P20701,Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a),o1090-1111i,1170
P20702,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)",o1108-1128i,1163
P20813,"Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1)",o21i,491
P20815,Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3),o12-25i,502
P20853,Cytochrome P450 2A7 (EC 1.14.14.1) (CYPIIA7) (Cytochrome P450 IIA4),o24i,494
P20916,Myelin-associated glycoprotein (Siglec-4a),o514-534i,626
P20963,T-cell surface glycoprotein CD3 zeta chain (T-cell receptor T3 zeta chain) (CD antigen CD247),o31-51i,164
P21217,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 (EC 2.4.1.65) (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase) (EC 2.4.1.152) (Alpha-3-fucosyltransferase FUT3) (EC 2.4.1.-) (Blood group Lewis alpha-4-fucosyltransferase) (Lewis FT) (Fucosyltransferase 3) (Fucosyltransferase III) (FucT-III),i17-34o,361
P21579,Synaptotagmin-1 (Synaptotagmin I) (SytI) (p65),o59-79i,422
P21583,Kit ligand (Mast cell growth factor) (MGF) (Stem cell factor) (SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand (sKITLG)],o216-236i,273
P21709,Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH),o548-568i,976
P21754,Zona pellucida sperm-binding protein 3 (Sperm receptor) (ZP3A/ZP3B) (Zona pellucida glycoprotein 3) (Zp-3) (Zona pellucida protein C) [Cleaved into: Processed zona pellucida sperm-binding protein 3],o388-410i,424
P21757,Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204),i51-71o,451
P21802,Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332),o378-398i,821
P21854,B-cell differentiation antigen CD72 (Lyb-2) (CD antigen CD72),i96-116o,359
P21860,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3),o644-664i,1342
P21964,Catechol O-methyltransferase (EC 2.1.1.6),o8-26i,271
P22083,"Alpha-(1,3)-fucosyltransferase 4 (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase) (EC 2.4.1.152) (ELAM-1 ligand fucosyltransferase) (Fucosyltransferase 4) (Fucosyltransferase IV) (Fuc-TIV) (FucT-IV) (Galactoside 3-L-fucosyltransferase)",i153-170o,530
P22223,Cadherin-3 (Placental cadherin) (P-cadherin),o656-676i,829
P22309,UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UDP-glucuronosyltransferase 1A isoform 1),o489-509i,533
P22310,UDP-glucuronosyltransferase 1A4 (UGT1A4) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 2) (hUG-BR2) (UDP-glucuronosyltransferase 1-4) (UDPGT 1-4) (UGT1*4) (UGT1-04) (UGT1.4) (UDP-glucuronosyltransferase 1-D) (UGT-1D) (UGT1D),o490-512i,534
P22413,"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]",i77-97o,925
P22455,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334),o370-389i,802
P22607,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333),o374-393i,806
P22760,Arylacetamide deacetylase (EC 3.1.1.3),o21i,399
P22794,Protein EVI2A (Ecotropic viral integration site 2A protein homolog) (EVI-2A),o139-159i,236
P22897,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),o1391-1411i,1456
P23229,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)],o1056-1076i,1130
P23276,Kell blood group glycoprotein (EC 3.4.24.-) (CD antigen CD238),i48-66o,732
P23467,Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP),o1619-1641i,1997
P23468,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),o1267-1289i,1912
P23469,Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48),o48-68i,700
P23470,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),o738-760i,1445
P23471,Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48) (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2),o1640-1660i,2315
P23510,Tumor necrosis factor ligand superfamily member 4 (Glycoprotein Gp34) (OX40 ligand) (OX40L) (TAX transcriptionally-activated glycoprotein 1) (CD antigen CD252),i25-45o,183
P23763,Vesicle-associated membrane protein 1 (VAMP-1) (Synaptobrevin-1),i97-117o,118
P24071,Immunoglobulin alpha Fc receptor (IgA Fc receptor) (CD antigen CD89),o228-246i,287
P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial (Cytochrome c oxidase subunit VIIa-heart) (Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase subunit VIIa-muscle) (Cytochrome c oxidase subunit VIIa-M)",i47-75o,79
P24311,"Cytochrome c oxidase subunit 7B, mitochondrial (Cytochrome c oxidase polypeptide VIIb)",i37-57o,80
P24394,Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)],o233-253i,825
P24462,Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2),o12-25i,503
P24903,Cytochrome P450 2F1 (EC 1.14.14.1) (CYPIIF1),o22i,491
P25092,Guanylyl cyclase C (GC-C) (EC 4.6.1.2) (Heat-stable enterotoxin receptor) (STA receptor) (hSTAR) (Intestinal guanylate cyclase),o434-454i,1073
P25189,Myelin protein P0 (Myelin peripheral protein) (MPP) (Myelin protein zero),o156-179i,248
P25445,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),o174-190i,335
P25942,Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40),o195-215i,277
P26006,Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain],o992-1014i,1051
P26010,Integrin beta-7 (Gut homing receptor beta subunit),o726-746i,798
P26012,Integrin beta-8,o685-704i,769
P26572,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)",i9-29o,445
P26678,Cardiac phospholamban (PLB),i31-51o,52
P26715,NKG2-A/NKG2-B type II integral membrane protein (CD159 antigen-like family member A) (NK cell receptor A) (NKG2-A/B-activating NK receptor) (CD antigen CD159a),i71-91o,233
P26717,NKG2-C type II integral membrane protein (CD159 antigen-like family member C) (NK cell receptor C) (NKG2-C-activating NK receptor) (CD antigen CD159c),i71-93o,231
P26718,NKG2-D type II integral membrane protein (Killer cell lectin-like receptor subfamily K member 1) (NK cell receptor D) (NKG2-D-activating NK receptor) (CD antigen CD314),i58-78o,216
P26842,CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27),o189-211i,260
P26951,Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123),o308-324i,378
P27037,Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA),o139-160i,513
P27469,G0/G1 switch protein 2 (G0/G1 switch regulatory protein 2) (Putative lymphocyte G0/G1 switch gene),i26-43o,103
P27487,Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)],i7-27o,766
P27824,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),o482-501i,592
P27930,"Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)]",o350-370i,398
P28067,"HLA class II histocompatibility antigen, DM alpha chain (MHC class II antigen DMA) (Really interesting new gene 6 protein)",o231-252i,261
P28068,"HLA class II histocompatibility antigen, DM beta chain (MHC class II antigen DMB) (Really interesting new gene 7 protein)",o219-239i,263
P28827,Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48),o743-764i,1452
P28906,Hematopoietic progenitor cell antigen CD34 (CD antigen CD34),o291-311i,385
P28907,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPR hydrolase 1) (T10) (CD antigen CD38),i24-44o,300
P28908,Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30),o387-407i,595
P29016,T-cell surface glycoprotein CD1b (CD antigen CD1b),o304-324i,333
P29017,T-cell surface glycoprotein CD1c (CD antigen CD1c),o302-322i,333
P29317,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),o541-558i,976
P29320,Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1),o542-564i,983
P29322,Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK),o542-562i,1005
P29323,Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2],o543-564i,1055
P29376,Leukocyte tyrosine kinase receptor (EC 2.7.10.1) (Protein tyrosine kinase 1),o426-449i,864
P29965,"CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)]",i23-44o,261
P30203,T-cell differentiation antigen CD6 (T12) (TP120) (CD antigen CD6) [Cleaved into: Soluble CD6],o403-424i,668
P30273,High affinity immunoglobulin epsilon receptor subunit gamma (Fc receptor gamma-chain) (FcRgamma) (Fc-epsilon RI-gamma) (IgE Fc receptor subunit gamma) (FceRI gamma),o24-44i,86
P30511,"HLA class I histocompatibility antigen, alpha chain F (CDA12) (HLA F antigen) (Leukocyte antigen F) (MHC class I antigen F)",o305-329i,346
P30519,Heme oxygenase 2 (HO-2) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 2 soluble form],i295-315o,316
P30530,Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene),o452-472i,894
P31431,Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein),o150-170i,198
P31513,Flavin-containing monooxygenase 3 (EC 1.14.13.148) (EC 1.14.13.32) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 3) (Dimethylaniline oxidase 3) (FMO II) (FMO form 2) (Hepatic flavin-containing monooxygenase 3) (FMO 3) (Trimethylamine monooxygenase),i517-531o,532
P31785,Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132),o263-279i,369
P31994,Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32),o224-245i,310
P31995,Low affinity immunoglobulin gamma Fc region receptor II-c (IgG Fc receptor II-c) (CDw32) (Fc-gamma RII-c) (Fc-gamma-RIIc) (FcRII-c) (CD antigen CD32),o225-246i,323
P31997,Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b),o334-348i,349
P32004,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171),o1122-1143i,1257
P32189,Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase),i532-552o,559
P32856,Syntaxin-2 (Epimorphin),i265-282o,288
P32926,Desmoglein-3 (130 kDa pemphigus vulgaris antigen) (PVA) (Cadherin family member 6),o628-637i,999
P32927,Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131),o445-465i,897
P32942,Intercellular adhesion molecule 3 (ICAM-3) (CDw50) (ICAM-R) (CD antigen CD50),o489-510i,547
P32970,CD70 antigen (CD27 ligand) (CD27-L) (Tumor necrosis factor ligand superfamily member 7) (CD antigen CD70),i18-38o,193
P32971,Tumor necrosis factor ligand superfamily member 8 (CD30 ligand) (CD30-L) (CD antigen CD153),i41-61o,234
P33121,Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24),o25-45i,698
P33151,Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144),o598-618i,784
P33261,Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase),o4-17i,490
P33681,T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80),o247-268i,288
P33908,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Man9-mannosidase) (Mannosidase alpha class 1A member 1) (Processing alpha-1,2-mannosidase IA) (Alpha-1,2-mannosidase IA)",i42-62o,653
P34741,Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD antigen CD362),o149-169i,201
P34810,Macrosialin (Gp110) (CD antigen CD68),o324-344i,354
P34910,Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361),o205-225i,448
P34925,Tyrosine-protein kinase RYK (EC 2.7.10.1),o231-250i,607
P35070,Probetacellulin [Cleaved into: Betacellulin (BTC)],o119-139i,178
P35503,UDP-glucuronosyltransferase 1A3 (UGT1A3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-3) (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A isoform 3),o490-512i,534
P35504,UDP-glucuronosyltransferase 1A5 (UGT1A5) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-5) (UDPGT 1-5) (UGT1*5) (UGT1-05) (UGT1.5) (UDP-glucuronosyltransferase 1-E) (UGT-1E) (UGT1E),o490-512i,534
P35590,Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1),o764-784i,1138
P35613,Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147),o324-344i,385
P35916,Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4),o777-797i,1363
P35968,Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309),o765-785i,1356
P36268,Inactive glutathione hydrolase 2 (Gamma-glutamyltransferase 2 pseudogene) (Inactive gamma-glutamyltranspeptidase 2) (GGT 2),i5-25o,569
P36269,Glutathione hydrolase 5 proenzyme (EC 3.4.19.13) (Gamma-glutamyl transpeptidase-related enzyme) (GGT-rel) (Gamma-glutamyltransferase 5) (GGT 5) (EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain],i9-29o,586
P36888,Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135),o542-562i,993
P36894,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),o154-174i,532
P36896,Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2),o127-149i,505
P36897,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),o127-147i,503
P36941,Tumor necrosis factor receptor superfamily member 3 (Lymphotoxin-beta receptor) (Tumor necrosis factor C receptor) (Tumor necrosis factor receptor 2-related protein) (Tumor necrosis factor receptor type III) (TNF-RIII) (TNFR-III),o227-245i,435
P37023,Serine/threonine-protein kinase receptor R3 (SKR3) (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (TGF-B superfamily receptor type I) (TSR-I),o121-141i,503
P37058,17-beta-hydroxysteroid dehydrogenase type 3 (17-beta-HSD 3) (Estradiol 17-beta-dehydrogenase 2) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 2) (Testicular 17-beta-hydroxysteroid dehydrogenase) (Testosterone 17-beta-dehydrogenase 3) (EC 1.1.1.64),o8-22i,310
P37173,TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II),o164-187i,567
P38484,Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1),o248-271i,337
P38570,Integrin alpha-E (HML-1 antigen) (Integrin alpha-IEL) (Mucosal lymphocyte 1 antigen) (CD antigen CD103) [Cleaved into: Integrin alpha-E light chain; Integrin alpha-E heavy chain],o1127-1147i,1179
P39656,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit),o423-444i,456
P40126,L-dopachrome tautomerase (DCT) (DT) (EC 5.3.3.12) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) (TRP-2) (TRP2),o473-493i,519
P40189,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130),o618-641i,918
P40197,Platelet glycoprotein V (GPV) (Glycoprotein 5) (CD antigen CD42d),o524-544i,560
P40198,Carcinoembryonic antigen-related cell adhesion molecule 3 (Carcinoembryonic antigen CGM1) (CD antigen CD66d),o153-175i,252
P40199,Carcinoembryonic antigen-related cell adhesion molecule 6 (Non-specific crossreacting antigen) (Normal cross-reacting antigen) (CD antigen CD66c),o333-343i,344
P40200,T-cell surface protein tactile (Cell surface antigen CD96) (T cell-activated increased late expression protein) (CD antigen CD96),o521-541i,585
P40238,Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110),o494-513i,635
P40259,B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b),o160-180i,229
P40305,"Interferon alpha-inducible protein 27, mitochondrial (p27) (Interferon alpha-induced 11.5 kDa protein) (Interferon-stimulated gene 12a protein) (ISG12(a)) (ISG12A)",o102-111i,122
P40967,Melanocyte protein PMEL (ME20-M) (ME20M) (Melanocyte protein Pmel 17) (Melanocytes lineage-specific antigen GP100) (Melanoma-associated ME20 antigen) (P1) (P100) (Premelanosome protein) (Silver locus protein homolog) [Cleaved into: M-alpha (95 kDa melanocyte-specific secreted glycoprotein) (P26) (Secreted melanoma-associated ME20 antigen) (ME20-S) (ME20S); M-beta],o596-616i,661
P41217,OX-2 membrane glycoprotein (CD antigen CD200),o237-257i,278
P41273,Tumor necrosis factor ligand superfamily member 9 (4-1BB ligand) (4-1BBL),i30-50o,254
P42081,T-lymphocyte activation antigen CD86 (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD antigen CD86),o248-268i,329
P42167,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",i413-434o,454
P42658,Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI),i96-116o,865
P42701,Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212),o547-570i,662
P42702,Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118),o836-856i,1097
P42857,Neuronal vesicle trafficking-associated protein 1 (Neuron-enriched endosomal protein of 21 kDa) (Neuron-specific protein family member 1),i83-103o,185
P42892,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),i69-89o,770
P43121,Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146),o560-580i,646
P43146,Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC),o1100-1120i,1447
P43307,Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha),o208-229i,286
P43489,Tumor necrosis factor receptor superfamily member 4 (ACT35 antigen) (OX40L receptor) (TAX transcriptionally-activated glycoprotein 1 receptor) (CD antigen CD134),o217-237i,277
P43626,Killer cell immunoglobulin-like receptor 2DL1 (CD158 antigen-like family member A) (Natural killer-associated transcript 1) (NKAT-1) (p58 natural killer cell receptor clones CL-42/47.11) (p58 NK receptor CL-42/47.11) (p58.1 MHC class-I-specific NK receptor) (CD antigen CD158a),o244-264i,348
P43628,Killer cell immunoglobulin-like receptor 2DL3 (CD158 antigen-like family member B2) (KIR-023GB) (Killer inhibitory receptor cl 2-3) (NKAT2a) (NKAT2b) (Natural killer-associated transcript 2) (NKAT-2) (p58 natural killer cell receptor clone CL-6) (p58 NK receptor CL-6) (p58.2 MHC class-I-specific NK receptor) (CD antigen CD158b2),o246-266i,341
P43629,Killer cell immunoglobulin-like receptor 3DL1 (CD158 antigen-like family member E) (HLA-BW4-specific inhibitory NK cell receptor) (Natural killer-associated transcript 3) (NKAT-3) (p70 natural killer cell receptor clones CL-2/CL-11) (p70 NK receptor CL-2/CL-11) (CD antigen CD158e),o341-361i,444
P43630,Killer cell immunoglobulin-like receptor 3DL2 (CD158 antigen-like family member K) (Natural killer-associated transcript 4) (NKAT-4) (p70 natural killer cell receptor clone CL-5) (p70 NK receptor CL-5) (CD antigen CD158k),o341-361i,455
P43631,Killer cell immunoglobulin-like receptor 2DS2 (CD158 antigen-like family member J) (NK receptor 183 ActI) (Natural killer-associated transcript 5) (NKAT-5) (p58 natural killer cell receptor clone CL-49) (p58 NK receptor CL-49) (CD antigen CD158j),o246-266i,304
P43632,Killer cell immunoglobulin-like receptor 2DS4 (CD158 antigen-like family member I) (Natural killer-associated transcript 8) (NKAT-8) (P58 natural killer cell receptor clones CL-39/CL-17) (p58 NK receptor CL-39/CL-17) (CD antigen CD158i),o246-266i,304
P46531,Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],o1736-1755i,2555
P46695,Radiation-inducible immediate-early gene IEX-1 (Differentiation-dependent gene 2 protein) (Protein DIF-2) (Immediate early protein GLY96) (Immediate early response 3 protein) (PACAP-responsive gene 1 protein) (Protein PRG1),i87-96o,156
P48023,"Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand) (APTL) (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]",i81-102o,281
P48357,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295),o842-862i,1165
P48551,Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2),o244-264i,515
P49257,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),o479-498i,510
P49326,Flavin-containing monooxygenase 5 (FMO 5) (Baeyer-Villiger monooxygenase 1) (hBVMO1) (EC 1.14.13.-) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (NADPH oxidase) (EC 1.6.3.1),i519-532o,533
P49641,"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",i9-26o,1150
P49755,Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (S31I125) (S31III125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1) (p24delta1) (p24delta),o186-206i,219
P49771,Fms-related tyrosine kinase 3 ligand (Flt3 ligand) (Flt3L) (SL cytokine),o186-205i,235
P50281,Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP),o542-562i,582
P50402,Emerin,i225-246o,254
P50591,Tumor necrosis factor ligand superfamily member 10 (Apo-2 ligand) (Apo-2L) (TNF-related apoptosis-inducing ligand) (Protein TRAIL) (CD antigen CD253),i17-37o,281
P50895,Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239),o551-571i,628
P51164,Potassium-transporting ATPase subunit beta (Gastric H(+)/K(+) ATPase subunit beta) (Proton pump beta chain),i42-62o,291
P51511,Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2),o627-647i,669
P51512,Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP),o565-585i,607
P51571,Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta),o151-164i,173
P51589,Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7),o35i,502
P51648,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 10) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase),i464-480o,485
P51693,Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1) (APLP) (APLP-1) [Cleaved into: C30],o584-603i,650
P51805,Plexin-A3 (Plexin-4) (Semaphorin receptor SEX),o1221-1241i,1871
P51809,Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1) (Tetanus-insensitive VAMP) (Ti-VAMP),i189-205o,220
P51841,"Retinal guanylyl cyclase 2 (RETGC-2) (EC 4.6.1.2) (Guanylate cyclase 2F, retinal) (Guanylate cyclase F) (GC-F) (Rod outer segment membrane guanylate cyclase 2) (ROS-GC2)",o468-490i,1108
P51993,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 (EC 2.4.1.152) (Fucosyltransferase 6) (Fucosyltransferase VI) (Fuc-TVI) (FucT-VI) (Galactoside 3-L-fucosyltransferase),i17-34o,359
P52429,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),o22-42i,567
P52799,Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L),o227-250i,333
P52848,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1) (NDST-1) (N-heparan sulfate sulfotransferase 1) (N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1) (HSNST 1) [Includes: Heparan sulfate N-deacetylase 1 (EC 3.5.1.-); Heparan sulfate N-sulfotransferase 1 (EC 2.8.2.8)],i18-35o,882
P52849,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) (N-heparan sulfate sulfotransferase 2) (N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)],i19-35o,883
P53708,Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain],o1013-1034i,1063
P53801,Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor) (PBF) (PTTG-binding factor),o98-118i,180
P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1],o1074-1094i,1103
P54709,Sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3) (ATPB-3) (CD antigen CD298),i40-60o,279
P54710,Sodium/potassium-transporting ATPase subunit gamma (Na(+)/K(+) ATPase subunit gamma) (FXYD domain-containing ion transport regulator 2) (Sodium pump gamma chain),o28-46i,66
P54753,Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6),o559-580i,998
P54756,Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7),o574-594i,1037
P54760,Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11),o541-561i,987
P54762,Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2),o541-562i,984
P54764,Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK),o549-569i,986
P54855,UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3),o492-517i,530
P55082,Microfibril-associated glycoprotein 3,o149-168i,362
P55283,Cadherin-4 (Retinal cadherin) (R-CAD) (R-cadherin),o735-755i,916
P55285,Cadherin-6 (Kidney cadherin) (K-cadherin),o614-634i,790
P55286,Cadherin-8,o623-642i,799
P55287,Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin),o620-638i,796
P55289,Cadherin-12 (Brain cadherin) (BR-cadherin) (Neural type cadherin 2) (N-cadherin 2),o617-635i,794
P55291,Cadherin-15 (Cadherin-14) (Muscle cadherin) (M-cadherin),o606-626i,814
P55899,IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor),o300-321i,365
P56134,"ATP synthase subunit f, mitochondrial (ATP synthase membrane subunit f)",i62-82o,94
P56199,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a),o1144-1164i,1179
P56817,Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),o457-477i,501
P57087,Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322),o240-258i,298
P57105,Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25),i120-139o,145
P57679,EvC complex member EVC (DWF-1) (Ellis-van Creveld syndrome protein),o27-47i,992
P57727,Transmembrane protease serine 3 (EC 3.4.21.-) (Serine protease TADG-12) (Tumor-associated differentially-expressed gene 12 protein),i49-69o,454
P58335,Anthrax toxin receptor 2 (Capillary morphogenesis gene 2 protein) (CMG-2),o319-339i,489
P58400,Neurexin-1-beta (Neurexin I-beta),o398-418i,472
P58401,Neurexin-2-beta (Neurexin II-beta),o592-612i,666
P59773,Major intrinsically disordered NOTCH2-binding receptor 1-like (Major intrinsically disordered NOTCH2-associated receptor 2) (Membrane integral NOTCH2-associated receptor 2),i168-188o,190
P59901,Leukocyte immunoglobulin-like receptor subfamily A member 4 (CD85 antigen-like family member G) (Immunoglobulin-like transcript 7) (ILT-7) (CD antigen CD85g),o447-467i,499
P60059,Protein transport protein Sec61 subunit gamma,i36-61o,68
P60468,Protein transport protein Sec61 subunit beta,i71-91o,96
P60507,Endogenous retrovirus group FC1 Env polyprotein (Envelope polyprotein) (Fc1env) (HERV-F(c)1_Xq21.33 provirus ancestral Env polyprotein) (HERV-Fc1env) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],o519-529i,584
P60508,Syncytin-2 (Endogenous retrovirus group FRD member 1) (Envelope polyprotein) (HERV-FRD) (HERV-FRD_6p24.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],o490-499i,538
P60852,Zona pellucida sperm-binding protein 1 (Zona pellucida glycoprotein 1) (Zp-1) [Cleaved into: Processed zona pellucida sperm-binding protein 1],o602-624i,638
P61009,Signal peptidase complex subunit 3 (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit),i11-31o,180
P61266,Syntaxin-1B (Syntaxin-1B1) (Syntaxin-1B2),i265-280o,288
P62952,Bladder cancer-associated protein (Bladder cancer 10 kDa protein) (Bc10),o45-57i,87
P63027,Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2),i95-112o,116
P69849,BOS complex subunit NOMO3 (Nodal modulator 3) (pM5 protein 3),o1160-1175i,1222
P78310,Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR),o238-258i,365
P78324,Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a),o374-394i,504
P78325,Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a),o656-677i,824
P78357,Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190),o1282-1306i,1384
P78380,"Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1) (C-type lectin domain family 8 member A) (Lectin-like oxidized LDL receptor 1) (LOX-1) (Lectin-like oxLDL receptor 1) (hLOX-1) (Lectin-type oxidized LDL receptor 1) [Cleaved into: Oxidized low-density lipoprotein receptor 1, soluble form]",i37-57o,273
P78410,Butyrophilin subfamily 3 member A2,o251-271i,334
P78423,Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine],o342-362i,397
P78504,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),o1069-1089i,1218
P78536,Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b),o672-691i,824
P78552,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1),o346-365i,427
P78562,Phosphate-regulating neutral endopeptidase PHEX (EC 3.4.24.-) (Metalloendopeptidase homolog PEX) (Vitamin D-resistant hypophosphatemic rickets protein) (X-linked hypophosphatemia protein) (HYP),i21-40o,749
P79483,"HLA class II histocompatibility antigen, DR beta 3 chain (MHC class II antigen DRB3)",o228-248i,266
P80370,Protein delta homolog 1 (DLK-1) (pG2) [Cleaved into: Fetal antigen 1 (FA1)],o307-327i,383
P82279,Protein crumbs homolog 1,o1348-1368i,1406
P98073,Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain],i19-39o,1019
P98153,Integral membrane protein DGCR2/IDD,o350-368i,550
P98155,Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R),o799-819i,873
P98164,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),o4425-4446i,4655
P98172,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment (Ephrin-B1 CTF); Ephrin-B1 intracellular domain (Ephrin-B1 ICD)],o240-263i,346
P98187,Cytochrome P450 4F8 (EC 1.14.14.1) (CYPIVF8),o36i,520
Q00LT1,Photoreceptor disk component PRCD (Progressive rod-cone degeneration protein),o5-14i,54
Q01113,Interleukin-9 receptor (IL-9 receptor) (IL-9R) (CD antigen CD129),o274-291i,521
Q01151,CD83 antigen (hCD83) (B-cell activation protein) (Cell surface protein HB15) (CD antigen CD83),o145-162i,205
Q01344,Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125),o342-362i,420
Q01628,Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Interferon-inducible protein 1-8U),i108-128o,133
Q01629,Interferon-induced transmembrane protein 2 (Dispanin subfamily A member 2c) (DSPA2c) (Interferon-inducible protein 1-8D),i105-125o,132
Q01638,Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2),o332-350i,556
Q01740,Flavin-containing monooxygenase 1 (EC 1.14.13.148) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 1) (Dimethylaniline oxidase 1) (Fetal hepatic flavin-containing monooxygenase 1) (FMO 1) (Trimethylamine monooxygenase),i511-531o,532
Q01973,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",o404-425i,937
Q01974,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",o404-425i,943
Q02223,Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269),o54-76i,184
Q02297,"Pro-neuregulin-1, membrane-bound isoform (Pro-NRG1) [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)]",o243-263i,640
Q02413,Desmoglein-1 (Cadherin family member 4) (Desmosomal glycoprotein 1) (DG1) (DGI) (Pemphigus foliaceus antigen),o551-569i,1049
Q02487,Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III),o697-715i,901
Q02505,Mucin-3A (MUC-3A) (Intestinal mucin-3A),o3226-3250i,3323
Q02742,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GlcNAcT) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Core 2 GNT) (Leukocyte type core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GnT-L)",i18-32o,428
Q02763,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b),o747-769i,1124
Q02846,"Retinal guanylyl cyclase 1 (RETGC-1) (EC 4.6.1.2) (CG-E) (Guanylate cyclase 2D, retinal) (Rod outer segment membrane guanylate cyclase) (ROS-GC)",o464-484i,1103
Q02928,Cytochrome P450 4A11 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),o35i,519
Q03167,Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III),o787-808i,851
Q04609,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase),i23-43o,750
Q04721,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)],o1678-1698i,2471
Q04771,Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I),o126-146i,509
Q04900,Sialomucin core protein 24 (MUC-24) (Endolyn) (Multi-glycosylated core protein 24) (MGC-24) (MGC-24v) (CD antigen CD164),o166-184i,197
Q04912,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],o959-979i,1400
Q05996,Zona pellucida sperm-binding protein 2 (Zona pellucida glycoprotein 2) (Zp-2) (Zona pellucida protein A) [Cleaved into: Processed zona pellucida sperm-binding protein 2],o716-737i,745
Q06136,3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1),o19i,332
Q06418,Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF),o432-451i,890
Q06481,Amyloid beta precursor like protein 2 (APPH) (Amyloid beta (A4) precursor-like protein 2) (Amyloid protein homolog) (Amyloid-like protein 2) (APLP-2) (CDEI box-binding protein) (CDEBP) (Sperm membrane protein YWK-II),o694-714i,763
Q06643,Lymphotoxin-beta (LT-beta) (Tumor necrosis factor C) (TNF-C) (Tumor necrosis factor ligand superfamily member 3),i19-43o,244
Q07011,Tumor necrosis factor receptor superfamily member 9 (4-1BB ligand receptor) (CDw137) (T-cell antigen 4-1BB homolog) (T-cell antigen ILA) (CD antigen CD137),o188-208i,255
Q07065,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),i107-127o,602
Q07075,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249),i19-39o,957
Q07108,Early activation antigen CD69 (Activation inducer molecule) (AIM) (BL-AC/P26) (C-type lectin domain family 2 member C) (EA1) (Early T-cell activation antigen p60) (GP32/28) (Leukocyte surface antigen Leu-23) (MLR-3) (CD antigen CD69),i44-61o,199
Q07444,NKG2-E type II integral membrane protein (NK cell receptor E) (NKG2-E-activating NK receptor),i74-94o,240
Q07699,Sodium channel subunit beta-1,o161-181i,218
Q07837,"Amino acid transporter heavy chain SLC3A1 (D2h) (Neutral and basic amino acid transport protein) (NBAT) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transporter-related heavy chain) (rBAT)",i88-110o,685
Q07954,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],o4424-4444i,4544
Q08174,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),o853-874i,1060
Q08334,Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b),o222-245i,325
Q08345,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),o418-438i,913
Q08380,Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K),o138-147i,585
Q08477,Cytochrome P450 4F3 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2) (EC 1.14.14.94),o39i,520
Q08554,Desmocollin-1 (Cadherin family member 1) (Desmosomal glycoprotein 2/3) (DG2/DG3),o694-710i,894
Q08708,CMRF35-like molecule 6 (CLM-6) (CD300 antigen-like family member C) (CMRF35-A1) (CMRF-35) (Immunoglobulin superfamily member 16) (IgSF16) (CD antigen CD300c),o184-205i,224
Q08ET2,Sialic acid-binding Ig-like lectin 14 (Siglec-14),o356-379i,396
Q09327,"Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III)",i8-26o,533
Q09328,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",i14-30o,741
Q0VAQ4,Small cell adhesion glycoprotein (Small transmembrane and glycosylated protein),o36-57i,97
Q10469,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",i10-25o,447
Q10471,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],i7-23o,571
Q10472,Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form],i9-26o,559
Q10589,Bone marrow stromal antigen 2 (BST-2) (HM1.24 antigen) (Tetherin) (CD antigen CD317),i22-43o,180
Q11128,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 (EC 2.4.1.152) (3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT5) (EC 2.4.1.65) (Fucosyltransferase 5) (Fucosyltransferase V) (Fuc-TV) (FucT-V) (Galactoside 3-L-fucosyltransferase),i17-34o,374
Q11201,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (Alpha 2,3-ST 1) (Beta-galactoside alpha-2,3-sialyltransferase 1) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (SIATFL) (ST3Gal I) (ST3GalI) (ST3GalA.1) (ST3O) (Sialyltransferase 4A) (SIAT4-A)",i8-26o,340
Q11203,"CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.3.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6)",i10-25o,375
Q12836,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],o506-528i,540
Q12846,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),i274-291o,297
Q12864,Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin) (LI-cadherin),o787-807i,832
Q12866,Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK),o502-522i,999
Q12884,"Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]",i7-26o,760
Q12907,Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36),o323-345i,356
Q12912,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",i496-519o,555
Q12913,Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148),o972-994i,1337
Q12918,Killer cell lectin-like receptor subfamily B member 1 (C-type lectin domain family 5 member B) (HNKR-P1a) (NKR-P1A) (Natural killer cell surface protein P1A) (CD antigen CD161),i43-60o,225
Q12981,Vesicle transport protein SEC20 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 1) (Transformation-related gene 8 protein) (TRG-8),i203-220o,228
Q12983,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,i164-184o,194
Q13018,Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)],o1401-1420i,1463
Q13113,PDZK1-interacting protein 1 (17 kDa membrane-associated protein) (Protein DD96),o34-50i,114
Q13145,BMP and activin membrane-bound inhibitor homolog (Non-metastatic gene A protein) (Putative transmembrane protein NMA),o153-173i,260
Q13190,Syntaxin-5,i334-354o,355
Q13217,"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)",o48-57i,504
Q13241,Natural killer cells antigen CD94 (KP43) (Killer cell lectin-like receptor subfamily D member 1) (NK cell receptor) (CD antigen CD94),i11-31o,179
Q13261,Interleukin-15 receptor subunit alpha (IL-15 receptor subunit alpha) (IL-15R-alpha) (IL-15RA) (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha (sIL-15 receptor subunit alpha) (sIL-15R-alpha) (sIL-15RA)],o213-225i,267
Q13277,Syntaxin-3,i265-282o,289
Q13291,Signaling lymphocytic activation molecule (CDw150) (IPO-3) (SLAM family member 1) (CD antigen CD150),o238-258i,335
Q13308,Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7),o705-720i,1070
Q13323,Bcl-2-interacting killer (Apoptosis inducer NBK) (BIP1) (BP4),i136-155o,160
Q13326,Gamma-sarcoglycan (Gamma-SG) (35 kDa dystrophin-associated glycoprotein) (35DAG),i36-58o,291
Q13332,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma),o1283-1305i,1948
Q13349,Integrin alpha-D (ADB2) (CD11 antigen-like family member D) (Leukointegrin alpha D) (CD antigen CD11d),o1103-1123i,1161
Q13410,Butyrophilin subfamily 1 member A1 (BT),o247-267i,526
Q13443,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),o698-718i,819
Q13444,"Disintegrin and metalloproteinase domain-containing protein 15 (ADAM 15) (EC 3.4.24.-) (Metalloprotease RGD disintegrin protein) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15) (MDC-15) (Metargidin)",o698-715i,863
Q13445,Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1) (Tp24) (p24gamma1),o193-215i,227
Q13477,Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) (hMAdCAM-1),o322-342i,382
Q13478,Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (EC 3.2.2.6) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a),o330-350i,541
Q13586,Stromal interaction molecule 1,o214-232i,685
Q13591,Semaphorin-5A (Semaphorin-F) (Sema F),o971-991i,1074
Q13634,Cadherin-18 (Cadherin-14),o616-634i,790
Q13641,Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1) (WAIF1),o356-376i,420
Q13651,Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210),o236-256i,578
Q13683,Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],o1084-1104i,1181
Q13705,Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB),o138-158i,512
Q13724,Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Processing A-glucosidase I),i44-64o,837
Q13740,CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166),o528-548i,583
Q13797,Integrin alpha-9 (Integrin alpha-RLC),o981-1001i,1035
Q13873,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),o151-171i,1038
Q13948,Protein CASP,i619-637o,678
Q14002,Carcinoembryonic antigen-related cell adhesion molecule 7 (CEA cell adhesion molecule 7) (Carcinoembryonic antigen CGM2),o251-264i,265
Q14114,Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2),o826-848i,963
Q14118,Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)],o753-773i,895
Q14126,Desmoglein-2 (Cadherin family member 5) (HDGC),o615-634i,1118
Q14162,Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1) (SREC-I),o422-442i,830
Q14165,Malectin,o270-290i,292
Q14242,P-selectin glycoprotein ligand 1 (PSGL-1) (Selectin P ligand) (CD antigen CD162),o321-343i,412
Q14392,Transforming growth factor beta activator LRRC32 (Garpin) (Glycoprotein A repetitions predominant) (GARP) (Leucine-rich repeat-containing protein 32),o628-648i,662
Q14410,"Glycerol kinase 2 (GK 2) (Glycerokinase 2) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 2) (Glycerol kinase, testis specific 2)",i526-546o,553
Q14435,Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3),i20-37o,633
Q14517,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",o4183-4201i,4588
Q14574,Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP),o693-711i,896
Q14626,Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)],o369-389i,422
Q14627,Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2),o344-363i,380
Q14667,Bridge-like lipid transfer protein family member 2 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein) (Protein hobbit homolog),o22i,2235
Q14703,Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1),o1001-1021i,1052
Q14773,Intercellular adhesion molecule 4 (ICAM-4) (Landsteiner-Wiener blood group glycoprotein) (LW blood group protein) (CD antigen CD242),o246-261i,271
Q14789,Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein) (GCP372) (Giantin) (Macrogolgin),i3236-3256o,3259
Q14802,FXYD domain-containing ion transport regulator 3 (Chloride conductance inducer protein Mat-8) (Mammary tumor 8 kDa protein) (Phospholemman-like) (Sodium/potassium-transporting ATPase subunit FXYD3),o37-57i,87
Q14943,Killer cell immunoglobulin-like receptor 3DS1 (Natural killer-associated transcript 10) (NKAT-10),o341-361i,382
Q14953,Killer cell immunoglobulin-like receptor 2DS5 (CD158 antigen-like family member G) (Natural killer-associated transcript 9) (NKAT-9) (CD antigen CD158g),o246-266i,304
Q14954,Killer cell immunoglobulin-like receptor 2DS1 (CD158 antigen-like family member H) (MHC class I NK cell receptor Eb6 ActI) (CD antigen CD158h),o246-266i,304
Q14956,Transmembrane glycoprotein NMB (Hematopoietic growth factor inducible neurokinin-1 type),o500-518i,572
Q14BN4,Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein),i804-824o,828
Q14CZ8,Hepatic and glial cell adhesion molecule (glialCAM) (Hepatocyte cell adhesion molecule) (Protein hepaCAM),o241-261i,416
Q15109,Advanced glycosylation end product-specific receptor (Receptor for advanced glycosylation end products),o341-361i,404
Q15116,Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279),o171-191i,288
Q15155,BOS complex subunit NOMO1 (Nodal modulator 1) (pM5 protein),o1160-1175i,1222
Q15223,Nectin-1 (Herpes virus entry mediator C) (Herpesvirus entry mediator C) (HveC) (Herpesvirus Ig-like receptor) (HIgR) (Nectin cell adhesion molecule 1) (Poliovirus receptor-related protein 1) (CD antigen CD111),o356-376i,517
Q15256,Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1),o228-248i,657
Q15262,Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48),o753-774i,1439
Q15303,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)],o652-673i,1308
Q15363,Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1),o169-191i,201
Q15375,Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11),o558-578i,998
Q15392,Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1),o4-18i,516
Q15399,Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281),o581-601i,786
Q15762,CD226 antigen (DNAX accessory molecule 1) (DNAM-1) (CD antigen CD226),o251-273i,336
Q15768,Ephrin-B3 (EPH-related receptor transmembrane ligand ELK-L3) (EPH-related receptor tyrosine kinase ligand 8) (LERK-8),o228-248i,340
Q15836,Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3),i78-98o,100
Q15904,V-type proton ATPase subunit S1 (V-ATPase subunit S1) (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1),o431-449i,470
Q16288,NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase),o434-453i,839
Q16394,Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1) (Putative tumor suppressor protein EXT1),i7-27o,746
Q16549,Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7),o665-685i,785
Q16585,Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) (A3b),i64-88o,318
Q16586,Alpha-sarcoglycan (Alpha-SG) (50 kDa dystrophin-associated glycoprotein) (50DAG) (Adhalin) (Dystroglycan-2),o291-311i,387
Q16620,BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B),o434-454i,822
Q16623,Syntaxin-1A (Neuron-specific antigen HPC-1),i266-286o,288
Q16647,Prostacyclin synthase (EC 5.3.99.4) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Prostaglandin I2 synthase),o21i,500
Q16655,Melanoma antigen recognized by T-cells 1 (MART-1) (Antigen LB39-AA) (Antigen SK29-AA) (Protein Melan-A),o28-48i,118
Q16671,Anti-Muellerian hormone type-2 receptor (EC 2.7.11.30) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII),o149-169i,573
Q16696,Cytochrome P450 2A13 (EC 1.14.14.1) (CYPIIA13),o24i,494
Q16706,"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",i7-26o,1144
Q16790,Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1),o415-435i,459
Q16819,Meprin A subunit alpha (EC 3.4.24.18) (Endopeptidase-2) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit alpha) (PABA peptide hydrolase) (PPH alpha),o719-740i,746
Q16820,Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta),o653-675i,701
Q16827,Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2),o820-843i,1216
Q16832,"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)",o400-420i,855
Q16842,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B)",i7-27o,350
Q16849,Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (Islet cell antigen 512) (ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)],o577-597i,979
Q16853,Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase) (SSAO) (Vascular adhesion protein 1) (VAP-1),i6-26o,763
Q16880,2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase),o474-496i,541
Q19T08,Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression) (ARIA) (Endothelial cell-specific molecule 2),o123-145i,205
Q24JP5,Transmembrane protein 132A (HSPA5-binding protein 1),o848-873i,1023
Q29980,MHC class I polypeptide-related sequence B (MIC-B),o312-329i,383
Q29983,MHC class I polypeptide-related sequence A (MIC-A),o307-328i,383
Q2HXU8,C-type lectin domain family 12 member B (Macrophage antigen H),i42-62o,276
Q2I0M4,Leucine-rich repeat-containing protein 26 (BK channel auxiliary gamma subunit LRRC26) (Cytokeratin-associated protein in cancer),o262-284i,334
Q2LD37,Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein),o27-47i,5005
Q2M385,Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2),o664-679i,716
Q30154,"HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5)",o228-248i,266
Q30201,Hereditary hemochromatosis protein (HLA-H),o309-329i,348
Q3KR37,Protein Aster-B (GRAM domain-containing protein 1B),i623-647o,738
Q3SXP7,Protein shisa-like-1,o99-119i,199
Q3SXY7,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3",o583-603i,679
Q3V5L5,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.-) (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase B) (GlcNAc-T Vb) (GNT-Vb) (hGnTVb) (Mannoside acetylglucosaminyltransferase 5B) (N-acetylglucosaminyl-transferase Vb) (N-acetylglucosaminyltransferase IX) (GNT-IX)",i22-41o,792
Q495A1,T-cell immunoreceptor with Ig and ITIM domains (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3),o142-162i,244
Q495T6,"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (Membrane metallo-endopeptidase-like 2) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]",i27-46o,779
Q496F6,CMRF35-like molecule 2 (CLM-2) (CD300 antigen-like family member E) (CMRF35-A5) (Immune receptor expressed on myeloid cells 2) (IREM-2) (Polymeric immunoglobulin receptor 2) (PIgR-2) (PIgR2) (Poly-Ig receptor 2) (CD antigen CD300e),o174-195i,205
Q49A17,Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17),i8-28o,601
Q4KMG0,Cell adhesion molecule-related/down-regulated by oncogenes,o965-985i,1287
Q4KMG9,Transmembrane protein 52B,o43-63i,183
Q4LDR2,Cortexin-3 (Kidney and brain-expressed protein),o29-49i,81
Q4V9L6,Transmembrane protein 119 (Osteoblast induction factor) (OBIF),o97-117i,283
Q53EL9,Seizure protein 6 homolog (SEZ-6) (hSEZ-6),o926-946i,994
Q53GQ0,Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 1),o11-31i,312
Q58DX5,Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 (NAALADase L2),i125-146o,795
Q58EX2,Protein sidekick-2,o1933-1953i,2172
Q5BVD1,TPA-induced transmembrane protein,i67-87o,217
Q5DID0,Uromodulin-like 1 (Olfactorin),o1273-1293i,1318
Q5DX21,Immunoglobulin superfamily member 11 (IgSF11) (Brain and testis-specific immunoglobulin superfamily protein) (Bt-IGSF) (V-set and immunoglobulin domain-containing protein 3),o249-266i,431
Q5IJ48,Protein crumbs homolog 2 (Crumbs-like protein 2),o1225-1245i,1285
Q5JPE7,BOS complex subunit NOMO2 (Nodal modulator 2) (pM5 protein 2),o1160-1175i,1267
Q5JRA6,Transport and Golgi organization protein 1 homolog (TANGO1) (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3),o1182-1198i,1907
Q5JX71,Protein FAM209A,o60-73i,171
Q5JZY3,Ephrin type-A receptor 10 (EC 2.7.10.1),o566-587i,1008
Q5K4L6,Long-chain fatty acid transport protein 3 (FATP-3) (Fatty acid transport protein 3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 3) (Very long-chain acyl-CoA synthetase homolog 3) (VLCS-3) (EC 6.2.1.-),o5-18i,683
Q5KU26,Collectin-12 (Collectin placenta protein 1) (CL-P1) (hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin),i38-58o,742
Q5QGZ9,C-type lectin domain family 12 member A (C-type lectin-like molecule 1) (CLL-1) (Dendritic cell-associated lectin 2) (DCAL-2) (Myeloid inhibitory C-type lectin-like receptor) (MICL) (CD antigen CD371),i42-62o,265
Q5R3F8,Protein phosphatase 1 regulatory subunit 29 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2) (Leucine-rich repeat and fibronectin type-III domain-containing protein 6) (Leucine-rich repeat-containing protein 62),o397-417i,820
Q5SQ64,Lymphocyte antigen 6 complex locus protein G6f,o235-256i,297
Q5SSG8,Mucin-21 (MUC-21) (Epiglycanin),o480-502i,566
Q5SZK8,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),o3111-3134i,3169
Q5T2D2,Trem-like transcript 2 protein (TLT-2) (Triggering receptor expressed on myeloid cells-like protein 2),o269-289i,321
Q5T700,Low-density lipoprotein receptor class A domain-containing protein 1,i36-57o,205
Q5T7P8,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),o61-81i,510
Q5T9A4,ATPase family AAA domain-containing protein 3B (AAA-TOB3),o247-262i,648
Q5TAT6,Collagen alpha-1(XIII) chain (COLXIIIA1),i47-61o,717
Q5TCH4,Cytochrome P450 4A22 (CYPIVA22) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),o35i,519
Q5UCC4,ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1),o222-242i,262
Q5VT99,Leucine-rich repeat-containing protein 38 (BK channel auxiliary gamma subunit LRRC38),o250-270i,294
Q5VUB5,Protein FAM171A1 (Astroprincin) (APCN),o304-325i,890
Q5VV42,Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase),i560-575o,579
Q5VV43,Dyslexia-associated protein KIAA0319,o956-978i,1072
Q5VWK5,Interleukin-23 receptor (IL-23 receptor) (IL-23R),o356-376i,629
Q5VX71,Sushi domain-containing protein 4,o322-340i,490
Q5VY43,Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12),o758-778i,1037
Q5VYJ5,MAM and LDL-receptor class A domain-containing protein 1,o2076-2096i,2156
Q5ZPR3,CD276 antigen (4Ig-B7-H3) (B7 homolog 3) (B7-H3) (Costimulatory molecule) (CD antigen CD276),o466-488i,534
Q685J3,Mucin-17 (MUC-17) (Small intestinal mucin-3) (MUC-3),o4390-4414i,4493
Q68CJ9,Cyclic AMP-responsive element-binding protein 3-like protein 3 (cAMP-responsive element-binding protein 3-like protein 3) (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3],i324-339o,461
Q68D85,Natural cytotoxicity triggering receptor 3 ligand 1 (B7 homolog 6) (B7-H6),o265-282i,454
Q68DV7,E3 ubiquitin-protein ligase RNF43 (EC 2.3.2.27) (RING finger protein 43) (RING-type E3 ubiquitin transferase RNF43),o199-219i,783
Q68G75,LEM domain-containing protein 1 (Cancer/testis antigen 50) (CT50) (LEM domain protein 1) (LEMP-1),i154-174o,181
Q6AZY7,Scavenger receptor class A member 3 (Cellular stress response gene protein),i57-77o,606
Q6DKI7,Transmembrane protein PVRIG (CD112 receptor) (CD112R) (Poliovirus receptor-related immunoglobulin domain-containing protein),o172-192i,326
Q6DN72,Fc receptor-like protein 6 (FcR-like protein 6) (FcRL6) (Fc receptor homolog 6) (FcRH6) (IFGP6),o308-328i,434
Q6EIG7,C-type lectin domain family 6 member A (C-type lectin superfamily member 10) (Dendritic cell-associated C-type lectin 2) (DC-associated C-type lectin 2) (Dectin-2),i23-41o,209
Q6EMK4,Vasorin (Protein slit-like 2),o576-596i,673
Q6GTX8,Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) (hLAIR1) (CD antigen CD305),o164-184i,287
Q6H3X3,UL-16 binding protein 5 (Retinoic acid early transcript 1G protein),o233-242i,334
Q6IA17,Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8),o119-140i,410
Q6IAN0,Dehydrogenase/reductase SDR family member 7B (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 32C member 1) (Protein SDR32C1),o23-38i,325
Q6IS24,Polypeptide N-acetylgalactosaminyltransferase 17 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 3) (GalNAc-T-like protein 3) (pp-GaNTase-like protein 3) (Protein-UDP acetylgalactosaminyltransferase-like protein 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3) (Williams-Beuren syndrome chromosomal region 17 protein),i9-26o,598
Q6ISU1,Pre T-cell antigen receptor alpha (pT-alpha) (pTa) (pT-alpha-TCR),o147-167i,281
Q6J9G0,Tyrosine-protein kinase STYK1 (EC 2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1),o27-47i,422
Q6L9W6,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",i25-44o,998
Q6MZM0,Ferroxidase HEPHL1 (EC 1.16.3.1) (Hephaestin-like protein 1),o1114-1135i,1159
Q6N022,Teneurin-4 (Ten-4) (Protein Odd Oz/ten-m homolog 4) (Tenascin-M4) (Ten-m4) (Teneurin transmembrane protein 4),i342-362o,2769
Q6NSJ0,Myogenesis-regulating glycosidase (EC 3.2.1.-) (Uncharacterized family 31 glucosidase KIAA1161),i57-77o,714
Q6NUJ2,Uncharacterized protein C11orf87,o62-82i,197
Q6NUQ4,Transmembrane protein 214,i482-501o,689
Q6P1J6,"Phospholipase B1, membrane-associated (Phospholipase B) (hPLB) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",o1418-1438i,1458
Q6P4F1,"Alpha-(1,3)-fucosyltransferase 10 (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10)",i10-30o,479
Q6P531,Glutathione hydrolase 6 (EC 3.4.19.13) (Gamma-glutamyltransferase 6) (GGT 6) (EC 2.3.2.2) (Gamma-glutamyltranspeptidase 6) [Cleaved into: Glutathione hydrolase 6 heavy chain; Glutathione hydrolase 6 light chain],i57-75o,493
Q6P9A2,Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase 18) (GalNAc-T18) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4),i10-30o,607
Q6PIU2,Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1),o21i,408
Q6PIZ9,T-cell receptor-associated transmembrane adapter 1 (T-cell receptor-interacting molecule) (TRIM) (pp29/30),o10-30i,186
Q6PJG9,Leucine-rich repeat and fibronectin type-III domain-containing protein 4,o518-539i,635
Q6PJW8,Consortin,i665-685o,725
Q6PKC3,Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1),i65-80o,985
Q6PL45,BRICHOS domain-containing protein 5,i29-49o,260
Q6Q4G3,Aminopeptidase Q (AP-Q) (APQ) (EC 3.4.11.-) (CHL2 antigen) (Laeverin),i14-36o,990
Q6UVK1,Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan),o2225-2244i,2322
Q6UVW9,C-type lectin domain family 2 member A (Keratinocyte-associated C-type lectin) (KACL) (Proliferation-induced lymphocyte-associated receptor) (PILAR),i28-46o,174
Q6UW56,All-trans retinoic acid-induced differentiation factor (Apoptosis-related protein 3) (APR-3) (p18),o200-220i,229
Q6UW60,Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (Proprotein convertase 4) (PC4),o709-729i,755
Q6UW88,Epigen (Epithelial mitogen) (EPG),o111-131i,154
Q6UWB1,Interleukin-27 receptor subunit alpha (IL-27 receptor subunit alpha) (IL-27R subunit alpha) (IL-27R-alpha) (IL-27RA) (Cytokine receptor WSX-1) (Cytokine receptor-like 1) (Type I T-cell cytokine receptor) (TCCR) (ZcytoR1),o517-537i,636
Q6UWF3,"SLP adapter and CSK-interacting membrane protein (SLP65/SLP76, Csk-interacting membrane protein)",o19-39i,145
Q6UWI2,Prostate androgen-regulated mucin-like protein 1 (PARM-1),o259-280i,310
Q6UWL6,Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3),o511-531i,708
Q6UWU4,Bombesin receptor-activated protein C6orf89 (Amfion),i64-79o,347
Q6UX15,Layilin,o236-256i,382
Q6UX27,V-set and transmembrane domain-containing protein 1 (Signal inhibitory receptor on leukocytes-1) (SIRL-1),o136-156i,236
Q6UX34,Protein SNORC (Secondary ossification center-associated regulator of chondrocyte maturation protein),o92-115i,121
Q6UX41,Butyrophilin-like protein 8,o236-258i,500
Q6UX71,Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein),o456-476i,529
Q6UXB4,C-type lectin domain family 4 member G (Liver and lymph node sinusoidal endothelial cell C-type lectin) (LSECtin),i33-53o,293
Q6UXD5,Seizure 6-like protein 2,o845-865i,910
Q6UXF1,Transmembrane protein 108 (Retrolinkin),o469-489i,575
Q6UXG2,Endosome/lysosome-associated apoptosis and autophagy regulator 1 (Estrogen-induced gene 121 protein),o911-931i,1013
Q6UXG3,CMRF35-like molecule 9 (CLM-9) (CD300 antigen-like family member G) (Triggering receptor expressed on myeloid cells 4) (TREM-4) (CD antigen CD300g),o248-268i,332
Q6UXG8,Butyrophilin-like protein 9,o258-278i,535
Q6UXK2,Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein),o590-612i,745
Q6UXL0,Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2),o234-254i,311
Q6UXN8,C-type lectin domain family 9 member A (CD antigen CD370),i35-56o,241
Q6UXV0,GDNF family receptor alpha-like,o352-371i,394
Q6UXZ0,Transmembrane and immunoglobulin domain-containing protein 1,o224-240i,262
Q6UXZ3,CMRF35-like molecule 5 (CLM-5) (CD300 antigen-like family member D) (CMRF35-A4) (CD antigen CD300d),o166-187i,194
Q6UXZ4,Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D),o382-402i,953
Q6UY09,Carcinoembryonic antigen-related cell adhesion molecule 20,o447-467i,596
Q6V0I7,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),o4505-4525i,4981
Q6V0L0,Cytochrome P450 26C1 (CYP26C1) (EC 1.14.14.1),o29i,522
Q6XYQ8,Synaptotagmin-10 (Synaptotagmin X) (SytX),o56-76i,523
Q6ZMC9,Sialic acid-binding Ig-like lectin 15 (Siglec-15) (CD33 antigen-like 3),o264-284i,328
Q6ZMJ2,Scavenger receptor class A member 5 (Scavenger receptor hlg),i61-81o,495
Q6ZMQ8,Serine/threonine-protein kinase LMTK1 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase) (AATYK) (Brain apoptosis-associated tyrosine kinase) (CDK5-binding protein) (Lemur tyrosine kinase 1) (p35-binding protein) (p35BP),o32-51i,1374
Q6ZMR5,Transmembrane protease serine 11A (EC 3.4.21.-) (Airway trypsin-like protease 1) (Epidermal type-II transmembrane serine protease) (Esophageal cancer-susceptibility gene 1 protein),i18-39o,418
Q6ZMZ3,Nesprin-3 (KASH domain-containing protein 3) (KASH3) (Nuclear envelope spectrin repeat protein 3),i926-946o,975
Q6ZN44,Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A),o305-326i,842
Q6ZRP7,Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1),o661-682i,698
Q6ZS10,"C-type lectin domain family 17, member A (Prolectin)",i173-193o,378
Q6ZSA7,Leucine-rich repeat-containing protein 55 (BK channel auxiliary gamma subunit LRRC55),o259-283i,298
Q6ZSJ9,Protein shisa-6,o177-197i,500
Q6ZTQ4,Cadherin-related family member 3 (Cadherin-like protein 28),o711-734i,885
Q6ZV29,Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5),o13-33i,1317
Q6ZWK4,Regulator of hemoglobinization and erythroid cell expansion protein (Regulator of human erythroid cell expansion protein),o12-32i,172
Q70JA7,Chondroitin sulfate synthase 3 (EC 2.4.1.175) (EC 2.4.1.226) (Carbohydrate synthase 2) (Chondroitin glucuronyltransferase 3) (Chondroitin synthase 2) (ChSy-2) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3) (N-acetylgalactosaminyltransferase 3),i12-28o,882
Q70SY1,Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) (BBF2 human homolog on chromosome 7) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2],i380-395o,520
Q70UQ0,Inhibitor of nuclear factor kappa-B kinase-interacting protein (I kappa-B kinase-interacting protein) (IKBKB-interacting protein) (IKK-interacting protein),i46-63o,350
Q71H61,Immunoglobulin-like domain-containing receptor 2 (Angulin-3),o188-206i,639
Q76MJ5,Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (hIRE2p) (Ire1-beta) (IRE1b) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],o433-450i,926
Q7KYR7,Butyrophilin subfamily 2 member A1,o249-269i,527
Q7L0X0,TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644),o698-718i,811
Q7L1S5,Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2),i13-31o,443
Q7LFX5,Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST),i80-98o,561
Q7LGA3,Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2OST) (EC 2.8.2.-),i14-29o,356
Q7LGC8,Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0),i25-38o,479
Q7Z407,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),o3631-3651i,3707
Q7Z410,Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3],i28-50o,1059
Q7Z449,Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),o34-47i,544
Q7Z4F1,Low-density lipoprotein receptor-related protein 10 (LRP-10),o441-461i,713
Q7Z4T8,Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 (Polypeptide GalNAc transferase 15) (GalNAc-T15) (pp-GaNTase 15) (Protein-UDP acetylgalactosaminyltransferase 15) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 15),i5-25o,443
Q7Z6A9,B- and T-lymphocyte attenuator (B- and T-lymphocyte-associated protein) (CD antigen CD272),o154-175i,289
Q7Z6J6,FERM domain-containing protein 5,i501-521o,570
Q7Z6M3,Allergin-1 (Allergy inhibitory receptor 1) (Mast cell antigen 32) (MCA-32) (Mast cell immunoglobulin-like receptor 1),o229-249i,343
Q7Z7D3,V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4) (B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x),i7-29o,282
Q7Z7H5,Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3),o195-214i,227
Q7Z7M0,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),o2648-2669i,2845
Q7Z7M9,Polypeptide N-acetylgalactosaminyltransferase 5 (EC 2.4.1.41) (Polypeptide GalNAc transferase 5) (GalNAc-T5) (pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5),i14-32o,940
Q86SF2,N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7),i5-25o,657
Q86SJ2,Amphoterin-induced protein 2 (AMIGO-2) (Alivin-1) (Differentially expressed in gastric adenocarcinomas) (DEGA),o399-417i,522
Q86SJ6,Desmoglein-4 (Cadherin family member 13),o632-652i,1040
Q86SR1,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),i8-28o,603
Q86SS6,Synaptotagmin-9 (Synaptotagmin IX) (SytIX),o54-75i,491
Q86SU0,Immunoglobulin-like domain-containing receptor 1 (Angulin-2),o171-189i,546
Q86T13,C-type lectin domain family 14 member A (Epidermal growth factor receptor 5) (EGFR-5),o398-418i,490
Q86T26,Transmembrane protease serine 11B (EC 3.4.21.-) (Airway trypsin-like protease 5),i18-38o,416
Q86T96,E3 ubiquitin-protein ligase RNF180 (EC 2.3.2.27) (RING finger protein 180) (RING-type E3 ubiquitin transferase RNF180),i566-590o,592
Q86UE4,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),o50-70i,582
Q86UE6,Leucine-rich repeat transmembrane neuronal protein 1,o428-448i,522
Q86UK5,Limbin (Ellis-van Creveld syndrome protein 2) (EVC2),o301-321i,1308
Q86UP0,Cadherin-24,o642-660i,819
Q86UP2,Kinectin (CG-1 antigen) (Kinesin receptor),o8-28i,1357
Q86UP6,CUB and zona pellucida-like domain-containing protein 1 (CUB and ZP domain-containing protein 1) (Transmembrane protein UO-44),o569-589i,607
Q86UW2,Organic solute transporter subunit beta (OST-beta) (Solute carrier family 51 subunit beta),o40-56i,128
Q86VB7,Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)],o1051-1071i,1156
Q86VH5,Leucine-rich repeat transmembrane neuronal protein 3,o420-440i,581
Q86VZ4,Low-density lipoprotein receptor-related protein 11 (LRP-11),o452-471i,500
Q86W10,Cytochrome P450 4Z1 (EC 1.14.14.1) (CYPIVZ1) (Laurate 7-monooxygenase) (EC 1.14.14.130),o14-30i,505
Q86W74,Ankyrin repeat domain-containing protein 46 (Ankyrin repeat small protein) (ANK-S),i195-213o,228
Q86WC4,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit),o285-305i,334
Q86WK6,Amphoterin-induced protein 1 (AMIGO-1) (Alivin-2),o373-393i,493
Q86X52,Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1),i10-27o,802
Q86XK7,V-set and immunoglobulin domain-containing protein 1 (Cell surface A33 antigen) (Glycoprotein A34),o236-256i,387
Q86XL3,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),o32i,938
Q86XM0,Cation channel sperm-associated auxiliary subunit delta (CatSper-delta) (CatSperdelta) (Transmembrane protein 146),o719-739i,798
Q86XX4,Extracellular matrix organizing protein FRAS1 (Fraser syndrome 1 protein),o3900-3922i,4008
Q86Y07,Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2),i492-507o,508
Q86Y38,Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I),i15-35o,959
Q86Y82,Syntaxin-12,i253-273o,276
Q86YC3,Transforming growth factor beta activator LRRC33 (Leucine-rich repeat-containing protein 33) (Negative regulator of reactive oxygen species),o651-672i,692
Q86YD3,Transmembrane protein 25,o235-256i,366
Q86YD5,Low-density lipoprotein receptor class A domain-containing protein 3 (LDLR class A domain-containing protein 3),o174-194i,345
Q86YL7,Podoplanin (Aggrus) (Glycoprotein 36) (Gp36) (PA2.26 antigen) (T1-alpha) (T1A) [Cleaved into: 29kDa cytosolic podoplanin intracellular domain (PICD)],o132-152i,162
Q86YT9,Junctional adhesion molecule-like (Adhesion molecule interacting with CXADR antigen 1) (Dendritic cell-specific protein CREA7-1),o276-296i,394
Q86YW5,Trem-like transcript 1 protein (TLT-1) (Triggering receptor expressed on myeloid cells-like protein 1),o163-183i,311
Q86Z14,Beta-klotho (BKL) (BetaKlotho) (Klotho beta-like protein),o997-1017i,1044
Q8IU57,Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2),o228-248i,520
Q8IU80,Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2),i54-75o,811
Q8IUC8,Polypeptide N-acetylgalactosaminyltransferase 13 (EC 2.4.1.41) (Polypeptide GalNAc transferase 13) (GalNAc-T13) (pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13),i9-26o,556
Q8IUK5,Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7),o427-447i,500
Q8IUN9,C-type lectin domain family 10 member A (C-type lectin superfamily member 14) (Macrophage lectin 2) (CD antigen CD301),i42-57o,316
Q8IUW5,RELT-like protein 1,o59-77i,271
Q8IUY3,GRAM domain-containing protein 2A,i312-332o,354
Q8IV08,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3),i39-59o,490
Q8IV45,UNC5C-like protein (Protein unc-5 homolog C-like) (ZU5 and death domain-containing protein),o13-31i,518
Q8IW00,V-set and transmembrane domain-containing protein 4 [Cleaved into: Peptide Lv],o179-200i,320
Q8IW45,ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase),o27i,347
Q8IW52,SLIT and NTRK-like protein 4,o619-642i,837
Q8IWR1,Tripartite motif-containing protein 59 (EC 2.3.2.27) (RING finger protein 104) (Tumor suppressor TSBF-1),i333-348o,403
Q8IWT1,Sodium channel subunit beta-4,o163-183i,228
Q8IWU2,Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2),o47-66i,1503
Q8IWV1,Lymphocyte transmembrane adapter 1 (Linker for activation of X cells) (Membrane-associated adapter protein LAX),o38-58i,398
Q8IX05,CD302 antigen (C-type lectin BIMLEC) (C-type lectin domain family 13 member A) (DEC205-associated C-type lectin 1) (Type I transmembrane C-type lectin receptor DCL-1) (CD antigen CD302),o171-191i,232
Q8IX19,Mast cell-expressed membrane protein 1,i82-106o,187
Q8IXA5,"Sperm acrosome membrane-associated protein 3 (Cancer/testis antigen 54) (CT54) (Lysozyme-like acrosomal sperm-specific secretory protein ALLP-17) (Lysozyme-like protein 3) (Sperm lysozyme-like protein 1) (Sperm protein reactive with antisperm antibodies) (Sperm protein reactive with ASA) [Cleaved into: Sperm acrosome membrane-associated protein 3, membrane form; Sperm acrosome membrane-associated protein 3, processed form]",i65-74o,215
Q8IXH8,Cadherin-like protein 26 (Cadherin-like protein VR20),o617-636i,832
Q8IXK2,Polypeptide N-acetylgalactosaminyltransferase 12 (EC 2.4.1.41) (Polypeptide GalNAc transferase 12) (GalNAc-T12) (pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12),i20-34o,581
Q8IXL6,Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK),i11-30o,584
Q8IY17,Patatin-like phospholipase domain-containing protein 6 (EC 3.1.1.5) (Neuropathy target esterase),o58-80i,1375
Q8IYJ0,PILR alpha-associated neural protein (PILR-associating neural protein) (Paired immunoglobin-like type 2 receptor-associating neural protein),o180-199i,282
Q8IYR6,Tomoregulin-1 (TR-1) (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain),o330-349i,380
Q8IYV9,Izumo sperm-egg fusion protein 1 (Oocyte binding/fusion factor) (OBF) (Sperm-specific protein izumo),o293-313i,350
Q8IZ52,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),i13-29o,775
Q8IZA0,Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR),o930-952i,1049
Q8IZJ1,Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1) (p53RDL1),o378-398i,945
Q8IZU9,Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3],o536-558i,778
Q8N0W4,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",o677-697i,816
Q8N114,Protein shisa-5 (Putative NF-kappa-B-activating protein 120) (Scotin),o117-128i,240
Q8N126,Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1),o332-352i,398
Q8N131,Porimin (Keratinocytes-associated transmembrane protein 3) (KCT-3) (Pro-oncosis receptor inducing membrane injury) (Transmembrane protein 123),o169-190i,208
Q8N149,Leukocyte immunoglobulin-like receptor subfamily A member 2 (CD85 antigen-like family member H) (Immunoglobulin-like transcript 1) (ILT-1) (Leukocyte immunoglobulin-like receptor 7) (LIR-7) (CD antigen CD85h),o447-468i,483
Q8N1N2,Dynactin-associated protein (Full),i114-135o,210
Q8N205,Nesprin-4 (KASH domain-containing protein 4) (KASH4) (Nuclear envelope spectrin repeat protein 4),i354-374o,404
Q8N2K0,Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (hABHD12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-),i75-92o,398
Q8N2K1,Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2),i233-253o,259
Q8N2Q7,Neuroligin-1,o716-738i,863
Q8N350,Voltage-dependent calcium channel beta subunit-associated regulatory protein,o47-69i,705
Q8N386,Leucine-rich repeat-containing protein 25 (Monocyte and plasmacytoid-activated protein),o166-187i,305
Q8N387,Mucin-15 (MUC-15),o238-260i,334
Q8N3G9,Transmembrane protein 130,o340-360i,435
Q8N3J6,Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D) (Nectin-like protein 3) (NECL-3) (Synaptic cell adhesion molecule 2) (SynCAM 2),o369-389i,435
Q8N3T1,Polypeptide N-acetylgalactosaminyltransferase 15 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 2) (GalNAc-T-like protein 2) (pp-GaNTase-like protein 2) (Polypeptide N-acetylgalactosaminyltransferase-like protein 2) (Protein-UDP acetylgalactosaminyltransferase-like protein 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2),i16-33o,639
Q8N423,Leukocyte immunoglobulin-like receptor subfamily B member 2 (LIR-2) (Leukocyte immunoglobulin-like receptor 2) (CD85 antigen-like family member D) (Immunoglobulin-like transcript 4) (ILT-4) (Monocyte/macrophage immunoglobulin-like receptor 10) (MIR-10) (CD antigen CD85d),o460-482i,597
Q8N428,Polypeptide N-acetylgalactosaminyltransferase 16 (EC 2.4.1.41) (Polypeptide GalNAc transferase 16) (GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1) (GalNAc-T-like protein 1) (pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1),i9-25o,558
Q8N441,Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5),o379-399i,504
Q8N4A0,Polypeptide N-acetylgalactosaminyltransferase 4 (EC 2.4.1.41) (Polypeptide GalNAc transferase 4) (GalNAc-T4) (pp-GaNTase 4) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4),i12-29o,578
Q8N539,Fibrinogen C domain-containing protein 1,i31-51o,461
Q8N5D6,"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (EC 2.4.1.-) (Forssman glycolipid synthase-like protein)",i6-25o,347
Q8N5G0,Small integral membrane protein 20 (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 7 kDa) (MITRAC7) [Cleaved into: Phoenixin-14 (PNX-14); Phoenixin-20 (PNX-20)],i7-27o,67
Q8N5K1,CDGSH iron-sulfur domain-containing protein 2 (Endoplasmic reticulum intermembrane small protein) (MitoNEET-related 1 protein) (Miner1) (Nutrient-deprivation autophagy factor-1) (NAF-1),o38-56i,135
Q8N5Y8,Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16),i293-308o,322
Q8N608,Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2),i35-55o,796
Q8N6G5,"Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2)",i14-32o,542
Q8N6K0,Testis-expressed protein 29,o57-79i,151
Q8N6L0,Protein KASH5 (Coiled-coil domain-containing protein 155) (KASH domain-containing protein 5),i522-542o,562
Q8N6P7,Interleukin-22 receptor subunit alpha-1 (IL-22 receptor subunit alpha-1) (IL-22R-alpha-1) (IL-22RA1) (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9) (CRF2-9) (ZcytoR11),o229-249i,574
Q8N6R1,Stress-associated endoplasmic reticulum protein 2 (Ribosome-associated membrane protein RAMP4-2),i38-58o,65
Q8N743,Killer cell immunoglobulin-like receptor 3DL3 (CD158 antigen-like family member Z) (Killer cell inhibitory receptor 1) (CD antigen CD158z),o322-343i,410
Q8N766,ER membrane protein complex subunit 1,o963-983i,993
Q8N7C0,Leucine-rich repeat-containing protein 52 (BK channel auxiliary gamma subunit LRRC52),o246-270i,313
Q8N8N0,E3 ubiquitin-protein ligase RNF152 (EC 2.3.2.27) (RING finger protein 152) (RING-type E3 ubiquitin transferase RNF152),i172-187o,203
Q8N912,Nutritionally-regulated adipose and cardiac enriched protein homolog,i104-121o,160
Q8N9F7,Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1),o22i,314
Q8N9I0,Synaptotagmin-2 (Synaptotagmin II) (SytII),o63-83i,419
Q8NAC3,Interleukin-17 receptor C (IL-17 receptor C) (IL-17RC) (Interleukin-17 receptor homolog) (IL17Rhom) (Interleukin-17 receptor-like protein) (IL-17RL) (ZcytoR14),o539-559i,791
Q8NAU1,Fibronectin type III domain-containing protein 5 (Fibronectin type III repeat-containing protein 2) [Cleaved into: Irisin],o155-172i,212
Q8NB59,Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV),o26-44i,555
Q8NBI6,"Xyloside xylosyltransferase 1 (EC 2.4.2.62) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)",i26-41o,393
Q8NBJ4,Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2),i14-34o,401
Q8NBU5,Outer mitochondrial transmembrane helix translocase (EC 7.4.2.-) (ATPase family AAA domain-containing protein 1) (hATAD1) (Thorase),o16-34i,361
Q8NBV8,Synaptotagmin-8 (Synaptotagmin VIII) (SytVIII),o50-70i,401
Q8NBZ7,UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1) (hUXS) (hUXS1),o35i,420
Q8NC01,C-type lectin domain family 1 member A (C-type lectin-like receptor 1) (CLEC-1),i50-70o,280
Q8NC24,RELT-like protein 2,o15-35i,303
Q8NC42,E3 ubiquitin-protein ligase RNF149 (EC 2.3.2.27) (DNA polymerase-transactivated protein 2) (RING finger protein 149) (RING-type E3 ubiquitin transferase RNF149),o201-221i,400
Q8NC67,Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2),o350-368i,525
Q8NCG5,Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2),i7-27o,386
Q8NCH0,Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1),i40-60o,376
Q8NCL4,Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6),i11-26o,622
Q8NCW0,Kremen protein 2 (Dickkopf receptor 2) (Kringle domain-containing transmembrane protein 2) (Kringle-containing protein marking the eye and the nose),o367-387i,462
Q8NCW6,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),i8-28o,608
Q8NDV1,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (EC 2.4.3.7) (GalNAc alpha-2,6-sialyltransferase III) (ST6GalNAc III) (ST6GalNAcIII) (STY) (Sialyltransferase 7C) (SIAT7-C)",i10-25o,305
Q8NEN9,PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104),o3-21i,1154
Q8NER5,Activin receptor type-1C (EC 2.7.11.30) (Activin receptor type IC) (ACTR-IC) (Activin receptor-like kinase 7) (ALK-7),o114-135i,493
Q8NET5,NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1),o165-185i,270
Q8NF91,Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),i8744-8765o,8797
Q8NFL0,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-)",i8-25o,401
Q8NFM7,Interleukin-17 receptor D (IL-17 receptor D) (IL-17RD) (IL17Rhom) (Interleukin-17 receptor-like protein) (Sef homolog) (hSef),o300-320i,739
Q8NFR3,Serine palmitoyltransferase small subunit B (Protein ADMP) (Small subunit of serine palmitoyltransferase B) (ssSPTb),i32-57o,76
Q8NFR9,Interleukin-17 receptor E (IL-17 receptor E) (IL-17RE),o455-475i,667
Q8NFT8,Delta and Notch-like epidermal growth factor-related receptor,o641-661i,737
Q8NFY4,Semaphorin-6D,o663-683i,1073
Q8NFZ3,"Neuroligin-4, Y-linked (Neuroligin Y)",o677-697i,816
Q8NFZ4,Neuroligin-2,o678-698i,835
Q8NFZ8,Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2),o324-345i,388
Q8NHJ6,Leukocyte immunoglobulin-like receptor subfamily B member 4 (B4) (CD85 antigen-like family member K) (Immunoglobulin-like transcript 3) (ILT-3) (Leukocyte immunoglobulin-like receptor 5) (LIR-5) (Monocyte inhibitory receptor HM18) (CD antigen CD85k),o260-280i,448
Q8NHL6,Leukocyte immunoglobulin-like receptor subfamily B member 1 (LIR-1) (Leukocyte immunoglobulin-like receptor 1) (CD85 antigen-like family member J) (Immunoglobulin-like transcript 2) (ILT-2) (Monocyte/macrophage immunoglobulin-like receptor 7) (MIR-7) (CD antigen CD85j),o461-483i,650
Q8NHP6,Motile sperm domain-containing protein 2,i497-516o,518
Q8NHY0,"Beta-1,4 N-acetylgalactosaminyltransferase 2 (EC 2.4.1.-) (Sd(a) beta-1,4-GalNAc transferase) (UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase)",i74-92o,566
Q8NI17,Interleukin-31 receptor subunit alpha (IL-31 receptor subunit alpha) (IL-31R subunit alpha) (IL-31R-alpha) (IL-31RA) (Cytokine receptor-like 3) (GLM-R) (hGLM-R) (Gp130-like monocyte receptor) (Gp130-like receptor) (ZcytoR17),o520-540i,732
Q8TAB3,Protocadherin-19,o679-701i,1148
Q8TAV3,Cytochrome P450 2W1 (EC 1.14.14.-) (CYPIIW1),o21i,490
Q8TB68,Proline-rich protein 7 (Synaptic proline-rich membrane protein),o10-30i,274
Q8TBA6,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),i699-719o,731
Q8TBE3,Fibronectin type III domain-containing protein 9,o113-133i,224
Q8TBM8,DnaJ homolog subfamily B member 14,i247-269o,379
Q8TBP5,Membrane protein FAM174A (Hepatitis C virus NS5A-transactivated protein 6) (HCV NS5A-transactivated protein 6) (Transmembrane protein 157),o124-141i,190
Q8TC12,Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1),o4-21i,318
Q8TC27,Disintegrin and metalloproteinase domain-containing protein 32 (ADAM 32),o683-703i,787
Q8TC36,SUN domain-containing protein 5 (Sad1 and UNC84 domain-containing protein 5) (Sperm-associated antigen 4-like protein) (Testis and spermatogenesis-related gene 4 protein),i101-118o,379
Q8TCY5,Melanocortin-2 receptor accessory protein (B27) (Fat cell-specific low molecular weight protein) (Fat tissue-specific low MW protein),o38-60i,172
Q8TCZ2,CD99 antigen-like protein 2 (MIC2-like protein 1) (CD antigen CD99),o186-206i,262
Q8TD07,Retinoic acid early transcript 1E (Lymphocyte effector toxicity activation ligand) (NKG2D ligand 4) (N2DL-4) (NKG2DL4) (RAE-1-like transcript 4) (UL16-binding protein 4),o230-246i,263
Q8TD46,Cell surface glycoprotein CD200 receptor 1 (CD200 cell surface glycoprotein receptor) (Cell surface glycoprotein OX2 receptor 1),o267-287i,348
Q8TD84,Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1),o1592-1612i,2053
Q8TDF5,Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1),o344-363i,533
Q8TDQ0,Hepatitis A virus cellular receptor 2 (HAVcr-2) (T-cell immunoglobulin and mucin domain-containing protein 3) (TIMD-3) (T-cell immunoglobulin mucin receptor 3) (TIM-3) (T-cell membrane protein 3) (CD antigen CD366),o203-224i,301
Q8TDQ1,CMRF35-like molecule 1 (CLM-1) (CD300 antigen-like family member F) (Immune receptor expressed on myeloid cells 1) (IREM-1) (Immunoglobulin superfamily member 13) (IgSF13) (NK inhibitory receptor) (CD antigen CD300f),o157-177i,290
Q8TDW7,Protocadherin Fat 3 (hFat3) (Cadherin family member 15) (FAT tumor suppressor homolog 3),o4155-4175i,4557
Q8TDX6,"Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CsGalNAcT-1) (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1) (Beta4GalNAcT-1)",i15-33o,532
Q8TEB7,E3 ubiquitin-protein ligase RNF128 (EC 2.3.2.27) (Gene related to anergy in lymphocytes protein) (GRAIL) (RING finger protein 128) (RING-type E3 ubiquitin transferase RNF128),o208-228i,428
Q8WZ75,Roundabout homolog 4 (Magic roundabout),o469-489i,1007
Q8WZA1,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2)",i38-59o,660
Q92185,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase (EC 2.4.3.8) (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Ganglioside GT3 synthase) (Sialyltransferase 8A) (SIAT8-A) (Sialyltransferase St8Sia I) (ST8SiaI)",i28-45o,356
Q92186,"Alpha-2,8-sialyltransferase 8B (EC 2.4.99.-) (Sialyltransferase 8B) (SIAT8-B) (Sialyltransferase St8Sia II) (ST8SiaII) (Sialyltransferase X) (STX)",i8-25o,375
Q92537,Sushi domain-containing protein 6 (Drug-activated gene overexpressed protein),o121-141i,303
Q92542,Nicastrin,o667-686i,709
Q92629,Delta-sarcoglycan (Delta-SG) (35 kDa dystrophin-associated glycoprotein) (35DAG),i34-56o,289
Q92637,Putative high affinity immunoglobulin gamma Fc receptor IB (IgG Fc receptor IB) (Fc gamma receptor IB pseudogene) (Fc-gamma RIB) (FcRIB) (hFcgammaRIB),o199-219i,280
Q92643,GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (GPI8 homolog) (hGPI8) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),o370-383i,395
Q92673,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),o2139-2159i,2214
Q92692,Nectin-2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin cell adhesion molecule 2) (Poliovirus receptor-related protein 2) (CD antigen CD112),o361-381i,538
Q92729,Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Pancreatic carcinoma phosphatase 2) (PCP-2) (Protein-tyrosine phosphatase J) (PTP-J) (hPTP-J) (Protein-tyrosine phosphatase pi) (PTP pi) (Protein-tyrosine phosphatase receptor omicron) (PTP-RO) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi),o747-770i,1446
Q92781,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (9cRDH) (Short chain dehydrogenase/reductase family 9C member 5),o18i,318
Q92823,Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related),o1169-1190i,1304
Q92824,Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (hPC6) (Subtilisin/kexin-like protease PC5),o1744-1764i,1860
Q92838,"Ectodysplasin-A (Ectodermal dysplasia protein) (EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form]",i41-59o,391
Q92854,Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100),o735-753i,862
Q92859,Neogenin (Immunoglobulin superfamily DCC subclass member 2),o1106-1126i,1461
Q92896,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),o1146-1166i,1179
Q92932,Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (Islet cell autoantigen-related protein) (IAR) (ICAAR) (Phogrin) [Cleaved into: IA-2beta60],o616-636i,1015
Q92935,Exostosin-like 1 (EC 2.4.1.224) (Exostosin-L) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein),i10-30o,676
Q92956,Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270),o203-223i,283
Q93033,Immunoglobulin superfamily member 2 (IgSF2) (Cell surface glycoprotein V7) (Glu-Trp-Ile EWI motif-containing protein 101) (EWI-101) (CD antigen CD101),o955-977i,1021
Q93038,Tumor necrosis factor receptor superfamily member 25 (Apo-3) (Apoptosis-inducing receptor AIR) (Apoptosis-mediating receptor DR3) (Apoptosis-mediating receptor TRAMP) (Death receptor 3) (Lymphocyte-associated receptor of death) (LARD) (Protein WSL) (Protein WSL-1),o201-221i,417
Q93063,Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2) (Putative tumor suppressor protein EXT2),i27-45o,718
Q95460,Major histocompatibility complex class I-related gene protein (MHC class I-related gene protein) (Class I histocompatibility antigen-like protein),o301-323i,341
Q969F0,Fetal and adult testis-expressed transcript protein (Cancer/testis antigen 43) (CT43) (Tumor antigen BJ-HCC-2),i163-181o,183
Q969N2,GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein),o528-547i,578
Q969P0,Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316),o580-602i,613
Q969V3,BOS complex subunit NCLN (Nicalin) (Nicastrin-like protein),o526-543i,563
Q969W0,Serine palmitoyltransferase small subunit A (Small subunit of serine palmitoyltransferase A) (ssSPTa),i36-56o,71
Q969W9,Protein TMEPAI (Prostate transmembrane protein androgen induced 1) (Solid tumor-associated 1 protein) (Transmembrane prostate androgen-induced protein),o44-62i,287
Q969X2,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI) (ST6GalNAcVI) (hST6GalNAc VI) (Sialyltransferase 7F) (SIAT7-F)",i43-59o,333
Q969Z4,Tumor necrosis factor receptor superfamily member 19L (Receptor expressed in lymphoid tissues),o165-185i,430
Q96A11,"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)",i20-38o,431
Q96A25,Transmembrane protein 106A,i94-115o,262
Q96A26,Protein FAM162A (E2-induced gene 5 protein) (Growth and transformation-dependent protein) (HGTD-P),i101-122o,154
Q96A33,PAT complex subunit CCDC47 (Calumin) (Coiled-coil domain-containing protein 47),o136-156i,483
Q96AE7,Tetratricopeptide repeat protein 17 (TPR repeat protein 17),o38i,1141
Q96AG4,"Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34) (p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]",i245-265o,307
Q96AJ9,Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2),i193-214o,217
Q96AP7,Endothelial cell-selective adhesion molecule,o249-269i,390
Q96AQ6,Pre-B-cell leukemia transcription factor-interacting protein 1 (Hematopoietic PBX-interacting protein),i195-215o,731
Q96AQ8,"Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)",i339-355o,359
Q96AW1,"WW domain binding protein VOPP1 (EGFR-coamplified and overexpressed protein) (ECop) (Glioblastoma-amplified secreted protein) (Putative NF-kappa-B-activating protein 055N) (Vesicular, overexpressed in cancer, prosurvival protein 1)",o61-81i,172
Q96B49,Mitochondrial import receptor subunit TOM6 homolog (Overexpressed breast tumor protein) (Translocase of outer membrane 6 kDa subunit homolog),i44-59o,74
Q96BA8,Cyclic AMP-responsive element-binding protein 3-like protein 1 (cAMP-responsive element-binding protein 3-like protein 1) (Old astrocyte specifically-induced substance) (OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1],i376-391o,519
Q96BF3,Transmembrane and immunoglobulin domain-containing protein 2 (CD28 homolog) (Immunoglobulin and proline-rich receptor 1) (IGPR-1),o150-170i,282
Q96BY9,Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66),o173-193i,339
Q96BZ4,5'-3' exonuclease PLD4 (EC 3.1.16.1) (Choline phosphatase 4) (Phosphatidylcholine-hydrolyzing phospholipase D4) (Phospholipase D family member 4) (Phospholipase D4) (PLD 4),i31-51o,506
Q96CP6,Protein Aster-A (GRAM domain-containing protein 1A),i607-631o,724
Q96D42,Hepatitis A virus cellular receptor 1 (HAVcr-1) (Kidney injury molecule 1) (KIM-1) (T-cell immunoglobulin and mucin domain-containing protein 1) (TIMD-1) (T-cell immunoglobulin mucin receptor 1) (TIM) (TIM-1) (T-cell membrane protein 1) (CD antigen CD365),o296-316i,364
Q96D59,E3 ubiquitin-protein ligase RNF183 (EC 2.3.2.27),i162-182o,192
Q96DB9,FXYD domain-containing ion transport regulator 5 (Dysadherin),o146-161i,178
Q96DU3,SLAM family member 6 (Activating NK receptor) (NK-T-B-antigen) (NTB-A) (CD antigen CD352),o226-248i,332
Q96DX8,Receptor-transporting protein 4 (28 kDa interferon-responsive protein) (3CxxC-type zinc finger protein 4),i230-240o,246
Q96E93,Killer cell lectin-like receptor subfamily G member 1 (C-type lectin domain family 15 member A) (ITIM-containing receptor MAFA-L) (MAFA-like receptor) (Mast cell function-associated antigen),i39-56o,195
Q96F05,Uncharacterized protein C11orf24 (Protein DM4E3),o402-422i,449
Q96F15,GTPase IMAP family member 5 (Immune-associated nucleotide-binding protein 5) (Immunity-associated nucleotide 4-like 1 protein) (Immunity-associated nucleotide 5 protein) (IAN-5) (hIAN5) (Immunity-associated protein 3),i285-304o,307
Q96F25,UDP-N-acetylglucosamine transferase subunit ALG14 homolog,o4-24i,216
Q96F46,Interleukin-17 receptor A (IL-17 receptor A) (IL-17RA) (CDw217) (CD antigen CD217),o321-341i,866
Q96FE5,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A),o558-580i,620
Q96FE7,Phosphoinositide-3-kinase-interacting protein 1 (PI3K-interacting protein 1) (Kringle domain-containing protein HGFL),o171-191i,263
Q96FL9,Polypeptide N-acetylgalactosaminyltransferase 14 (EC 2.4.1.41) (Polypeptide GalNAc transferase 14) (GalNAc-T14) (pp-GaNTase 14) (Protein-UDP acetylgalactosaminyltransferase 14) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14),i8-26o,552
Q96G30,Melanocortin-2 receptor accessory protein 2 (MC2R accessory protein 2),o45-67i,205
Q96GF1,E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185),i177-191o,192
Q96GL9,Protein FAM163A (Cebelin) (Neuroblastoma-derived secretory protein),o6-26i,167
Q96GP6,Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),o442-462i,871
Q96GX1,Tectonic-2,o669-685i,697
Q96H15,T-cell immunoglobulin and mucin domain-containing protein 4 (TIMD-4) (T-cell immunoglobulin mucin receptor 4) (TIM-4) (T-cell membrane protein 4),o315-335i,378
Q96HH9,GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2),i346-364o,432
Q96HY6,DDRGK domain-containing protein 1 (Dashurin) (UFM1-binding and PCI domain-containing protein 1),o5-22i,314
Q96J42,Thioredoxin domain-containing protein 15,o324-342i,360
Q8TEM1,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),o1808-1828i,1887
Q8TEY5,Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) (Androgen-induced basic leucine zipper protein) (AIbZIP) (Attaching to CRE-like 1) (ATCE1) (Cyclic AMP-responsive element-binding protein 4) (CREB-4) (cAMP-responsive element-binding protein 4) (Transcript induced in spermiogenesis protein 40) (Tisp40) (hJAL) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4],i298-313o,395
Q8TF66,Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib),o541-561i,581
Q8WTT0,C-type lectin domain family 4 member C (Blood dendritic cell antigen 2) (BDCA-2) (C-type lectin superfamily member 7) (Dendritic lectin) (CD antigen CD303),i22-39o,213
Q8WVB3,Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase),i84-93o,486
Q8WVN6,Secreted and transmembrane protein 1 (Protein K-12),o148-168i,248
Q8WVQ1,Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107),i45-60o,401
Q8WVV5,Butyrophilin subfamily 2 member A2,o266-286i,523
Q8WVX3,Uncharacterized protein C4orf3 (Hepatitis C virus F protein-transactivated protein 1) (HCV F-transactivated protein 1),i48-64o,66
Q8WWB7,Glycosylated lysosomal membrane protein (Lysosomal protein NCU-G1),o369-394i,406
Q8WWF3,Serine-rich single-pass membrane protein 1,o38-58i,244
Q8WWG9,Potassium voltage-gated channel subfamily E member 4 (MinK-related peptide 3) (Minimum potassium ion channel-related peptide 3) (Potassium channel subunit beta MiRP3),o87-109i,221
Q8WWP7,GTPase IMAP family member 1 (Immunity-associated protein 1) (hIMAP1),i276-292o,306
Q8WWQ8,"Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]",o2461-2481i,2551
Q8WWV6,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor (Fc alpha/mu receptor) (CD antigen CD351),o451-470i,532
Q8WXH0,Nesprin-2 (KASH domain-containing protein 2) (KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),i6832-6853o,6885
Q8WXH2,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),i727-747o,748
Q8WXI7,Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125),o14456-14476i,14507
Q8WY21,VPS10 domain-containing receptor SorCS1 (hSorCS),o1102-1120i,1168
Q8WZ59,Transmembrane protein 190,o83-103i,177
Q96J84,Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1),o497-518i,757
Q96JA1,Leucine-rich repeats and immunoglobulin-like domains protein 1 (LIG-1),o793-815i,1093
Q96JF0,"Beta-galactoside alpha-2,6-sialyltransferase 2 (Alpha 2,6-ST 2) (EC 2.4.3.1) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 2) (ST6Gal II) (ST6GalII) (hST6Gal II) (Sialyltransferase 2)",i12-30o,529
Q96JJ6,Junctophilin-4 (JP-4) (Junctophilin-like 1 protein),i607-627o,628
Q96JJ7,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),o376-396i,454
Q96JN2,Coiled-coil domain-containing protein 136 (Nasopharyngeal carcinoma-associated gene 6 protein),i1135-1150o,1154
Q96JP9,Cadherin-related family member 1 (Photoreceptor cadherin) (prCAD) (Protocadherin-21),o702-722i,859
Q96JQ0,Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1),o2938-2958i,3298
Q96KC8,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),o151-171i,554
Q96KG7,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),o858-878i,1140
Q96L08,Sushi domain-containing protein 3,o106-124i,255
Q96LA5,Fc receptor-like protein 2 (FcR-like protein 2) (FcRL2) (Fc receptor homolog 2) (FcRH2) (IFGP family protein 4) (Immunoglobulin receptor translocation-associated protein 4) (SH2 domain-containing phosphatase anchor protein 1) (CD antigen CD307b),o401-422i,508
Q96LA6,Fc receptor-like protein 1 (FcR-like protein 1) (FcRL1) (Fc receptor homolog 1) (FcRH1) (IFGP family protein 1) (hIFGP1) (Immune receptor translocation-associated protein 5) (CD antigen CD307a),o309-329i,429
Q96LC7,Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Siglec-like protein 2),o552-571i,697
Q96LL9,"DnaJ homolog subfamily C member 30, mitochondrial (Williams-Beuren syndrome chromosomal region 18 protein)",i210-224o,226
Q96MG2,Junctional sarcoplasmic reticulum protein 1 (Junctional-face membrane protein of 45 kDa homolog) (JP-45),i127-144o,331
Q96MK3,Pseudokinase FAM20A,i9-25o,541
Q96MM7,Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (EC 2.8.2.-),i154-171o,605
Q96MS0,Roundabout homolog 3 (Roundabout-like protein 3),o892-912i,1386
Q96MU8,Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose),o393-413i,473
Q96NI6,Leucine-rich repeat and fibronectin type-III domain-containing protein 5,o530-550i,719
Q96NR8,Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2),o3-18i,316
Q96NY8,Nectin-4 (Ig superfamily receptor LNIR) (Nectin cell adhesion molecule 4) (Poliovirus receptor-related protein 4) [Cleaved into: Processed poliovirus receptor-related protein 4],o350-370i,510
Q96P31,Fc receptor-like protein 3 (FcR-like protein 3) (FcRL3) (Fc receptor homolog 3) (FcRH3) (IFGP family protein 3) (hIFGP3) (Immune receptor translocation-associated protein 3) (MAIA) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c),o577-596i,734
Q96PC5,Melanoma inhibitory activity protein 2 (MIA protein 2) (CTAGE family member 5 ER export factor) (Cutaneous T-cell lymphoma-associated antigen 5) (Meningioma-expressed antigen 6/11),o651-667i,1412
Q96PD2,"Discoidin, CUB and LCCL domain-containing protein 2 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1) (Endothelial and smooth muscle cell-derived neuropilin-like protein)",o532-552i,775
Q96PJ5,Fc receptor-like protein 4 (FcR-like protein 4) (FcRL4) (Fc receptor homolog 4) (FcRH4) (IFGP family protein 2) (hIFGP2) (Immune receptor translocation-associated protein 1) (CD antigen CD307d),o386-408i,515
Q96PL5,Erythroid membrane-associated protein (hERMAP) (Radin blood group antigen) (Scianna blood group antigen),o155-175i,475
Q96PQ0,VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain],o1080-1100i,1159
Q96PQ1,Sialic acid-binding Ig-like lectin 12 (Siglec-12) (Sialic acid-binding Ig-like lectin-like 1) (Siglec-L1),o482-502i,595
Q96PX8,SLIT and NTRK-like protein 1 (Leucine-rich repeat-containing protein 12),o620-642i,696
Q96PZ7,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),o3488-3508i,3564
Q96Q04,Serine/threonine-protein kinase LMTK3 (EC 2.7.11.1) (Lemur tyrosine kinase 3),o40-60i,1460
Q96QU1,Protocadherin-15,o1373-1397i,1955
Q96RD9,Fc receptor-like protein 5 (FcR-like protein 5) (FcRL5) (BXMAS1) (Fc receptor homolog 5) (FcRH5) (Immune receptor translocation-associated protein 2) (CD antigen CD307e),o848-869i,977
Q96RJ3,Tumor necrosis factor receptor superfamily member 13C (B-cell-activating factor receptor) (BAFF receptor) (BAFF-R) (BLyS receptor 3) (CD antigen CD268),o81-99i,184
Q96RL6,Sialic acid-binding Ig-like lectin 11 (Sialic acid-binding lectin 11) (Siglec-11),o564-584i,698
Q96RP7,"Galactose-3-O-sulfotransferase 4 (Gal3ST-4) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 4) (Gal-beta-1,3-GalNAc 3'-sulfotransferase)",i18-36o,486
Q96SQ9,Cytochrome P450 2S1 (EC 1.14.14.-) (CYPIIS1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Thromboxane-A synthase) (EC 5.3.99.5),o23i,504
Q99062,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114),o628-648i,836
Q99075,Proheparin-binding EGF-like growth factor [Cleaved into: Heparin-binding EGF-like growth factor (HB-EGF) (HBEGF) (Diphtheria toxin receptor) (DT-R)],o162-183i,208
Q99102,Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1) (ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2) (ASGP-2)],o5368-5391i,5412
Q99466,Neurogenic locus notch homolog protein 4 (Notch 4) (hNotch4) [Cleaved into: Notch 4 extracellular truncation; Notch 4 intracellular domain],o1448-1468i,2003
Q99467,CD180 antigen (Lymphocyte antigen 64) (Radioprotective 105 kDa protein) (CD antigen CD180),o630-650i,661
Q99518,Flavin-containing monooxygenase 2 (EC 1.14.13.-) (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2) (FMO 2),i514-534o,535
Q99523,Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3),o759-778i,831
Q99623,Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity),i21-36o,299
Q99650,Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB),o740-760i,979
Q99665,Interleukin-12 receptor subunit beta-2 (IL-12 receptor subunit beta-2) (IL-12R subunit beta-2) (IL-12R-beta-2) (IL-12RB2),o624-644i,862
Q99706,Killer cell immunoglobulin-like receptor 2DL4 (CD158 antigen-like family member D) (G9P) (Killer cell inhibitory receptor 103AS) (KIR-103AS) (MHC class I NK cell receptor KIR103AS) (CD antigen CD158d),o243-263i,377
Q99720,Sigma non-opioid intracellular receptor 1 (Aging-associated gene 8 protein) (SR31747-binding protein) (SR-BP) (Sigma 1-type opioid receptor) (SIG-1R) (Sigma1-receptor) (Sigma1R) (hSigmaR1),o30i,223
Q99795,Cell surface A33 antigen (Glycoprotein A33),o237-257i,319
Q99941,Cyclic AMP-dependent transcription factor ATF-6 beta (cAMP-dependent transcription factor ATF-6 beta) (Activating transcription factor 6 beta) (ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein) (Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta],i397-416o,703
Q99942,E3 ubiquitin-protein ligase RNF5 (EC 2.3.2.27) (RING finger protein 5) (Ram1 homolog) (HsRma1),i165-178o,180
Q99946,Proline-rich transmembrane protein 1 (Dispanin subfamily D member 1) (DSPD1) (Synapse differentiation-induced protein 4) (SynDIG4),i276-296o,306
Q99965,Disintegrin and metalloproteinase domain-containing protein 2 (ADAM 2) (Cancer/testis antigen 15) (CT15) (Fertilin subunit beta) (PH-30) (PH30) (PH30-beta),o689-707i,735
Q99999,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),i13-33o,423
Q9BPW9,Dehydrogenase/reductase SDR family member 9 (EC 1.1.1.209) (EC 1.1.1.53) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (EC 1.1.1.105) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),o16i,319
Q9BQ51,Programmed cell death 1 ligand 2 (PD-1 ligand 2) (PD-L2) (PDCD1 ligand 2) (Programmed death ligand 2) (Butyrophilin B7-DC) (B7-DC) (CD antigen CD273),o222-242i,273
Q9BQE4,Selenoprotein S (SelS) (VCP-interacting membrane protein),o29-48i,189
Q9BQG1,Synaptotagmin-3 (Synaptotagmin III) (SytIII),o55-75i,590
Q9BQS2,Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV),o6-26i,421
Q9BQS7,Hephaestin (EC 1.-.-.-),o1111-1131i,1158
Q9BQT9,Calsyntenin-3 (Alcadein-beta) (Alc-beta),o848-868i,956
Q9BR39,Junctophilin-2 (JP-2) (Junctophilin type 2) [Cleaved into: Junctophilin-2 N-terminal fragment (JP2NT)],i674-694o,696
Q9BRK3,Matrix remodeling-associated protein 8 (Limitrin),o342-362i,442
Q9BRR6,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147) (RbBP-35),o23i,497
Q9BT22,"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)",o6-22i,464
Q9BT88,Synaptotagmin-11 (Synaptotagmin XI) (SytXI),o16-36i,431
Q9BTN0,Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (Synaptic adhesion-like molecule 4),o540-560i,628
Q9BUF7,Protein crumbs homolog 3,o60-80i,120
Q9BV40,Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB),i76-96o,100
Q9BVK6,Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2) (p25),o203-222i,235
Q9BVX2,Transmembrane protein 106C (Endoplasmic reticulum membrane protein overexpressed in cancer),i87-107o,250
Q9BWL3,Protein C1orf43 (Hepatitis C virus NS5A-transactivated protein 4) (HCV NS5A-transactivated protein 4) (Protein NICE-3) (S863-3),o11-31i,253
Q9BWV1,Brother of CDO (Protein BOC),o856-878i,1114
Q9BX59,Tapasin-related protein (TAPASIN-R) (TAP-binding protein-like) (TAP-binding protein-related protein) (TAPBP-R) (Tapasin-like),o406-426i,468
Q9BX67,Junctional adhesion molecule C (JAM-C) (JAM-2) (Junctional adhesion molecule 3) (JAM-3) [Cleaved into: Soluble form of JAM-C (sJAM-C)],o244-263i,310
Q9BX97,Plasmalemma vesicle-associated protein (Fenestrated endothelial-linked structure protein) (Plasmalemma vesicle protein 1) (PV-1),i27-48o,442
Q9BXJ7,Protein amnionless [Cleaved into: Soluble protein amnionless],o361-383i,453
Q9BXN2,C-type lectin domain family 7 member A (Beta-glucan receptor) (C-type lectin superfamily member 12) (Dendritic cell-associated C-type lectin 1) (DC-associated C-type lectin 1) (Dectin-1) (CD antigen CD369),i45-65o,247
Q9BXR5,Toll-like receptor 10 (CD antigen CD290),o577-597i,811
Q9BXS0,Collagen alpha-1(XXV) chain (Alzheimer disease amyloid-associated protein) (AMY) (CLAC-P) [Cleaved into: Collagen-like Alzheimer amyloid plaque component (CLAC)],i34-54o,654
Q9BXS4,Transmembrane protein 59 (Liver membrane-bound protein),o240-257i,323
Q9BXU9,Calcium-binding protein 8 (CaBP8) (Calneuron I) (Calneuron-1),i235-252o,261
Q9BY64,UDP-glucuronosyltransferase 2B28 (UDPGT 2B28) (UGT2B28) (EC 2.4.1.17),o491-516i,529
Q9BY67,Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1),o376-396i,442
Q9BY79,Membrane frizzled-related protein (Membrane-type frizzled-related protein),i70-90o,579
Q9BYC5,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)",i10-27o,575
Q9BYE2,Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease),i166-186o,586
Q9BYE9,Cadherin-related family member 2 (Protocadherin LKC) (PC-LKC) (Protocadherin-24),o1155-1175i,1310
Q9BYF1,Angiotensin-converting enzyme 2 (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (ACE-related carboxypeptidase) (EC 3.4.17.-) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2],o744-766i,805
Q9BYG0,"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5)",i16-32o,378
Q9BYH1,Seizure 6-like protein,o959-979i,1024
Q9BZ11,Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-),o702-722i,813
Q9BZA7,Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X) (Protocadherin-S),o813-834i,1347
Q9BZA8,Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22),o845-866i,1340
Q9BZD6,Transmembrane gamma-carboxyglutamic acid protein 4 (Proline-rich gamma-carboxyglutamic acid protein 4) (Proline-rich Gla protein 4),o117-137i,226
Q9BZF1,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),i871-888o,889
Q9BZG2,Testicular acid phosphatase (EC 3.1.3.2) (Acid phosphatase 4),o398-413i,426
Q9BZL3,Small integral membrane protein 3 (NGF-induced differentiation clone 67 protein) (Small membrane protein NID67),o22-42i,60
Q9BZV3,Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa) (IPM 200) (Sialoprotein associated with cones and rods proteoglycan) (Spacrcan),o1100-1124i,1241
Q9BZW8,Natural killer cell receptor 2B4 (NK cell activation-inducing ligand) (NAIL) (NK cell type I receptor protein 2B4) (NKR2B4) (h2B4) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244),o227-248i,370
Q9BZZ2,Sialoadhesin (Sialic acid-binding Ig-like lectin 1) (Siglec-1) (CD antigen CD169),o1642-1662i,1709
Q9C0A0,Contactin-associated protein-like 4 (Cell recognition molecule Caspr4),o1242-1262i,1308
Q9C0C4,Semaphorin-4C,o664-684i,833
Q9C0I4,Thrombospondin type-1 domain-containing protein 7B,o1558-1578i,1606
Q9GZS9,Carbohydrate sulfotransferase 5 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha) (GST4-alpha) (Intestinal N-acetylglucosamine-6-O-sulfotransferase) (I-GlcNAc6ST) (Intestinal GlcNAc-6-sulfotransferase) (hIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3) (GlcNAc6ST-3) (Gn6st-3),i32-49o,411
Q9GZY6,Linker for activation of T-cells family member 2 (Linker for activation of B-cells) (Membrane-associated adapter molecule) (Non-T-cell activation linker) (Williams-Beuren syndrome chromosomal region 15 protein) (Williams-Beuren syndrome chromosomal region 5 protein),o7-26i,243
Q9GZY8,Mitochondrial fission factor,i322-340o,342
Q9H013,Disintegrin and metalloproteinase domain-containing protein 19 (ADAM 19) (EC 3.4.24.-) (Meltrin-beta) (Metalloprotease and disintegrin dendritic antigen marker) (MADDAM),o703-721i,955
Q9H0Q3,FXYD domain-containing ion transport regulator 6 (Phosphohippolin),o39-57i,95
Q9H0R3,Transmembrane protein 222,i191-201o,208
Q9H0V9,VIP36-like protein (Lectin mannose-binding 2-like) (LMAN2-like protein),o315-336i,348
Q9H0X9,Oxysterol-binding protein-related protein 5 (ORP-5) (OSBP-related protein 5) (Oxysterol-binding protein homolog 1),i860-878o,879
Q9H156,SLIT and NTRK-like protein 2,o620-643i,845
Q9H173,Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP),o32i,461
Q9H1B5,Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II),i16-32o,865
Q9H251,Cadherin-23 (Otocadherin),o3067-3086i,3354
Q9H2A7,C-X-C motif chemokine 16 (Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein) (SR-PSOX) (Small-inducible cytokine B16) (Transmembrane chemokine CXCL16),o206-226i,254
Q9H2B2,Synaptotagmin-4 (Synaptotagmin IV) (SytIV),o16-36i,425
Q9H2E6,Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1),o650-673i,1030
Q9H2S6,Tenomodulin (TeM) (hTeM) (Chondromodulin-1-like protein) (ChM1L) (hChM1L) (Chondromodulin-I-like protein) (Myodulin) (Tendin),i29-49o,317
Q9H2U9,Disintegrin and metalloproteinase domain-containing protein 7 (ADAM 7) (Sperm maturation-related glycoprotein GP-83),o671-690i,754
Q9H2X3,C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein) (DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2) (DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin) (L-SIGN) (CD antigen CD299),i49-70o,399
Q9H3N1,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),o183-203i,280
Q9H3Q3,"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2) (Glycoprotein beta-Gal 3'-sulfotransferase 2)",i14-31o,398
Q9H3R1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 4) (NDST-4) (N-heparan sulfate sulfotransferase 4) (N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 4 (EC 2.8.2.-)],i14-33o,872
Q9H3R2,Mucin-13 (MUC-13) (Down-regulated in colon cancer 1),o419-443i,512
Q9H3S1,Semaphorin-4A (Semaphorin-B) (Sema B),o684-704i,761
Q9H3S3,Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin),i49-69o,457
Q9H3T2,Semaphorin-6C (Semaphorin-Y) (Sema Y),o605-625i,930
Q9H3T3,Semaphorin-6B (Semaphorin-Z) (Sema Z),o600-622i,888
Q9H400,Lck-interacting transmembrane adapter 1 (Lck-interacting membrane protein) (Lck-interacting molecule),o11-27i,295
Q9H4D0,Calsyntenin-2 (Alcadein-gamma) (Alc-gamma),o833-853i,955
Q9H4I9,"Essential MCU regulator, mitochondrial (Single-pass membrane protein with aspartate-rich tail 1, mitochondrial)",i65-84o,107
Q9H5V8,CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein) (SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318),o668-688i,836
Q9H5Y7,SLIT and NTRK-like protein 6,o609-629i,841
Q9H6B4,CXADR-like membrane protein (Adipocyte adhesion molecule) (Coxsackie- and adenovirus receptor-like membrane protein) (CAR-like membrane protein),o234-256i,373
Q9H6X2,Anthrax toxin receptor 1 (Tumor endothelial marker 8),o322-342i,564
Q9H6Y7,E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167),o174-194i,350
Q9H741,SREBP regulating gene protein (SREBF pathway regulator in Golgi 1),i17-32o,205
Q9H7M9,V-type immunoglobulin domain-containing suppressor of T-cell activation (Platelet receptor Gi24) (Stress-induced secreted protein-1) (Sisp-1) (V-set domain-containing immunoregulatory receptor) (V-set immunoregulatory receptor),o196-216i,311
Q9H8M9,Protein eva-1 homolog A (Protein FAM176A) (Transmembrane protein 166),o34-55i,152
Q9H9K5,"Endogenous retroviral envelope protein HEMO (Endogenous retrovirus group MER34 member 1 Env polyprotein) (HERV-MER_4q12 provirus ancestral Env polyprotein) (Human endogenous MER34 (medium-reiteration-frequency-family-34) open reading frame) (Human endogenous MER34 ORF) (HEMO) [Cleaved into: Endogenous retroviral envelope protein HEMO, secreted form (Endogenous retroviral envelope protein HEMO, 48 kDa form)]",o493-507i,563
Q9H9P2,Chondrolectin (Transmembrane protein MT75),o220-240i,273
Q9H9V4,RING finger protein 122,o37-55i,155
Q9HAV5,Tumor necrosis factor receptor superfamily member 27 (X-linked ectodysplasin-A2 receptor) (EDA-A2 receptor),o140-160i,297
Q9HAW7,UDP-glucuronosyltransferase 1A7 (UGT1A7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-7) (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G),o486-506i,530
Q9HAW8,UDP-glucuronosyltransferase 1A10 (UGT1A10) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-10) (UDPGT 1-10) (UGT1*10) (UGT1-10) (UGT1.10) (UDP-glucuronosyltransferase 1-J) (UGT-1J) (UGT1J),o486-506i,530
Q9HAW9,UDP-glucuronosyltransferase 1A8 (UGT1A8) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-8) (UDPGT 1-8) (UGT1*8) (UGT1-08) (UGT1.8) (UDP-glucuronosyltransferase 1-H) (UGT-1H) (UGT1H),o486-506i,530
Q9HB29,Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2),o336-355i,575
Q9HBB8,Cadherin-related family member 5 (Mu-protocadherin) (Mucin and cadherin-like protein) (Mucin-like protocadherin) (MLPCDH),o669-690i,845
Q9HBE5,Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360),o238-253i,538
Q9HBG7,T-lymphocyte surface antigen Ly-9 (Cell surface molecule Ly-9) (Lymphocyte antigen 9) (SLAM family member 3) (SLAMF3) (Signaling lymphocytic activation molecule 3) (CD antigen CD229),o455-475i,655
Q9HBI6,Cytochrome P450 4F11 (CYPIVF11) (EC 1.14.14.1) (3-hydroxy fatty acids omega-hydroxylase CYP4F11) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) (Phylloquinone omega-hydroxylase CYP4F11) (EC 1.14.14.78),o36i,524
Q9HBJ8,Collectrin (Transmembrane protein 27),o142-167i,222
Q9HBT6,Cadherin-20,o622-640i,801
Q9HBV2,Sperm acrosome membrane-associated protein 1 (Sperm acrosomal membrane-associated protein 32),o218-241i,294
Q9HBW1,Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand) (NGL-2),o528-548i,653
Q9HC10,Otoferlin (Fer-1-like protein 2),i1965-1985o,1997
Q9HC73,Cytokine receptor-like factor 2 (Cytokine receptor-like 2) (IL-XR) (Thymic stromal lymphopoietin protein receptor) (TSLP receptor),o232-252i,371
Q9HCJ2,Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1),o528-548i,640
Q9HCK4,Roundabout homolog 2,o860-880i,1378
Q9HCM2,Plexin-A4,o1238-1258i,1894
Q9HCM3,UPF0606 protein KIAA1549,o1301-1319i,1950
Q9HCN6,Platelet glycoprotein VI (GPVI) (Glycoprotein 6),o270-289i,339
Q9HCQ5,Polypeptide N-acetylgalactosaminyltransferase 9 (EC 2.4.1.41) (Polypeptide GalNAc transferase 9) (GalNAc-T9) (pp-GaNTase 9) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9),i10-26o,603
Q9HCS2,Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12),o39i,524
Q9HCU0,Endosialin (Tumor endothelial marker 1) (CD antigen CD248),o688-708i,757
Q9HCU5,Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12),i391-409o,417
Q9HD36,Bcl-2-like protein 10 (Bcl2-L-10) (Anti-apoptotic protein Boo) (Anti-apoptotic protein NrH) (Apoptosis regulator Bcl-B),i183-200o,204
Q9HD43,Receptor-type tyrosine-protein phosphatase H (R-PTP-H) (EC 3.1.3.48) (Stomach cancer-associated protein tyrosine phosphatase 1) (SAP-1) (Transmembrane-type protein-tyrosine phosphatase type H),o754-774i,1115
Q9HDB5,"Neurexin-3-beta (Neurexin III-beta) [Cleaved into: Neurexin-3-beta, soluble form; Neurexin-3-beta, C-terminal fragment (NRXN3-CTF)]",o564-583i,637
Q9HDC5,Junctophilin-1 (JP-1) (Junctophilin type 1),i640-657o,661
Q9HDC9,Adipocyte plasma membrane-associated protein (Protein BSCv),i41-61o,416
Q9N2K0,HERV-H_2q24.3 provirus ancestral Env polyprotein (Env protein HERV-H/p62) (Env protein HERV-H19) (Env protein HERV-Hcl.3) (Envelope polyprotein) (HERV-H/env62) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],o526-537i,584
Q9NNX6,CD209 antigen (C-type lectin domain family 4 member L) (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN) (DC-SIGN1) (CD antigen CD209),i43-58o,404
Q9NP60,X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (EC 3.2.2.6) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1),o355-375i,686
Q9NP84,Tumor necrosis factor receptor superfamily member 12A (Fibroblast growth factor-inducible immediate-early response protein 14) (FGF-inducible 14) (Tweak-receptor) (TweakR) (CD antigen CD266),o81-101i,129
Q9NP99,Triggering receptor expressed on myeloid cells 1 (TREM-1) (Triggering receptor expressed on monocytes 1) (CD antigen CD354),o207-229i,234
Q9NPA0,ER membrane protein complex subunit 7,o165-183i,242
Q9NPC4,"Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (CD77 synthase) (Globotriaosylceramide synthase) (Gb3 synthase) (P1/Pk synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase)",i23-38o,353
Q9NPF0,CD320 antigen (8D6 antigen) (FDC-signaling molecule 8D6) (FDC-SM-8D6) (Transcobalamin receptor) (TCblR) (CD antigen CD320),o231-250i,282
Q9NPF2,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),i17-33o,352
Q9NPG4,"Protocadherin-12 (Vascular cadherin-2) (Vascular endothelial cadherin-2) (VE-cad-2) (VE-cadherin-2) [Cleaved into: Protocadherin-12, secreted form]",o724-737i,1184
Q9NPH3,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (EC 3.2.2.6) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3),o357-377i,570
Q9NPR2,Semaphorin-4B (Semaphorin-C),o718-737i,837
Q9NPY3,Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR) (C1qR(p)) (C1qRp) (CDw93) (Complement component 1 q subcomponent receptor 1) (Matrix-remodeling-associated protein 4) (CD antigen CD93),o582-603i,652
Q9NPZ5,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 2) (GlcAT-D) (UDP-glucuronosyltransferase S) (GlcAT-S) (Glucuronosyltransferase S)",i9-23o,323
Q9NQ25,SLAM family member 7 (CD2 subset 1) (CD2-like receptor-activating cytotoxic cells) (CRACC) (Membrane protein FOAP-12) (Novel Ly9) (Protein 19A) (CD antigen CD319),o226-248i,335
Q9NQG1,Protein MANBAL,o21-42i,85
Q9NQS3,Nectin-3 (CDw113) (Nectin cell adhesion molecule 3) (Poliovirus receptor-related protein 3) (CD antigen CD113),o405-427i,549
Q9NQX5,Neural proliferation differentiation and control protein 1 (NPDC-1),o186-206i,325
Q9NQX7,Integral membrane protein 2C (Cerebral protein 14) (Transmembrane protein BRI3) [Cleaved into: CT-BRI3],i57-79o,267
Q9NR16,Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b),o1360-1380i,1453
Q9NR34,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC (EC 3.2.1.113) (HMIC) (Mannosidase alpha class 1C member 1) (Processing alpha-1,2-mannosidase IC) (Alpha-1,2-mannosidase IC)",i23-43o,630
Q9NR61,Delta-like protein 4 (Drosophila Delta homolog 4) (Delta4),o532-552i,685
Q9NR71,Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 2) (BCDase) (LCDase) (hCD) (N-acylsphingosine amidohydrolase 2) (Non-lysosomal ceramidase) [Cleaved into: Neutral ceramidase soluble form],i12-32o,780
Q9NR96,Toll-like receptor 9 (CD antigen CD289),o814-835i,1032
Q9NR97,Toll-like receptor 8 (CD antigen CD288),o829-848i,1041
Q9NRB3,Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo),i6-26o,414
Q9NRJ7,Protocadherin beta-16 (PCDH-beta-16) (Protocadherin-3X),o690-711i,776
Q9NRM1,Enamelin,o719-728i,1142
Q9NRM6,Interleukin-17 receptor B (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor),o293-313i,502
Q9NRQ5,Single-pass membrane and coiled-coil domain-containing protein 4 (Protein FN5),i33-51o,59
Q9NRR2,Tryptase gamma (EC 3.4.21.-) (Serine protease 31) (Transmembrane tryptase) [Cleaved into: Tryptase gamma light chain; Tryptase gamma heavy chain],o284-304i,321
Q9NRS4,Transmembrane protease serine 4 (EC 3.4.21.-) (Channel-activating protease 2) (CAPH2) (Membrane-type serine protease 2) (MT-SP2) [Cleaved into: Transmembrane protease serine 4 catalytic chain],i32-53o,437
Q9NS00,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)",i9-26o,363
Q9NS62,Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module),o415-435i,852
Q9NS64,Protein reprimo,o59-77i,109
Q9NS68,Tumor necrosis factor receptor superfamily member 19 (TRADE) (Toxicity and JNK inducer),o171-191i,423
Q9NS69,Mitochondrial import receptor subunit TOM22 homolog (hTom22) (1C9-2) (Translocase of outer membrane 22 kDa subunit homolog),i83-101o,142
Q9NS84,Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4),i14-32o,486
Q9NSC7,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAc-I) (ST6GalNAcI) (hST6GalNAc-I) (Sialyltransferase 7A) (SIAT7-A)",i14-35o,600
Q9NSU2,Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1) (Deoxyribonuclease III) (DNase III),i287-307o,314
Q9NT68,"Teneurin-2 (Ten-2) (Protein Odd Oz/ten-m homolog 2) (Tenascin-M2) (Ten-m2) (Teneurin transmembrane protein 2) [Cleaved into: Ten-2, soluble form; Ten-2 intracellular domain (Ten-2 ICD)]",i376-396o,2774
Q9NT99,Leucine-rich repeat-containing protein 4B (Netrin-G3 ligand) (NGL-3),o577-597i,713
Q9NTJ4,Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1),i623-632o,1040
Q9NTN9,Semaphorin-4G,o678-698i,838
Q9NUM4,Transmembrane protein 106B,i96-117o,274
Q9NUQ2,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),o35i,364
Q9NWQ8,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp),o16-36i,432
Q9NWS8,Required for meiotic nuclear division protein 1 homolog,i428-448o,449
Q9NX14,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 17.3) (Np17.3) (p17.3)",i89-109o,153
Q9NX94,WW domain binding protein 1-like (Outcome predictor in acute leukemia 1),o42-55i,342
Q9NXG6,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),i62-82o,502
Q9NXS2,Glutaminyl-peptide cyclotransferase-like protein (EC 2.3.2.5) (Golgi-resident glutaminyl-peptide cyclotransferase) (isoQC) (gQC),i35-52o,382
Q9NXW2,DnaJ homolog subfamily B member 12,i244-262o,375
Q9NY15,"Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen)",o2476-2499i,2570
Q9NY25,C-type lectin domain family 5 member A (C-type lectin superfamily member 5) (Myeloid DAP12-associating lectin 1) (MDL-1),i6-26o,188
Q9NY28,Probable polypeptide N-acetylgalactosaminyltransferase 8 (EC 2.4.1.41) (Polypeptide GalNAc transferase 8) (GalNAc-T8) (pp-GaNTase 8) (Protein-UDP acetylgalactosaminyltransferase 8) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8),i10-27o,637
Q9NY72,Sodium channel subunit beta-3,o160-180i,215
Q9NY97,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (EC 2.4.1.149) (Beta-1,3-N-acetylglucosaminyltransferase 1) (BGnT-1) (Beta-1,3-Gn-T1) (Beta3Gn-T1) (Beta-1,3-galactosyltransferase 7) (Beta-1,3-GalTase 7) (Beta3Gal-T7) (Beta3GalT7) (b3Gal-T7) (Beta-3-Gx-T7) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 7) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) (BGnT-2) (Beta-1,3-Gn-T2) (Beta-1,3-N-acetylglucosaminyltransferase 2) (Beta3Gn-T2) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 7)",i10-25o,397
Q9NYJ7,Delta-like protein 3 (Drosophila Delta homolog 3) (Delta3),o492-513i,618
Q9NYK1,Toll-like receptor 7,o840-860i,1049
Q9NYL5,24-hydroxycholesterol 7-alpha-hydroxylase (EC 1.14.14.26) (Cytochrome P450 39A1) (hCYP39A1) (Oxysterol 7-alpha-hydroxylase),o8-20i,469
Q9NYQ8,Protocadherin Fat 2 (hFat2) (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1) (Multiple EGF-like domains protein 1),o4049-4068i,4349
Q9NYX4,Neuron-specific vesicular protein calcyon,i86-106o,217
Q9NYZ4,Sialic acid-binding Ig-like lectin 8 (Siglec-8) (Sialoadhesin family member 2) (SAF-2),o364-384i,499
Q9NZ43,Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31),i234-254o,259
Q9NZ53,Podocalyxin-like protein 2 (Endoglycan),o502-522i,605
Q9NZ94,Neuroligin-3 (Gliotactin homolog),o710-730i,848
Q9NZC2,Triggering receptor expressed on myeloid cells 2 (TREM-2) (Triggering receptor expressed on monocytes 2),o175-195i,230
Q9NZJ5,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK),o525-540i,1116
Q9NZM1,Myoferlin (Fer-1-like protein 3),i2027-2046o,2061
Q9NZN1,Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (EC 3.2.2.6) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1),o358-378i,696
Q9NZP6,Nuclear pore-associated protein 1,i716-725o,1156
Q9NZQ7,Programmed cell death 1 ligand 1 (PD-L1) (PDCD1 ligand 1) (Programmed death ligand 1) (hPD-L1) (B7 homolog 1) (B7-H1) (CD antigen CD274),o239-259i,290
Q9NZR2,Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT),o4444-4466i,4599
Q9NZS2,Killer cell lectin-like receptor subfamily F member 1 (Lectin-like receptor F1) (Activating coreceptor NKp80) (C-type lectin domain family 5 member C),i39-59o,231
Q9NZU0,Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3),o530-550i,649
Q9NZU1,Leucine-rich repeat transmembrane protein FLRT1 (Fibronectin-like domain-containing leucine-rich transmembrane protein 1),o527-547i,646
Q9NZV1,Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein],o940-960i,1036
Q9P0B6,Coiled-coil domain-containing protein 167,i78-96o,97
Q9P0K1,"Disintegrin and metalloproteinase domain-containing protein 22 (ADAM 22) (Metalloproteinase-disintegrin ADAM22-3) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2)",o737-757i,906
Q9P0L0,Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33),i231-248o,249
Q9P0T7,Proton-transporting V-type ATPase complex assembly regulator TMEM9 (v-ATPase assembly regulator TMEM9) (Dermal papilla-derived protein 4) (Transmembrane protein 9) (Protein TMEM9),o88-108i,183
Q9P0U1,Mitochondrial import receptor subunit TOM7 homolog (Translocase of outer membrane 7 kDa subunit homolog),i21-36o,55
Q9P0V8,SLAM family member 8 (B-lymphocyte activator macrophage expressed) (BCM-like membrane protein) (CD antigen CD353),o234-254i,285
Q9P109,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102) (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3) (C2GnT3)",i16-32o,453
Q9P126,C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2),i32-53o,229
Q9P1W8,Signal-regulatory protein gamma (SIRP-gamma) (CD172 antigen-like family member B) (Signal-regulatory protein beta-2) (SIRP-b2) (SIRP-beta-2) (CD antigen CD172g),o370-379i,387
Q9P273,Teneurin-3 (Ten-3) (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3) (Ten-m3) (Teneurin transmembrane protein 3),i311-329o,2699
Q9P283,Semaphorin-5B,o1037-1057i,1151
Q9P2B2,Prostaglandin F2 receptor negative regulator (CD9 partner 1) (CD9P-1) (Glu-Trp-Ile EWI motif-containing protein F) (EWI-F) (Prostaglandin F2-alpha receptor regulatory protein) (Prostaglandin F2-alpha receptor-associated protein) (CD antigen CD315),o833-853i,879
Q9P2E5,Chondroitin sulfate glucuronyltransferase (EC 2.4.1.226) (CSGlcA-T) (Chondroitin glucuronyltransferase) (Chondroitin polymerizing factor 2) (ChPF-2) (Chondroitin synthase 3) (ChSy-3) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase),i13-29o,772
Q9P2E9,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),o9-28i,1410
Q9P2J2,Protein turtle homolog A (Immunoglobulin superfamily member 9A) (IgSF9A),o737-757i,1179
Q9P2S2,Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha),o1638-1658i,1712
Q9P2W7,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P)",i7-24o,334
Q9P2W9,Syntaxin-18 (Cell growth-inhibiting gene 9 protein),i314-333o,335
Q9UBG0,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),o1415-1435i,1479
Q9UBK5,Hematopoietic cell signal transducer (DNAX-activation protein 10) (Membrane protein DAP10) (Transmembrane adapter protein KAP10),o49-70i,93
Q9UBM8,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",i26-42o,478
Q9UBN6,Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2) (DcR2) (TNF-related apoptosis-inducing ligand receptor 4) (TRAIL receptor 4) (TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264),o213-230i,386
Q9UBQ6,"Exostosin-like 2 (EC 2.4.1.223) (Alpha-1,4-N-acetylhexosaminyltransferase EXTL2) (Alpha-GalNAcT EXTL2) (EXT-related protein 2) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) [Cleaved into: Processed exostosin-like 2]",i21-36o,330
Q9UBV2,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),o745-761i,794
Q9UBV7,"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)",i34-51o,327
Q9UBX8,"Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6)",i14-34o,382
Q9UDW1,Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein),i22-47o,63
Q9UEF7,Klotho (EC 3.2.1.31) [Cleaved into: Klotho peptide],o982-1002i,1012
Q9UEU0,Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1),i207-228o,232
Q9UEW3,Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2),i48-65o,520
Q9UF33,Ephrin type-A receptor 6 (EC 2.7.10.1) (EPH homology kinase 2) (EHK-2) (EPH-like kinase 12) (EK12),o556-571i,1036
Q9UFP1,Golgi-associated kinase 1A (Protein FAM198A),i16-25o,575
Q9UGN4,CMRF35-like molecule 8 (CLM-8) (CD300 antigen-like family member A) (CMRF-35-H9) (CMRF35-H9) (CMRF35-H) (IRC1/IRC2) (Immunoglobulin superfamily member 12) (IgSF12) (Inhibitory receptor protein 60) (IRp60) (NK inhibitory receptor) (CD antigen CD300a),o181-201i,299
Q9UGT4,Sushi domain-containing protein 2,o787-807i,822
Q9UH99,SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein) (Rab5IP) (Sad1/unc-84 protein-like 2),i213-233o,717
Q9UHC6,Contactin-associated protein-like 2 (Cell recognition molecule Caspr2),o1263-1283i,1331
Q9UHF4,Interleukin-20 receptor subunit alpha (IL-20 receptor subunit alpha) (IL-20R-alpha) (IL-20RA) (Cytokine receptor class-II member 8) (Cytokine receptor family 2 member 8) (CRF2-8) (IL-20R1) (ZcytoR7),o252-273i,553
Q9UHN6,Inactive cell surface hyaluronidase CEMIP2 (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2),i83-103o,1383
Q9UHP7,C-type lectin domain family 2 member D (Lectin-like NK cell receptor) (Lectin-like transcript 1) (LLT-1) (Osteoclast inhibitory lectin),i38-55o,191
Q9UIB8,SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84),o226-246i,345
Q9UIK5,Tomoregulin-2 (TR-2) (Hyperplastic polyposis protein 1) (Transmembrane protein with EGF-like and two follistatin-like domains),o319-339i,374
Q9UIQ6,"Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form]",i111-131o,1025
Q9UIW2,Plexin-A1 (Semaphorin receptor NOV),o1245-1265i,1896
Q9UJ14,Glutathione hydrolase 7 (EC 3.4.19.13) (Gamma-glutamyltransferase 7) (GGT 7) (EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) [Cleaved into: Glutathione hydrolase 7 heavy chain; Glutathione hydrolase 7 light chain],i107-127o,662
Q9UJ37,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B)",i8-28o,374
Q9UJ71,C-type lectin domain family 4 member K (Langerin) (CD antigen CD207),i44-64o,328
Q9UJ90,Potassium voltage-gated channel subfamily E regulatory beta subunit 5 (AMME syndrome candidate gene 2 protein) (Potassium channel subunit beta MiRP4) (Potassium voltage-gated channel subfamily E member 1-like protein),o60-80i,142
Q9UJA9,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-),o432-452i,477
Q9UJQ1,Lysosome-associated membrane glycoprotein 5 (Brain and dendritic cell-associated LAMP) (Brain-associated LAMP-like protein) (BAD-LAMP) (Lysosome-associated membrane protein 5) (LAMP-5),o240-258i,280
Q9UK23,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),o451-473i,515
Q9UKB5,Adherens junction-associated protein 1 (Membrane protein shrew-1),o283-303i,411
Q9UKF2,Disintegrin and metalloproteinase domain-containing protein 30 (ADAM 30) (EC 3.4.24.-),o686-706i,790
Q9UKF5,Disintegrin and metalloproteinase domain-containing protein 29 (ADAM 29) (Cancer/testis antigen 73) (CT73),o676-695i,820
Q9UKJ1,Paired immunoglobulin-like type 2 receptor alpha (Cell surface receptor FDF03) (Inhibitory receptor PILR-alpha),o198-218i,303
Q9UKJ8,Disintegrin and metalloproteinase domain-containing protein 21 (ADAM 21) (EC 3.4.24.-),o686-706i,722
Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)",i84-104o,699
Q9UKN1,Mucin-12 (MUC-12) (Mucin-11) (MUC-11),o5378-5403i,5478
Q9UKQ2,"Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L)",o667-686i,775
Q9UKU0,Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6) (LACS 6),o25-45i,697
Q9UKU6,Thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) (TRH-degrading ectoenzyme) (EC 3.4.19.6) (Pyroglutamyl-peptidase II) (PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase),i40-61o,1024
Q9UKX5,Integrin alpha-11,o1142-1164i,1188
Q9UKZ4,Teneurin-1 (Ten-1) (Protein Odd Oz/ten-m homolog 1) (Tenascin-M1) (Ten-m1) (Teneurin transmembrane protein 1) [Cleaved into: Ten-1 intracellular domain (IDten-1) (Ten-1 ICD); Teneurin C-terminal-associated peptide (TCPA-1) (Ten-1 extracellular domain) (Ten-1 ECD)],i319-339o,2725
Q9UL52,Transmembrane protease serine 11E (EC 3.4.21.-) (Serine protease DESC1) (Transmembrane protease serine 11E2) [Cleaved into: Transmembrane protease serine 11E non-catalytic chain; Transmembrane protease serine 11E catalytic chain],i20-40o,423
Q9ULB1,Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha),o1403-1423i,1477
Q9ULB4,Cadherin-9,o616-634i,789
Q9ULC0,Endomucin (Endomucin-2) (Gastric cancer antigen Ga34) (Mucin-14) (MUC-14),o192-212i,261
Q9ULC5,Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5),o16-32i,683
Q9ULG6,Cell cycle progression protein 1 (Cell cycle progression restoration protein 8),i218-235o,757
Q9ULH4,Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1),o535-555i,789
Q9ULI3,Protein HEG homolog 1,o1248-1270i,1381
Q9ULL4,Plexin-B3,o1256-1275i,1909
Q9ULT6,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),o219-238i,936
Q9ULX7,Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV),o295-312i,337
Q9ULY5,C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE),i25-40o,219
Q9UM07,Protein-arginine deiminase type-4 (EC 3.5.3.15) (HL-60 PAD) (Peptidylarginine deiminase IV) (Protein-arginine deiminase type IV),o261-270i,663
Q9UM21,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa) (GlcNAc-T IVa) (GnT-IVa) (N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form]",i8-23o,535
Q9UM44,HERV-H LTR-associating protein 2 (Human endogenous retrovirus-H long terminal repeat-associating protein 2),o346-365i,414
Q9UM47,Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain],o1643-1663i,2321
Q9UM73,ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246),o1035-1057i,1620
Q9UMD9,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)],i467-487o,1497
Q9UMF0,Intercellular adhesion molecule 5 (ICAM-5) (Telencephalin),o836-858i,924
Q9UMR7,C-type lectin domain family 4 member A (C-type lectin DDB27) (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (Lectin-like immunoreceptor) (CD antigen CD367),i47-67o,237
Q9UMZ3,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48),o1948-1969i,2332
Q9UN42,"Protein ATP1B4 (X,K-ATPase subunit beta-m) (X/potassium-transporting ATPase subunit beta-m)",i114-134o,357
Q9UN72,Protocadherin alpha-7 (PCDH-alpha-7),o698-721i,937
Q9UN73,Protocadherin alpha-6 (PCDH-alpha-6),o698-720i,950
Q9UN74,Protocadherin alpha-4 (PCDH-alpha-4),o698-720i,947
Q9UNE0,Tumor necrosis factor receptor superfamily member EDAR (Anhidrotic ectodysplasin receptor 1) (Downless homolog) (EDA-A1 receptor) (Ectodermal dysplasia receptor) (Ectodysplasin-A receptor),o187-208i,448
Q9UNG2,Tumor necrosis factor ligand superfamily member 18 (Activation-inducible TNF-related ligand) (AITRL) (Glucocorticoid-induced TNF-related ligand) (hGITRL),i26-49o,177
Q9UNK0,Syntaxin-8,i216-233o,236
Q9UNN8,Endothelial protein C receptor (Activated protein C receptor) (APC receptor) (Endothelial cell protein C receptor) (CD antigen CD201),o211-231i,238
Q9UNP4,"Lactosylceramide alpha-2,3-sialyltransferase (EC 2.4.3.9) (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase) (GM3 synthase) (Ganglioside GM3 synthase) (ST3Gal V) (ST3GalV) (Sialyltransferase 9)",i67-83o,418
Q9UNU6,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase (EC 1.14.14.139) (7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase) (CYPVIIIB1) (Cytochrome P450 8B1) (Sterol 12-alpha-hydroxylase),o21i,501
Q9UP52,Transferrin receptor protein 2 (TfR2),i84-104o,801
Q9UPX0,Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B),o727-744i,1349
Q9UPX6,Major intrinsically disordered Notch2-binding receptor 1 (Membrane integral NOTCH2-associated receptor 1) (Ubiquitination and mTOR signaling protein),i892-912o,916
Q9UPZ6,"Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form]",o1607-1627i,1657
Q9UQ53,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",i7-27o,548
Q9UQC9,"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]",o902-922i,943
Q9UQF0,Syncytin-1 (Endogenous retrovirus group W member 1) (Env-W) (Envelope polyprotein gPr73) (Enverin) (HERV-7q Envelope protein) (HERV-W envelope protein) (HERV-W_7q21.2 provirus ancestral Env polyprotein) (Syncytin) [Cleaved into: Surface protein (SU) (gp50); Transmembrane protein (TM) (gp24)],o455-464i,538
Q9UQQ1,Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L),i6-24o,740
Q9UQV4,Lysosome-associated membrane glycoprotein 3 (LAMP-3) (Lysosomal-associated membrane protein 3) (DC-lysosome-associated membrane glycoprotein) (DC LAMP) (Protein TSC403) (CD antigen CD208),o382-404i,416
Q9Y219,Protein jagged-2 (Jagged2) (hJ2),o1083-1103i,1238
Q9Y225,RING finger protein 24,o22-42i,148
Q9Y228,TRAF3-interacting JNK-activating modulator (TRAF3-interacting protein 3),i527-545o,551
Q9Y231,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 (EC 2.4.1.152) (Fucosyltransferase 9) (Fucosyltransferase IX) (Fuc-TIX) (FucT-IX) (Galactoside 3-L-fucosyltransferase),i12-30o,359
Q9Y274,"Type 2 lactosamine alpha-2,3-sialyltransferase (EC 2.4.99.-) (CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI) (ST3Gal VI) (ST3GalVI) (Sialyltransferase 10)",i3-23o,331
Q9Y275,"Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]",i47-67o,285
Q9Y276,Mitochondrial chaperone BCS1 (h-BCS1) (BCS1-like protein),o15-36i,419
Q9Y278,Heparan sulfate glucosamine 3-O-sulfotransferase 2 (EC 2.8.2.29) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 2) (3-OST-2) (Heparan sulfate 3-O-sulfotransferase 2) (h3-OST-2),i20-37o,367
Q9Y279,V-set and immunoglobulin domain-containing protein 4 (Protein Z39Ig),o286-306i,399
Q9Y286,Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328),o353-376i,467
Q9Y287,"Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)]",i55-75o,266
Q9Y2B1,"Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.61) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase)",i11-24o,443
Q9Y2C4,"Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)",i30-39o,368
Q9Y2C9,Toll-like receptor 6 (CD antigen CD286),o586-607i,796
Q9Y2G1,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",i769-789o,1151
Q9Y2G8,DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8),o536-556i,782
Q9Y2H6,Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts),i1177-1197o,1198
Q9Y2J8,Protein-arginine deiminase type-2 (EC 3.5.3.15) (PAD-H19) (Peptidylarginine deiminase II) (Protein-arginine deiminase type II),o261-270i,665
Q9Y2L9,Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81),i702-721o,728
Q9Y2P4,"Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLCSH1) (hVLCS-H1) (EC 6.2.1.-)",o5-19i,619
Q9Y2R0,"Cytochrome c oxidase assembly factor 3 homolog, mitochondrial (Coiled-coil domain-containing protein 56) (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa)",i58-78o,106
Q9Y2Y6,Transmembrane protein 98 (Protein TADA1),o5-25i,226
Q9Y328,Neuronal vesicle trafficking-associated protein 2 (Neuron-specific protein family member 2) (Protein p19) (Hmp19),i71-91o,171
Q9Y336,Sialic acid-binding Ig-like lectin 9 (Siglec-9) (CDw329) (Protein FOAP-9) (CD antigen CD329),o349-370i,463
Q9Y385,Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e),i289-309o,318
Q9Y394,Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1),o6-23i,339
Q9Y3A6,Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma-2) (p24gamma2) (p28),o195-217i,229
Q9Y3B3,Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27),o186-208i,224
Q9Y3P8,Signaling threshold-regulating transmembrane adapter 1 (SHP2-interacting transmembrane adapter protein) (Suppression-inducing transmembrane adapter 1) (gp30/40),o43-63i,196
Q9Y3Q0,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),i10-31o,740
Q9Y3Q3,Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26),o184-200i,217
Q9Y3Q7,"Disintegrin and metalloproteinase domain-containing protein 18 (ADAM 18) (Transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein III) (tMDC III)",o688-708i,739
Q9Y493,Zonadhesin,o2762-2782i,2812
Q9Y4C0,Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha),o1570-1590i,1643
Q9Y4C5,Carbohydrate sulfotransferase 2 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2) (GST-2) (N-acetylglucosamine 6-O-sulfotransferase 1) (GlcNAc6ST-1) (Gn6ST-1),i55-75o,530
Q9Y4D7,Plexin-D1,o1272-1292i,1925
Q9Y561,Low-density lipoprotein receptor-related protein 12 (LDLR-related protein 12) (LRP-12) (Suppressor of tumorigenicity 7 protein),o493-513i,859
Q9Y584,Mitochondrial import inner membrane translocase subunit Tim22 (Testis-expressed protein 4),i176-193o,194
Q9Y5E3,Protocadherin beta-6 (PCDH-beta-6),o688-709i,794
Q9Y5E9,Protocadherin beta-14 (PCDH-beta-14),o688-711i,798
Q9Y5F1,Protocadherin beta-12 (PCDH-beta-12),o690-711i,795
Q9Y5F2,Protocadherin beta-11 (PCDH-beta-11),o688-711i,797
Q9Y5F7,Protocadherin gamma-C4 (PCDH-gamma-C4),o693-713i,938
Q9Y5H5,Protocadherin alpha-9 (PCDH-alpha-9),o698-720i,950
Q9Y5H8,Protocadherin alpha-3 (PCDH-alpha-3),o698-720i,950
Q9Y5H9,Protocadherin alpha-2 (PCDH-alpha-2),o698-720i,948
Q9Y5I2,Protocadherin alpha-10 (PCDH-alpha-10),o696-718i,948
Q9Y5I3,Protocadherin alpha-1 (PCDH-alpha-1),o698-720i,950
Q9Y5L3,Ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase 2) (EC 3.6.1.-) (CD39 antigen-like 1) (Ecto-ATP diphosphohydrolase 2) (Ecto-ATPDase 2) (Ecto-ATPase 2),o465-483i,495
Q9Y5Q5,"Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment]",i46-66o,1042
Q9Y5R2,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],o603-623i,645
Q9Y5U5,Tumor necrosis factor receptor superfamily member 18 (Activation-inducible TNFR family receptor) (Glucocorticoid-induced TNFR-related protein) (CD antigen CD357),o166-187i,241
Q9Y5Y6,Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein),i56-77o,855
Q9Y5Y7,Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1) (Cell surface retention sequence-binding protein 1) (CRSBP-1) (Extracellular link domain-containing protein 1) (Hyaluronic acid receptor),o239-256i,322
Q9Y5Z0,Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase),o470-492i,518
Q9Y624,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321),o238-258i,299
Q9Y639,Neuroplastin (Stromal cell-derived receptor 1) (SDR-1),o339-359i,398
Q9Y662,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1) (3-OST-3B) (Heparan sulfate 3-O-sulfotransferase 3B1) (h3-OST-3B),i33-49o,390
Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (3-OST-3A) (Heparan sulfate 3-O-sulfotransferase 3A1) (h3-OST-3A),i25-43o,406
Q9Y673,Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog),o26i,324
Q9Y6A2,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),o23i,500
Q9Y6F6,"Inositol 1,4,5-triphosphate receptor associated 1 (Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate) (JAW1-related protein MRVI1) (Protein MRVI1)",i846-866o,904
Q9Y6H6,Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2),o58-78i,103
Q9Y6J6,Potassium voltage-gated channel subfamily E member 2 (MinK-related peptide 1) (Minimum potassium ion channel-related peptide 1) (Potassium channel subunit beta MiRP1),o49-69i,123
Q9Y6N7,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),o898-918i,1651
Q9Y6N8,Cadherin-10 (T2-cadherin),o614-632i,788
Q9Y6Q6,Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor) (ODFR) (Receptor activator of NF-KB) (CD antigen CD265),o213-233i,616
Q9Y6W8,Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278),o141-161i,199
Q9Y6X1,Stress-associated endoplasmic reticulum protein 1 (Ribosome-attached membrane protein 4),i41-59o,66
Q9Y6X5,Bis(5'-adenosyl)-triphosphatase ENPP4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4),o408-428i,453
A0A1B0GTB2,Protein TUNAR (pTUNAR) (Beta cell and neural cell-regulin) (BNLN) (TCL1 upstream neural differentiation-associated RNA),i24-44o,48
A0A1B0GVQ0,Small regulatory polypeptide of amino acid response,o18-38i,90
A0A5B9,T cell receptor beta constant 2,o146-170i,178
A2A2V5,Serine-rich and transmembrane domain-containing protein 1,o43-63i,107
A6NDA9,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 (Leucine-rich repeat-containing protein 22)",o463-483i,550
A6NFR6,Uncharacterized protein C5orf60,o37-54i,353
A6NMB1,Sialic acid-binding Ig-like lectin 16 (Siglec-16) (Siglec-P16),o435-457i,481
A8MWY0,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),o926-950i,1029
A8MXK1,V-set and transmembrane domain-containing protein 5,o148-168i,200
A9Z1Z3,Fer-1-like protein 4,i1760-1780o,1794
B1AL88,NALCN channel auxiliary factor 1 (Transmembrane protein FAM155A),i40-52o,458
B4DS77,Protein shisa-9,o152-171i,424
B8ZZ34,Protein shisa-8 (Shisa family member 8),o141-159i,397
O14548,"Cytochrome c oxidase subunit 7A-related protein, mitochondrial (COX7a-related protein) (Cytochrome c oxidase subunit VIIa-related protein) (EB1)",i85-106o,114
O14668,Transmembrane gamma-carboxyglutamic acid protein 1 (Proline-rich gamma-carboxyglutamic acid protein 1) (Proline-rich Gla protein 1),o81-101i,218
O14957,Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 6.4 kDa protein),i13-36o,56
O43677,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial (Complex I-KFYI) (CI-KFYI) (NADH-ubiquinone oxidoreductase KFYI subunit)",i39-59o,76
O43736,Integral membrane protein 2A (Protein E25),i54-74o,263
O43908,NKG2-F type II integral membrane protein (NK cell receptor F) (NKG2-F-activating NK receptor),i71-88o,158
O60245,Protocadherin-7 (Brain-heart protocadherin) (BH-Pcdh),o880-900i,1069
O60279,Sushi domain-containing protein 5,o576-596i,629
O60330,Protocadherin gamma-A12 (PCDH-gamma-A12) (Cadherin-21) (Fibroblast cadherin-3),o693-714i,932
O60774,Putative dimethylaniline monooxygenase [N-oxide-forming] 6 (EC 1.14.13.8) (Dimethylaniline oxidase 6) (Flavin-containing monooxygenase 6) (FMO 6),i521-538o,539
O75310,UDP-glucuronosyltransferase 2B11 (UDPGT 2B11) (EC 2.4.1.17),o491-516i,529
O75325,Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5),o630-648i,713
O75964,"ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)",i73-93o,103
O95178,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (Complex I-AGGG) (CI-AGGG) (NADH-ubiquinone oxidoreductase AGGG subunit)",i53-74o,105
O95258,Brain mitochondrial carrier protein 1 (BMCP-1) (Mitochondrial uncoupling protein 5) (UCP 5) (Solute carrier family 25 member 14),i307-316o,325
O95976,Immunoglobulin superfamily member 6 (IgSF6) (Protein DORA),o154-176i,241
P0C6T2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4,o7-25i,37
P0C7U0,Protein ELFN1 (Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1) (Protein phosphatase 1 regulatory subunit 28),o418-438i,828
P0DJ07,"Protein PET100 homolog, mitochondrial",o3-23i,73
P36537,UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17),o490-515i,528
P43308,Translocon-associated protein subunit beta (TRAP-beta) (Signal sequence receptor subunit beta) (SSR-beta),o147-169i,183
P43627,Killer cell immunoglobulin-like receptor 2DL2 (CD158 antigen-like family member B1) (Natural killer-associated transcript 6) (NKAT-6) (p58 natural killer cell receptor clone CL-43) (p58 NK receptor CL-43) (CD antigen CD158b1),o244-264i,348
P48060,Glioma pathogenesis-related protein 1 (GliPR 1) (Protein RTVP-1),o236-255i,266
P55808,Glycoprotein Xg (Protein PBDX),o143-160i,180
P57738,T-cell leukemia translocation-altered gene protein (T-cell leukemia translocation-associated gene protein),i38-58o,103
P58658,Protein eva-1 homolog C (Protein FAM176C) (SUE21),o322-343i,441
P59025,Receptor-transporting protein 1 (3CxxC-type zinc finger protein 1),i239-257o,263
P60509,Endogenous retrovirus group PABLB member 1 Env polyprotein (Endogenous retrovirus group PABLB member 1) (Envelope polyprotein) (HERV-R(b) Env protein) (HERV-R(b)_3p24.3 provirus ancestral Env polyprotein) [Includes: Surface protein domain (SU); Transmembrane protein domain (TM)],o452-469i,514
P61550,Endogenous retrovirus group S71 member 1 Env polyprotein (Envelope polyprotein) (HERV-T Env protein) (HERV-T_19q13.11 provirus ancestral Env polyprotein) [Includes: Surface protein (SU); Transmembrane protein (TM)],o572-592i,626
P61566,Endogenous retrovirus group K member 24 Env polyprotein (Envelope polyprotein) (HERV-K101 envelope protein) (HERV-K_22q11.21 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],o526-535i,588
P61567,Endogenous retrovirus group K member 7 Env polyprotein (Envelope polyprotein) (HERV-K(III) envelope protein) (HERV-K102 envelope protein) (HERV-K_1q22 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],o526-535i,588
Q02221,"Cytochrome c oxidase subunit 6A2, mitochondrial (Cytochrome c oxidase polypeptide VIa-heart) (COXVIAH) (Cytochrome c oxidase subunit VIA-muscle) (COX VIa-M)",i27-47o,97
Q14952,Killer cell immunoglobulin-like receptor 2DS3 (Natural killer-associated transcript 7) (NKAT-7),o244-265i,304
Q14C87,Transmembrane protein 132D (Mature oligodendrocytes transmembrane protein) (Mature OL transmembrane protein),o920-939i,1099
Q2M2H8,"Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]",i10-30o,2515
Q2VWP7,Protogenin (Protein Shen-Dan),o950-970i,1150
Q3KNT9,Sperm-egg fusion protein TMEM95 (Transmembrane protein 95),o144-165i,176
Q3KPI0,Carcinoembryonic antigen-related cell adhesion molecule 21,o239-260i,293
Q3MIW9,Mucin-like protein 3 (Diffuse panbronchiolitis critical region protein 1),o449-470i,517
Q3SY77,UDP-glucuronosyltransferase 3A2 (UDPGT 3A2) (EC 2.4.1.17),o484-511i,523
Q3ZCQ3,Membrane protein FAM174B,o93-111i,159
Q4G0T1,Scavenger receptor cysteine-rich domain-containing protein SCART1 (Scavenger receptor family member expressed on T cells 1),o904-924i,1027
Q4G1C9,GLIPR1-like protein 2,o254-274i,344
Q5JRM2,Uncharacterized protein CXorf66,o47-67i,361
Q5JU69,Torsin-2A (Torsin family 2 member A) (Torsin-related protein 1),o35i,321
Q5JXA9,Signal-regulatory protein beta-2 (SIRP-beta-2) (Protein tyrosine phosphatase non-receptor type substrate 1-like 3) (Protein tyrosine phosphatase non-receptor type substrate protein),o291-311i,342
Q5SRI9,"Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (hEndo) (EC 3.2.1.130) (Mandaselin)",i9-29o,462
Q5SRN2,Testis-expressed basic protein 1 (Uncharacterized protein C6orf10),o8-24i,563
Q5SY80,Cation channel sperm-associated auxiliary subunit epsilon (CatSper-epsilon) (CatSperepsilon),o904-924i,951
Q5TFQ8,Signal-regulatory protein beta-1 isoform 3 (SIRP-beta-1 isoform 3),o371-391i,398
Q5VU97,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),o1100-1116i,1274
Q5VV63,Attractin-like protein 1,o1230-1252i,1379
Q69YU5,Ubiquinol-cytochrome-c reductase complex assembly factor 6 (Protein BRAWNIN),i10-27o,71
Q6IEE7,Transmembrane protein 132E,o887-914i,1074
Q6NUM9,"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)",o22i,610
Q6NUS8,UDP-glucuronosyltransferase 3A1 (UDPGT 3A1) (EC 2.4.1.17),o484-511i,523
Q6P4E1,Protein GOLM2 (Cancer susceptibility candidate gene 4 protein) (CASC4) (Golgi membrane protein 2),i13-33o,436
Q6P9G4,Transmembrane protein 154,o76-98i,183
Q6PCB8,Embigin,o263-281i,327
Q6PI73,Leukocyte immunoglobulin-like receptor subfamily A member 6 (Immunoglobulin-like transcript 8) (ILT-8) (Leukocyte Ig-like receptor),o445-469i,481
Q6Q8B3,Cell surface glycoprotein CD200 receptor 2 (CD200 cell surface glycoprotein receptor-like 2) (CD200 receptor-like 2) (HuCD200R2) (CD200 cell surface glycoprotein receptor-like a) (CD200RLa) (Cell surface glycoprotein CD200 receptor 1-like) (Cell surface glycoprotein OX2 receptor 2),o240-260i,271
Q6UWD8,Transmembrane protein C16orf54,o32-53i,224
Q6UWL2,Sushi domain-containing protein 1,o725-745i,747
Q6UWM7,Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein),o542-562i,567
Q6UWV2,Myelin protein zero-like protein 3,o159-179i,235
Q6UWW9,Transmembrane protein 207,o51-71i,146
Q6UX07,Dehydrogenase/reductase SDR family member 13 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 7C member 5) (Protein SDR7C5),o3-18i,377
Q6UXC1,Apical endosomal glycoprotein (MAM domain-containing protein 4),o1159-1173i,1216
Q6UXK5,Leucine-rich repeat neuronal protein 1 (Neuronal leucine-rich repeat protein 1) (NLRR-1),o632-652i,716
Q6UXM1,Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3),o810-830i,1119
Q6UY11,Protein delta homolog 2 (DLK-2) (Epidermal growth factor-like protein 9) (EGF-like protein 9),o308-329i,383
Q6V1P9,Protocadherin-23 (Cadherin-27) (Cadherin-like protein CDHJ) (Cadherin-like protein VR8) (Protein dachsous homolog 2) (Protocadherin PCDHJ),o2996-3016i,3371
Q6ZNB6,NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein) (hOZFP),i890-907o,911
Q6ZRH7,Cation channel sperm-associated auxiliary subunit gamma,o1068-1088i,1159
Q6ZUB1,Spermatogenesis-associated protein 31E1 (Protein FAM75E1),o64-84i,1445
Q6ZWK6,Transmembrane protease serine 11F (EC 3.4.21.-) (Airway trypsin-like protease 4),i28-48o,438
Q76KP1,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",i15-28o,1039
Q7L8C5,Synaptotagmin-13 (Synaptotagmin XIII) (SytXIII),o7-27i,426
Q7RTY8,Transmembrane protease serine 7 (EC 3.4.21.-) (Matriptase-3),i77-97o,843
Q7Z3D4,LysM and putative peptidoglycan-binding domain-containing protein 3,i218-238o,306
Q7Z408,CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2),o3411-3420i,3487
Q7Z692,Carcinoembryonic antigen-related cell adhesion molecule 19 (Carcinoembryonic antigen-like 1),o160-182i,300
Q86VR7,V-set and immunoglobulin domain-containing protein 10-like (VSIG10-like protein),o777-797i,867
Q86WK7,Amphoterin-induced protein 3 (AMIGO-3) (Alivin-3),o384-404i,504
Q86XR5,Proline-rich membrane anchor 1 (PRiMA),o93-113i,153
Q86Y22,Collagen alpha-1(XXIII) chain,i35-56o,540
Q8IV01,Synaptotagmin-12 (Synaptotagmin XII) (SytXII),o21-40i,421
Q8IYS0,Protein Aster-C (GRAM domain-containing protein 1C),i557-577o,662
Q8IZP7,Heparan-sulfate 6-O-sulfotransferase 3 (HS6ST-3) (EC 2.8.2.-),i8-23o,471
Q8N109,Killer cell immunoglobulin-like receptor 2DL5A (CD antigen CD158f1),o241-261i,375
Q8N111,Cell cycle exit and neuronal differentiation protein 1 (BM88 antigen),o125-146i,149
Q8N112,Leucine-rich single-pass membrane protein 2,i98-118o,164
Q8N118,Cytochrome P450 4X1 (EC 1.14.14.-) (CYPIVX1),o30i,509
Q8N292,"Protein GAPT (Growth factor receptor-bound protein 2-binding adapter protein, transmembrane)",o12-31i,157
Q8N4H5,Mitochondrial import receptor subunit TOM5 homolog,i24-44o,51
Q8N6Y1,Protocadherin-20 (Protocadherin-13),o889-909i,951
Q8N7P1,Inactive phospholipase D5 (Inactive PLD 5) (Inactive choline phosphatase 5) (Inactive phosphatidylcholine-hydrolyzing phospholipase D5) (PLDc),i69-89o,536
Q8NBR0,Tumor protein p53-inducible protein 13 (Damage-stimulated cytoplasmic protein 1),o311-329i,393
Q8NDH2,Leucine-rich repeat transmembrane protein CCDC168 (Coiled-coil domain-containing protein 168),o38-55i,7081
Q8NEW7,Transmembrane inner ear expressed protein,o59-78i,156
Q8NHK3,Killer cell immunoglobulin-like receptor 2DL5B (CD158 antigen-like family member F2) (Killer cell immunoglobulin-like receptor 2DLX) (CD antigen CD158f2),o241-261i,375
Q8TAQ9,SUN domain-containing protein 3 (Sad1/unc-84 domain-containing protein 1),i48-65o,357
Q8TB96,T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin),o566-590i,612
Q8TBF5,Phosphatidylinositol-glycan biosynthesis class X protein (PIG-X),o230-251i,258
Q8TCD1,UPF0729 protein C18orf32 (Putative NF-kappa-B-activating protein 200),o7-16i,76
Q8TCW7,"Zona pellucida-like domain-containing protein 1 (ZP domain-containing protein 1) (Cupulin) [Cleaved into: Zona pellucida-like domain-containing protein 1, secreted form]",o373-396i,415
Q8TDY8,Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36),o956-976i,1250
Q8WUT4,Leucine-rich repeat neuronal protein 4 (Neuronal leucine-rich repeat protein 4) (NLRR-4),o683-703i,740
Q8WV48,Coiled-coil domain-containing protein 107,o65-82i,283
Q8WVZ7,E3 ubiquitin-protein ligase RNF133 (EC 2.3.2.27) (RING finger protein 133) (RING-type E3 ubiquitin transferase RNF133),o190-210i,376
Q8WWG1,"Pro-neuregulin-4, membrane-bound isoform (Pro-NRG4) [Cleaved into: Neuregulin-4 (NRG-4)]",o61-82i,115
Q92617,Nuclear pore complex-interacting protein family member B3 (Nuclear pore complex-interacting protein-like 3) (Protein pps22-1),o71-87i,1050
Q96A28,SLAM family member 9 (CD2 family member 10) (CD2F-10) (CD84 homolog 1) (CD84-H1),o237-257i,289
Q96DD7,Protein shisa-4 (Transmembrane protein 58),o92-104i,197
Q96IQ7,V-set and immunoglobulin domain-containing protein 2 (Cortical thymocyte-like protein) (CT-like protein),o242-264i,327
Q96J86,Cysteine and tyrosine-rich protein 1 (Proline-rich domain-containing protein),o64-84i,154
Q96JQ2,Calmin (Calponin-like transmembrane domain protein),i977-994o,1002
Q96KJ9,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (Cytochrome c oxidase subunit IV isoform 2) (COX IV-2)",i101-126o,171
Q96LD1,Zeta-sarcoglycan (Zeta-SG) (ZSG1),i36-58o,299
Q96NU0,Contactin-associated protein-like 3B (Cell recognition molecule Caspr3b),o1246-1266i,1288
Q96PB8,Leucine-rich repeat-containing protein 3B (Leucine-rich repeat protein 15),o204-225i,259
Q96PE5,Opalin (Oligodendrocytic myelin paranodal and inner loop protein) (Transmembrane protein 10),o36-53i,141
Q96SE0,Protein ABHD1 (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 1) (Abhydrolase domain-containing protein 1) (Lung alpha/beta hydrolase 1),o14-31i,405
Q9BZ76,Contactin-associated protein-like 3 (Cell recognition molecule Caspr3),o1246-1266i,1288
Q9BZD7,Transmembrane gamma-carboxyglutamic acid protein 3 (Proline-rich gamma-carboxyglutamic acid protein 3) (Proline-rich Gla protein 3),o80-100i,231
Q9GZT6,"Coiled-coil domain-containing protein 90B, mitochondrial",i234-250o,254
Q9H0X4,Protein FAM234A (Protein ITFG3),i49-69o,552
Q9H158,Protocadherin alpha-C1 (PCDH-alpha-C1),o682-703i,963
Q9H159,Cadherin-19,o597-616i,772
Q9H1U4,Multiple epidermal growth factor-like domains protein 9 (Multiple EGF-like domains protein 9) (Epidermal growth factor-like protein 5) (EGF-like protein 5),o515-537i,602
Q9H2X8,Interferon alpha-inducible protein 27-like protein 2 (Interferon-stimulated gene 12b protein) (ISG12(b)) (ISG12B) (Protein TLH29) (pIFI27-like protein),o35i,130
Q9H665,IGF-like family receptor 1 (Transmembrane protein 149) (U2 small nuclear RNA auxiliary factor 1-like 4),o164-184i,355
Q9H6D8,Fibronectin type III domain-containing protein 4 (Fibronectin type III repeat-containing protein 1),o170-187i,234
Q9H756,Leucine-rich repeat-containing protein 19,o271-291i,370
Q9H7T0,Cation channel sperm-associated auxiliary subunit beta (CatSper-beta),o1058-1078i,1116
Q9H8J5,MANSC domain-containing protein 1 (Loss of heterozygosity 12 chromosomal region 3 protein),o385-405i,431
Q9HAT1,Protein ERGIC-53-like (ERGIC53-like protein) (Lectin mannose-binding 1-like) (LMAN1-like protein),o465-481i,526
Q9HBL6,Leucine-rich repeat and transmembrane domain-containing protein 1,o289-309i,345
Q9HC56,Protocadherin-9,o816-836i,1237
Q9HCL0,Protocadherin-18,o700-720i,1135
Q9N2J8,HERV-H_2q24.1 provirus ancestral Env polyprotein (Env protein HERV-H/p59) (Envelope polyprotein) (HERV-H/env59) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],o518-529i,555
Q9NQ34,Transmembrane protein 9B,o101-121i,198
Q9NQ60,Equatorin (Acrosome formation-associated factor),o182-203i,294
Q9NSI5,Immunoglobulin superfamily member 5 (IgSF5) (Junctional adhesion molecule 4) (JAM-4),o267-285i,407
Q9NV66,S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 (EC 4.1.3.44) (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein),o22-38i,732
Q9NYL4,Peptidyl-prolyl cis-trans isomerase FKBP11 (PPIase FKBP11) (EC 5.2.1.8) (19 kDa FK506-binding protein) (19 kDa FKBP) (FKBP-19) (FK506-binding protein 11) (FKBP-11) (Rotamase),o156-177i,201
Q9NYM9,BET1-like protein (Golgi SNARE with a size of 15 kDa) (GOS-15) (GS15) (Vesicle transport protein GOS15),i87-106o,111
Q9P0S2,"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial (hCOX16)",i14-33o,106
Q9P244,Leucine-rich repeat and fibronectin type III domain-containing protein 1 (Synaptic adhesion-like molecule 2),o537-557i,771
Q9P2E7,Protocadherin-10,o725-738i,1040
Q9P2V4,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 (Leucine-rich repeat-containing protein 21) (Photoreceptor-associated LRR superfamily protein) (Retina-specific protein PAL)",o527-547i,623
Q9UJ99,Cadherin-22 (Pituitary and brain cadherin) (PB-cadherin),o627-645i,828
Q9UKJ0,Paired immunoglobulin-like type 2 receptor beta (Activating receptor PILR-beta) (Cell surface receptor FDFACT),o192-212i,227
Q9ULB5,Cadherin-7,o610-628i,785
Q9ULK6,RING finger protein 150,o209-229i,438
Q9UN66,Protocadherin beta-8 (PCDH-beta-8) (Protocadherin-3I),o691-712i,801
Q9UN67,Protocadherin beta-10 (PCDH-beta-10),o692-713i,800
Q9UN70,Protocadherin gamma-C3 (PCDH-gamma-C3) (Protocadherin-2) (Protocadherin-43) (PC-43),o694-715i,934
Q9UN71,Protocadherin gamma-B4 (PCDH-gamma-B4) (Cadherin-20) (Fibroblast cadherin-2),o690-711i,923
Q9UN75,Protocadherin alpha-12 (PCDH-alpha-12),o698-720i,941
Q9UPU3,VPS10 domain-containing receptor SorCS3,o1126-1144i,1222
Q9Y2B2,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) (Phosphatidylinositol-glycan biosynthesis class L protein) (PIG-L),o5-22i,252
Q9Y2C2,Uronyl 2-sulfotransferase (EC 2.8.2.-),i49-67o,406
Q9Y4P3,Transducin beta-like protein 2 (WS beta-transducin repeats protein) (WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein),o11-28i,447
Q9Y5E1,Protocadherin beta-9 (PCDH-beta-9) (Protocadherin-3H),o690-711i,797
Q9Y5E2,Protocadherin beta-7 (PCDH-beta-7),o688-709i,793
Q9Y5E4,Protocadherin beta-5 (PCDH-beta-5),o689-710i,795
Q9Y5E5,Protocadherin beta-4 (PCDH-beta-4),o689-710i,795
Q9Y5E6,Protocadherin beta-3 (PCDH-beta-3),o690-711i,796
Q9Y5E7,Protocadherin beta-2 (PCDH-beta-2),o690-713i,798
Q9Y5E8,Protocadherin beta-15 (PCDH-beta-15),o690-711i,787
Q9Y5F0,Protocadherin beta-13 (PCDH-beta-13),o690-711i,798
Q9Y5F3,Protocadherin beta-1 (PCDH-beta-1),o691-712i,818
Q9Y5F6,Protocadherin gamma-C5 (PCDH-gamma-C5),o694-714i,944
Q9Y5F8,Protocadherin gamma-B7 (PCDH-gamma-B7),o692-713i,929
Q9Y5F9,Protocadherin gamma-B6 (PCDH-gamma-B6),o692-713i,930
Q9Y5G0,Protocadherin gamma-B5 (PCDH-gamma-B5),o688-709i,923
Q9Y5G1,Protocadherin gamma-B3 (PCDH-gamma-B3),o692-713i,929
Q9Y5G2,Protocadherin gamma-B2 (PCDH-gamma-B2),o693-713i,931
Q9Y5G3,Protocadherin gamma-B1 (PCDH-gamma-B1),o689-709i,927
Q9Y5G4,Protocadherin gamma-A9 (PCDH-gamma-A9),o694-714i,932
Q9Y5G5,Protocadherin gamma-A8 (PCDH-gamma-A8),o693-713i,932
Q9Y5G6,Protocadherin gamma-A7 (PCDH-gamma-A7),o693-713i,932
Q9Y5G7,Protocadherin gamma-A6 (PCDH-gamma-A6),o693-713i,932
Q9Y5G8,Protocadherin gamma-A5 (PCDH-gamma-A5),o693-713i,931
Q9Y5G9,Protocadherin gamma-A4 (PCDH-gamma-A4),o724-744i,962
Q9Y5H0,Protocadherin gamma-A3 (PCDH-gamma-A3),o693-713i,932
Q9Y5H1,Protocadherin gamma-A2 (PCDH-gamma-A2),o693-713i,932
Q9Y5H2,Protocadherin gamma-A11 (PCDH-gamma-A11),o694-714i,935
Q9Y5H3,Protocadherin gamma-A10 (PCDH-gamma-A10),o697-717i,936
Q9Y5H4,Protocadherin gamma-A1 (PCDH-gamma-A1),o693-713i,931
Q9Y5H6,Protocadherin alpha-8 (PCDH-alpha-8),o698-720i,950
Q9Y5H7,Protocadherin alpha-5 (PCDH-alpha-5),o697-719i,936
Q9Y5I0,Protocadherin alpha-13 (PCDH-alpha-13),o698-720i,950
Q9Y5I1,Protocadherin alpha-11 (PCDH-alpha-11),o697-717i,949
Q9Y5I4,Protocadherin alpha-C2 (PCDH-alpha-C2),o708-729i,1007
Q9Y5M8,Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1),o36-54i,271
Q9Y661,Heparan sulfate glucosamine 3-O-sulfotransferase 4 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4) (3-OST-4) (Heparan sulfate 3-O-sulfotransferase 4) (h3-OST-4),i35-53o,456
U3KPV4,"Alpha-1,3-galactosyltransferase 2 (EC 2.4.1.87) (Isoglobotriaosylceramide synthase) (iGb3 synthase) (iGb3S)",i18-32o,340
W5XKT8,Sperm acrosome membrane-associated protein 6 (BACHELOR-like protein),o295-317i,324
A0A087WTH5,#N/A,o47-69i,132
A0A0U1RRN3,Mitochondrial sheath formation-associated protein (Putative transmembrane protein SPTY2D1OS) (SPTY2D1 antisense RNA 1) (SPTY2D1 opposite strand),o11i,59
A0AVI2,Fer-1-like protein 5,i1962-1980o,2057
A0PJX4,Protein shisa-3 homolog,o99-118i,238
A0ZSE6,Cell cycle control protein 50C (Transmembrane protein 30C),i35-55o,113
A1L1A6,Immunoglobulin superfamily member 23,o158-178i,192
A2RRL7,Transmembrane protein 213,o71-91i,107
A2RUR9,Coiled-coil domain-containing protein 144A,i1401-1420o,1427
A4D1S0,Killer cell lectin-like receptor subfamily G member 2 (C-type lectin domain family 15 member B),i261-281o,409
A4D2H0,cTAGE family member 15 (Protein cTAGE-15),o43-60i,777
A6H8M9,Cadherin-related family member 4 (Cadherin-like protein 29),o688-708i,788
A6NF34,Anthrax toxin receptor-like,o354-372i,631
A6NG13,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D (N-acetylglucosaminyltransferase MGAT1 inhibitory protein) (GlcNAcT-I inhibitory protein) (GnT1IP)",i8-25o,374
A6NHS7,MANSC domain-containing protein 4,o285-306i,340
A6NJW4,Leucine-rich repeat-containing protein 3C,o223-245i,275
A6NJW9,T-cell surface glycoprotein CD8 beta-2 chain (CD8b pseudogene),o171-191i,210
A6NM11,Leucine-rich repeat-containing protein 37A2,o1583-1604i,1700
A6NMS7,Leucine-rich repeat-containing protein 37A,o1583-1604i,1700
A8MVS5,Protein HIDE1,o118-142i,230
A8MVW0,Protein FAM171A2,o316-337i,826
A8MVZ5,Putative butyrophilin-like protein 10 pseudogene,o254-274i,291
A8MXE2,"Beta-1,3-galactosyltransferase 9 (EC 2.4.1.-) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10)",i15-28o,369
B4DYI2,Putative spermatogenesis-associated protein 31C2 (Protein FAM75C2),o25-43i,1134
B7Z8K6,T cell receptor delta constant,o128-148i,153
C9JQL5,Putative dispanin subfamily A member 2d (DSPA2d),i108-128o,133
E2RYF6,Mucin-22 (Panbronchiolitis-related mucin-like protein 1),o1663-1683i,1773
I3L273,Golgi-associated olfactory signaling regulator (Golgi protein in olfactory neurons) (Goofy),o410-430i,518
O60309,Leucine-rich repeat-containing protein 37A3,o1582-1604i,1634
O75949,NALCN channel auxiliary factor 2 (Protein TED) (Transmembrane protein 28) (Transmembrane protein FAM155B),i48-58o,472
O95424,Dexamethasone-induced protein (Protein MYLE),o46i,95
P03986,T cell receptor gamma constant 2,o155-177i,189
P0C6S8,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 (Leucine-rich repeat neuronal protein 2) (Leucine-rich repeat neuronal protein 6B),o527-549i,592
P0CF51,T cell receptor gamma constant 1,o139-161i,173
P0DKV0,Putative spermatogenesis-associated protein 31C1 (Protein FAM75C1),o25-43i,1188
P0DP72,V-set and immunoglobulin domain-containing protein 10-like 2,o704-724i,767
P15421,Glycophorin-E,o58-73i,78
P58511,Small integral membrane protein 11,o10-30i,58
P58549,FXYD domain-containing ion transport regulator 7,o27-45i,80
P84157,Matrix-remodeling-associated protein 7,o7-27i,204
Q0P6D2,Divergent protein kinase domain 1C (Protein FAM69C),i25-43o,419
Q0VDE8,Adipogenin,o35i,80
Q14761,Protein tyrosine phosphatase receptor type C-associated protein (PTPRC-associated protein) (CD45-associated protein) (CD45-AP) (Lymphocyte phosphatase-associated phosphoprotein),o34-54i,206
Q14DG7,Transmembrane protein 132B,o897-922i,1078
Q17R55,Protein FAM187B (Transmembrane protein 162),o333-351i,369
Q2TBF2,Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2),i19-35o,565
Q2WGJ9,Fer-1-like protein 6,i1824-1844o,1857
Q3B7T3,Protein BEAN1 (Brain-expressed protein associating with Nedd4 homolog) (BEAN),o36-56i,259
Q4G0I0,Ubiquinol-cytochrome-c reductase complex assembly factor 4 (Protein CCSMST1),i75-95o,132
Q50LG9,Leucine-rich repeat-containing protein 24,o406-426i,513
Q5JX69,Protein FAM209B,o60-73i,171
Q5SWX8,Protein odr-4 homolog (hODR-4) (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1),i432-449o,454
Q5T1S8,Noncompact myelin-associated protein (Myelin protein of 11 kDa) (MP11),o31-51i,102
Q5T292,Transmembrane protein 273,o34-54i,105
Q5T7M9,Divergent protein kinase domain 1A (Protein FAM69A),i28-45o,428
Q5TEA6,Protein sel-1 homolog 2 (Suppressor of lin-12-like protein 2) (Sel-1L2),o667-683i,688
Q5TZJ5,Spermatogenesis-associated protein 31A1 (Protein FAM75A1),o25-43i,1347
Q5VSG8,"Glycoprotein endo-alpha-1,2-mannosidase-like protein (EC 3.2.1.-)",i9-29o,457
Q5VU65,Nuclear pore membrane glycoprotein 210-like (Nucleoporin 210 kDa-like) (Nucleoporin Nup210-like),o1813-1831i,1888
Q5VUD6,Divergent protein kinase domain 1B (Protein FAM69B),i32-48o,431
Q5VUY0,Arylacetamide deacetylase-like 3 (EC 3.1.1.-),o4-24i,407
Q5XG99,LysM and putative peptidoglycan-binding domain-containing protein 4,i218-240o,296
Q63HM9,PI-PLC X domain-containing protein 3,i139-148o,321
Q658N2,Sialate:O-sulfotransferase 1 (WSC domain-containing protein 1),i17-35o,575
Q68CR1,Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3),o1061-1079i,1132
Q6P995,Protein FAM171B,o354-375i,826
Q6UWF7,NXPE family member 4 (Protein FAM55D),i11-27o,544
Q6UWH4,Golgi-associated kinase 1B (Expressed in nerve and epithelium during development) (Protein FAM198B),i38-53o,519
Q6UWI4,Protein shisa-2 homolog (Transmembrane protein 46),o118-137i,295
Q6UWJ8,CD164 sialomucin-like 2 protein,o142-160i,174
Q6UWM9,UDP-glucuronosyltransferase 2A3 (UDPGT 2A3) (EC 2.4.1.17),o491-512i,527
Q6UWS5,"Protein PET117 homolog, mitochondrial",o7-25i,81
Q6UWT2,Adropin (Energy homeostasis-associated protein),o10-30i,76
Q6UWV7,Protein shisa-like-2A,o65-85i,190
Q6UXE8,Butyrophilin-like protein 3 (Butyrophilin-like receptor),o238-259i,466
Q6UXT9,Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15),o21i,468
Q6UXU6,Transmembrane protein 92,o56-76i,159
Q6UXV1,Izumo sperm-egg fusion protein 2,o189-209i,221
Q6UY18,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D),o532-554i,593
Q6ZS82,Regulator of G-protein signaling 9-binding protein (RGS9-anchoring protein),i211-231o,235
Q6ZU69,Protein SPATA31F1 (Protein FAM205A),o13-28i,1335
Q6ZVL6,UPF0606 protein KIAA1549L,o1182-1203i,1849
Q71RC9,Small integral membrane protein 5,o32-52i,77
Q7L985,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C),o541-565i,606
Q7Z2Q7,Leucine-rich repeat-containing protein 70 (Synleurin),o527-547i,622
Q7Z4L0,"Cytochrome c oxidase subunit 8C, mitochondrial (Cytochrome c oxidase polypeptide 8 isoform 3) (Cytochrome c oxidase polypeptide VIII isoform 3) (COX VIII-3) (Cytochrome c oxidase subunit 8-3) (COX8-3) (Cytochrome c oxidase subunit VIIIC)",i44-64o,72
Q7Z4Y8,"Putative ATP synthase subunit g 2, mitochondrial (ATPase subunit g 2) (ATP synthase membrane subunit g-like protein)",i72-92o,100
Q7Z6W1,Transmembrane and coiled-coil domain-containing protein 2,o50-70i,182
Q86T20,Small integral membrane protein 29 (Protein LBH),o18-41i,102
Q86TY3,Armadillo-like helical domain-containing protein 4 (Upstream of mTORC2 protein),o715-732i,774
Q86UF2,cTAGE family member 6 (Protein cTAGE-6),o43-60i,777
Q86V35,Calcium-binding protein 7 (CaBP7) (Calneuron II) (Calneuron-2),i189-206o,215
Q86VH4,Leucine-rich repeat transmembrane neuronal protein 4,o425-445i,590
Q8IVU1,Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule),o641-661i,814
Q8IVY1,Type III endosome membrane protein TEMP (TEMP),o33-52i,113
Q8IWB4,Spermatogenesis-associated protein 31A7 (Protein FAM75A7),o25-43i,1347
Q8IX94,cTAGE family member 4 (Protein cTAGE-4),o43-60i,777
Q8N0Z9,V-set and immunoglobulin domain-containing protein 10,o411-434i,540
Q8N1L4,Putative inactive cytochrome P450 family member 4Z2,o30i,340
Q8N1N0,C-type lectin domain family 4 member F (C-type lectin superfamily member 13) (C-type lectin 13),i40-60o,589
Q8N323,NXPE family member 1 (Protein FAM55A),i11-27o,547
Q8N3T6,Transmembrane protein 132C,o923-948i,1108
Q8N699,Myc target protein 1 (Myc target in myeloid cells protein 1),o68-91i,235
Q8N6Q1,Transmembrane and coiled-coil domain-containing protein 5A,i224-244o,288
Q8N7C7,RING finger protein 148,o190-207i,305
Q8N8F7,Leucine-rich single-pass membrane protein 1,i63-83o,131
Q8N8Z6,"Discoidin, CUB and LCCL domain-containing protein 1",o459-479i,715
Q8N967,Leucine-rich repeat and transmembrane domain-containing protein 2,o311-331i,370
Q8NEA5,Uncharacterized protein C19orf18,o101-121i,215
Q8TF08,"Cytochrome c oxidase subunit 7B2, mitochondrial (Cytochrome c oxidase polypeptide VIIb2)",i38-61o,81
Q8WUS8,Short-chain dehydrogenase/reductase family 42E member 1 (EC 1.1.1.-),i368-385o,393
Q8WVC6,Dephospho-CoA kinase domain-containing protein,i207-223o,231
Q8WW52,Protein FAM151A,i14-32o,585
Q8WW62,Transmembrane emp24 domain-containing protein 6 (p24 family protein gamma-5) (p24gamma5),o201-223i,240
Q8WYK1,Contactin-associated protein-like 5 (Cell recognition molecule Caspr5),o1242-1262i,1306
Q8WZ71,Transmembrane protein 158 (40 kDa BINP-binding protein) (p40BBP) (Ras-induced senescence protein 1),o223-243i,300
Q92545,Transmembrane protein 131 (Protein RW1),o1119-1137i,1883
Q969Y0,NXPE family member 3 (Protein FAM55C),i10-25o,559
Q96DL1,NXPE family member 2 (Protein FAM55B),i22-38o,559
Q96E16,Small integral membrane protein 19,o25-41i,107
Q96G27,WW domain-binding protein 1 (WBP-1),o56-69i,269
Q96HA4,Uncharacterized protein C1orf159,o149-169i,380
Q96KV6,Putative butyrophilin subfamily 2 member A3,o245-265i,586
Q96LU7,Myelin regulatory factor-like protein,i628-648o,910
Q96NA8,t-SNARE domain-containing protein 1,i490-508o,513
Q96QE4,Leucine-rich repeat-containing protein 37B (C66 SLIT-like testicular protein),o906-926i,947
Q96QK8,Small integral membrane protein 14,o53-70i,99
Q96RT6,cTAGE family member 2 (Protein cTAGE-2) (Cancer/testis antigen 21.2) (CT21.2),o14-30i,745
Q96TA0,Putative protocadherin beta-18 (PCDH-beta-18) (PCDH-psi2),o635-658i,734
Q9BUJ0,Protein ABHD14A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14A) (Abhydrolase domain-containing protein 14A),i35-52o,271
Q9BVV8,Protein FAM174C,o74-90i,132
Q9BY71,Leucine-rich repeat-containing protein 3,o205-226i,257
Q9H195,Mucin-3B (MUC-3B) (Intestinal mucin-3B),o1140-1164i,1237
Q9H1C3,Glycosyltransferase 8 domain-containing protein 2 (EC 2.4.1.-),i7-24o,349
Q9H1E5,Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13),o190-210i,349
Q9H3W5,Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3) (NLRR-3),o629-646i,708
Q9H819,DnaJ homolog subfamily C member 18,i228-248o,358
Q9NVM1,Protein eva-1 homolog B (Protein FAM176B),o28-49i,165
Q9NX77,Endogenous retrovirus group K member 13-1 Env polyprotein (Envelope polyprotein) (HERV-K_16p13.3 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],o461-470i,482
Q9UK28,Transmembrane protein 59-like (Brain-specific membrane-anchored protein),o268-286i,342
Q9UND3,Nuclear pore complex-interacting protein family member A1 (Nuclear pore complex-interacting protein) (NPIP),o41-68i,350
Q9Y426,C2 domain-containing protein 2 (Transmembrane protein 24-like),o15-34i,696
Q9Y6U7,RING finger protein 215,o254-271i,377
A0A087WTH1,Transmembrane protein 265,i78-99o,108
A0A0D9SF12,Transmembrane protein CCDC163 (Coiled-coil domain-containing protein 163) (coiled-coil domain containing 163 pseudogene),o37-46i,145
A0A1B0GTY4,Testis-expressed protein 50,o75-95i,177
A0A1B0GUW6,Uncharacterized protein SPEM3,o27-48i,1196
A0A1B0GUW7,Small integral membrane protein 27 (TOPORS antisense RNA 1),o11-31i,55
A0A1B0GV85,Reelin domain-containing protein 1,o444-462i,526
A0A1B0GVN3,Uncharacterized protein C2orf92 (Long intergenic non-protein coding RNA 1125),o192-213i,265
A0A1B0GVV1,Small integral membrane protein 35 (TMPRSS4 antisense RNA 1),o10-31i,85
A0A1B0GVY4,Small integral membrane protein 31,o10-20i,71
A0A1B0GW64,Small integral membrane protein 33,o43-63i,132
A0A1B0GWB2,Proline rich transmembrane protein 1B,i238-258o,263
A0A1B0GWG4,Serine-rich and transmembrane domain-containing 2,o38-58i,90
A0A286YF18,Small integral membrane protein 44,o36-56i,149
A2RU67,Protein FAM234B,i105-125o,622
A2RUT3,Transmembrane protein 89,o73-82i,159
A4D0T7,Small integral membrane protein 30,o30-50i,59
A4FU28,cTAGE family member 9 (Protein cTAGE-9),o43-60i,777
A6NCI5,Putative transmembrane protein encoded by LINC00862 (Small integral membrane protein 16),o48-69i,91
A6NCQ9,RING finger protein 222,i194-214o,220
A6NE02,BTB/POZ domain-containing protein 17 (Galectin-3-binding protein-like),o85-94i,478
A6NFA0,Protein SPATA31F3 (Protein FAM205C),o15-29i,338
A6NFE2,Single-pass membrane and coiled-coil domain-containing protein 2,i284-301o,343
A6NFU0,Ig-like V-type domain-containing protein FAM187A,o380-395i,413
A6NFZ4,Protein FAM24A,o11-31i,105
A6NGB0,Transmembrane protein 191C,i286-306o,347
A6NGZ8,Small integral membrane protein 9,o72-92i,99
A6NH11,Glycolipid transfer protein domain-containing protein 2,o32i,291
A6NHN6,Nuclear pore complex-interacting protein family member B15 (Nuclear pore complex-interacting protein-like 2),o75-84i,443
A6NJ64,Putative nuclear pore complex-interacting protein family member B2,o44-68i,397
A6NJU9,Nuclear pore complex-interacting protein family member B13,o73-87i,1138
A6NKP2,Putative short-chain dehydrogenase/reductase family 42E member 2 (EC 1.1.1.-),i392-407o,422
A6NKW6,Protein shisa-like-2B,o68-88i,160
A6NLX4,Transmembrane protein 210,o45-68i,147
A6NM62,Leucine-rich repeat-containing protein 53,o292-314i,1247
A6NNC1,Putative POM121-like protein 1-like,i877-893o,897
A6NNL5,Uncharacterized protein C15orf61,i106-129o,157
A8MRT5,Nuclear pore complex-interacting protein family member B5,o73-87i,1133
A8MWV9,Small integral membrane protein 34,o49-73i,139
A8MYB1,Transmembrane and coiled-coil domain-containing protein 5B,i247-263o,307
A8MZ97,Uncharacterized protein C2orf74,o10-30i,187
B0FP48,Uroplakin-3b-like protein 1,o205-225i,263
B6SEH9,Endogenous retrovirus group V member 2 Env polyprotein (HERV-V_19q13.41 provirus ancestral Env polyprotein 2),o460-469i,535
C9JG80,Nuclear pore complex-interacting protein family member B4,o73-87i,1138
C9JVW0,Putative transmembrane protein INAFM1 (InaF-motif-containing protein 1) (Proline-rich protein 24),i30-50o,142
E5RHQ5,Nuclear pore complex-interacting protein family member B11,o71-87i,1161
E5RIL1,Uroplakin-3b-like protein 2,o205-225i,263
E7ERA6,RING finger protein 223,i197-215o,249
E9PJI5,Nuclear pore complex-interacting protein family member A7,o41-68i,369
E9PKD4,Nuclear pore complex-interacting protein family member A5,o41-68i,350
F2Z333,Fibronectin type III domain-containing protein 10,o185-205i,226
F5H4A9,Uncharacterized membrane protein C3orf80,o78-98i,247
F8W0I5,Nuclear pore complex-interacting protein family member B12,o71-87i,928
H3BTG2,Testis-expressed protein 46,o41i,121
H3BV60,Transforming growth factor-beta receptor type 3-like protein (TGF-beta receptor type-3-like protein) (TGFR-3L) (Transforming growth factor-beta receptor type III-like protein) (TGF-beta receptor type III-like protein),o270-290i,316
H7C350,Coiled-coil domain-containing protein 188,i340-363o,402
M0QZC1,RING finger protein 225,i200-220o,329
O75071,EF-hand calcium-binding domain-containing protein 14,i77-93o,495
O75200,Nuclear pore complex-interacting protein family member B7 (Nuclear pore complex-interacting protein-like 1),o60-69i,414
O75264,Small integral membrane protein 24,o31-51i,130
P0C2L3,Protein FAM163B,o6-26i,166
P0C2S0,Cortexin-2,o29-49i,81
P0C7M8,C-type lectin domain family 2 member L,i69-89o,214
P0C7N4,Transmembrane protein 191B,i285-305o,346
P0C874,Spermatogenesis-associated protein 31D3 (Protein FAM75D3),o27-47i,917
P0CG41,cTAGE family member 8 (Protein cTAGE-8),o43-60i,777
P0DI80,Small integral membrane protein 6,o25-45i,62
P0DJ93,Small integral membrane protein 13,o5-31i,91
P0DKB5,Trophoblast glycoprotein-like,o308-328i,382
P0DKX4,Small integral membrane protein 18,o36-56i,95
P0DL12,Small integral membrane protein 17,i96-116o,118
P0DM63,Nuclear pore complex-interacting protein family member A8,o41-68i,369
P0DMQ5,Putative transmembrane protein INAFM2 (InaF-motif-containing protein 2) (Osteogenesis up-regulated transcript 1),i36-56o,153
P0DPA2,V-set and immunoglobulin domain-containing protein 8,o264-284i,414
P0DPE3,Transmembrane and death domain protein 1,o219-244i,317
P0DTF9,PTTG1IP family member 2,o98-118i,154
P58550,Putative FXYD domain-containing ion transport regulator 8,o38-56i,94
P59646,FXYD domain-containing ion transport regulator 4,o41-57i,89
P60606,Cortexin-1,o30-50i,82
Q0P670,Uncharacterized protein SPEM2,o26-46i,501
Q15053,Uncharacterized protein KIAA0040,o26-46i,99
Q52LC2,V-type proton ATPase subunit S1-like protein (Vacuolar proton pump subunit S1-like protein),o149-171i,224
Q5H943,Kita-kyushu lung cancer antigen 1 (KK-LC-1) (Cancer/testis antigen 83),o3-19i,113
Q5SRD1,Mitochondrial import inner membrane translocase subunit Tim23B (TIMM23B),i163-172o,188
Q5T6X4,Protein FAM162B,i107-128o,162
Q5VU36,Spermatogenesis-associated protein 31A5 (Protein FAM75A5),o25-43i,1347
Q5VUY2,Arylacetamide deacetylase-like 4 (EC 3.1.1.-),o5-25i,407
Q5VVP1,Spermatogenesis-associated protein 31A6 (Protein FAM75A6),o25-43i,1343
Q5VYP0,Spermatogenesis-associated protein 31A3 (Protein FAM75A3),o25-43i,1347
Q5VZ72,Izumo sperm-egg fusion protein 3,o175-195i,239
Q68CR7,Leucine-rich repeat-containing protein 66,o375-397i,880
Q6NXN4,Putative C-mannosyltransferase DPY19L2P1 (EC 2.4.1.-) (Dpy-19-like protein 2 pseudogene 1) (Protein dpy-19 homolog 2-like 1),i107-117o,242
Q6P7N7,Transmembrane protein 81,o227-247i,255
Q6PEX7,Testis-expressed protein 38 (ATPAF1 antisense RNA 1) (ATPAF1 antisense gene protein 1),o15-35i,206
Q6UXD1,Histidine-rich carboxyl terminus protein 1,o10-30i,115
Q6ZQQ2,Spermatogenesis-associated protein 31D1 (Protein FAM75D1),o29-47i,1576
Q6ZS62,Colorectal cancer-associated protein 1,o81-96i,124
Q6ZUB0,Spermatogenesis-associated protein 31D4 (Protein FAM75D4),o27-47i,917
Q7Z3B0,Small integral membrane protein 15,o22-40i,74
Q86UQ5,Gilles de la Tourette syndrome chromosomal region candidate gene 1 protein,o79-88i,136
Q8N4C9,Uncharacterized protein C17orf78,o183-206i,275
Q8N4K4,Reprimo-like protein,o70-88i,120
Q8N4L4,Spermatid maturation protein 1,o29-49i,309
Q8N5W8,Protein FAM24B,o4-24i,94
Q8N614,Transmembrane protein 156,o217-232i,296
Q8N7X8,SIGLEC family-like protein 1,o118-138i,197
Q8NC54,Keratinocyte-associated transmembrane protein 2,o199-215i,265
Q8NCQ3,Putative uncharacterized protein encoded by LINC00301,o38i,95
Q8ND94,LRRN4 C-terminal-like protein,o198-218i,238
Q8NDY8,Transmembrane protein 52,o56-76i,209
Q8NEQ5,Transmembrane protein C1orf162,o41-62i,155
Q8TEF2,Uncharacterized protein C10orf105,o36-56i,133
Q8WUY1,Protein THEM6 (Mesenchymal stem cell protein DSCD75) (Thioesterase superfamily member 6),o5-25i,208
Q96EE4,Coiled-coil domain-containing protein 126,i14-30o,140
Q96KF7,Small integral membrane protein 8,i47-67o,97
Q96MH6,"Monoacylglycerol/Diacylglycerol O-acyltransferase (MGAT/DGAT) (EC 2.3.1.20) (EC 2.3.1.22) (2-acylglycerol/1,2-diacylglycerol O-acyltransferase) (Transmembrane protein 68) (Tmem68)",o43-71i,324
Q9BVW6,Small integral membrane protein 2,o26-35i,85
Q9H1X3,DnaJ homolog subfamily C member 25,o150-168i,360
Q9NPU4,Uncharacterized protein C14orf132,i59-79o,83
Q9NRX3,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 (NADH-ubiquinone oxidoreductase MLRQ subunit homolog) (NUOMS),i18-38o,87
Q9NU53,Glycoprotein integral membrane protein 1,o263-284i,330
Q9UK00,Uncharacterized protein C3orf18 (Protein G20),o59-82i,162
A0A0B4J1W7,Nuclear pore complex-interacting protein family member A9,o42-62i,369
A0A1B0GTU2,Cortexin domain-containing 1 protein,o17-34i,59
A0A1B0GU29,Small integral membrane protein 28,o52-72i,152
A0A1B0GUA5,Small integral membrane protein 32,o54-74i,103
A0A1B0GV90,Cortexin domain containing 2,o16-33i,55
A0A1B0GVG4,Coiled-coil domain-containing protein 194,i14-34o,234
A0A1B0GVT2,Small integral membrane protein 36,o14-34i,93
A0A1B0GW54,Small integral membrane protein 39,i33-53o,56
A0A286YFK9,Small integral membrane protein 38,o14-32i,51
A0A2R8YCJ5,Small integral membrane protein 41,o38-58i,93
A0A5F9ZH02,Small integral membrane protein 42,o26-46i,70
D0EPY3,Small integral membrane protein 47,o3-23i,28
P0DQW1,Small integral membrane protein 46,o17-37i,50
Q5STR5,Small integral membrane protein 40,i34-59o,79
Q5T7R7,Uncharacterized protein C1orf185,o13-37i,199
O43674,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)",i67-92o,189
O43676,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit),i63-88o,98
O43699,Sialic acid-binding Ig-like lectin 6 (Siglec-6) (CD33 antigen-like 1) (CDw327) (Obesity-binding protein 1) (OB-BP1) (CD antigen CD327),o350-368i,453
O43752,Syntaxin-6,i237-254o,255
O43819,"Protein SCO2 homolog, mitochondrial",i61-78o,266
O43825,"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2)",i27-43o,422
O43889,Cyclic AMP-responsive element-binding protein 3 (CREB-3) (cAMP-responsive element-binding protein 3) (Leucine zipper protein) (Luman) (Transcription factor LZIP-alpha) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3 (N-terminal Luman) (Transcriptionally active form)],i231-246o,371
O43909,Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3),i29-47o,919
O43914,TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein),o45-65i,113
O60235,Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain],i18-40o,418
O60238,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L),i188-208o,219
O60243,Heparan-sulfate 6-O-sulfotransferase 1 (HS6ST-1) (EC 2.8.2.-),i18-33o,411
O60449,Lymphocyte antigen 75 (Ly-75) (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205),o1670-1691i,1722
O60462,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),o865-888i,931
O60469,Cell adhesion molecule DSCAM (CHD2) (Down syndrome cell adhesion molecule),o1596-1616i,2012
O60476,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",i37-57o,641
O60486,Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232),o946-965i,1568
O60487,Myelin protein zero-like protein 2 (Epithelial V-like antigen 1),o153-175i,215
O60499,Syntaxin-10 (Syn10),i231-247o,249
O60500,Nephrin (Renal glomerulus-specific cell adhesion receptor),o1065-1085i,1241
O60507,Protein-tyrosine sulfotransferase 1 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 1) (TPST-1),i9-26o,370
O60512,"Beta-1,4-galactosyltransferase 3 (Beta-1,4-GalTase 3) (Beta4Gal-T3) (b4Gal-T3) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3)",i11-26o,393
O60513,"Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4)",i15-29o,344
O60602,Toll-like receptor 5 (Toll/interleukin-1 receptor-like protein 3),o640-660i,858
O60603,Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282),o589-609i,784
O60656,UDP-glucuronosyltransferase 1A9 (UGT1A9) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-9) (UDPGT 1-9) (UGT1*9) (UGT1-09) (UGT1.9) (UDP-glucuronosyltransferase 1-I) (UGT-1I) (UGT1I) (lugP4),o486-506i,530
O60667,Fas apoptotic inhibitory molecule 3 (IgM Fc fragment receptor) (Regulator of Fas-induced apoptosis Toso),o252-272i,390
O60704,Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2),o25i,377
O60858,E3 ubiquitin-protein ligase TRIM13 (EC 2.3.2.27) (B-cell chronic lymphocytic leukemia tumor suppressor Leu5) (Leukemia-associated protein 5) (Putative tumor suppressor RFP2) (RING finger protein 77) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13),i317-336o,407
O60894,Receptor activity-modifying protein 1 (Calcitonin-receptor-like receptor activity-modifying protein 1) (CRLR activity-modifying protein 1),o118-136i,148
O60895,Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2),o148-166i,175
O60896,Receptor activity-modifying protein 3 (Calcitonin-receptor-like receptor activity-modifying protein 3) (CRLR activity-modifying protein 3),o120-139i,148
O60909,"Beta-1,4-galactosyltransferase 2 (Beta-1,4-GalTase 2) (Beta4Gal-T2) (b4Gal-T2) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2)",i12-32o,372
O60939,Sodium channel subunit beta-2,o160-180i,215
O75015,Low affinity immunoglobulin gamma Fc region receptor III-B (Fc-gamma RIII-beta) (CD16-I) (Fc-gamma RIII) (Fc-gamma RIIIb) (FcRIII) (FcRIIIb) (FcR-10) (IgG Fc receptor III-1) (CD antigen CD16b),o207-229i,233
O75019,Leukocyte immunoglobulin-like receptor subfamily A member 1 (CD85 antigen-like family member I) (Leukocyte immunoglobulin-like receptor 6) (LIR-6) (CD antigen CD85i),o459-480i,489
O75022,Leukocyte immunoglobulin-like receptor subfamily B member 3 (LIR-3) (Leukocyte immunoglobulin-like receptor 3) (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5) (ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a),o444-464i,631
O75023,Leukocyte immunoglobulin-like receptor subfamily B member 5 (CD85 antigen-like family member C) (Leukocyte immunoglobulin-like receptor 8) (LIR-8) (CD antigen CD85c),o457-479i,590
O75051,Plexin-A2 (Semaphorin receptor OCT),o1238-1258i,1894
O75054,Immunoglobulin superfamily member 3 (IgSF3) (Glu-Trp-Ile EWI motif-containing protein 3) (EWI-3),o1125-1147i,1194
O75056,Syndecan-3 (SYND3),o389-409i,442
O75072,Ribitol-5-phosphate transferase FKTN (EC 2.7.8.-) (Fukutin) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase),i9-25o,461
O75074,Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (hLRp105),o500-520i,770
O75077,"Disintegrin and metalloproteinase domain-containing protein 23 (ADAM 23) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3) (MDC-3)",o794-814i,832
O75078,"Disintegrin and metalloproteinase domain-containing protein 11 (ADAM 11) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein) (MDC)",o735-755i,769
O75096,Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7),o1726-1746i,1905
O75106,Retina-specific copper amine oxidase (RAO) (EC 1.4.3.21) (Amine oxidase [copper-containing]) (Semicarbazide-sensitive amine oxidase) (SSAO),i5-25o,756
O75121,Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9),o150-170i,409
O75144,ICOS ligand (B7 homolog 2) (B7-H2) (B7-like protein Gl50) (B7-related protein 1) (B7RP-1) (CD antigen CD275),o259-276i,302
O75197,Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7),o1387-1407i,1615
O75309,Cadherin-16 (Kidney-specific cadherin) (Ksp-cadherin),o785-805i,829
O75324,Stannin (AG8_1),o12-32i,88
O75354,Ectonucleoside triphosphate diphosphohydrolase 6 (NTPDase 6) (EC 3.6.1.6) (CD39 antigen-like 2),i43-60o,484
O75379,Vesicle-associated membrane protein 4 (VAMP-4),i118-137o,141
